Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Physical measures,X4270.Volume level set by participant (left),LRRN1,Leucine-rich repeat neuronal protein 1,33273,-0.168681761951424,0.0461969213646962,-0.259227727826228,-0.0781357960766191,0.000262361632604187
Physical measures,X4270.Volume level set by participant (left),KIAA0319,Dyslexia-associated protein KIAA0319,32353,-0.22510844943092,0.0623716263287524,-0.347356837035275,-0.102860061826566,0.000309105155522824
Physical measures,X4270.Volume level set by participant (left),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,33509,-0.222813196040664,0.0660025991831231,-0.352178290439585,-0.0934481016417427,0.000739042968098102
Physical measures,X4270.Volume level set by participant (left),CA14,Carbonic anhydrase 14,33509,-0.166079263067089,0.0496602002935129,-0.263413255642375,-0.0687452704918039,0.000828215391975902
Physical measures,X4270.Volume level set by participant (left),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,32350,-0.234817291000354,0.0725737082510816,-0.377061759172474,-0.0925728228282345,0.00121900542902955
Physical measures,X4270.Volume level set by participant (left),VGF,Neurosecretory protein VGF,32350,-0.213156347054832,0.0667206813175968,-0.343928882437322,-0.0823838116723423,0.00140499066565275
Physical measures,X4270.Volume level set by participant (left),DPP6,Dipeptidyl aminopeptidase-like protein 6,33386,-0.167709424905944,0.053091263617328,-0.271768301595907,-0.0636505482159812,0.0015889965101636
Physical measures,X4270.Volume level set by participant (left),NTRK3,NT-3 growth factor receptor,33500,-0.242733283562571,0.0778856135523573,-0.395389086125191,-0.0900774809999502,0.00183562833583129
Physical measures,X4270.Volume level set by participant (left),GALNT7,N-acetylgalactosaminyltransferase 7,33386,-0.260827643497545,0.0839059671626155,-0.425283339136271,-0.0963719478588183,0.00188585405716056
Physical measures,X4270.Volume level set by participant (left),ADGRG2,Adhesion G-protein coupled receptor G2,33434,-0.194621932438991,0.0631458154081547,-0.318387730638974,-0.0708561342390075,0.00206166104433334
Physical measures,X4270.Volume level set by participant (left),IL36A,Interleukin-36 alpha,32140,-0.102554504517585,0.0344202028421122,-0.170018102088125,-0.0350909069470454,0.00289635637743117
Physical measures,X4270.Volume level set by participant (left),TEX33,Testis-expressed protein 33,32235,-0.141834178608583,0.0480177908332546,-0.235949048641763,-0.0477193085754043,0.00314843267896672
Physical measures,X4270.Volume level set by participant (left),LHB,Lutropin subunit beta,33232,0.0601757835839516,0.0205185213195047,0.0199594817977225,0.100392085370181,0.00336837958779722
Physical measures,X4270.Volume level set by participant (left),PI3,Elafin,33285,0.0932058757988455,0.0324746240589045,0.0295556126433927,0.156856138954298,0.0041129842797845
Physical measures,X4270.Volume level set by participant (left),AGBL2,Cytosolic carboxypeptidase 2,32111,-0.0651658982285293,0.0227123910940359,-0.10968218477284,-0.020649611684219,0.0041266608058225
Physical measures,X4270.Volume level set by participant (left),IL17C,Interleukin-17C,33273,0.0716909428913551,0.025139589298367,0.0224173478665557,0.120964537916154,0.00435851252919462
Physical measures,X4270.Volume level set by participant (left),PCDH1,Protocadherin-1,33497,-0.222235592733931,0.0785561503192339,-0.37620564735963,-0.0682655381082328,0.00467960473667392
Physical measures,X4270.Volume level set by participant (left),HDDC2,5'-deoxynucleotidase HDDC2,32329,-0.125239442299953,0.0445591503189616,-0.212575376925118,-0.0379035076747888,0.0049566170417812
Physical measures,X4270.Volume level set by participant (left),RANBP1,Ran-specific GTPase-activating protein,32163,-0.108791911821133,0.0387884224148391,-0.184817219754218,-0.0327666038880486,0.00504813580347252
Physical measures,X4270.Volume level set by participant (left),COL5A1,Collagen alpha-1(V) chain,32213,-0.140249137451806,0.0511724786278598,-0.240547195562411,-0.039951079341201,0.00614461343917492
Physical measures,X4270.Volume level set by participant (left),GHRL,Appetite-regulating hormone,33434,-0.0603498383038606,0.0220603686632081,-0.103588160883749,-0.0171115157239727,0.0062376146993549
Physical measures,X4270.Volume level set by participant (left),F3,Tissue factor,33467,-0.165791969423692,0.0611353562343926,-0.285617267643102,-0.0459666712042828,0.00670289820802618
Physical measures,X4270.Volume level set by participant (left),PRND,Prion-like protein doppel,32353,-0.100634794514889,0.0372242372390119,-0.173594299503352,-0.0276752895264254,0.00687654868999928
Physical measures,X4270.Volume level set by participant (left),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,32329,-0.167814785684633,0.0621230626580964,-0.289575988494502,-0.0460535828747639,0.00692109908364073
Physical measures,X4270.Volume level set by participant (left),CTSE,Cathepsin E,32213,-0.105899152879651,0.0392083700242457,-0.182747558127173,-0.0290507476321296,0.00692955803452819
Physical measures,X4270.Volume level set by participant (left),NOS3,"Nitric oxide synthase, endothelial",33219,0.0869582709246555,0.0323374151461769,0.0235769372381488,0.150339604611162,0.00717823383863366
Physical measures,X4270.Volume level set by participant (left),TFF1,Trefoil factor 1,33401,0.0615606686639188,0.0229463507057515,0.0165858212806459,0.106535516047192,0.00731409553163289
Physical measures,X4270.Volume level set by participant (left),PCDH17,Protocadherin-17,33434,-0.132085434854469,0.0495532633066609,-0.229209830935525,-0.0349610387734138,0.00770059120521756
Physical measures,X4270.Volume level set by participant (left),IGF1R,Insulin-like growth factor 1 receptor,33386,-0.216275291515215,0.081210008647923,-0.375446908465144,-0.057103674565286,0.00775493131599304
Physical measures,X4270.Volume level set by participant (left),RBFOX3,RNA binding protein fox-1 homolog 3,32350,-0.146186118099986,0.0549149073932795,-0.253819336590813,-0.0385528996091578,0.00778241633352646
Physical measures,X4270.Volume level set by participant (left),EFHD1,EF-hand domain-containing protein D1,32350,-0.152292411627736,0.0572816268059572,-0.264564400167412,-0.0400204230880603,0.00786101443927731
Physical measures,X4270.Volume level set by participant (left),NCAM1,Neural cell adhesion molecule 1,33452,-0.16318878150143,0.0616171757263179,-0.283958445925013,-0.0424191170778471,0.00810077266062584
Physical measures,X4270.Volume level set by participant (left),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,33273,-0.153161476382857,0.0578390880990145,-0.266526089056926,-0.0397968637087892,0.00810988412111031
Physical measures,X4270.Volume level set by participant (left),MEGF10,Multiple epidermal growth factor-like domains protein 10,33424,-0.118060736204081,0.0446595694928318,-0.205593492410032,-0.0305279799981311,0.00821792949510189
Physical measures,X4270.Volume level set by participant (left),LXN,Latexin,33321,-0.0651772285122623,0.0247319594855508,-0.113651869103942,-0.0167025879205828,0.00841982455864513
Physical measures,X4270.Volume level set by participant (left),DIPK2B,Divergent protein kinase domain 2B,32213,-0.19954596367733,0.0758939861903909,-0.348298176610496,-0.0507937507441641,0.00857365740957
Physical measures,X4270.Volume level set by participant (left),NECAP2,Adaptin ear-binding coat-associated protein 2,32122,-0.0811828180898391,0.0309966576036258,-0.141936266992946,-0.0204293691867325,0.00883400573595386
Physical measures,X4270.Volume level set by participant (left),XCL1,Lymphotactin,33509,0.0806311217028077,0.0308799199885841,0.0201064785251829,0.141155764880433,0.0090395493665017
Physical measures,X4270.Volume level set by participant (left),SPINK6,Serine protease inhibitor Kazal-type 6,33509,0.0806905307319988,0.0309278073805701,0.0200720282660814,0.141309033197916,0.00909575569826421
Physical measures,X4270.Volume level set by participant (left),HEPACAM2,HEPACAM family member 2,32353,-0.127324070475158,0.048828354202264,-0.223027644711595,-0.0316204962387201,0.00913550349075549
Physical measures,X4270.Volume level set by participant (left),KLK8,Kallikrein-8,33161,0.129005100594944,0.0494862192997275,0.0320121107674778,0.22599809042241,0.00915246425179713
Physical measures,X4270.Volume level set by participant (left),GAS2,Growth arrest-specific protein 2,32235,-0.0946256955309172,0.0364868641706015,-0.166139949305296,-0.0231114417565382,0.00952051462260545
Physical measures,X4270.Volume level set by participant (left),BCAN,Brevican core protein,33380,-0.135628899494102,0.0524067780471397,-0.238346184466495,-0.0329116145217079,0.0096690575601789
Physical measures,X4270.Volume level set by participant (left),EFCAB14,EF-hand calcium-binding domain-containing protein 14,32329,-0.189642895686446,0.0733670708234858,-0.333442354500478,-0.045843436872414,0.00975994667432245
Physical measures,X4270.Volume level set by participant (left),EPN1,Epsin-1,32235,-0.12229197771007,0.0473358300809745,-0.215070204668781,-0.0295137507513604,0.00979850109737099
Physical measures,X4270.Volume level set by participant (left),SNAPIN,SNARE-associated protein Snapin,32350,-0.0895409586913534,0.0347030367283093,-0.15755891067884,-0.0215230067038671,0.00989205684319658
Physical measures,X4270.Volume level set by participant (left),S100A16,Protein S100-A16,33204,-0.0729224316399594,0.0283118663447451,-0.12841368967566,-0.0174311736042589,0.0100204525903038
Physical measures,X4270.Volume level set by participant (left),ICAM4,Intercellular adhesion molecule 4,33421,-0.0830975276143693,0.0323096243149217,-0.146424391271616,-0.0197706639571228,0.0101298014407787
Physical measures,X4270.Volume level set by participant (left),KLK12,Kallikrein-12,33232,0.0318653209836563,0.0124132840924429,0.00753528416246835,0.0561953578048443,0.010273679701862
Physical measures,X4270.Volume level set by participant (left),CHIT1,Chitotriosidase-1,33442,-0.0288110856286294,0.0112238908127999,-0.0508099116217172,-0.00681225963554153,0.0102759931993017
Physical measures,X4270.Volume level set by participant (left),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,32075,-0.0857511735737057,0.0334151036748922,-0.151244776776494,-0.0202575703709171,0.0102997064297172
Physical measures,X4270.Volume level set by participant (left),ACAN,Aggrecan core protein,33370,-0.158400262584912,0.0622240024089675,-0.280359307306488,-0.0364412178633353,0.0109242730328177
Physical measures,X4270.Volume level set by participant (left),OMG,Oligodendrocyte-myelin glycoprotein,33386,-0.0703456801906838,0.0276668910876329,-0.124572786722444,-0.0161185736589233,0.0110200236703099
Physical measures,X4270.Volume level set by participant (left),CCND2,G1/S-specific cyclin-D2,32235,-0.143109024172427,0.0564333979810365,-0.253718484215258,-0.0324995641295953,0.0112355191544329
Physical measures,X4270.Volume level set by participant (left),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",32350,-0.108238656332417,0.0432169498354806,-0.192943878009959,-0.0235334346548755,0.0122810103004601
Physical measures,X4270.Volume level set by participant (left),SIGLEC8,Sialic acid-binding Ig-like lectin 8,32163,-0.111597735733992,0.0447234668553861,-0.199255730770549,-0.0239397406974357,0.0126063999355007
Physical measures,X4270.Volume level set by participant (left),CCL20,C-C motif chemokine 20,33527,0.0489194074309629,0.0196257752571008,0.0104528879270452,0.0873859269348805,0.0126984950475294
Physical measures,X4270.Volume level set by participant (left),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",33409,0.0653771179549034,0.0262463559553113,0.0139342602824932,0.116819975627314,0.0127598757654122
Physical measures,X4270.Volume level set by participant (left),KLK14,Kallikrein-14,33509,0.0913327872338948,0.0367135635343754,0.0193742027065191,0.163291371761271,0.0128746199128355
Physical measures,X4270.Volume level set by participant (left),GAST,Gastrin,32353,0.0388830717004856,0.0156443675135677,0.00822011137389301,0.0695460320270783,0.0129598242259598
Physical measures,X4270.Volume level set by participant (left),CCS,Copper chaperone for superoxide dismutase,33380,-0.0903529978081468,0.0363554860405758,-0.161609750447675,-0.0190962451686184,0.0129636961636865
Physical measures,X4270.Volume level set by participant (left),PLXDC2,Plexin domain-containing protein 2,32353,-0.179459426686783,0.0722331172890289,-0.32103633657328,-0.0378825168002864,0.0129958056859247
Physical measures,X4270.Volume level set by participant (left),RYR1,Ryanodine receptor 1,32122,-0.146385796178543,0.0589841815766285,-0.261994792068735,-0.030776800288351,0.0130940343581647
Physical measures,X4270.Volume level set by participant (left),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,32163,-0.255491345630584,0.103027908103134,-0.457426045512727,-0.0535566457484401,0.0131658331337333
Physical measures,X4270.Volume level set by participant (left),SLURP1,Secreted Ly-6/uPAR-related protein 1,32306,0.126815292413626,0.0512829441656103,0.0263007218490303,0.227329862978223,0.0134248642731782
Physical measures,X4270.Volume level set by participant (left),RICTOR,Rapamycin-insensitive companion of mTOR,32140,-0.0945821646723509,0.038299340662163,-0.16964887237019,-0.0195154569745114,0.0135498534655813
Physical measures,X4270.Volume level set by participant (left),DTX3,Probable E3 ubiquitin-protein ligase DTX3,33386,-0.186880117875571,0.0760233741774111,-0.335885931263296,-0.0378743044878451,0.013982663962682
Physical measures,X4270.Volume level set by participant (left),FGF21,Fibroblast growth factor 21,33499,0.0362676608400196,0.0147577061228407,0.00734255683925189,0.0651927648407874,0.0140078324016356
Physical measures,X4270.Volume level set by participant (left),GPRC5C,G-protein coupled receptor family C group 5 member C,32319,-0.0884991600577557,0.0361221733088363,-0.159298619743075,-0.0176997003724365,0.0143074469016251
Physical measures,X4270.Volume level set by participant (left),SV2A,Synaptic vesicle glycoprotein 2A,32154,-0.0801742691462074,0.0327442458255471,-0.14435299096428,-0.0159955473281351,0.0143674164568084
Physical measures,X4270.Volume level set by participant (left),DDX1,ATP-dependent RNA helicase DDX1,32329,-0.092162662661638,0.0377413294396652,-0.166135668363382,-0.0181896569598942,0.0146297809670217
Physical measures,X4270.Volume level set by participant (left),BOC,Brother of CDO,33273,-0.178925520563002,0.0738123508170887,-0.323597728164496,-0.0342533129615086,0.0153680727490142
Physical measures,X4270.Volume level set by participant (left),CSRP3,Cysteine and glycine-rich protein 3,32122,0.0505914198940113,0.0209357345963953,0.00955738008507655,0.091625459702946,0.0156932826586468
Physical measures,X4270.Volume level set by participant (left),SLITRK1,SLIT and NTRK-like protein 1,32140,-0.155415787482407,0.0643766248154084,-0.281593972120608,-0.0292376028442066,0.0157945422213724
Physical measures,X4270.Volume level set by participant (left),TSNAX,Translin-associated protein X,32122,-0.12330647492106,0.0510885704654192,-0.223440073033282,-0.0231728768088385,0.0158198463720506
Physical measures,X4270.Volume level set by participant (left),SPARCL1,SPARC-like protein 1,33424,-0.145704356179936,0.0605281385429987,-0.264339507724214,-0.0270692046356587,0.0160946940873984
Physical measures,X4270.Volume level set by participant (left),SPINK8,Serine protease inhibitor Kazal-type 8,32122,-0.138054193871582,0.057917612129371,-0.251572713645149,-0.0245356740980151,0.0171669940885241
Physical measures,X4270.Volume level set by participant (left),MRPL52,"39S ribosomal protein L52, mitochondrial",32055,-0.190126755474381,0.0799522289211118,-0.34683312415976,-0.0334203867890017,0.017431195968044
Physical measures,X4270.Volume level set by participant (left),APOBR,Apolipoprotein B receptor,32163,-0.11536643684501,0.0485334058382027,-0.210491912287887,-0.0202409614021328,0.0174758843808689
Physical measures,X4270.Volume level set by participant (left),TSPYL1,Testis-specific Y-encoded-like protein 1,32140,-0.120425687941145,0.0508445904444598,-0.220081085212286,-0.0207702906700034,0.0178847135600923
Physical measures,X4270.Volume level set by participant (left),RAPGEF2,Rap guanine nucleotide exchange factor 2,32235,-0.0912249044961606,0.0386152948466944,-0.166910882395682,-0.0155389265966396,0.0181813485223359
Physical measures,X4270.Volume level set by participant (left),FGF12,Fibroblast growth factor 12,32140,-0.102245062201352,0.0433185268642369,-0.187149374855257,-0.017340749547448,0.0182846141164895
Physical measures,X4270.Volume level set by participant (left),PSMD1,26S proteasome non-ATPase regulatory subunit 1,32350,-0.0922649281915048,0.0391459089155931,-0.168990909666067,-0.0155389467169424,0.0184500359030995
Physical measures,X4270.Volume level set by participant (left),SUSD2,Sushi domain-containing protein 2,33441,-0.144549434716107,0.0614027403607048,-0.264898805823088,-0.0242000636091251,0.0185880088998282
Physical measures,X4270.Volume level set by participant (left),LY6D,Lymphocyte antigen 6D,33374,0.11230200456903,0.0477739359484306,0.0186650901101059,0.205938919027954,0.0187599867964345
Physical measures,X4270.Volume level set by participant (left),COPE,Coatomer subunit epsilon,33219,0.0874702211368465,0.0372277375988101,0.0145038554431786,0.160436586830514,0.0188157592609651
Physical measures,X4270.Volume level set by participant (left),CFHR4,Complement factor H-related protein 4,32383,0.0639007443971134,0.0272985467195241,0.0103955928268461,0.117405895967381,0.0192665469241107
Physical measures,X4270.Volume level set by participant (left),CNTN2,Contactin-2,33509,-0.0883941633420105,0.0378802181744076,-0.162639390963849,-0.0141489357201717,0.0196427592289825
Physical measures,X4270.Volume level set by participant (left),ATP6V1D,V-type proton ATPase subunit D,33386,-0.155155593814629,0.0666626364793264,-0.285814361314109,-0.0244968263151497,0.0199622501795542
Physical measures,X4270.Volume level set by participant (left),PRR5,Proline-rich protein 5,32140,-0.0979672633819752,0.0423922141082888,-0.181056003034221,-0.0148785237297292,0.0208606807801668
Physical measures,X4270.Volume level set by participant (left),HRG,Histidine-rich glycoprotein,32353,-0.141852920231431,0.0615443425820288,-0.262479831692208,-0.021226008770655,0.0211985572566024
Physical measures,X4270.Volume level set by participant (left),EVI2B,Protein EVI2B,32075,-0.122118830601704,0.0530603885861693,-0.226117192230596,-0.0181204689728126,0.0213898663664533
Physical measures,X4270.Volume level set by participant (left),FCRL3,Fc receptor-like protein 3,33273,-0.0730952197858775,0.0318764157141823,-0.135572994585675,-0.0106174449860803,0.0218667350924543
Physical measures,X4270.Volume level set by participant (left),HLA_A,,32350,-0.140526071128136,0.0616045430795156,-0.261270975563986,-0.0197811666922854,0.0225690939321074
Physical measures,X4270.Volume level set by participant (left),AKAP12,A-kinase anchor protein 12,32213,-0.219320668657943,0.0965362431550558,-0.408531705241852,-0.0301096320740331,0.0231198213340856
Physical measures,X4270.Volume level set by participant (left),B2M,Beta-2-microglobulin,32398,-0.139262471931643,0.0614310792755333,-0.259667387311688,-0.0188575565515978,0.0234187656618136
Physical measures,X4270.Volume level set by participant (left),CRYGD,Gamma-crystallin D,32353,-0.0485984052837506,0.0215129797402868,-0.0907638455747126,-0.0064329649927885,0.0239088459308829
Physical measures,X4270.Volume level set by participant (left),CCL28,C-C motif chemokine 28,33395,-0.0666864636472229,0.0295437600831082,-0.124592233410115,-0.00878069388433096,0.0240190025192843
Physical measures,X4270.Volume level set by participant (left),TMEM106A,Transmembrane protein 106A,32319,-0.0644286103137874,0.0286558624624918,-0.120594100740271,-0.00826311988730349,0.0245810114473887
Physical measures,X4270.Volume level set by participant (left),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",32140,-0.124295194472059,0.0553262646532786,-0.232734673192485,-0.0158557157516324,0.0246947927106053
Physical measures,X4270.Volume level set by participant (left),DCTPP1,dCTP pyrophosphatase 1,33434,-0.122482765819909,0.0549386258254431,-0.230162472437778,-0.0148030592020408,0.0258088017796335
Physical measures,X4270.Volume level set by participant (left),GCG,Pro-glucagon,33232,-0.031918003088584,0.0143260466663531,-0.059997054554636,-0.00383895162253194,0.0259077544381331
Physical measures,X4270.Volume level set by participant (left),CLEC1A,C-type lectin domain family 1 member A,33273,-0.120089738040158,0.0539639109171513,-0.225859003437775,-0.014320472642542,0.0260815162018813
Physical measures,X4270.Volume level set by participant (left),GPR158,Probable G-protein coupled receptor 158,32350,-0.119628528468975,0.054067327522088,-0.225600490412267,-0.0136565665256825,0.026954815240165
Physical measures,X4270.Volume level set by participant (left),GSTP1,Glutathione S-transferase P,33170,-0.0557827617119839,0.025233975267389,-0.105241353236066,-0.00632417018790151,0.0270879527440342
Physical measures,X4270.Volume level set by participant (left),LSM1,U6 snRNA-associated Sm-like protein LSm1,33232,-0.0679129552868477,0.03082065981423,-0.128321448522738,-0.00750446205095701,0.0275862465885601
Physical measures,X4270.Volume level set by participant (left),CSF3,Granulocyte colony-stimulating factor,33273,0.0778880798983116,0.0354379432386528,0.00842971115055206,0.147346448646071,0.0279840963287709
Physical measures,X4270.Volume level set by participant (left),ADGRF5,Adhesion G protein-coupled receptor F5,32365,-0.149688744200644,0.0681400295061168,-0.283243202032633,-0.0161342863686553,0.0280649735254372
Physical measures,X4270.Volume level set by participant (left),FABP6,Gastrotropin,33261,0.0700146564235143,0.0318997826889161,0.0074910823532388,0.13253823049379,0.0282016822123523
Physical measures,X4270.Volume level set by participant (left),PTS,6-pyruvoyl tetrahydrobiopterin synthase,33188,0.0708055799135778,0.0322800099419381,0.00753676042737911,0.134074399399776,0.0282990279255184
Physical measures,X4270.Volume level set by participant (left),CEBPB,CCAAT/enhancer-binding protein beta,33273,0.0972199407542573,0.0443462039684804,0.0103013809760356,0.184138500532479,0.0283842897259589
Physical measures,X4270.Volume level set by participant (left),BOLA1,BolA-like protein 1,32111,-0.0829823147136535,0.0379805569973428,-0.157424206428445,-0.0085404229988615,0.0289291065738412
Physical measures,X4270.Volume level set by participant (left),SEZ6L2,Seizure 6-like protein 2,33386,-0.158589878094934,0.0726729794133088,-0.301028917745019,-0.0161508384448488,0.0291177963593672
Physical measures,X4270.Volume level set by participant (left),TNXB,Tenascin-X,33441,-0.143990829691991,0.0659916422801005,-0.273334448560988,-0.0146472108229936,0.0291386292542495
Physical measures,X4270.Volume level set by participant (left),CLUL1,Clusterin-like protein 1,33426,-0.0824498064248762,0.0378309070764268,-0.156598384294673,-0.0083012285550797,0.0293256755489743
Physical measures,X4270.Volume level set by participant (left),GM2A,Ganglioside GM2 activator,32166,0.112034044091451,0.0514274134715462,0.0112363136872208,0.212831774495682,0.0293998504416077
Physical measures,X4270.Volume level set by participant (left),ROBO1,Roundabout homolog 1,33453,-0.156804621310244,0.0720284804926074,-0.297980443075754,-0.0156287995447331,0.0295079023099338
Physical measures,X4270.Volume level set by participant (left),NME3,Nucleoside diphosphate kinase 3,33453,-0.162382023012459,0.0746197400039423,-0.308636713420186,-0.0161273326047325,0.029571699272782
Physical measures,X4270.Volume level set by participant (left),ITGA11,Integrin alpha-11,33421,-0.108209286397751,0.0498448225656573,-0.205905138626439,-0.0105134341690626,0.0299631189449974
Physical measures,X4270.Volume level set by participant (left),BTNL10,Butyrophilin-like protein 10,32075,0.107830563545715,0.049806426165893,0.0102099682605643,0.205451158830865,0.0304191621710998
Physical measures,X4270.Volume level set by participant (left),ABCA2,ATP-binding cassette sub-family A member 2,32122,-0.120766911202629,0.0557925311343405,-0.230120272225936,-0.0114135501793212,0.0304512941121564
Physical measures,X4270.Volume level set by participant (left),PDIA2,Protein disulfide-isomerase A2,32075,-0.11018645194438,0.0509747438896923,-0.210096949968177,-0.0102759539205831,0.0306808997498631
Physical measures,X4270.Volume level set by participant (left),PCDH7,Protocadherin-7,32329,-0.124554601838468,0.0576540518191789,-0.237556543404058,-0.0115526602728771,0.0307734148888971
Physical measures,X4270.Volume level set by participant (left),IDS,Iduronate 2-sulfatase,33527,-0.425905673617029,0.197711819558265,-0.813420839951229,-0.0383905072828286,0.031252775460631
Physical measures,X4270.Volume level set by participant (left),TNFSF12,Tumor necrosis factor ligand superfamily member 12,33527,-0.127355818442358,0.0591923412205653,-0.243372807234667,-0.0113388296500504,0.0314584138318473
Physical measures,X4270.Volume level set by participant (left),PNMA2,Paraneoplastic antigen Ma2,32111,0.102404554557172,0.0475962523288379,0.00911589999264921,0.195693209121694,0.0314659221553776
Physical measures,X4270.Volume level set by participant (left),SEZ6L,Seizure 6-like protein,33456,-0.134701032809564,0.0627191606795071,-0.257630587741398,-0.0117714778777306,0.0317653640142254
Physical measures,X4270.Volume level set by participant (left),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,32122,-0.11848512642966,0.055242373523472,-0.226760178535665,-0.0102100743236552,0.0319983131752184
Physical measures,X4270.Volume level set by participant (left),FDX1,"Adrenodoxin, mitochondrial",32122,-0.0715995749833476,0.0334184067282345,-0.137099652170687,-0.00609949779600785,0.0321831291519013
Physical measures,X4270.Volume level set by participant (left),ATRAID,All-trans retinoic acid-induced differentiation factor,32329,-0.158012178549056,0.0738509146748882,-0.302759971311837,-0.0132643857862752,0.0324169243074824
Physical measures,X4270.Volume level set by participant (left),PLIN1,Perilipin-1,33219,0.105459449600188,0.049297710057642,0.00883593788720949,0.202082961313166,0.0324440857531714
Physical measures,X4270.Volume level set by participant (left),HIP1,Huntingtin-interacting protein 1,32122,-0.126878192138323,0.0593500730482072,-0.243204335312809,-0.0105520489638367,0.032565049155636
Physical measures,X4270.Volume level set by participant (left),IGBP1,Immunoglobulin-binding protein 1,32350,-0.0715028664621985,0.0334516533777857,-0.137068107082658,-0.00593762584173856,0.0325880777889711
Physical measures,X4270.Volume level set by participant (left),C7,Complement component C7,32179,-0.136059136778732,0.0639569801561836,-0.261414817884852,-0.0107034556726126,0.0334222741353382
Physical measures,X4270.Volume level set by participant (left),PRC1,Protein regulator of cytokinesis 1,32319,-0.0948730484392144,0.0447462545181434,-0.182575707294775,-0.00717038958365325,0.0340165648341873
Physical measures,X4270.Volume level set by participant (left),GAMT,Guanidinoacetate N-methyltransferase,32122,-0.12006661151971,0.0566452105472696,-0.231091224192359,-0.00904199884706199,0.0340697162454716
Physical measures,X4270.Volume level set by participant (left),TMED4,Transmembrane emp24 domain-containing protein 4,32122,0.0755807344460424,0.0357444946244784,0.00552152498206471,0.14563994391002,0.0345071591316917
Physical measures,X4270.Volume level set by participant (left),TFF2,Trefoil factor 2,33468,0.0631947649981316,0.0298958803601677,0.00459883949220285,0.12179069050406,0.0345573113190132
Physical measures,X4270.Volume level set by participant (left),DCTN2,Dynactin subunit 2,33386,-0.0387319777945775,0.0183279390466443,-0.0746547383260003,-0.00280921726315458,0.0346048873312861
Physical measures,X4270.Volume level set by participant (left),UMOD,Uromodulin,33507,-0.0673475897502146,0.0319249151467581,-0.129920423437861,-0.00477475606256864,0.034923474466062
Physical measures,X4270.Volume level set by participant (left),DDC,Aromatic-L-amino-acid decarboxylase,33418,-0.0742298700551524,0.0352148811819307,-0.143251037171737,-0.00520870293856834,0.0350662938237541
Physical measures,X4270.Volume level set by participant (left),NXPH3,Neurexophilin-3,32140,-0.143555531538867,0.0682535556620505,-0.277332500636486,-0.00977856244124842,0.0354747578698482
Physical measures,X4270.Volume level set by participant (left),MCAM,Cell surface glycoprotein MUC18,33452,-0.105767094173102,0.0503674344056394,-0.204487265608155,-0.00704692273804891,0.0357645073661654
Physical measures,X4270.Volume level set by participant (left),C1GALT1C1,C1GALT1-specific chaperone 1,32122,0.13073233451992,0.0622828115270046,0.00865802392699111,0.252806645112849,0.0358485094065929
Physical measures,X4270.Volume level set by participant (left),GCLM,Glutamate--cysteine ligase regulatory subunit,32122,-0.0908770836748154,0.0433569451891492,-0.175856696245548,-0.00589747110408294,0.0361129955949007
Physical measures,X4270.Volume level set by participant (left),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",32235,-0.0903030085586647,0.043084944772376,-0.174749500312522,-0.00585651680480768,0.0361206694836914
Physical measures,X4270.Volume level set by participant (left),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,33380,0.114445306999213,0.0546134881269783,0.00740287027033594,0.221487743728091,0.0361502110872503
Physical measures,X4270.Volume level set by participant (left),CXCL10,C-X-C motif chemokine 10,33481,-0.0544319303730772,0.0260367827449194,-0.105464024553119,-0.00339983619303513,0.0365937950577553
Physical measures,X4270.Volume level set by participant (left),TMEM25,Transmembrane protein 25,32350,-0.0925503113016572,0.0442976171524532,-0.179373640920465,-0.00572698168284899,0.0367140837931991
Physical measures,X4270.Volume level set by participant (left),ROBO4,Roundabout homolog 4,32163,-0.238631965967897,0.114219434507086,-0.462502057601784,-0.014761874334009,0.0367187139603335
Physical measures,X4270.Volume level set by participant (left),CLEC4G,C-type lectin domain family 4 member G,33421,0.108263844962688,0.051910834366128,0.00651860960507752,0.210009080320299,0.0370455079939868
Physical measures,X4270.Volume level set by participant (left),CCN1,CCN family member 1,33374,-0.0464868329572176,0.0223687230849416,-0.0903295302037032,-0.00264413571073201,0.0377188414047786
Physical measures,X4270.Volume level set by participant (left),LEPR,Leptin receptor,33434,-0.120386904830454,0.057952902033953,-0.233974592817002,-0.00679921684390605,0.0378001014000824
Physical measures,X4270.Volume level set by participant (left),PRTG,Protogenin,33509,-0.143240113850509,0.0689816327693519,-0.278444114078439,-0.00803611362257919,0.0378762027121186
Physical measures,X4270.Volume level set by participant (left),MMP12,Macrophage metalloelastase,33433,0.071419159881877,0.0344121780274099,0.00397129094815352,0.1388670288156,0.0379775449362032
Physical measures,X4270.Volume level set by participant (left),PF4,Platelet factor 4,32310,-0.0416599359153074,0.0201781400099574,-0.0812090903348239,-0.00211078149579096,0.0389929172223287
Physical measures,X4270.Volume level set by participant (left),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,32122,-0.0889959626665206,0.0431380042412432,-0.173546450979357,-0.00444547435368399,0.0391412443701093
Physical measures,X4270.Volume level set by participant (left),NMI,N-myc-interactor,32286,-0.0587548042271075,0.0285035076734436,-0.114621679267057,-0.00288792918715795,0.0393056108581197
Physical measures,X4270.Volume level set by participant (left),TK1,"Thymidine kinase, cytosolic",32235,-0.0924208220125922,0.0448776419777041,-0.180381000288892,-0.00446064373629219,0.0394895504242106
Physical measures,X4270.Volume level set by participant (left),TG,Thyroglobulin,32319,-0.0343544084604885,0.0167228998870381,-0.0671312922390832,-0.00157752468189381,0.039976430487551
Physical measures,X4270.Volume level set by participant (left),SUMF1,Formylglycine-generating enzyme,32140,-0.0588859182311324,0.0286726303404989,-0.11508427369851,-0.00268756276375455,0.0400353318513916
Physical measures,X4270.Volume level set by participant (left),TGFA,Protransforming growth factor alpha,33421,0.0777452934812712,0.0378639042413967,0.00353204116813371,0.151958545794409,0.0400741305402397
Physical measures,X4270.Volume level set by participant (left),CD164,Sialomucin core protein 24,33441,-0.133399244334332,0.0649970067303594,-0.260793377525836,-0.00600511114282751,0.0401606222333269
Physical measures,X4270.Volume level set by participant (left),FGF7,Fibroblast growth factor 7,32075,-0.0513143415691875,0.0250153128128805,-0.100344354682433,-0.00228432845594163,0.0402701790948317
Physical measures,X4270.Volume level set by participant (left),FGF9,Fibroblast growth factor 9,32059,-0.104610491775054,0.0510093211119799,-0.204588761154535,-0.00463222239557326,0.0403195256575572
Physical measures,X4270.Volume level set by participant (left),ENG,Endoglin,33533,-0.204997548694351,0.0999701111861192,-0.400938966619144,-0.00905613076955714,0.0403356986464712
Physical measures,X4270.Volume level set by participant (left),TXN,Thioredoxin,32250,-0.0975472243536132,0.0475811271768224,-0.190806233620185,-0.00428821508704125,0.0403856820817642
Physical measures,X4270.Volume level set by participant (left),RGS10,Regulator of G-protein signaling 10,32350,-0.0705696269251956,0.0344470201346761,-0.138085786389161,-0.00305346746123043,0.0405300857166026
Physical measures,X4270.Volume level set by participant (left),GSR,"Glutathione reductase, mitochondrial",32331,-0.188197905615735,0.091874118356816,-0.368271177595095,-0.00812463363637606,0.0405507436057159
Physical measures,X4270.Volume level set by participant (left),CANT1,Soluble calcium-activated nucleotidase 1,33407,-0.175803227188753,0.0862649391745437,-0.344882507970859,-0.00672394640664767,0.0415847395828505
Physical measures,X4270.Volume level set by participant (left),UHRF2,E3 ubiquitin-protein ligase UHRF2,32122,-0.109041349660919,0.0535862739161153,-0.214070446536505,-0.0040122527853335,0.0418978209509411
Physical measures,X4270.Volume level set by participant (left),LYZL2,Lysozyme-like protein 2,32075,-0.112626963996968,0.0553549773685289,-0.221122719639285,-0.00413120835465175,0.041922546021389
Physical measures,X4270.Volume level set by participant (left),LEP,Leptin,33434,0.0548816146424233,0.0270405124967889,0.00188221014871709,0.10788101913613,0.0424259293709015
Physical measures,X4270.Volume level set by participant (left),IL6ST,Interleukin-6 receptor subunit beta,33434,-0.203636825592107,0.100339804052071,-0.400302841534166,-0.00697080965004876,0.0424396692865751
Physical measures,X4270.Volume level set by participant (left),GPA33,Cell surface A33 antigen,33386,-0.0255175895748083,0.0125993787524221,-0.0502123719295557,-0.000822807220060933,0.0428657000627414
Physical measures,X4270.Volume level set by participant (left),REN,Renin,33434,0.0498226791204341,0.0246324367902282,0.00154310301158683,0.0981022552292814,0.043139327144064
Physical measures,X4270.Volume level set by participant (left),DNAJB2,DnaJ homolog subfamily B member 2,32213,-0.0757801573677247,0.0374818257828883,-0.149244535902186,-0.00231577883326368,0.0432329273183666
Physical measures,X4270.Volume level set by participant (left),RABEPK,Rab9 effector protein with kelch motifs,33232,-0.0588150549471184,0.0291292693956268,-0.115908422962547,-0.00172168693168995,0.0435066441142929
Physical measures,X4270.Volume level set by participant (left),PTPRF,Receptor-type tyrosine-protein phosphatase F,33533,-0.119851487283008,0.0593665927125998,-0.236210008999704,-0.00349296556631268,0.0435334822686331
Physical measures,X4270.Volume level set by participant (left),SERPINA11,Serpin A11,33533,-0.0837021469639233,0.0415268882156717,-0.16509484786664,-0.00230944606120682,0.0438698413828887
Physical measures,X4270.Volume level set by participant (left),FSTL1,Follistatin-related protein 1,32163,-0.17871185809583,0.0887075945843921,-0.352578743481238,-0.00484497271042145,0.0439794222942564
Physical measures,X4270.Volume level set by participant (left),CDNF,Cerebral dopamine neurotrophic factor,33386,-0.111476596368013,0.0554078363255692,-0.220075955566129,-0.00287723716989728,0.0442574649795245
Physical measures,X4270.Volume level set by participant (left),CTSC,Dipeptidyl peptidase 1,33420,-0.0804530203001297,0.0400278012642329,-0.158907510778026,-0.00199852982223331,0.044468655232904
Physical measures,X4270.Volume level set by participant (left),RAD51,DNA repair protein RAD51 homolog 1,32235,-0.07473557438176,0.0372853901644268,-0.147814939104036,-0.00165620965948349,0.0450597028654026
Physical measures,X4270.Volume level set by participant (left),PNLIPRP1,Inactive pancreatic lipase-related protein 1,32353,-0.0523808161342938,0.0261952754744247,-0.103723556064166,-0.00103807620442145,0.0455745986700716
Physical measures,X4270.Volume level set by participant (left),COMMD9,COMM domain-containing protein 9,32319,-0.098512424957645,0.0494594615649597,-0.195452969624966,-0.00157188029032405,0.0464295977754733
Physical measures,X4270.Volume level set by participant (left),INPP1,Inositol polyphosphate 1-phosphatase,33386,-0.0650693507945502,0.032671916475034,-0.129106307085617,-0.00103239450348361,0.0464454962412301
Physical measures,X4270.Volume level set by participant (left),SERPINE2,Glia-derived nexin,32365,-0.062318946989053,0.0313079320475422,-0.123682493802236,-0.000955400175870223,0.0465684527924376
Physical measures,X4270.Volume level set by participant (left),FAM171B,Protein FAM171B,32319,-0.143991908995125,0.0723928097365298,-0.285881816078724,-0.00210200191152685,0.0467318142682001
Physical measures,X4270.Volume level set by participant (left),GFRAL,GDNF family receptor alpha-like,32111,-0.0650752605968668,0.0327822860556847,-0.129328541266009,-0.00082197992772487,0.0471718766048172
Physical measures,X4270.Volume level set by participant (left),IL2RG,Cytokine receptor common subunit gamma,32319,-0.1048735075294,0.0529539663524988,-0.208663281580297,-0.00108373347850188,0.0476860301769367
Physical measures,X4270.Volume level set by participant (left),THTPA,Thiamine-triphosphatase,32305,-0.0468439803338196,0.0237466821901915,-0.0933874774265951,-0.00030048324104423,0.0485700671621111
Physical measures,X4270.Volume level set by participant (left),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,31879,-0.0834987562960828,0.0423436395064712,-0.166492289728766,-0.00050522286339931,0.0486544917173453
Physical measures,X4270.Volume level set by participant (left),MMP15,Matrix metalloproteinase-15,32365,0.076843733321139,0.0389855811625152,0.000431994242609077,0.153255472399669,0.0487494325003479
Physical measures,X4270.Volume level set by participant (left),GSTT2B,Glutathione S-transferase theta-2B,32353,-0.0163938791859803,0.00832790979133915,-0.032716582377005,-7.11759949555378e-05,0.049040087474698
Physical measures,X4270.Volume level set by participant (left),BAP18,Chromatin complexes subunit BAP18,32353,0.0626969634989307,0.0318775625869887,0.000216940828432724,0.125176986169429,0.04924060188635
Physical measures,X4270.Volume level set by participant (left),TYRO3,Tyrosine-protein kinase receptor TYRO3,33434,-0.119795274880538,0.0610625745726778,-0.239477921042986,-0.000112628718089564,0.0498114400217712
Physical measures,X4270.Volume level set by participant (left),NAP1L4,Nucleosome assembly protein 1-like 4,32309,-0.102387104843558,0.0522291779379428,-0.204756293601926,-1.79160851904447e-05,0.0499910093644473
Physical measures,X4270.Volume level set by participant (left),EPCAM,Epithelial cell adhesion molecule,33437,-0.0338628306283575,0.0172852936036661,-0.0677420060915431,1.63448348280762e-05,0.0501373069223584
Physical measures,X4270.Volume level set by participant (left),EPPK1,Epiplakin,32163,0.0532292161689465,0.0272119096448875,-0.000106126735033032,0.106564559072926,0.0504894418225084
Physical measures,X4270.Volume level set by participant (left),YY1,Transcriptional repressor protein YY1,32140,-0.142284014797615,0.0729437791805348,-0.285253821991463,0.000685792396233287,0.051141143416996
Physical measures,X4270.Volume level set by participant (left),GMPR2,GMP reductase 2,32213,-0.0616911703456616,0.0316294889124794,-0.123684968614121,0.000302627922797997,0.05116060059152
Physical measures,X4270.Volume level set by participant (left),VNN1,Pantetheinase,32381,0.0527453913837405,0.027109752096004,-0.000389722724427263,0.105880505491908,0.0517351947801576
Physical measures,X4270.Volume level set by participant (left),ARID4B,AT-rich interactive domain-containing protein 4B,33219,-0.0843629894598886,0.043380696352545,-0.169389154310877,0.000663175391099613,0.0518415171284353
Physical measures,X4270.Volume level set by participant (left),OFD1,Oral-facial-digital syndrome 1 protein,32235,0.058574311464395,0.0302435306984671,-0.000703008704600536,0.117851631633391,0.0528114526856788
Physical measures,X4270.Volume level set by participant (left),FAM3C,Protein FAM3C,33418,-0.115296502404241,0.0595428753608356,-0.232000538111479,0.00140753330299692,0.0528548977620492
Physical measures,X4270.Volume level set by participant (left),SCG2,Secretogranin-2,33473,-0.104412376813789,0.0540115241376307,-0.210274964123546,0.00145021049596683,0.0532489901714463
Physical measures,X4270.Volume level set by participant (left),IL19,Interleukin-19,33208,0.0496225625364004,0.0256883516509742,-0.000726606699509046,0.0999717317723099,0.0534269883279878
Physical measures,X4270.Volume level set by participant (left),HDGFL2,Hepatoma-derived growth factor-related protein 2,32353,-0.0642379406209627,0.0332769128337631,-0.129460689775138,0.000984808533212908,0.0535923532102056
Physical measures,X4270.Volume level set by participant (left),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,33481,-0.0802114665574568,0.0415643158516173,-0.161677525626627,0.00125459251171309,0.053660985742388
Physical measures,X4270.Volume level set by participant (left),PAGR1,PAXIP1-associated glutamate-rich protein 1,32163,-0.0890498101588656,0.0461525818113699,-0.179508870509151,0.00140925019141941,0.0537097703089917
Physical measures,X4270.Volume level set by participant (left),KLK15,Kallikrein-15,32300,-0.0757614527794624,0.0393905583308591,-0.152966947107946,0.0014440415490214,0.0544734622104682
Physical measures,X4270.Volume level set by participant (left),INSR,Insulin receptor,32140,-0.235841219718209,0.122751225152914,-0.476433621017921,0.00475118158150278,0.0547315718011129
Physical measures,X4270.Volume level set by participant (left),SLC13A1,Solute carrier family 13 member 1,32319,-0.0625071294762356,0.0325431462454267,-0.126291696117272,0.00127743716480067,0.0547998099146918
Physical measures,X4270.Volume level set by participant (left),UBE2B,Ubiquitin-conjugating enzyme E2 B,32319,-0.13104560576432,0.0684441444049,-0.265196128797924,0.00310491726928455,0.0555752171430592
Physical measures,X4270.Volume level set by participant (left),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,32365,-0.0620946800518736,0.0324519893974509,-0.125700579270877,0.00151121916713017,0.055728809562741
Physical measures,X4270.Volume level set by participant (left),FASLG,Tumor necrosis factor ligand superfamily member 6,33527,-0.0887699642655694,0.0465772747760213,-0.180061422826571,0.00252149429543248,0.0566993906620002
Physical measures,X4270.Volume level set by participant (left),FGFBP3,Fibroblast growth factor-binding protein 3,32353,-0.103605001131666,0.054388234848624,-0.210205941434969,0.00299593917163703,0.056827320150584
Physical measures,X4270.Volume level set by participant (left),PON3,Serum paraoxonase/lactonase 3,33481,-0.109265375151415,0.0573657970480711,-0.221702337365634,0.00317158706280464,0.0568491533165259
Physical measures,X4270.Volume level set by participant (left),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,32350,-0.0568758212839781,0.0299098625708602,-0.115499151922864,0.00174750935490788,0.057263218954896
Physical measures,X4270.Volume level set by participant (left),KLK13,Kallikrein-13,33222,0.0767248494086445,0.0403980826655599,-0.0024553926158529,0.155905091433142,0.057568339884368
Physical measures,X4270.Volume level set by participant (left),IGFBP2,Insulin-like growth factor-binding protein 2,33515,-0.051221858386342,0.0270387854403636,-0.104217877849455,0.00177416107677073,0.0582057968119772
Physical measures,X4270.Volume level set by participant (left),STX7,Syntaxin-7,32140,-0.0750772881794874,0.0397783352209694,-0.153042825212587,0.00288824885361258,0.0591453491358517
Physical measures,X4270.Volume level set by participant (left),KLKB1,Plasma kallikrein,32204,-0.146759614702983,0.0778458574663328,-0.299337495336995,0.00581826593102971,0.0594322396271896
Physical measures,X4270.Volume level set by participant (left),DEFB104A_DEFB104B,Beta-defensin 104,32111,-0.0690024295000335,0.0366058713046317,-0.140749937257112,0.00274507825704472,0.0594663419605567
Physical measures,X4270.Volume level set by participant (left),DLL4,Delta-like protein 4,32163,-0.0436625789908208,0.0231657471651422,-0.0890674434344994,0.00174228545285782,0.0594957236737286
Physical measures,X4270.Volume level set by participant (left),GPC5,Glypican-5,33380,-0.0588648557698284,0.0312628342757108,-0.120140010950222,0.00241029941056475,0.0597461340961793
Physical measures,X4270.Volume level set by participant (left),CD5L,CD5 antigen-like,32353,-0.0810099733098426,0.0430546609918313,-0.165397108853832,0.00337716223414677,0.0599323847782875
Physical measures,X4270.Volume level set by participant (left),LEFTY2,Left-right determination factor 2,33499,-0.0604956396605005,0.0322637395866936,-0.12373256925042,0.00274128992941893,0.0608201124716104
Physical measures,X4270.Volume level set by participant (left),NEK7,Serine/threonine-protein kinase Nek7,32235,-0.0500914031520504,0.0267180860078998,-0.102458851727534,0.00227604542343313,0.0608559489313005
Physical measures,X4270.Volume level set by participant (left),CST1,Cystatin-SN,31300,-0.040480073768943,0.0216050040133717,-0.0828258816351515,0.00186573409726551,0.0610221609077955
Physical measures,X4270.Volume level set by participant (left),KIRREL1,Kin of IRRE-like protein 1,32111,0.0625598416725363,0.0334020551439889,-0.00290818640968189,0.128027869754755,0.061115588768507
Physical measures,X4270.Volume level set by participant (left),BPIFB1,BPI fold-containing family B member 1,33409,0.0514877194917945,0.0275209268819428,-0.00245329719681341,0.105428736180402,0.0613974915406829
Physical measures,X4270.Volume level set by participant (left),GLYR1,Putative oxidoreductase GLYR1,32319,-0.0609813342290168,0.0326640216297072,-0.125002816623243,0.00304014816520937,0.061949005882983
Physical measures,X4270.Volume level set by participant (left),APOC1,Apolipoprotein C-I,32381,-0.100412735658059,0.0537921794934282,-0.205845407465178,0.00501993614906039,0.0619833134841925
Physical measures,X4270.Volume level set by participant (left),ST13,Hsc70-interacting protein,32213,-0.0701068043402772,0.0376256514609879,-0.143853081203813,0.00363947252325907,0.0624618347366956
Physical measures,X4270.Volume level set by participant (left),CRTAC1,Cartilage acidic protein 1,33533,-0.109118385294953,0.0586674546532621,-0.224106596415347,0.00586982582544082,0.0629252752004337
Physical measures,X4270.Volume level set by participant (left),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,32350,0.154592138186232,0.0832559405988589,-0.00858950538753125,0.317773781759995,0.0633725467185249
Physical measures,X4270.Volume level set by participant (left),GGCT,Gamma-glutamylcyclotransferase,32347,-0.0788828204961234,0.042489393852583,-0.162162032447186,0.00439639145493928,0.0634153367771864
Physical measures,X4270.Volume level set by participant (left),APOF,Apolipoprotein F,32381,-0.142133251678521,0.0765827338859706,-0.292235410095024,0.00796890673798109,0.0634986561386602
Physical measures,X4270.Volume level set by participant (left),DNM3,Dynamin-3,32350,-0.0677945359039443,0.0365530939252532,-0.139438599997441,0.00384952818955203,0.0636782421050583
Physical measures,X4270.Volume level set by participant (left),CDH22,Cadherin-22,32235,-0.130937309638388,0.0706169975276337,-0.26934662479255,0.00747200551577376,0.0637498426835518
Physical measures,X4270.Volume level set by participant (left),IL36G,Interleukin-36 gamma,32101,0.0547812071394843,0.0295815890143121,-0.00319870732856739,0.112761121607536,0.0640832594313899
Physical measures,X4270.Volume level set by participant (left),FMR1,Synaptic functional regulator FMR1,33232,-0.0920711344419402,0.0497596793648029,-0.189600105996954,0.00545783711307346,0.0643015914644761
Physical measures,X4270.Volume level set by participant (left),SPINK1,Serine protease inhibitor Kazal-type 1,33441,0.0758815415348594,0.0410156516648117,-0.00450913572817147,0.15627221879789,0.0643372696955818
Physical measures,X4270.Volume level set by participant (left),S100A3,Protein S100-A3,32319,-0.0832250132708641,0.0450552400317001,-0.171533283732996,0.00508325719126806,0.0647589974068583
Physical measures,X4270.Volume level set by participant (left),FETUB,Fetuin-B,33435,0.0942773036957698,0.0511043394728368,-0.0058872016709904,0.19444180906253,0.0650994951758067
Physical measures,X4270.Volume level set by participant (left),PDGFRB,Platelet-derived growth factor receptor beta,33533,-0.0904011731738026,0.049080839937633,-0.186599619451563,0.0057972731039581,0.0655248388690622
Physical measures,X4270.Volume level set by participant (left),CD3G,T-cell surface glycoprotein CD3 gamma chain,32140,-0.0419976184788269,0.0228438431589861,-0.0867715510704398,0.00277631411278589,0.066032402541224
Physical measures,X4270.Volume level set by participant (left),DPP4,Dipeptidyl peptidase 4,33223,-0.10928728439645,0.0594910045671423,-0.225889653348049,0.00731508455514895,0.0662379914324155
Physical measures,X4270.Volume level set by participant (left),ERBB4,Receptor tyrosine-protein kinase erbB-4,33456,-0.128149353106997,0.0699835622708852,-0.265317135157932,0.00901842894393806,0.0671134268577581
Physical measures,X4270.Volume level set by participant (left),LSM8,U6 snRNA-associated Sm-like protein LSm8,32235,-0.0399390372243133,0.021817341617932,-0.08270102679546,0.00282295234683334,0.067197050635359
Physical measures,X4270.Volume level set by participant (left),MDM1,Nuclear protein MDM1,32154,-0.116766525586492,0.0638378490370911,-0.241888709699191,0.00835565852620637,0.0674216082306382
Physical measures,X4270.Volume level set by participant (left),WFDC12,WAP four-disulfide core domain protein 12,33506,0.0482949523143354,0.0264114667197762,-0.00347152245642593,0.100061427085097,0.0674984375421748
Physical measures,X4270.Volume level set by participant (left),ACRBP,Acrosin-binding protein,32319,-0.0990345265784843,0.0541989200850672,-0.205264409945216,0.00719535678824733,0.0677013162887215
Physical measures,X4270.Volume level set by participant (left),IFNAR1,Interferon alpha/beta receptor 1,32329,-0.13949869426923,0.07640018476207,-0.289243056402887,0.0102456678644277,0.0679039740849093
Physical measures,X4270.Volume level set by participant (left),MMP7,Matrilysin,33263,0.0677851858788776,0.0371614855375129,-0.00505132577464769,0.140621697532403,0.0681752138882019
Physical measures,X4270.Volume level set by participant (left),LIPF,Gastric triacylglycerol lipase,32163,-0.0621481039747664,0.0340806313643027,-0.1289461414488,0.00464993349926694,0.0682572022103319
Physical measures,X4270.Volume level set by participant (left),MTSS1,Protein MTSS 1,32329,-0.0340783410797608,0.0186883015491001,-0.0707074121159971,0.00255072995647541,0.0682637819378803
Physical measures,X4270.Volume level set by participant (left),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,32319,-0.0427016826918189,0.0234174900318419,-0.0885999631542289,0.00319659777059114,0.0682663509226002
Physical measures,X4270.Volume level set by participant (left),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,32140,-0.12371169466439,0.0678830546629567,-0.256762481803785,0.009339092475005,0.068429547789383
Physical measures,X4270.Volume level set by participant (left),FAM3B,Protein FAM3B,33386,-0.0856092453974309,0.0470088303129178,-0.17774655281075,0.0065280620158879,0.0686203642519939
Physical measures,X4270.Volume level set by participant (left),PRUNE2,Protein prune homolog 2,32235,-0.132332419190048,0.0726711243396888,-0.274767822895838,0.0101029845157423,0.0686488009789131
Physical measures,X4270.Volume level set by participant (left),GFRA2,GDNF family receptor alpha-2,33386,-0.147394515262605,0.0809887026970573,-0.306132372548837,0.0113433420236275,0.0688017222494729
Physical measures,X4270.Volume level set by participant (left),FAP,Prolyl endopeptidase FAP,33533,-0.115041785367565,0.0632441174508691,-0.239000255571268,0.00891668483613886,0.0689425851998978
Physical measures,X4270.Volume level set by participant (left),CD5,T-cell surface glycoprotein CD5,33499,0.095118235390245,0.0523132638912706,-0.0074157618366453,0.197652232617135,0.0690600371643717
Physical measures,X4270.Volume level set by participant (left),NID1,Nidogen-1,33409,-0.0809341843312776,0.0445130757211387,-0.168179812744709,0.00631144408215426,0.0690652165960584
Physical measures,X4270.Volume level set by participant (left),ARID3A,AT-rich interactive domain-containing protein 3A,32111,-0.0931413432080872,0.0512456205675249,-0.193582759520436,0.00730007310426159,0.0691724114736084
Physical measures,X4270.Volume level set by participant (left),TP53I3,Quinone oxidoreductase PIG3,32034,-0.0723436708696319,0.0398213972877593,-0.15039360955364,0.00570626781437633,0.06930201073197
Physical measures,X4270.Volume level set by participant (left),BCAM,Basal cell adhesion molecule,33441,-0.127761727153777,0.0706373195289678,-0.266210873430554,0.0106874191229999,0.0705310171950259
Physical measures,X4270.Volume level set by participant (left),UROD,Uroporphyrinogen decarboxylase,32213,-0.0543841130251655,0.0301159257853438,-0.113411327564439,0.00464310151410832,0.0709843124692656
Physical measures,X4270.Volume level set by participant (left),OPTC,Opticin,33386,-0.0709470273727156,0.0392929705910978,-0.147961249731267,0.00606719498583599,0.0710159346968665
Physical measures,X4270.Volume level set by participant (left),SH3BP1,SH3 domain-binding protein 1,32329,-0.0767094474797374,0.0425265240177156,-0.16006143455446,0.00664253959498515,0.0713004887620786
Physical measures,X4270.Volume level set by participant (left),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,32288,-0.114965887152124,0.0638573908825109,-0.240126373281846,0.0101945989775972,0.0718432707620021
Physical measures,X4270.Volume level set by participant (left),PEPD,Xaa-Pro dipeptidase,32381,-0.137619597139613,0.0766044477645107,-0.287764314758054,0.012525120478828,0.0724537046039008
Physical measures,X4270.Volume level set by participant (left),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",33232,-0.0611208500785132,0.0340608319251734,-0.127880080651853,0.00563838049482659,0.0727739453863758
Physical measures,X4270.Volume level set by participant (left),DPEP2,Dipeptidase 2,33386,-0.108503689703464,0.060660212095063,-0.227397705409788,0.0103903260028591,0.0736949833385372
Physical measures,X4270.Volume level set by participant (left),PROS1,Vitamin K-dependent protein S,32398,-0.139435481953255,0.0782791706809452,-0.292862656487908,0.0139916925813972,0.0749083407954478
Physical measures,X4270.Volume level set by participant (left),APOM,Apolipoprotein M,33435,-0.114631683795637,0.0643814373489848,-0.240819300999647,0.0115559334083735,0.0750266108197323
Physical measures,X4270.Volume level set by participant (left),AMY2A,Pancreatic alpha-amylase,33067,-0.0697744090515943,0.0392007037521417,-0.146607788405792,0.0070589703026035,0.0751230840160553
Physical measures,X4270.Volume level set by participant (left),TNFSF11,Tumor necrosis factor ligand superfamily member 11,33421,-0.0501100395568133,0.0282440143449215,-0.105468307672859,0.00524822855923287,0.0760668760930518
Physical measures,X4270.Volume level set by participant (left),HBEGF,Proheparin-binding EGF-like growth factor,33489,-0.0418825443265186,0.0236440594032517,-0.088224900756892,0.00445981210385479,0.0765317285188179
Physical measures,X4270.Volume level set by participant (left),PPY,Pancreatic prohormone,33408,-0.0309118356713608,0.0174530750363682,-0.0651198627426424,0.00329619139992084,0.0765714733778016
Physical measures,X4270.Volume level set by participant (left),AMY2B,Alpha-amylase 2B,32818,-0.0696146125192197,0.0393405645982976,-0.146722119131883,0.00749289409344371,0.0768406186815999
Physical measures,X4270.Volume level set by participant (left),SBSN,Suprabasin,32362,0.103846784817648,0.0586904688631116,-0.0111865341540503,0.218880103789347,0.0768660552964871
Physical measures,X4270.Volume level set by participant (left),NRN1,Neuritin,32350,-0.0974031205703307,0.0550703681347535,-0.205341042114448,0.0105348009737863,0.0769820717346987
Physical measures,X4270.Volume level set by participant (left),TRIM24,Transcription intermediary factor 1-alpha,32216,-0.0563051599885459,0.0318393208689432,-0.118710228891675,0.00609990891458281,0.0770306834927969
Physical measures,X4270.Volume level set by participant (left),GDF2,Growth/differentiation factor 2,33434,-0.0834833968035098,0.0472454647265846,-0.176084507667616,0.00911771406059603,0.0772598514986056
Physical measures,X4270.Volume level set by participant (left),SEPTIN9,Septin-9,33386,-0.1117403033216,0.0632530605103612,-0.235716301921908,0.0122356952787077,0.0773361592912231
Physical measures,X4270.Volume level set by participant (left),SLC39A5,Zinc transporter ZIP5,33421,-0.054858355556033,0.0310586409348173,-0.115733291788275,0.00601658067620887,0.0773823721395682
Physical measures,X4270.Volume level set by participant (left),UNG,Uracil-DNA glycosylase,32319,-0.104031474481506,0.0588978595680208,-0.219471279234827,0.0114083302718147,0.0773837947048999
Physical measures,X4270.Volume level set by participant (left),NPTXR,Neuronal pentraxin receptor,33434,-0.0896721502712082,0.0507809545569711,-0.189202821202872,0.00985852066045514,0.0774530075685515
Physical measures,X4270.Volume level set by participant (left),JAM3,Junctional adhesion molecule C,32213,-0.0705270624150761,0.0399955598606773,-0.148918359742004,0.00786423491185148,0.0778770777259299
Physical measures,X4270.Volume level set by participant (left),PTTG1,Securin,32235,0.0852581819345869,0.0484173117877691,-0.00963974916944052,0.180156113038614,0.078294129467962
Physical measures,X4270.Volume level set by participant (left),APLP1,Amyloid-like protein 1,33434,-0.0588098410185737,0.0335011113163578,-0.124472019198635,0.00685233716148766,0.0792148546359642
Physical measures,X4270.Volume level set by participant (left),BMP10,Bone morphogenetic protein 10,32213,-0.125000769356401,0.0712176558520096,-0.26458737482634,0.0145858361135378,0.0792656750495736
Physical measures,X4270.Volume level set by participant (left),JCHAIN,Immunoglobulin J chain,33273,-0.0499908464037717,0.0285417851130102,-0.105932745225272,0.00595105241772817,0.0798951287163956
Physical measures,X4270.Volume level set by participant (left),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],33386,-0.0545631028502642,0.0311539515907607,-0.115624847968155,0.00649864226762686,0.0799109595939291
Physical measures,X4270.Volume level set by participant (left),NAA10,N-alpha-acetyltransferase 10,32122,-0.0716920003457762,0.0409610080008085,-0.151975576027361,0.00859157533580845,0.0801151990680063
Physical measures,X4270.Volume level set by participant (left),OSM,Oncostatin-M,33368,0.0419445443379383,0.0239764995769537,-0.005049394832891,0.0889384835087676,0.0802559133534296
Physical measures,X4270.Volume level set by participant (left),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,33421,-0.0783505477716869,0.044842972640561,-0.166242774147186,0.00954167860381262,0.0806333843149361
Physical measures,X4270.Volume level set by participant (left),CETN2,Centrin-2,33219,-0.0461232400877,0.0264422286850667,-0.0979500083104309,0.00570352813503078,0.0811414488978786
Physical measures,X4270.Volume level set by participant (left),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,32101,0.126492648010121,0.0725181455316379,-0.0156429172318894,0.268628213252131,0.0811487846826389
Physical measures,X4270.Volume level set by participant (left),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,32319,0.0497062010358037,0.0285069958892907,-0.00616751090720616,0.105579912978814,0.0812593522713681
Physical measures,X4270.Volume level set by participant (left),AGRN,Agrin,33481,0.0901972277384488,0.0517394598565338,-0.0112121135803575,0.191606569057255,0.0813158573999125
Physical measures,X4270.Volume level set by participant (left),PLXDC1,Plexin domain-containing protein 1,33232,-0.0844099993285872,0.0484434351996738,-0.179359132319948,0.0105391336627734,0.0814657119806788
Physical measures,X4270.Volume level set by participant (left),PAXX,Protein PAXX,32213,-0.0795374834210057,0.0456598463072875,-0.169030782183289,0.00995581534127783,0.0815556206631445
Physical measures,X4270.Volume level set by participant (left),PNLIPRP2,Pancreatic lipase-related protein 2,33424,0.0102907158562969,0.0059138895597735,-0.00130050768085911,0.021881939393453,0.0818770469549624
Physical measures,X4270.Volume level set by participant (left),SEPTIN8,Septin-8,32326,-0.105765650811523,0.0608042601278198,-0.22494200066205,0.0134106990390041,0.0819956549426502
Physical measures,X4270.Volume level set by participant (left),EPHA4,Ephrin type-A receptor 4,32213,-0.12679347207961,0.0728965221607055,-0.269670655514593,0.0160837113553729,0.082010693982622
Physical measures,X4270.Volume level set by participant (left),TP53INP1,Tumor protein p53-inducible nuclear protein 1,33273,-0.088877330631259,0.0512337715106358,-0.189295522792105,0.0115408615295872,0.0828216099659752
Physical measures,X4270.Volume level set by participant (left),PNLIP,Pancreatic triacylglycerol lipase,32381,-0.0573403936059402,0.033081886484942,-0.122180891116427,0.00750010390454612,0.0830836158887165
Physical measures,X4270.Volume level set by participant (left),GSN,Gelsolin,32355,-0.181644557868084,0.104974063081682,-0.38739372150818,0.0241046057720128,0.0836022413237547
Physical measures,X4270.Volume level set by participant (left),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,32235,-0.0532654705262968,0.0309291849904418,-0.113886673107563,0.0073557320549691,0.0850775592064826
Physical measures,X4270.Volume level set by participant (left),ERVV_1,,32122,-0.0719266534791331,0.0417941430997837,-0.153843173954709,0.00998986699644298,0.0852957998166362
Physical measures,X4270.Volume level set by participant (left),VEGFD,Vascular endothelial growth factor D,33512,-0.0861402773658755,0.0500757833735161,-0.184288812777967,0.012008258046216,0.0854305616878172
Physical measures,X4270.Volume level set by participant (left),IL6R,Interleukin-6 receptor subunit alpha,33327,-0.0884776051510743,0.0515018881153213,-0.189421305857104,0.0124660955549554,0.0858408535322236
Physical measures,X4270.Volume level set by participant (left),SMTN,Smoothelin,32330,-0.0337133925703065,0.0196291167640639,-0.0721864614278717,0.00475967628725874,0.0859235931151713
Physical measures,X4270.Volume level set by participant (left),C2CD2L,Phospholipid transfer protein C2CD2L,33195,-0.0709551572085646,0.0413329428483826,-0.151967725191395,0.0100574107742654,0.0860743227131991
Physical measures,X4270.Volume level set by participant (left),RTN4R,Reticulon-4 receptor,33509,0.0887277391364242,0.0517534808127597,-0.0127090832565847,0.190164561529433,0.0864839384208523
Physical measures,X4270.Volume level set by participant (left),FGFBP2,Fibroblast growth factor-binding protein 2,32384,-0.0680254125749163,0.039746084633973,-0.145927738457503,0.00987691330767074,0.0870280119293245
Physical measures,X4270.Volume level set by participant (left),ANXA10,Annexin A10,33219,0.0370232692407201,0.0216682119533777,-0.0054464261879002,0.0794929646693405,0.0875522449493873
Physical measures,X4270.Volume level set by participant (left),SUOX,"Sulfite oxidase, mitochondrial",32350,-0.0535729969002511,0.0313632256245485,-0.115044919124366,0.00789892532386394,0.0876483969658123
Physical measures,X4270.Volume level set by participant (left),MZB1,Marginal zone B- and B1-cell-specific protein,33466,0.0578601137237233,0.0338818824615286,-0.00854837590087273,0.124268603348319,0.0877263414429992
Physical measures,X4270.Volume level set by participant (left),ITGB1,Integrin beta-1,33405,-0.135810349242145,0.0798350907677831,-0.292287127146999,0.0206664286627102,0.0889521829666439
Physical measures,X4270.Volume level set by participant (left),FABP4,"Fatty acid-binding protein, adipocyte",33533,0.0600517261551058,0.0353422154504702,-0.00921901612781589,0.129322468438027,0.0893251828444837
Physical measures,X4270.Volume level set by participant (left),SERPINH1,Serpin H1,32235,-0.0272471176161017,0.0160584103215844,-0.0587216018464072,0.00422736661420375,0.0897838198809511
Physical measures,X4270.Volume level set by participant (left),PHLDB1,Pleckstrin homology-like domain family B member 1,32329,-0.0615408830405352,0.0362917980589994,-0.132672807236174,0.00959104115510368,0.0899776416893956
Physical measures,X4270.Volume level set by participant (left),SERPIND1,Heparin cofactor 2,32381,0.121831379162895,0.0718581791296721,-0.0190106519312626,0.262673410257052,0.090030869265507
Physical measures,X4270.Volume level set by participant (left),IL17A,Interleukin-17A,33263,0.0695992262670885,0.0410776013312945,-0.0109128723422488,0.150111324876426,0.0902369557893549
Physical measures,X4270.Volume level set by participant (left),PZP,Pregnancy zone protein,32398,0.0515383081091892,0.0304800283935132,-0.00820254754209659,0.111279163760475,0.0908974667676008
Physical measures,X4270.Volume level set by participant (left),NELL2,Protein kinase C-binding protein NELL2,33481,-0.101225697040126,0.0599041680640676,-0.218637866445698,0.0161864723654465,0.0911019272932213
Physical measures,X4270.Volume level set by participant (left),C1QA,Complement C1q subcomponent subunit A,33490,-0.125923029734283,0.0746136806182861,-0.272165843746123,0.0203197842775582,0.0915097285420998
Physical measures,X4270.Volume level set by participant (left),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,32127,-0.0989805011517855,0.0586870539564265,-0.214007126906381,0.0160461246028104,0.0917245031794115
Physical measures,X4270.Volume level set by participant (left),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,32350,-0.0914041921477041,0.0542423172385413,-0.197719133935245,0.0149107496398368,0.0920071528460563
Physical measures,X4270.Volume level set by participant (left),CHI3L1,Chitinase-3-like protein 1,33199,0.0393759771822619,0.0233775844491112,-0.00644408833799616,0.0851960427025199,0.0921502097264232
Physical measures,X4270.Volume level set by participant (left),TPK1,Thiamin pyrophosphokinase 1,32365,-0.124728343929458,0.0741066791714122,-0.269977435105426,0.0205207472465098,0.0923967849192749
Physical measures,X4270.Volume level set by participant (left),NEB,Nebulin,32122,-0.0871296086892402,0.0518177985019877,-0.188692493753136,0.0144332763746557,0.0927141279797117
Physical measures,X4270.Volume level set by participant (left),CPPED1,Serine/threonine-protein phosphatase CPPED1,33500,-0.0440199789039841,0.0261957136206526,-0.0953635776004631,0.00732361979249492,0.0929088378783284
Physical measures,X4270.Volume level set by participant (left),LAMA4,Laminin subunit alpha-4,33481,-0.0908828224287089,0.0540906710168094,-0.196900537621655,0.0151348927642374,0.0929541754358393
Physical measures,X4270.Volume level set by participant (left),CFHR2,Complement factor H-related protein 2,32352,0.0601971999154972,0.0358388454555997,-0.0100469371774781,0.130441337008473,0.0930623650118352
Physical measures,X4270.Volume level set by participant (left),OTUD6B,Deubiquitinase OTUD6B,32329,-0.0597481553522766,0.0356174980377352,-0.129558451506238,0.0100621408016843,0.0934855226168965
Physical measures,X4270.Volume level set by participant (left),EFNB2,Ephrin-B2,32154,-0.0582209997879506,0.0347711948505735,-0.126372541695075,0.0099305421191735,0.0940920014066408
Physical measures,X4270.Volume level set by participant (left),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,32353,-0.0698331972229132,0.0417152140222765,-0.151595016706575,0.0119286222607488,0.0941611075764636
Physical measures,X4270.Volume level set by participant (left),IMPA1,Inositol monophosphatase 1,33380,-0.0489369601006276,0.0292644913310176,-0.106295363109422,0.00842144290816691,0.0945140303445047
Physical measures,X4270.Volume level set by participant (left),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,32350,-0.0730107011449456,0.0436770587463739,-0.158617736287838,0.0125963339979472,0.0946422681613929
Physical measures,X4270.Volume level set by participant (left),NME1,Nucleoside diphosphate kinase A,32140,-0.153337961364891,0.0917586111532951,-0.33318483922535,0.026508916495567,0.09474232893833
Physical measures,X4270.Volume level set by participant (left),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,32319,-0.0594544739927498,0.0355855195050236,-0.129202092222596,0.0102931442370966,0.0948110422500683
Physical measures,X4270.Volume level set by participant (left),CLEC12A,C-type lectin domain family 12 member A,32140,-0.168390735254811,0.100959512217943,-0.366271379201979,0.0294899086923559,0.0953756031589244
Physical measures,X4270.Volume level set by participant (left),IL18,Interleukin-18,33408,0.0581209884310235,0.0348535693065299,-0.010192007409775,0.126433984271822,0.0954348262494317
Physical measures,X4270.Volume level set by participant (left),TIMP2,Metalloproteinase inhibitor 2,32365,-0.138393141820536,0.0830070650677298,-0.301086989353287,0.0243007057122142,0.0955052188621082
Physical measures,X4270.Volume level set by participant (left),GNPDA1,Glucosamine-6-phosphate isomerase 1,32163,-0.103230770362399,0.0621411322796944,-0.2250273896306,0.0185658489058023,0.0967077462227586
Physical measures,X4270.Volume level set by participant (left),TAP1,Antigen peptide transporter 1,32235,-0.0534535639078082,0.0321926258496852,-0.116551110573191,0.00964398275757475,0.0968685130587223
Physical measures,X4270.Volume level set by participant (left),IL32,Interleukin-32,33421,-0.0682164093668218,0.0411155950058656,-0.148802975578318,0.0123701568446747,0.097123142443805
Physical measures,X4270.Volume level set by participant (left),CA7,Carbonic anhydrase 7,32235,-0.0941980359962307,0.0569107868547769,-0.205743178231593,0.017347106239132,0.0979267573642835
Physical measures,X4270.Volume level set by participant (left),ZFYVE19,Abscission/NoCut checkpoint regulator,32329,-0.0389124702667516,0.023511787818314,-0.084995574390647,0.00717063385714384,0.0979603702321258
Physical measures,X4270.Volume level set by participant (left),GUCY2C,Heat-stable enterotoxin receptor,32235,-0.0381495831971956,0.0230583199099454,-0.0833438902206886,0.00704472382629736,0.0980698858831873
Physical measures,X4270.Volume level set by participant (left),IL6,Interleukin-6,33386,0.0390361537060614,0.0235957689917763,-0.00721155351782025,0.085283860929943,0.0980873145796277
Physical measures,X4270.Volume level set by participant (left),SERPINA4,Kallistatin,32234,-0.139229309207649,0.0841599335363923,-0.304182778938978,0.0257241605236798,0.0980983968445322
Physical measures,X4270.Volume level set by participant (left),GHRHR,Growth hormone-releasing hormone receptor,33219,-0.0501689929392144,0.0303421843580568,-0.109639674281006,0.0093016884025768,0.0982770851459901
Physical measures,X4270.Volume level set by participant (left),IL3RA,Interleukin-3 receptor subunit alpha,33273,-0.087972067137381,0.0532360200180488,-0.192314666372757,0.0163705320979947,0.0984700111491015
Physical measures,X4270.Volume level set by participant (left),CENPF,Centromere protein F,32235,-0.0592851092328358,0.0359014667500891,-0.12965198406301,0.0110817655973387,0.0987119088659531
Physical measures,X4270.Volume level set by participant (left),ATP5PO,"ATP synthase subunit O, mitochondrial",33219,-0.067327168019493,0.0408713357965058,-0.147434986180644,0.0127806501416584,0.0995331701105346
Physical measures,X4270.Volume level set by participant (left),NPTN,Neuroplastin,33232,-0.0339835230927572,0.0206433837342491,-0.0744445552118854,0.00647750902637095,0.0997545558822512
Physical measures,X4270.Volume level set by participant (left),LRRC37A2,Leucine-rich repeat-containing protein 37A2,32329,-0.0781637513393532,0.0474920405322023,-0.17124815078247,0.0149206481037632,0.0998389947847489
Physical measures,X4270.Volume level set by participant (left),APOA1,Apolipoprotein A-I,32398,-0.116362794530296,0.0707028496368955,-0.254940379818611,0.022214790758019,0.0998443769840974
Physical measures,X4270.Volume level set by participant (left),AIF1L,Allograft inflammatory factor 1-like,32163,-0.0573408910536074,0.0350643570459682,-0.126067030863705,0.0113852487564903,0.10202612098362
Physical measures,X4270.Volume level set by participant (left),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,33418,0.0889542515927231,0.0544209363577532,-0.0177107836684732,0.195619286853919,0.102176568219514
Physical measures,X4270.Volume level set by participant (left),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",32140,-0.119672802730781,0.0732671588818604,-0.263276434139227,0.0239308286776656,0.102430952139358
Physical measures,X4270.Volume level set by participant (left),SCARF2,Scavenger receptor class F member 2,33500,-0.0921690976718271,0.0564764665509662,-0.202862972111721,0.0185247767680667,0.102716146553811
Physical measures,X4270.Volume level set by participant (left),FLT3LG,Fms-related tyrosine kinase 3 ligand,33527,-0.0841218670876887,0.0515856499188783,-0.18522974092869,0.0169860067533127,0.10298365278613
Physical measures,X4270.Volume level set by participant (left),SYT1,Synaptotagmin-1,32353,-0.086046482665736,0.0527674184893706,-0.189470622904902,0.0173776575734303,0.102998897690044
Physical measures,X4270.Volume level set by participant (left),CES1,Liver carboxylesterase 1,33454,0.0369857128667833,0.0227000682152359,-0.00750642083507912,0.0814778465686457,0.103279943732898
Physical measures,X4270.Volume level set by participant (left),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,32154,-0.0645190218242113,0.039598108680274,-0.142131314837548,0.0130932711891257,0.103280694253496
Physical measures,X4270.Volume level set by participant (left),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,32235,-0.0898030915642679,0.0551821207061916,-0.197960048148403,0.0183538650198676,0.103693787859898
Physical measures,X4270.Volume level set by participant (left),ADGRE2,Adhesion G protein-coupled receptor E2,33481,-0.0995569509404121,0.0612909284144989,-0.21968717063283,0.0205732687520057,0.104339419835833
Physical measures,X4270.Volume level set by participant (left),UXS1,UDP-glucuronic acid decarboxylase 1,33232,0.0513409912389589,0.031617420683842,-0.0106291533013714,0.113311135779289,0.10445019959999
Physical measures,X4270.Volume level set by participant (left),AHSG,Alpha-2-HS-glycoprotein,32381,-0.114827173564231,0.0708086417705906,-0.253612111434589,0.0239577643061261,0.104917057735118
Physical measures,X4270.Volume level set by participant (left),DUSP13,Dual specificity protein phosphatase 13 isoform A,32319,0.0799640981764546,0.0493812231082483,-0.016823099115712,0.176751295468621,0.105418110545324
Physical measures,X4270.Volume level set by participant (left),OXT,Oxytocin-neurophysin 1,33500,0.0210264417817497,0.0129901095573075,-0.00443417295057292,0.0464870565140723,0.105557440615604
Physical measures,X4270.Volume level set by participant (left),UBXN1,UBX domain-containing protein 1,32213,-0.0493154223241262,0.0304935902961001,-0.109082859304482,0.0104520146562301,0.105867364729951
Physical measures,X4270.Volume level set by participant (left),BDNF,Brain-derived neurotrophic factor,32384,-0.0381467721339552,0.023641773208362,-0.0844846476223446,0.00819110335443427,0.106668637278425
Physical measures,X4270.Volume level set by participant (left),IL1RN,Interleukin-1 receptor antagonist protein,33410,0.0502816376482122,0.0312101325563106,-0.0108902221621565,0.111453497458581,0.107200202219854
Physical measures,X4270.Volume level set by participant (left),EGLN1,Egl nine homolog 1,33421,0.0530333794311299,0.0329575304654273,-0.0115633802811077,0.117630139143367,0.10762028274261
Physical measures,X4270.Volume level set by participant (left),PLAU,Urokinase-type plasminogen activator,33441,-0.0968739780451863,0.0602887723222568,-0.21503997179681,0.0212920157064371,0.108126181410019
Physical measures,X4270.Volume level set by participant (left),PDZD2,PDZ domain-containing protein 2,32122,-0.0522786111837247,0.0325624951600683,-0.116101101697459,0.0115438793300092,0.108428203502129
Physical measures,X4270.Volume level set by participant (left),CAPN3,Calpain-3,32319,-0.0857754929712842,0.0534664942182431,-0.190569821639041,0.0190188356964721,0.108691409316635
Physical measures,X4270.Volume level set by participant (left),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,32163,-0.126018680588348,0.0789769273526927,-0.280813458199625,0.0287760970229298,0.11061036790631
Physical measures,X4270.Volume level set by participant (left),NRTN,Neurturin,33273,-0.0563272903718299,0.0353061507828872,-0.125527345906289,0.012872765162629,0.110659554684408
Physical measures,X4270.Volume level set by participant (left),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,33273,-0.103936483383851,0.0652093840324662,-0.231746876087484,0.0238739093197831,0.110996863835402
Physical measures,X4270.Volume level set by participant (left),SFTPA1,Pulmonary surfactant-associated protein A1,33232,-0.0468623508013766,0.0294382647171351,-0.104561349646962,0.0108366480442082,0.111446415036529
Physical measures,X4270.Volume level set by participant (left),BRD1,Bromodomain-containing protein 1,32235,-0.100042602977263,0.0628465346454213,-0.223221810882289,0.0231366049277624,0.11145779891349
Physical measures,X4270.Volume level set by participant (left),PDRG1,p53 and DNA damage-regulated protein 1,32154,-0.0619942151313723,0.0389541780301798,-0.138344404070525,0.0143559738077801,0.111545997038157
Physical measures,X4270.Volume level set by participant (left),MAPKAPK2,MAP kinase-activated protein kinase 2,32235,-0.0454676889683079,0.0285864951327144,-0.101497219428428,0.0105618414918124,0.111755933312953
Physical measures,X4270.Volume level set by participant (left),LEG1,Protein LEG1 homolog,31952,0.0482818329446815,0.0303891324619767,-0.0112808666807928,0.107844532570156,0.112150847893118
Physical measures,X4270.Volume level set by participant (left),SLC12A2,Solute carrier family 12 member 2,32122,-0.120235933956341,0.0757029464539569,-0.268613709006096,0.0281418410934146,0.112268875773512
Physical measures,X4270.Volume level set by participant (left),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",33219,0.0935100804054932,0.0588793150000251,-0.021893376994556,0.208913537805542,0.112285056184201
Physical measures,X4270.Volume level set by participant (left),PTH,Parathyroid hormone,32154,-0.0399999097491846,0.0251908920328767,-0.0893740581336229,0.00937423863525369,0.112356371236376
Physical measures,X4270.Volume level set by participant (left),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",32163,-0.0706232132908838,0.0445010434237275,-0.15784525840139,0.016598831819622,0.112553370463835
Physical measures,X4270.Volume level set by participant (left),COL28A1,Collagen alpha-1(XXVIII) chain,32154,-0.0440228302118129,0.0278129004969084,-0.0985361151857534,0.0104904547621277,0.113503448112854
Physical measures,X4270.Volume level set by participant (left),CD58,Lymphocyte function-associated antigen 3,33410,-0.155531512755168,0.098393752441749,-0.348383267540995,0.0373202420306604,0.113980783862478
Physical measures,X4270.Volume level set by participant (left),PTPRR,Receptor-type tyrosine-protein phosphatase R,32353,-0.0901141063323812,0.0570245134828794,-0.201882152758825,0.0216539400940624,0.114085178112255
Physical measures,X4270.Volume level set by participant (left),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,32353,-0.077305311239582,0.0489862838185818,-0.173318427524002,0.0187078050448383,0.114582420152009
Physical measures,X4270.Volume level set by participant (left),IL1R2,Interleukin-1 receptor type 2,33411,0.13904320265146,0.0881490227280479,-0.0337288818955138,0.311815287198434,0.114746831437873
Physical measures,X4270.Volume level set by participant (left),ACYP1,Acylphosphatase-1,32175,-0.0492116480801489,0.0312881042655328,-0.110536332440593,0.0121130362802953,0.115793399330925
Physical measures,X4270.Volume level set by participant (left),SLAMF6,SLAM family member 6,33232,-0.0733351981510758,0.0466809098466707,-0.16482978145055,0.0181593851483988,0.116221238710648
Physical measures,X4270.Volume level set by participant (left),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,33420,-0.0446476521314677,0.0285105764634116,-0.100528381999755,0.0112330777368191,0.117383177654264
Physical measures,X4270.Volume level set by participant (left),NINJ1,Ninjurin-1,33232,-0.0474049861163376,0.030288075493768,-0.106769614084123,0.0119596418514476,0.117586852283333
Physical measures,X4270.Volume level set by participant (left),PVALB,Parvalbumin alpha,33481,-0.0240590690350796,0.0153987696559722,-0.054240657560785,0.0061225194906258,0.118228366334307
Physical measures,X4270.Volume level set by participant (left),NOMO1,Nodal modulator 1,33441,0.114652004141751,0.0734315028034188,-0.0292737413529497,0.258577749636452,0.118477282925563
Physical measures,X4270.Volume level set by participant (left),DKK4,Dickkopf-related protein 4,33362,-0.0591307184843583,0.0378847301867758,-0.133384789650439,0.0151233526817222,0.11860503180849
Physical measures,X4270.Volume level set by participant (left),NTRK2,BDNF/NT-3 growth factors receptor,33434,-0.106560449702389,0.0683002280832989,-0.240428896745655,0.0273079973408773,0.11875328546648
Physical measures,X4270.Volume level set by participant (left),MYOM1,Myomesin-1,32111,-0.068639755538806,0.0440302643785751,-0.154939073720813,0.0176595626432012,0.119056134123634
Physical measures,X4270.Volume level set by participant (left),ARHGAP30,Rho GTPase-activating protein 30,32235,-0.0790248540149083,0.0507205470693841,-0.178437126270901,0.0203874182410845,0.11926344616026
Physical measures,X4270.Volume level set by participant (left),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",32122,-0.0712611982126764,0.0457927987899487,-0.161015083840976,0.0184926874156231,0.119709889739697
Physical measures,X4270.Volume level set by participant (left),GORASP2,Golgi reassembly-stacking protein 2,32329,-0.0685106984411723,0.0440358864784585,-0.154821035938951,0.0177996390566064,0.119797650429385
Physical measures,X4270.Volume level set by participant (left),TDGF1,Teratocarcinoma-derived growth factor 1,33219,0.0194312032777731,0.0124931714395208,-0.00505541274368765,0.0439178192992339,0.119899813800162
Physical measures,X4270.Volume level set by participant (left),CKB,Creatine kinase B-type,32384,-0.0514312367933555,0.0330792159343212,-0.116266500024625,0.013404026437914,0.120035983280583
Physical measures,X4270.Volume level set by participant (left),ATRN,"Attractin, Isoform 2",32398,-0.187811076995888,0.120846399327584,-0.424670019677952,0.0490478656861768,0.120193127890707
Physical measures,X4270.Volume level set by participant (left),PRDX1,Peroxiredoxin-1,33155,-0.0298818859978968,0.0192788620183797,-0.067668455553921,0.00790468355812744,0.121182248689948
Physical measures,X4270.Volume level set by participant (left),STOML2,"Stomatin-like protein 2, mitochondrial",32075,-0.0343099369442912,0.0221392211776947,-0.0777028104525727,0.00908293656399038,0.121246543095035
Physical measures,X4270.Volume level set by participant (left),PSRC1,Proline/serine-rich coiled-coil protein 1,33232,-0.0460337882180253,0.0297525750608504,-0.104348835337292,0.0122812589012415,0.121846185273522
Physical measures,X4270.Volume level set by participant (left),PLAT,Tissue-type plasminogen activator,33492,0.0547768242659775,0.0354204346405536,-0.0146472276295076,0.124200876161463,0.122024857481518
Physical measures,X4270.Volume level set by participant (left),SF3B4,Splicing factor 3B subunit 4,33386,-0.0367901596419984,0.0238507598244635,-0.0835376488979469,0.00995732961395007,0.122983875790257
Physical measures,X4270.Volume level set by participant (left),DNAJC9,DnaJ homolog subfamily C member 9,32329,-0.0411082546513447,0.0266793305396487,-0.0933997425090562,0.0111832332063668,0.123398881281152
Physical measures,X4270.Volume level set by participant (left),EGFR,Epidermal growth factor receptor,33533,-0.159849584318061,0.10375099664152,-0.36320153773544,0.0435023690993183,0.123423676716068
Physical measures,X4270.Volume level set by participant (left),IL17D,Interleukin-17D,33273,-0.0802429324594442,0.0520890205342826,-0.182337412706638,0.0218515477877496,0.123475357171987
Physical measures,X4270.Volume level set by participant (left),SCP2,Non-specific lipid-transfer protein,33232,-0.0342642138922266,0.0222452788976848,-0.0778649605316888,0.00933653274723556,0.123525365400567
Physical measures,X4270.Volume level set by participant (left),ACE2,Angiotensin-converting enzyme 2,33273,0.0575166324856189,0.0373469975049339,-0.0156834826240515,0.130716747595289,0.123581509226818
Physical measures,X4270.Volume level set by participant (left),ENOPH1,Enolase-phosphatase E1,32319,-0.0525364221418989,0.0341252897758046,-0.119421990102476,0.0143491458186782,0.123718662187459
Physical measures,X4270.Volume level set by participant (left),RARRES2,Retinoic acid receptor responder protein 2,33475,0.0572237335752044,0.0371746281238528,-0.0156385375475471,0.130086004697956,0.123760713165196
Physical measures,X4270.Volume level set by participant (left),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,32163,-0.0764810214974982,0.0497559839803527,-0.17400275009899,0.0210407071039932,0.12430446299324
Physical measures,X4270.Volume level set by participant (left),TNPO1,Transportin-1,32235,-0.0854002396924609,0.0556007820120361,-0.194377772436052,0.0235772930511298,0.124590344061116
Physical measures,X4270.Volume level set by participant (left),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,33533,0.0962140643033464,0.0628257644993151,-0.026924434115311,0.219352562722004,0.125694839559121
Physical measures,X4270.Volume level set by participant (left),MRPL46,"39S ribosomal protein L46, mitochondrial",33219,0.0979395281536384,0.0639658658293482,-0.027433568871884,0.223312625179161,0.125775399323006
Physical measures,X4270.Volume level set by participant (left),VPS28,Vacuolar protein sorting-associated protein 28 homolog,32235,-0.0481317080558104,0.0314506858540704,-0.109775052329788,0.0135116362181676,0.125961721581201
Physical measures,X4270.Volume level set by participant (left),CXCL14,C-X-C motif chemokine 14,33273,0.042265131896857,0.0276491973394374,-0.0119272948884402,0.0964575586821543,0.126394401063208
Physical measures,X4270.Volume level set by participant (left),S100P,Protein S100-P,33273,0.0472800228591799,0.0309563392218274,-0.0133944020156017,0.107954447733962,0.126719036362321
Physical measures,X4270.Volume level set by participant (left),TPT1,Translationally-controlled tumor protein,33273,-0.0409748875655056,0.0268287918828555,-0.0935593196559024,0.0116095445248913,0.12672902434687
Physical measures,X4270.Volume level set by participant (left),PCDHB15,Protocadherin beta-15,32319,-0.0750768011303638,0.0492605757192708,-0.171627529540135,0.0214739272794069,0.127530242965323
Physical measures,X4270.Volume level set by participant (left),IGLC2,Immunoglobulin lambda constant 2,32380,-0.120804395572123,0.0793573714692688,-0.27634484365189,0.0347360525076439,0.12797802685196
Physical measures,X4270.Volume level set by participant (left),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,33533,-0.0371666279838077,0.0244327523741037,-0.085054822637051,0.0107215666694357,0.128249360638255
Physical measures,X4270.Volume level set by participant (left),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",32319,-0.0842946227801169,0.0554906981070542,-0.193056391069943,0.0244671455097093,0.128783408382777
Physical measures,X4270.Volume level set by participant (left),AZU1,Azurocidin,33131,0.032910931892479,0.0216679261001721,-0.00955820326385833,0.0753800670488163,0.128829696002718
Physical measures,X4270.Volume level set by participant (left),RAB6A,Ras-related protein Rab-6A,33421,-0.0521543538329589,0.0343562236791007,-0.119492552243996,0.0151838445780785,0.129037870094588
Physical measures,X4270.Volume level set by participant (left),APOA4,Apolipoprotein A-IV,32398,-0.0821439039107552,0.0541204316109653,-0.188219949868247,0.0239321420467368,0.129105028949053
Physical measures,X4270.Volume level set by participant (left),SLC51B,Organic solute transporter subunit beta,32122,-0.0395489330514448,0.0260576949592042,-0.090622015171485,0.0115241490685954,0.129119955959926
Physical measures,X4270.Volume level set by participant (left),CXCL3,C-X-C motif chemokine 3,33427,-0.0274127406354355,0.0180725444593307,-0.0628349277757236,0.00800944650485272,0.129348153312409
Physical measures,X4270.Volume level set by participant (left),CD302,CD302 antigen,33386,-0.0880811006913398,0.0581141962146151,-0.201984925271985,0.0258227238893059,0.129641877643048
Physical measures,X4270.Volume level set by participant (left),SNU13,NHP2-like protein 1,32122,-0.0466689623561517,0.0308215383088039,-0.107079177441407,0.013741252729104,0.130024659178039
Physical measures,X4270.Volume level set by participant (left),TRIM58,E3 ubiquitin-protein ligase TRIM58,32319,-0.0360820337658854,0.0239358865530539,-0.0829963714098711,0.0108323038781003,0.131736786915239
Physical measures,X4270.Volume level set by participant (left),PRTN3,Myeloblastin,33178,0.0531029793982743,0.0352353498971498,-0.0159583064001393,0.122164265196688,0.131822813317759
Physical measures,X4270.Volume level set by participant (left),FRMD7,FERM domain-containing protein 7,32154,0.0904819789692382,0.0601019497049415,-0.0273178424524471,0.208281800390924,0.132243038927116
Physical measures,X4270.Volume level set by participant (left),ACTA2,"Actin, aortic smooth muscle",33273,-0.0571564797731845,0.0379715949015594,-0.131580805780241,0.0172678462338719,0.132297414716184
Physical measures,X4270.Volume level set by participant (left),ATP6V1G1,V-type proton ATPase subunit G 1,32163,-0.0428703623821842,0.0284807884930845,-0.0986927078286299,0.0129519830642615,0.132303897951427
Physical measures,X4270.Volume level set by participant (left),TXK,Tyrosine-protein kinase TXK,32235,-0.0385835693146433,0.0256436783236907,-0.088845178829077,0.0116780401997905,0.132466627630185
Physical measures,X4270.Volume level set by participant (left),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,32235,-0.0290148851301816,0.0193047279020176,-0.0668521518181361,0.00882238155777293,0.132881246924639
Physical measures,X4270.Volume level set by participant (left),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,33418,0.025308198550374,0.0168555299290621,-0.00772864011058784,0.0583450372113358,0.133267334248024
Physical measures,X4270.Volume level set by participant (left),CNTN4,Contactin-4,33441,-0.105574257167586,0.0703152414550979,-0.243392130419577,0.0322436160844062,0.13327641214903
Physical measures,X4270.Volume level set by participant (left),PCSK7,Proprotein convertase subtilisin/kexin type 7,32319,-0.0644532134244932,0.0429962659322483,-0.1487258946517,0.0198194678027135,0.133902847095495
Physical measures,X4270.Volume level set by participant (left),NFASC,Neurofascin,33527,-0.0932814029003274,0.062244769440427,-0.215281151003564,0.0287183452029095,0.134006424368321
Physical measures,X4270.Volume level set by participant (left),PDGFB,Platelet-derived growth factor subunit B,33481,-0.029984873551227,0.020009299814086,-0.0692031011868355,0.00923335408438156,0.134026196711344
Physical measures,X4270.Volume level set by participant (left),COL4A4,Collagen alpha-4(IV) chain,32225,-0.0584494176907404,0.0390256972955586,-0.134939784390035,0.0180409490085545,0.134247631106474
Physical measures,X4270.Volume level set by participant (left),CTSB,Cathepsin B,33417,-0.0477413356480459,0.0319449050641765,-0.110353349573832,0.0148706782777401,0.13508284615995
Physical measures,X4270.Volume level set by participant (left),AP3S2,AP-3 complex subunit sigma-2,32353,-0.0625486407868756,0.04188942473601,-0.144651913269455,0.0195546316957041,0.135428836688791
Physical measures,X4270.Volume level set by participant (left),PDGFRA,Platelet-derived growth factor receptor alpha,33434,-0.0892645882550764,0.0598716891275736,-0.206613098945121,0.0280839224349679,0.136014603784636
Physical measures,X4270.Volume level set by participant (left),SFTPA2,Pulmonary surfactant-associated protein A2,33232,-0.052655379126027,0.0353697251237092,-0.121980040368497,0.016669282116443,0.136598817089781
Physical measures,X4270.Volume level set by participant (left),MCTS1,Malignant T-cell-amplified sequence 1,32329,-0.112550512867312,0.0756159859994168,-0.260757845426169,0.0356568196915451,0.136672659411503
Physical measures,X4270.Volume level set by participant (left),SELL,L-selectin,32398,-0.129703074676777,0.0871463423055528,-0.300509905595661,0.0411037562421061,0.136701894579602
Physical measures,X4270.Volume level set by participant (left),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,33386,-0.128733320394141,0.0865775521972795,-0.298425322700809,0.0409586819125265,0.137072992385779
Physical measures,X4270.Volume level set by participant (left),ECHS1,"Enoyl-CoA hydratase, mitochondrial",32163,-0.0321102623121346,0.0216105860135126,-0.0744670108986192,0.01024648627435,0.137357579856571
Physical measures,X4270.Volume level set by participant (left),TACSTD2,Tumor-associated calcium signal transducer 2,32415,-0.0934907440059514,0.0631244225647029,-0.217214612232769,0.0302331242208663,0.138631488343639
Physical measures,X4270.Volume level set by participant (left),ENO2,Gamma-enolase,33500,-0.0405235343109705,0.0273617191327761,-0.0941525038112116,0.0131054351892707,0.138633339534702
Physical measures,X4270.Volume level set by participant (left),HSP90B1,Endoplasmin,33166,-0.037319252310252,0.0252425154861829,-0.0867945826631705,0.0121560780426665,0.139329299193588
Physical measures,X4270.Volume level set by participant (left),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,32353,-0.0352301635555328,0.023831149683754,-0.0819392169356907,0.0114788898246251,0.139360920274063
Physical measures,X4270.Volume level set by participant (left),FKBPL,FK506-binding protein-like,32329,-0.0525674320846519,0.0355721948204966,-0.122288933932825,0.0171540697635215,0.139510026362758
Physical measures,X4270.Volume level set by participant (left),CDSN,Corneodesmosin,33509,0.0578566051088019,0.0392209009201108,-0.0190163606946153,0.134729570912219,0.140207724847163
Physical measures,X4270.Volume level set by participant (left),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,33432,0.0516101142998304,0.0350272761673367,-0.0170433469881496,0.12026357558781,0.140671151400725
Physical measures,X4270.Volume level set by participant (left),MMP9,Matrix metalloproteinase-9,33424,0.0418835180412633,0.0284453868284985,-0.0138694401425938,0.0976364762251203,0.140942948822681
Physical measures,X4270.Volume level set by participant (left),RAC3,Ras-related C3 botulinum toxin substrate 3,32154,-0.0428689652007156,0.0291366697550892,-0.0999768379206904,0.0142389075192592,0.141249175879458
Physical measures,X4270.Volume level set by participant (left),PCARE,Photoreceptor cilium actin regulator,32111,0.0339279740386183,0.0230904707100726,-0.011329348553124,0.0791852966303605,0.141779076961794
Physical measures,X4270.Volume level set by participant (left),COL4A1,Collagen alpha-1(IV) chain,33434,-0.0628958397763238,0.0428237244816104,-0.14683033976028,0.0210386602076325,0.141945181220749
Physical measures,X4270.Volume level set by participant (left),CASP10,Caspase-10,33219,0.0377191571587121,0.0256948234357414,-0.012642696775341,0.0880810110927652,0.142149028642864
Physical measures,X4270.Volume level set by participant (left),CLSTN3,Calsyntenin-3,32353,-0.0944954411903993,0.0644715371113534,-0.220859653928652,0.0318687715478534,0.142771917370285
Physical measures,X4270.Volume level set by participant (left),CFC1,Cryptic protein,33232,-0.0547997085031944,0.0374096634205184,-0.12812264880741,0.0185232318010216,0.142996474955563
Physical measures,X4270.Volume level set by participant (left),FLT4,Vascular endothelial growth factor receptor 3,33456,0.0753185482221115,0.0514429178926602,-0.0255095708475024,0.176146667291726,0.143196387029622
Physical measures,X4270.Volume level set by participant (left),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,32319,-0.0389720345887094,0.0266237327011212,-0.0911545506829069,0.0132104815054881,0.143286368227171
Physical measures,X4270.Volume level set by participant (left),DNAJC6,Putative tyrosine-protein phosphatase auxilin,32163,-0.0369174970146018,0.0252303165107028,-0.0863689173755793,0.0125339233463757,0.143448037298942
Physical measures,X4270.Volume level set by participant (left),PTPRH,Receptor-type tyrosine-protein phosphatase H,32329,-0.0604627868829582,0.0414158341310326,-0.141637821779782,0.0207122480138657,0.144358710596108
Physical measures,X4270.Volume level set by participant (left),CCN5,CCN family member 5,33441,0.0646715912753528,0.0443063235607204,-0.0221688029036592,0.151511985454365,0.144422077586343
Physical measures,X4270.Volume level set by participant (left),MOG,Myelin-oligodendrocyte glycoprotein,33509,-0.0787034220692588,0.0539525131229789,-0.184450347790297,0.0270435036517798,0.144667630089544
Physical measures,X4270.Volume level set by participant (left),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",32140,-0.0631331651471818,0.0433148483688507,-0.148030267950129,0.0217639376557655,0.145007977066652
Physical measures,X4270.Volume level set by participant (left),THBD,Thrombomodulin,33434,-0.091873909854912,0.0630624981424349,-0.215476406214084,0.0317285865042603,0.145187025732306
Physical measures,X4270.Volume level set by participant (left),CCL3,C-C motif chemokine 3,33421,0.0370967634333756,0.0254879816228038,-0.0128596805473199,0.0870532074140712,0.145576687965112
Physical measures,X4270.Volume level set by participant (left),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,32329,-0.0475069557315526,0.0326595289140736,-0.111519632403137,0.0165057209400316,0.145816456641548
Physical measures,X4270.Volume level set by participant (left),TBCA,Tubulin-specific chaperone A,32213,-0.0354540686759464,0.0243757172345682,-0.0832304744557001,0.0123223371038073,0.145852872151525
Physical measures,X4270.Volume level set by participant (left),APOD,Apolipoprotein D,32053,-0.0686243844819437,0.0472541135490773,-0.161242447038135,0.0239936780742477,0.146475760520951
Physical measures,X4270.Volume level set by participant (left),SSH3,Protein phosphatase Slingshot homolog 3,32075,-0.100211131460766,0.06905716018071,-0.235563165414958,0.035140902493425,0.146783963782372
Physical measures,X4270.Volume level set by participant (left),C1RL,Complement C1r subcomponent-like protein,32381,0.146840976577278,0.101271394586073,-0.0516509568114254,0.345332909965981,0.147105096432901
Physical measures,X4270.Volume level set by participant (left),BPIFB2,BPI fold-containing family B member 2,32346,0.0422286818314372,0.0291569162239522,-0.0149188739675092,0.0993762376303835,0.147565995566727
Physical measures,X4270.Volume level set by participant (left),NOTCH3,Neurogenic locus notch homolog protein 3,33533,-0.0714657980553833,0.049400494368603,-0.168290767017845,0.0253591709070786,0.148026251594032
Physical measures,X4270.Volume level set by participant (left),SIGLEC1,Sialoadhesin,33481,0.0576512195283853,0.0398534929055753,-0.0204616265665422,0.135764065623313,0.148049640880763
Physical measures,X4270.Volume level set by participant (left),CTSS,Cathepsin S,31376,0.125504925246497,0.086769255637414,-0.0445628158028343,0.295572666295829,0.148104272571869
Physical measures,X4270.Volume level set by participant (left),IL7R,Interleukin-7 receptor subunit alpha,33441,-0.0483228731448605,0.0334777515889889,-0.113939266259279,0.0172935199695578,0.14893354639591
Physical measures,X4270.Volume level set by participant (left),FHIP2A,FHF complex subunit HOOK interacting protein 2A,32122,-0.0605653403635509,0.0420713099099091,-0.143025107786973,0.021894427059871,0.150024907319163
Physical measures,X4270.Volume level set by participant (left),ASGR1,Asialoglycoprotein receptor 1,33380,0.0859732390029102,0.0597369930860079,-0.0311112674456652,0.203057745451486,0.150130079536632
Physical measures,X4270.Volume level set by participant (left),SPAG1,Sperm-associated antigen 1,32350,0.048122606282686,0.0334434929855311,-0.0174266399689549,0.113671852534327,0.150212024618651
Physical measures,X4270.Volume level set by participant (left),PNMA1,Paraneoplastic antigen Ma1,32163,-0.0531395972057937,0.0369435628873062,-0.125548980464914,0.0192697860533264,0.15036137407404
Physical measures,X4270.Volume level set by participant (left),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,33452,0.0563649526286301,0.039203152910752,-0.0204732270764439,0.133203132333704,0.150535294271268
Physical measures,X4270.Volume level set by participant (left),AMIGO2,Amphoterin-induced protein 2,33386,-0.111126952049883,0.077436964147514,-0.26290340177901,0.040649497679245,0.1513040529082
Physical measures,X4270.Volume level set by participant (left),CHL1,Neural cell adhesion molecule L1-like protein,33438,-0.0775365405149174,0.0540412388507167,-0.183457368662322,0.0283842876324873,0.151388557754363
Physical measures,X4270.Volume level set by participant (left),HAVCR2,Hepatitis A virus cellular receptor 2,33441,0.073008032139482,0.0508922571334727,-0.0267407918421246,0.172756856121089,0.151447119105662
Physical measures,X4270.Volume level set by participant (left),DKK3,Dickkopf-related protein 3,33533,-0.0835419411617376,0.0583001996453104,-0.197810332466546,0.0307264501430708,0.151903277624691
Physical measures,X4270.Volume level set by participant (left),IL31,Interleukin-31,32140,-0.0498404053654086,0.0348242703094353,-0.118095975171902,0.0184151644410846,0.152414309189418
Physical measures,X4270.Volume level set by participant (left),GMPR,GMP reductase 1,33527,-0.0503841695564634,0.0352215753993837,-0.119418457339255,0.0186501182263286,0.15261040120783
Physical measures,X4270.Volume level set by participant (left),LYAR,Cell growth-regulating nucleolar protein,33232,0.0516523738724284,0.0361091688181977,-0.0191215970112391,0.122426344756096,0.152623398788742
Physical measures,X4270.Volume level set by participant (left),PILRA,Paired immunoglobulin-like type 2 receptor alpha,33441,0.0601812489866309,0.0420934650106331,-0.02232194243421,0.142684440407472,0.152836390393224
Physical measures,X4270.Volume level set by participant (left),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,33164,0.0291326270573584,0.0203803040096822,-0.0108127688016187,0.0690780229163355,0.152910783803703
Physical measures,X4270.Volume level set by participant (left),SUSD5,Sushi domain-containing protein 5,32153,-0.0854293820711676,0.059926812585735,-0.202885934739208,0.0320271705968731,0.154035380110346
Physical measures,X4270.Volume level set by participant (left),HBZ,Hemoglobin subunit zeta,32365,0.0255689210602767,0.0179411297829772,-0.00959569331435872,0.060733535434912,0.154151369343628
Physical measures,X4270.Volume level set by participant (left),TRPV3,Transient receptor potential cation channel subfamily V member 3,32122,-0.0581466874194751,0.0408114151733239,-0.13813706115919,0.0218436863202399,0.154265763964753
Physical measures,X4270.Volume level set by participant (left),NAGA,Alpha-N-acetylgalactosaminidase,32128,-0.0478885504198077,0.0336624542289349,-0.11386696070852,0.0180898598689047,0.154889839764179
Physical measures,X4270.Volume level set by participant (left),C19orf12,Protein C19orf12,33219,0.0393936019073895,0.0277371960578657,-0.0149713023660273,0.0937585061808063,0.155572066349507
Physical measures,X4270.Volume level set by participant (left),TFPI,Tissue factor pathway inhibitor,33368,-0.0764874588790092,0.0539316982449481,-0.182193587439107,0.0292186696810891,0.156159093646845
Physical measures,X4270.Volume level set by participant (left),NGFR,Tumor necrosis factor receptor superfamily member 16,32365,-0.0948448906389438,0.0668845984517842,-0.225938703604441,0.0362489223265532,0.156219114248795
Physical measures,X4270.Volume level set by participant (left),CFHR5,Complement factor H-related protein 5,32269,0.0689722373670773,0.0486893452527743,-0.0264588793283603,0.164403354062515,0.156646315769747
Physical measures,X4270.Volume level set by participant (left),CFD,Complement factor D,32398,-0.144934648570832,0.102473832202464,-0.345783359687661,0.0559140625459965,0.157296113551727
Physical measures,X4270.Volume level set by participant (left),KIF20B,Kinesin-like protein KIF20B,32111,0.036949251999058,0.0261624068068949,-0.014329065342456,0.088227569340572,0.157901336931095
Physical measures,X4270.Volume level set by participant (left),BOLA2_BOLA2B,BolA-like protein 2,32163,-0.0534178458301999,0.0378337709585522,-0.127572036908962,0.0207363452485624,0.158017092627189
Physical measures,X4270.Volume level set by participant (left),SORT1,Sortilin,33418,-0.0675781078526602,0.0478742932383628,-0.161411722599851,0.0262555068945308,0.158110143272036
Physical measures,X4270.Volume level set by participant (left),EIF4B,Eukaryotic translation initiation factor 4B,33380,-0.0460115371600571,0.0326034089327928,-0.109914218668331,0.0178911443482168,0.158205983477906
Physical measures,X4270.Volume level set by participant (left),CD226,CD226 antigen,32140,-0.0700236603735511,0.0496349334485337,-0.167308129932677,0.0272608091855748,0.158351818765351
Physical measures,X4270.Volume level set by participant (left),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,33273,-0.118518398882393,0.0840169883777723,-0.283191696102827,0.0461548983380408,0.158383698131615
Physical measures,X4270.Volume level set by participant (left),TERF1,Telomeric repeat-binding factor 1,32140,-0.0956127329901865,0.0678873719667457,-0.228671982045008,0.0374465160646351,0.159052422685724
Physical measures,X4270.Volume level set by participant (left),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",32122,0.0335869304434249,0.0238566386209055,-0.0131720812535498,0.0803459421403997,0.159211543314493
Physical measures,X4270.Volume level set by participant (left),GLI2,Zinc finger protein GLI2,32140,-0.0820497364624479,0.0583132319388298,-0.196343671062554,0.0322441981376586,0.15945247694702
Physical measures,X4270.Volume level set by participant (left),RBM19,Probable RNA-binding protein 19,32122,-0.0638217781983222,0.0454042184537565,-0.152814046367685,0.0251704899710406,0.159872929926949
Physical measures,X4270.Volume level set by participant (left),DDHD2,Phospholipase DDHD2,32350,-0.0444308738698713,0.0316480187358908,-0.106460990592217,0.0175992428524746,0.160385889370195
Physical measures,X4270.Volume level set by participant (left),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",32163,-0.0528375052514715,0.037641114883986,-0.126614090424084,0.0209390799211411,0.160443167501197
Physical measures,X4270.Volume level set by participant (left),COL15A1,Collagen alpha-1(XV) chain,32384,-0.108627293318679,0.0774931346314423,-0.260513837196305,0.0432592505589483,0.161024077619906
Physical measures,X4270.Volume level set by participant (left),CD300LF,CMRF35-like molecule 1,33509,0.0400407966371574,0.0285742273099103,-0.0159646888902668,0.0960462821645816,0.161161461243378
Physical measures,X4270.Volume level set by participant (left),MYH9,Myosin-9,32384,-0.025000479563113,0.0178412338790218,-0.0599692979659958,0.00996833883976979,0.161170916111369
Physical measures,X4270.Volume level set by participant (left),KLK4,Kallikrein-4,33509,-0.0392948049351267,0.0280451763642535,-0.0942633506090635,0.0156737407388101,0.161210894211044
Physical measures,X4270.Volume level set by participant (left),LGALS3,Galectin-3,33425,0.0816925704532043,0.0583526498292444,-0.0326786232121147,0.196063764118523,0.161553750034648
Physical measures,X4270.Volume level set by participant (left),LYPLA2,Acyl-protein thioesterase 2,32111,0.0257269829148456,0.0183856257730845,-0.0103088436004,0.0617628094300912,0.161763931534932
Physical measures,X4270.Volume level set by participant (left),PRRT3,Proline-rich transmembrane protein 3,32163,-0.0756597063442929,0.05410330494829,-0.181702184042941,0.0303827713543556,0.162024090438871
Physical measures,X4270.Volume level set by participant (left),TMPRSS11D,Transmembrane protease serine 11D,32326,0.0734052993364742,0.0525175907370555,-0.0295291785081545,0.176339777181103,0.162234197189609
Physical measures,X4270.Volume level set by participant (left),CTSO,Cathepsin O,33527,-0.0786572768708228,0.0562839597394122,-0.188973837960071,0.0316592842184251,0.162295074493599
Physical measures,X4270.Volume level set by participant (left),KCNC4,Potassium voltage-gated channel subfamily C member 4,32111,-0.0506440517479078,0.0362573525023352,-0.121708462652485,0.0204203591566692,0.162516019193603
Physical measures,X4270.Volume level set by participant (left),NUDT5,ADP-sugar pyrophosphatase,33441,-0.0489633174722215,0.035064784860498,-0.117690295798798,0.0197636608543546,0.162638420048568
Physical measures,X4270.Volume level set by participant (left),DSG3,Desmoglein-3,33472,0.071794523706554,0.0514649692669032,-0.0290768160565763,0.172665863469684,0.163044974848992
Physical measures,X4270.Volume level set by participant (left),DYNLT1,Dynein light chain Tctex-type 1,32154,0.035618298260738,0.0255761069143746,-0.0145108712914362,0.0857474678129123,0.163769029373629
Physical measures,X4270.Volume level set by participant (left),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,33500,-0.0503589828476411,0.0362034113121478,-0.121317669019451,0.0205997033241686,0.16425932642013
Physical measures,X4270.Volume level set by participant (left),IGFBPL1,Insulin-like growth factor-binding protein-like 1,33434,-0.0715674718004177,0.0514704429540737,-0.172449539990402,0.0293145963895668,0.16442440887858
Physical measures,X4270.Volume level set by participant (left),ART3,Ecto-ADP-ribosyltransferase 3,33452,-0.0731288596248549,0.0526034730892084,-0.176231666879703,0.0299739476299937,0.164505363975308
Physical measures,X4270.Volume level set by participant (left),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",32350,-0.0653260114256219,0.0470466602658734,-0.157537465546734,0.02688544269549,0.165012869052097
Physical measures,X4270.Volume level set by participant (left),S100A14,Protein S100-A14,32350,-0.050641751248566,0.0364787063210424,-0.122140015637809,0.020856513140677,0.165098538996833
Physical measures,X4270.Volume level set by participant (left),FOXO3,Forkhead box protein O3,33232,-0.0260446680723729,0.0187610481490131,-0.0628163224444386,0.0107269862996927,0.165101957619865
Physical measures,X4270.Volume level set by participant (left),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,33380,0.0342886856662987,0.0247126984080198,-0.0141482032134202,0.0827255745460176,0.165326253885407
Physical measures,X4270.Volume level set by participant (left),MRI1,Methylthioribose-1-phosphate isomerase,32154,-0.0404600274923778,0.0291843316064321,-0.0976613174409847,0.0167412624562291,0.165676756700371
Physical measures,X4270.Volume level set by participant (left),SNCA,Alpha-synuclein,32213,-0.0257872774788668,0.0186361150246024,-0.0623140629270875,0.0107395079693539,0.166482169389591
Physical measures,X4270.Volume level set by participant (left),ATXN3,Ataxin-3,32353,-0.045273047530864,0.0327333112142268,-0.109430337510749,0.0188842424490206,0.166677004107791
Physical measures,X4270.Volume level set by participant (left),CUZD1,CUB and zona pellucida-like domain-containing protein 1,32154,0.0780267865156326,0.0564278925961519,-0.0325718829728251,0.18862545600409,0.166775561330073
Physical measures,X4270.Volume level set by participant (left),PCDH12,Protocadherin-12,32350,-0.10863446348509,0.0785762070353435,-0.262643829274363,0.0453749023041837,0.166846178774757
Physical measures,X4270.Volume level set by participant (left),CSF1R,Macrophage colony-stimulating factor 1 receptor,32381,-0.070637100004983,0.0511824356016371,-0.170954673784192,0.0296804737742257,0.167593455019314
Physical measures,X4270.Volume level set by participant (left),IL20RA,Interleukin-20 receptor subunit alpha,33273,0.0543433351195052,0.0395808256458084,-0.0232350831462791,0.13192175338529,0.169796201229683
Physical measures,X4270.Volume level set by participant (left),FAM20A,Pseudokinase FAM20A,32365,0.0980386103376726,0.0714551346111729,-0.0420134535002262,0.238090674175571,0.170092911623513
Physical measures,X4270.Volume level set by participant (left),F11,Coagulation factor XI,32271,-0.0889712759405993,0.0648546076444369,-0.216086306923696,0.0381437550424971,0.170147196505902
Physical measures,X4270.Volume level set by participant (left),GIPC2,PDZ domain-containing protein GIPC2,32353,-0.0877436339183877,0.0640077614762341,-0.213198846411807,0.0377115785750312,0.170467522370824
Physical measures,X4270.Volume level set by participant (left),DARS1,"Aspartate--tRNA ligase, cytoplasmic",33356,-0.0352042224193276,0.0256949910902704,-0.0855664049562575,0.0151579601176024,0.1706961335355
Physical measures,X4270.Volume level set by participant (left),SLA2,Src-like-adapter 2,32350,-0.0271168749966034,0.0198217960255134,-0.0659675952066098,0.0117338452134029,0.171340618899223
Physical measures,X4270.Volume level set by participant (left),IMPACT,Protein IMPACT,32353,-0.0509042929894265,0.0372920783132051,-0.123996766483308,0.0221881805044555,0.172286823590558
Physical measures,X4270.Volume level set by participant (left),SEZ6,Seizure protein 6 homolog,32154,-0.0885451814287877,0.0649509172443984,-0.215848979227809,0.0387586163702332,0.172839506797192
Physical measures,X4270.Volume level set by participant (left),NXPH1,Neurexophilin-1,33219,-0.0664282237411691,0.0487412959373793,-0.161961163778433,0.0291047162960942,0.17295737691481
Physical measures,X4270.Volume level set by participant (left),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,32350,-0.0253830270672441,0.0186451693522063,-0.0619275589975684,0.0111615048630803,0.173434746713795
Physical measures,X4270.Volume level set by participant (left),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",32111,-0.0593252711875103,0.0435897582472538,-0.144761197352128,0.0261106549771071,0.173556573690529
Physical measures,X4270.Volume level set by participant (left),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,32319,-0.0562986054510068,0.0413968734112342,-0.137436477337026,0.0248392664350122,0.17387764256011
Physical measures,X4270.Volume level set by participant (left),YOD1,Ubiquitin thioesterase OTU1,32122,-0.0442683802072613,0.0326180578071879,-0.10819977350935,0.019663013094827,0.174765878075282
Physical measures,X4270.Volume level set by participant (left),TSC1,Hamartin,32140,-0.035675084437892,0.0262926659531787,-0.0872087097061224,0.0158585408303383,0.174870171718877
Physical measures,X4270.Volume level set by participant (left),NFE2,Transcription factor NF-E2 45 kDa subunit,32163,-0.0376264003193025,0.0277497405781542,-0.0920158918524848,0.0167630912138798,0.175164664543215
Physical measures,X4270.Volume level set by participant (left),COCH,Cochlin,32365,-0.057473625258831,0.0424231204253295,-0.140622941292477,0.0256756907748148,0.175529130552313
Physical measures,X4270.Volume level set by participant (left),MST1,Hepatocyte growth factor-like protein,32228,-0.043404642750782,0.0320550392956274,-0.106232519770212,0.0194232342686477,0.175754647487986
Physical measures,X4270.Volume level set by participant (left),RSPO3,R-spondin-3,33509,-0.0832341504203348,0.0615142325565923,-0.203802046231256,0.037333745390586,0.176061403605637
Physical measures,X4270.Volume level set by participant (left),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",33453,-0.0672596003521942,0.0497231442095367,-0.164716963002886,0.0301977622984977,0.176191244056177
Physical measures,X4270.Volume level set by participant (left),PPBP,Platelet basic protein,32318,-0.0316577047852052,0.0234111085242956,-0.0775434774928246,0.0142280679224141,0.176333788375435
Physical measures,X4270.Volume level set by participant (left),FGF6,Fibroblast growth factor 6,32140,0.0610865961012892,0.0451871152753684,-0.0274801498384329,0.149653342041011,0.176460298071388
Physical measures,X4270.Volume level set by participant (left),CD34,Hematopoietic progenitor cell antigen CD34,33463,-0.0968204663201621,0.0717179191113186,-0.237387587778347,0.0437466551380224,0.177044198280526
Physical measures,X4270.Volume level set by participant (left),NFAT5,Nuclear factor of activated T-cells 5,32140,-0.0306309693368846,0.022713795012457,-0.0751500075613003,0.0138880688875312,0.177517312181742
Physical measures,X4270.Volume level set by participant (left),TCP11,T-complex protein 11 homolog,32235,-0.044783550066881,0.0332140357594113,-0.109883060155327,0.0203159600215652,0.177590848103049
Physical measures,X4270.Volume level set by participant (left),SCT,Secretin,32154,-0.060426271258321,0.0449077154785138,-0.148445393596208,0.0275928510795661,0.178482319301892
Physical measures,X4270.Volume level set by participant (left),HNF1A,Hepatocyte nuclear factor 1-alpha,32154,-0.038181002431085,0.0283838056994654,-0.0938132616020371,0.0174512567398672,0.178610433362562
Physical measures,X4270.Volume level set by participant (left),GGT5,Glutathione hydrolase 5 proenzyme,33380,-0.101350945102561,0.0754259795676546,-0.249185865055164,0.0464839748500424,0.179075046311218
Physical measures,X4270.Volume level set by participant (left),DKKL1,Dickkopf-like protein 1,33386,-0.0265021441372392,0.019724686765303,-0.0651625301972331,0.0121582419227547,0.179111002668892
Physical measures,X4270.Volume level set by participant (left),NXPE4,NXPE family member 4,32122,0.0751811240973639,0.0559937273099706,-0.0345665814301785,0.184928829624906,0.179418450515258
Physical measures,X4270.Volume level set by participant (left),ROBO2,Roundabout homolog 2,33500,-0.0982129007481924,0.0731714217230209,-0.241628887325313,0.0452030858289284,0.179555017049234
Physical measures,X4270.Volume level set by participant (left),FCER2,Low affinity immunoglobulin epsilon Fc receptor,33441,0.0477482489109808,0.0356203880360501,-0.0220677116396774,0.117564209461639,0.180124770384714
Physical measures,X4270.Volume level set by participant (left),PECR,Peroxisomal trans-2-enoyl-CoA reductase,32163,-0.0960768537635658,0.0717162890142432,-0.236640780231483,0.0444870727043509,0.180389007804481
Physical measures,X4270.Volume level set by participant (left),DMP1,Dentin matrix acidic phosphoprotein 1,32163,-0.0411064709560561,0.0307076956539848,-0.101293554437866,0.0190806125257541,0.180728213020049
Physical measures,X4270.Volume level set by participant (left),SIGLEC5,Sialic acid-binding Ig-like lectin 5,33441,0.0189966616348181,0.0141973103869783,-0.00883006672365948,0.0468233899932956,0.180915133313727
Physical measures,X4270.Volume level set by participant (left),NCF2,Neutrophil cytosol factor 2,33406,0.0277185137288949,0.0207202278795069,-0.0128931329149386,0.0683301603727284,0.181011477967843
Physical measures,X4270.Volume level set by participant (left),KITLG,Kit ligand,33434,-0.0640144414289427,0.0479229659016059,-0.15794345459609,0.029914571738205,0.181655716137897
Physical measures,X4270.Volume level set by participant (left),KRT14,"Keratin, type I cytoskeletal 14",32981,0.0852345752518536,0.064005301983224,-0.0402158166352655,0.210684967138973,0.183000990979163
Physical measures,X4270.Volume level set by participant (left),BATF,Basic leucine zipper transcriptional factor ATF-like,32154,-0.0323168469966824,0.0243264024587806,-0.0799965958158922,0.0153629018225275,0.184062926447474
Physical measures,X4270.Volume level set by participant (left),C5,Complement C5,32398,-0.169303366804565,0.127491823902097,-0.419187341652675,0.0805806080435453,0.184231230532437
Physical measures,X4270.Volume level set by participant (left),LMOD2,Leiomodin-2,32111,-0.0422513866929989,0.0318245235667574,-0.104627452883843,0.0201246794978456,0.184337932748671
Physical measures,X4270.Volume level set by participant (left),OPLAH,5-oxoprolinase,32163,-0.0400339476107742,0.0301716652325697,-0.0991704114666109,0.0191025162450625,0.184590225339494
Physical measures,X4270.Volume level set by participant (left),BCL7B,B-cell CLL/lymphoma 7 protein family member B,32319,-0.0575003336981467,0.0433571075824006,-0.142480264559652,0.0274795971633585,0.184810923483497
Physical measures,X4270.Volume level set by participant (left),ERBB2,Receptor tyrosine-protein kinase erbB-2,33456,-0.0932227618675442,0.0702958507742082,-0.231002629384992,0.0445571056499039,0.184824046553519
Physical measures,X4270.Volume level set by participant (left),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,32235,-0.0739072021843902,0.0558447066735322,-0.183362827264513,0.0355484228957329,0.185727488641856
Physical measures,X4270.Volume level set by participant (left),COL3A1,Collagen alpha-1(III) chain,32384,-0.111549374175935,0.0843104534048623,-0.276797862849465,0.0536991144975951,0.185847324216688
Physical measures,X4270.Volume level set by participant (left),MELTF,Melanotransferrin,32365,-0.0907085996094074,0.0685857101527657,-0.225136591508828,0.0437193922900133,0.186020548988671
Physical measures,X4270.Volume level set by participant (left),MYO6,Unconventional myosin-VI,32350,-0.0722191436154916,0.0546144579934467,-0.179263481282647,0.034825194051664,0.186091672606079
Physical measures,X4270.Volume level set by participant (left),SPART,Spartin,32213,-0.0359912307926963,0.0272303255341574,-0.0893626688396448,0.0173802072542522,0.186295914982015
Physical measures,X4270.Volume level set by participant (left),ADD1,Alpha-adducin,32213,-0.0407940162936148,0.0308710196288039,-0.10130121476607,0.0197131821788409,0.186395649395652
Physical measures,X4270.Volume level set by participant (left),SERPINI1,Neuroserpin,32192,-0.0829163234807525,0.0627912296214936,-0.20598713353888,0.0401544865773751,0.186704513533132
Physical measures,X4270.Volume level set by participant (left),CCL14,C-C motif chemokine 14,33368,0.0579690440877948,0.0439607045513857,-0.0281939368329212,0.144132025008511,0.187318044714538
Physical measures,X4270.Volume level set by participant (left),CD177,CD177 antigen,33430,0.0179308747888041,0.013618410182859,-0.00876120916959948,0.0446229587472077,0.187984788224608
Physical measures,X4270.Volume level set by participant (left),UGDH,UDP-glucose 6-dehydrogenase,32122,-0.026546011525629,0.0201942694144953,-0.0661267795780397,0.0130347565267817,0.188706588307725
Physical measures,X4270.Volume level set by participant (left),F2,Prothrombin,32398,-0.174114090565012,0.132684565124924,-0.434175838209863,0.0859476570798387,0.189476842302049
Physical measures,X4270.Volume level set by participant (left),GP5,Platelet glycoprotein V,32213,-0.0737979058734434,0.0562685970041768,-0.18408435600163,0.0364885442547431,0.189717859728121
Physical measures,X4270.Volume level set by participant (left),CASP8,Caspase-8,33489,-0.0380435134781326,0.0290150273934519,-0.0949129671692984,0.0188259402130332,0.189835057202712
Physical measures,X4270.Volume level set by participant (left),GUCA2A,Guanylin,33383,-0.0689547501776585,0.0529873550149641,-0.172809966006988,0.0349004656516712,0.193174483051191
Physical measures,X4270.Volume level set by participant (left),SORBS1,Sorbin and SH3 domain-containing protein 1,32350,-0.0638587328215955,0.0490742606005016,-0.160044283598579,0.0323268179553876,0.193204933028103
Physical measures,X4270.Volume level set by participant (left),SCN4B,Sodium channel subunit beta-4,32163,-0.0628589003283503,0.0483541521999017,-0.157633038640158,0.0319152379834571,0.193650455765637
Physical measures,X4270.Volume level set by participant (left),SAT2,Thialysine N-epsilon-acetyltransferase,32235,-0.0383177969189564,0.0294806262555919,-0.0960998243799166,0.0194642305420038,0.193721071408658
Physical measures,X4270.Volume level set by participant (left),DDT,D-dopachrome decarboxylase,32384,-0.0614146554269886,0.0472645122394955,-0.1540530994164,0.0312237885624227,0.193850651910919
Physical measures,X4270.Volume level set by participant (left),NGRN,Neugrin,32353,-0.119644306297755,0.0921839761037599,-0.300324899461125,0.0610362868656144,0.194364360398619
Physical measures,X4270.Volume level set by participant (left),TFAP2A,Transcription factor AP-2-alpha,32111,0.0442399503548013,0.0341022913977329,-0.0226005407847552,0.111080441494358,0.194576678385366
Physical measures,X4270.Volume level set by participant (left),ING1,Inhibitor of growth protein 1,33195,0.0528401641818782,0.0407549655125488,-0.0270395682227174,0.132719896586474,0.194826094073289
Physical measures,X4270.Volume level set by participant (left),SNX15,Sorting nexin-15,32213,-0.0485263490088079,0.0374274985253233,-0.121884246118441,0.0248315481008257,0.194827151202944
Physical measures,X4270.Volume level set by participant (left),MTIF3,"Translation initiation factor IF-3, mitochondrial",32329,-0.0308694915522574,0.0238136319095245,-0.0775442100949255,0.0158052269904107,0.194911867638178
Physical measures,X4270.Volume level set by participant (left),ANGPTL1,Angiopoietin-related protein 1,33285,-0.0774735483396833,0.0598437728169429,-0.194767343060891,0.0398202463815247,0.195493257979626
Physical measures,X4270.Volume level set by participant (left),PRR4,Proline-rich protein 4,32161,0.0384264810110073,0.0296837986363335,-0.0197537643162064,0.096606726338221,0.195522212281128
Physical measures,X4270.Volume level set by participant (left),DNAJB14,DnaJ homolog subfamily B member 14,32329,-0.0420557778070999,0.0325024798236611,-0.105760638261476,0.0216490826472759,0.195729208987824
Physical measures,X4270.Volume level set by participant (left),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,32213,-0.0457432157108236,0.035375525592623,-0.115079245872365,0.0235928144507174,0.196023546716405
Physical measures,X4270.Volume level set by participant (left),CTSH,Pro-cathepsin H,33239,-0.0316418128223857,0.0244832399654334,-0.0796289631546351,0.0163453375098638,0.196257268783674
Physical measures,X4270.Volume level set by participant (left),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",33441,-0.0504064890481539,0.0390287587830229,-0.126902856262879,0.0260898781665709,0.196556052971048
Physical measures,X4270.Volume level set by participant (left),CRIM1,Cysteine-rich motor neuron 1 protein,33481,-0.106087882822605,0.0822557901411263,-0.267309231499213,0.0551334658540022,0.197176946857865
Physical measures,X4270.Volume level set by participant (left),STAMBP,STAM-binding protein,33356,-0.0368481336939811,0.0285763720213296,-0.0928578228557871,0.0191615554678248,0.19727117122203
Physical measures,X4270.Volume level set by participant (left),SCGB3A2,Secretoglobin family 3A member 2,33468,0.02654171293443,0.0206023738791538,-0.0138389398687114,0.0669223657375713,0.197680118729365
Physical measures,X4270.Volume level set by participant (left),VPS4B,Vacuolar protein sorting-associated protein 4B,32319,-0.0286388631687937,0.0222382619029029,-0.0722258564984834,0.014948130160896,0.197846762224152
Physical measures,X4270.Volume level set by participant (left),RLN2,Prorelaxin H2,32204,-0.0177626958597559,0.0137996058006272,-0.0448099232289852,0.0092845315094733,0.198066990606035
Physical measures,X4270.Volume level set by participant (left),RLN1,Prorelaxin H1,32350,-0.0301480743785686,0.0234661715492208,-0.0761417706150413,0.0158456218579042,0.198918685623067
Physical measures,X4270.Volume level set by participant (left),ENSA,Alpha-endosulfine,32319,-0.0512415753848381,0.0398853821959443,-0.129416924488889,0.0269337737192128,0.198927749090634
Physical measures,X4270.Volume level set by participant (left),SRPX,Sushi repeat-containing protein SRPX,32365,-0.0772746432159192,0.0601946416336435,-0.19525614081786,0.040706854386022,0.199268372500342
Physical measures,X4270.Volume level set by participant (left),IMMT,MICOS complex subunit MIC60,32319,-0.0576860228861238,0.0449383173650218,-0.145765124921567,0.030393079149319,0.199294854503892
Physical measures,X4270.Volume level set by participant (left),NEDD9,Enhancer of filamentation 1,32140,0.074777222936674,0.0582912190592714,-0.0394735664194981,0.189028012292846,0.199593344421512
Physical measures,X4270.Volume level set by participant (left),YWHAQ,14-3-3 protein theta,32213,-0.0368094368159168,0.0286957680460128,-0.093053142186102,0.0194342685542683,0.199618727227983
Physical measures,X4270.Volume level set by participant (left),EDNRB,Endothelin receptor type B,32140,-0.0553994352734788,0.0432032171490318,-0.140077740885581,0.0292788703386235,0.1997765126435
Physical measures,X4270.Volume level set by participant (left),ITGAV,Integrin alpha-V,33509,-0.13516593708495,0.105423657152208,-0.341796305103278,0.0714644309333777,0.199832856523603
Physical measures,X4270.Volume level set by participant (left),CD300E,CMRF35-like molecule 2,33471,0.0558857348542471,0.0436220396044156,-0.0296134627704074,0.141384932478902,0.20017909681298
Physical measures,X4270.Volume level set by participant (left),PRELP,Prolargin,33424,-0.0939947745325226,0.0734962554250125,-0.238047435165547,0.050057886100502,0.200963379697227
Physical measures,X4270.Volume level set by participant (left),ASPN,Asporin,32365,-0.0952576951012194,0.0744997449947064,-0.241277195290844,0.0507618050884053,0.201064486215772
Physical measures,X4270.Volume level set by participant (left),PEAR1,Platelet endothelial aggregation receptor 1,33533,-0.0955653030507877,0.0748110166087382,-0.242194895603915,0.0510642895023392,0.20148566523822
Physical measures,X4270.Volume level set by participant (left),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,33232,0.0369121831504483,0.028948530852094,-0.0198269373196559,0.0936513036205526,0.202308682603611
Physical measures,X4270.Volume level set by participant (left),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",33386,-0.0510107217099795,0.0400099130147603,-0.12943015121891,0.0274087077989506,0.202359371208426
Physical measures,X4270.Volume level set by participant (left),CNTNAP4,Contactin-associated protein-like 4,32154,-0.0248398217451388,0.0194898127380047,-0.0630398547116279,0.0133602112213503,0.202523731084774
Physical measures,X4270.Volume level set by participant (left),CD300LG,CMRF35-like molecule 9,33441,-0.059067756869716,0.0464113104734159,-0.150033925397611,0.0318984116581791,0.203156817963685
Physical measures,X4270.Volume level set by participant (left),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,32140,-0.0750584554943844,0.0590425025510377,-0.190781760494418,0.0406648495056495,0.203674138319082
Physical measures,X4270.Volume level set by participant (left),SNX18,Sorting nexin-18,32329,-0.0550936665433481,0.0433430381642603,-0.140046021345298,0.0298586882586021,0.203727909765967
Physical measures,X4270.Volume level set by participant (left),TNNI3,"Troponin I, cardiac muscle",33273,0.0262339898507334,0.0206447197602157,-0.0142296608792893,0.0666976405807561,0.20385608540888
Physical measures,X4270.Volume level set by participant (left),LMOD1,Leiomodin-1,32350,-0.0720361445586868,0.0567204310764177,-0.183208189468465,0.0391359003510919,0.204114541382139
Physical measures,X4270.Volume level set by participant (left),IL12RB2,Interleukin-12 receptor subunit beta-2,32140,-0.0604043787148279,0.0475786483467516,-0.153658529474461,0.0328497720448053,0.204276628026036
Physical measures,X4270.Volume level set by participant (left),OGFR,Opioid growth factor receptor,33386,-0.068265687678724,0.0538271409997993,-0.173766884038331,0.0372355086808826,0.204745617456281
Physical measures,X4270.Volume level set by participant (left),NCS1,Neuronal calcium sensor 1,33509,-0.0767548878260445,0.0606184298155978,-0.195567010264616,0.0420572346125272,0.205475055895104
Physical measures,X4270.Volume level set by participant (left),GDF15,Growth/differentiation factor 15,33533,0.0510697305191413,0.0403341556577664,-0.0279852145700808,0.130124675608363,0.205486200443315
Physical measures,X4270.Volume level set by participant (left),SMS,Spermine synthase,32111,-0.0399994631909579,0.0316274217134594,-0.101989209749338,0.0219902833674225,0.2060144046313
Physical measures,X4270.Volume level set by participant (left),TPMT,Thiopurine S-methyltransferase,33232,-0.0308501018325475,0.0244052311191471,-0.0786843548260759,0.0169841511609809,0.206235805614147
Physical measures,X4270.Volume level set by participant (left),CD163,Scavenger receptor cysteine-rich type 1 protein M130,33452,0.0515119605515819,0.0408297782199975,-0.0285144047596132,0.131538325862777,0.207115656080702
Physical measures,X4270.Volume level set by participant (left),TPP1,Tripeptidyl-peptidase 1,33363,-0.0490716367070983,0.0389090453721028,-0.12533336563642,0.0271900922222233,0.207274003997634
Physical measures,X4270.Volume level set by participant (left),PSMG4,Proteasome assembly chaperone 4,32140,-0.0430739519854734,0.0341614797192252,-0.110030452235155,0.023882548264208,0.207385874786785
Physical measures,X4270.Volume level set by participant (left),THOP1,Thimet oligopeptidase,33390,-0.0704145718861926,0.0558857400521253,-0.179950622388358,0.039121478615973,0.207711697678689
Physical measures,X4270.Volume level set by participant (left),REEP4,Receptor expression-enhancing protein 4,32350,-0.0379624248237644,0.0301588392789552,-0.0970737498105165,0.0211489001629878,0.208158033216275
Physical measures,X4270.Volume level set by participant (left),CASP4,Caspase-4,32235,0.014920429733745,0.0118785090982044,-0.00836144809873555,0.0382023075662256,0.209122485779044
Physical measures,X4270.Volume level set by participant (left),ALPP,"Alkaline phosphatase, placental type",33386,-0.0211509078668974,0.0168778049925999,-0.0542314056523932,0.0119295899185983,0.210173440790137
Physical measures,X4270.Volume level set by participant (left),DEFA1_DEFA1B,Neutrophil defensin 1,33235,0.0405289598501301,0.0323409443787366,-0.0228592911321936,0.103917210832454,0.210174307596633
Physical measures,X4270.Volume level set by participant (left),MTSS2,Protein MTSS 2,32319,-0.0263645246655214,0.0210435209398996,-0.0676098257077246,0.0148807763766817,0.210294968242037
Physical measures,X4270.Volume level set by participant (left),ADM,Pro-adrenomedullin,33509,0.0778420644041963,0.0621358070981904,-0.0439441175082568,0.199628246316649,0.210320667916454
Physical measures,X4270.Volume level set by participant (left),PDLIM5,PDZ and LIM domain protein 5,32350,-0.0222723682598585,0.0177900081924085,-0.0571407843169791,0.0125960477972621,0.210621741292642
Physical measures,X4270.Volume level set by participant (left),MXRA8,Matrix remodeling-associated protein 8,32213,-0.0836420821713919,0.0668250183866161,-0.214619118209159,0.0473349538663758,0.210732175417288
Physical measures,X4270.Volume level set by participant (left),SERPINB9,Serpin B9,33380,-0.0701186389494383,0.0560265282597625,-0.179930634338573,0.0396933564396962,0.210775551107797
Physical measures,X4270.Volume level set by participant (left),FAM172A,Cotranscriptional regulator FAM172A,32163,-0.0424349103530161,0.033908838997836,-0.108896234788775,0.0240264140827425,0.210811615796719
Physical measures,X4270.Volume level set by participant (left),RTBDN,Retbindin,33386,-0.0758475729471998,0.0606202953613253,-0.194663351855398,0.0429682059609978,0.210897544340875
Physical measures,X4270.Volume level set by participant (left),PPIE,Peptidyl-prolyl cis-trans isomerase E,32235,-0.0393538367507571,0.0314559747620486,-0.101007547284372,0.0222998737828582,0.210944118912331
Physical measures,X4270.Volume level set by participant (left),C2orf69,UPF0565 protein C2orf69,32154,-0.0444888004284835,0.0356785354592166,-0.114418729928548,0.0254411290715809,0.212459410047583
Physical measures,X4270.Volume level set by participant (left),HPGDS,Hematopoietic prostaglandin D synthase,33232,0.0574647732725873,0.0461005100764683,-0.0328922264772907,0.147821773022465,0.212610275706725
Physical measures,X4270.Volume level set by participant (left),BEX3,Protein BEX3,32075,-0.0540981966734537,0.0434131188811295,-0.139187909680467,0.0309915163335602,0.212756614825273
Physical measures,X4270.Volume level set by participant (left),DCN,Decorin,33273,-0.0971639804973342,0.0780330612054275,-0.250108780459972,0.0557808194653036,0.21310445720216
Physical measures,X4270.Volume level set by participant (left),MPO,Myeloperoxidase,33441,0.044805032068164,0.0360137538394033,-0.0257819254570665,0.115391989593395,0.213491932553936
Physical measures,X4270.Volume level set by participant (left),LTO1,Protein LTO1 homolog,33273,-0.0508415099113521,0.040923984448187,-0.131052519429799,0.0293694996070944,0.214144116641913
Physical measures,X4270.Volume level set by participant (left),DNAJA1,DnaJ homolog subfamily A member 1,32075,0.0553326298197056,0.0445611244682799,-0.0320071741381231,0.142672433777534,0.214376530223862
Physical measures,X4270.Volume level set by participant (left),LYPD8,Ly6/PLAUR domain-containing protein 8,33232,-0.0413137050571836,0.0332981695988967,-0.106578117471021,0.023950707356654,0.214742365221136
Physical measures,X4270.Volume level set by participant (left),CDH23,Cadherin-23,32353,-0.0937440084135459,0.0758159367767462,-0.242343244495969,0.0548552276688766,0.216321280608171
Physical measures,X4270.Volume level set by participant (left),SDC4,Syndecan-4,33434,-0.0460221034344516,0.0372278848924923,-0.118988757823736,0.0269445509548333,0.216406664304459
Physical measures,X4270.Volume level set by participant (left),A1BG,Alpha-1B-glycoprotein,32398,-0.13799890127644,0.111666454940072,-0.356865152958981,0.080867350406101,0.216564479507777
Physical measures,X4270.Volume level set by participant (left),PSMD9,26S proteasome non-ATPase regulatory subunit 9,33386,-0.0369971978605805,0.0299544118162007,-0.0957078450203338,0.0217134492991728,0.216819521470974
Physical measures,X4270.Volume level set by participant (left),BLMH,Bleomycin hydrolase,33533,-0.0665394400216418,0.0539090684475208,-0.172201214178783,0.039122334135499,0.217126701138692
Physical measures,X4270.Volume level set by participant (left),CTSV,Cathepsin L2,33496,-0.0493628473145061,0.0400255868867376,-0.127812997612512,0.0290873029834996,0.217502527370847
Physical measures,X4270.Volume level set by participant (left),TP53BP1,TP53-binding protein 1,32140,-0.0285481217799156,0.0231665106624251,-0.0739544826782687,0.0168582391184376,0.217874244914229
Physical measures,X4270.Volume level set by participant (left),CD3D,T-cell surface glycoprotein CD3 delta chain,32111,-0.0724415607674347,0.0588553657544242,-0.187798077646106,0.0429149561112368,0.218420381249063
Physical measures,X4270.Volume level set by participant (left),COL2A1,Collagen alpha-1(II) chain,32163,-0.0309707639992672,0.0251794662459327,-0.0803225178412953,0.0183809898427608,0.218734338637128
Physical measures,X4270.Volume level set by participant (left),RABEP1,Rab GTPase-binding effector protein 1,32213,-0.0338348852623738,0.0275272017108425,-0.0877882006156252,0.0201184300908775,0.219055229805167
Physical measures,X4270.Volume level set by participant (left),SULT2A1,Bile salt sulfotransferase,33421,-0.0391403188366826,0.0318642634989879,-0.101594275294699,0.0233136376213336,0.219349608195374
Physical measures,X4270.Volume level set by participant (left),MICALL2,MICAL-like protein 2,32154,-0.0332548135324806,0.0270766501014781,-0.0863250477313777,0.0198154206664165,0.219419535231205
Physical measures,X4270.Volume level set by participant (left),CSF2RB,Cytokine receptor common subunit beta,32140,-0.0564847889405535,0.0460338022840958,-0.146711041417381,0.0337414635362743,0.219849454542709
Physical measures,X4270.Volume level set by participant (left),CSNK2A1,Casein kinase II subunit alpha,32350,-0.0543937114907305,0.0443868960620479,-0.141392027772344,0.0326046047908834,0.220444057386405
Physical measures,X4270.Volume level set by participant (left),THSD1,Thrombospondin type-1 domain-containing protein 1,32098,-0.0717050449708697,0.0585569643231001,-0.186476695044146,0.0430666051024065,0.220788259597251
Physical measures,X4270.Volume level set by participant (left),ZBTB17,Zinc finger and BTB domain-containing protein 17,33273,0.050605909095197,0.0413806231003524,-0.0305001121814936,0.131711930371888,0.221386046511686
Physical measures,X4270.Volume level set by participant (left),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,32111,-0.0391805377030767,0.0320381786313054,-0.101975367820435,0.0236142924142819,0.22139274228535
Physical measures,X4270.Volume level set by participant (left),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,32059,-0.0472144458057189,0.0386451275935343,-0.122958895889046,0.0285300042776083,0.221842393467201
Physical measures,X4270.Volume level set by participant (left),MYL6B,Myosin light chain 6B,32154,-0.0268165414701734,0.0219494943011624,-0.0698375503004516,0.0162044673601048,0.221843951766426
Physical measures,X4270.Volume level set by participant (left),ELN,Elastin,32365,-0.0685798743576044,0.0561396486369217,-0.178613585685971,0.0414538369707622,0.221897493619042
Physical measures,X4270.Volume level set by participant (left),IL13RA1,Interleukin-13 receptor subunit alpha-1,33335,0.100477652946316,0.0824369023666132,-0.0610986756922458,0.262053981584878,0.222936111404265
Physical measures,X4270.Volume level set by participant (left),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,32143,-0.066035584036784,0.0542197113261596,-0.172306218236057,0.0402350501624888,0.223289556751356
Physical measures,X4270.Volume level set by participant (left),IGFBP4,Insulin-like growth factor-binding protein 4,33327,0.0523422417116415,0.0430051319455493,-0.0319478169016351,0.136632300324918,0.223592391017192
Physical measures,X4270.Volume level set by participant (left),EXTL1,Exostosin-like 1,32122,-0.0516128416347406,0.0424538470538074,-0.134822381860203,0.031596698590722,0.224121398419409
Physical measures,X4270.Volume level set by participant (left),BGLAP,Osteocalcin,32384,0.0261840127956337,0.0215426304129517,-0.0160395428137516,0.0684075684050191,0.224230295354002
Physical measures,X4270.Volume level set by participant (left),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,33474,0.0603832211986729,0.0497507349532645,-0.0371282193097254,0.157894661707071,0.224888295979205
Physical measures,X4270.Volume level set by participant (left),CASP9,Caspase-9,32140,-0.039693520481372,0.0327140579089606,-0.103813073982935,0.0244260330201908,0.225034279354889
Physical measures,X4270.Volume level set by participant (left),ACE,Angiotensin-converting enzyme,32381,-0.0903239400729803,0.0745750668450634,-0.236491071089305,0.0558431909433441,0.225861968518858
Physical measures,X4270.Volume level set by participant (left),CRYZL1,Quinone oxidoreductase-like protein 1,32163,-0.0281973097470921,0.023299913131697,-0.0738651394852181,0.0174705199910339,0.226243304052467
Physical measures,X4270.Volume level set by participant (left),EDN1,Endothelin-1,32163,-0.0841556489882415,0.069564126425518,-0.220501336782257,0.0521900388057738,0.226409471183375
Physical measures,X4270.Volume level set by participant (left),FSTL3,Follistatin-related protein 3,33429,0.0688216638506511,0.0569127439216276,-0.042727314235739,0.180370641937041,0.226599154751201
Physical measures,X4270.Volume level set by participant (left),ITGB6,Integrin beta-6,33273,-0.0708207293070793,0.0585671903110803,-0.185612422316797,0.0439709637026381,0.226610025141742
Physical measures,X4270.Volume level set by participant (left),FIS1,Mitochondrial fission 1 protein,33426,-0.0274573340778347,0.0227087794443924,-0.0719665417888439,0.0170518736331744,0.226653776151123
Physical measures,X4270.Volume level set by participant (left),ADGRE5,Adhesion G protein-coupled receptor E5,33474,-0.0711705543358024,0.0589338399082648,-0.186680880556001,0.0443397718843965,0.227219445153887
Physical measures,X4270.Volume level set by participant (left),ABO,Histo-blood group ABO system transferase,32381,0.0165419161800497,0.0137059270036865,-0.0103217007471758,0.0434055331072751,0.227500131854323
Physical measures,X4270.Volume level set by participant (left),MN1,Transcriptional activator MN1,32154,-0.0410236433111712,0.0340091924638045,-0.107681660540228,0.0256343739178856,0.227757553396047
Physical measures,X4270.Volume level set by participant (left),GPI,Glucose-6-phosphate isomerase,32381,-0.0522939711037673,0.0433596485884275,-0.137278882337085,0.0326909401295507,0.22783361652762
Physical measures,X4270.Volume level set by participant (left),HPSE,Heparanase,32241,-0.0262286831007956,0.0217494324670837,-0.0688575707362796,0.0164002045346885,0.227874212009111
Physical measures,X4270.Volume level set by participant (left),ASRGL1,Isoaspartyl peptidase/L-asparaginase,32163,-0.0252153755999573,0.0209114099158127,-0.0662017390349501,0.0157709878350355,0.227924296471385
Physical measures,X4270.Volume level set by participant (left),PILRB,Paired immunoglobulin-like type 2 receptor beta,33434,0.0370245670373101,0.0307273187784345,-0.0232009777684215,0.0972501118430417,0.228258328010684
Physical measures,X4270.Volume level set by participant (left),MEP1A,Meprin A subunit alpha,32329,0.0344461622925004,0.0285942635687954,-0.0215985943023386,0.0904909188873393,0.228373535557667
Physical measures,X4270.Volume level set by participant (left),TST,Thiosulfate sulfurtransferase,33191,-0.0284605276865162,0.023629722243949,-0.0747747832846562,0.0178537279116237,0.228453087998445
Physical measures,X4270.Volume level set by participant (left),CYB5R2,NADH-cytochrome b5 reductase 2,32227,-0.0431912940236006,0.0358943557951697,-0.113544231382133,0.027161643334932,0.228901041979136
Physical measures,X4270.Volume level set by participant (left),FGFR4,Fibroblast growth factor receptor 4,32213,-0.0456339582667635,0.0379662421331507,-0.120047792847739,0.0287798763142118,0.229415163801268
Physical measures,X4270.Volume level set by participant (left),CAT,Catalase,32259,-0.0422600577794277,0.0351687212497752,-0.111190751428987,0.0266706358701318,0.229540431280487
Physical measures,X4270.Volume level set by participant (left),PRCP,Lysosomal Pro-X carboxypeptidase,33482,0.0655088476097163,0.0545677981557454,-0.0414440367755447,0.172461731994977,0.229975249876627
Physical measures,X4270.Volume level set by participant (left),DHODH,Dihydroorotate dehydrogenase,32122,-0.0507965259165874,0.0423366681370549,-0.133776395465215,0.0321833436320402,0.230245000954542
Physical measures,X4270.Volume level set by participant (left),GET3,ATPase GET3,32365,-0.0425782602350117,0.0355065651822138,-0.112171127992151,0.0270146075221273,0.230499385831772
Physical measures,X4270.Volume level set by participant (left),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",33386,-0.0598243857833818,0.0498947862562909,-0.157618166845712,0.0379693952789484,0.2305555714521
Physical measures,X4270.Volume level set by participant (left),VWF,von Willebrand factor,33533,0.0279500606130378,0.0233127403721967,-0.0177429105164678,0.0736430317425434,0.230591183762126
Physical measures,X4270.Volume level set by participant (left),MKI67,Proliferation marker protein Ki-67,32140,-0.061695262144862,0.0514610788760532,-0.162558976741926,0.0391684524522022,0.230614568467182
Physical measures,X4270.Volume level set by participant (left),CCN3,CCN family member 3,33518,-0.0612099877685862,0.0510845442307695,-0.161335694460894,0.0389157189237221,0.230866788338223
Physical measures,X4270.Volume level set by participant (left),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,32235,0.0467419119984825,0.0390314865787984,-0.0297598016959623,0.123243625692927,0.231131177909874
Physical measures,X4270.Volume level set by participant (left),ICOSLG,ICOS ligand,33386,-0.106969638086672,0.0893507262210687,-0.282097061479967,0.0681577853066222,0.231264970333374
Physical measures,X4270.Volume level set by participant (left),SAFB2,Scaffold attachment factor B2,32350,-0.0855686233308375,0.0715129341654843,-0.225733974295187,0.0545967276335116,0.231518900306179
Physical measures,X4270.Volume level set by participant (left),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",32140,0.0395430560497839,0.0331510506446014,-0.0254330032136349,0.104519115313203,0.23297883059763
Physical measures,X4270.Volume level set by participant (left),TFF3,Trefoil factor 3,33422,0.0392244400329733,0.0328850580255002,-0.0252302736970071,0.103679153762954,0.232989481487753
Physical measures,X4270.Volume level set by participant (left),IL12RB1,Interleukin-12 receptor subunit beta-1,33273,-0.056068692923431,0.0470124412680084,-0.148213077808728,0.0360756919618655,0.233044359466612
Physical measures,X4270.Volume level set by participant (left),CASP7,Caspase-7,32353,-0.0295427512926614,0.0247754743593996,-0.0781026810370846,0.0190171784517617,0.233132739817527
Physical measures,X4270.Volume level set by participant (left),CLGN,Calmegin,32154,0.0552450527734932,0.0463462886871815,-0.0355936730533826,0.146083778600369,0.233295644905731
Physical measures,X4270.Volume level set by participant (left),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,33380,-0.0499899928043019,0.0419396305060908,-0.13219166859624,0.032211682987636,0.23331207398888
Physical measures,X4270.Volume level set by participant (left),BECN1,Beclin-1,32163,-0.0404869908603328,0.0339676029833496,-0.107063492707698,0.0260895109870324,0.233325552925463
Physical measures,X4270.Volume level set by participant (left),BRD2,Bromodomain-containing protein 2,32111,-0.0694717459872735,0.0582967767033881,-0.183733428325914,0.0447899363513671,0.233419355029403
Physical measures,X4270.Volume level set by participant (left),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,32111,0.0491503419443299,0.0412819184661229,-0.031762218249271,0.130062902137931,0.233846710873259
Physical measures,X4270.Volume level set by participant (left),FGF20,Fibroblast growth factor 20,32140,0.052746675034059,0.0445025761083407,-0.0344783741382888,0.139971724206407,0.235955294328462
Physical measures,X4270.Volume level set by participant (left),PLEKHO1,Pleckstrin homology domain-containing family O member 1,32353,-0.034494451313393,0.029131915075913,-0.0915930048621826,0.0226041022353966,0.236417935989577
Physical measures,X4270.Volume level set by participant (left),CEP170,Centrosomal protein of 170 kDa,32163,-0.0306060627280269,0.0258825972067273,-0.0813359532532124,0.0201238277971586,0.237045501914634
Physical measures,X4270.Volume level set by participant (left),LIFR,Leukemia inhibitory factor receptor,33421,-0.0830659471993662,0.0705034748675798,-0.221252757939823,0.0551208635410902,0.238755200360161
Physical measures,X4270.Volume level set by participant (left),GGACT,Gamma-glutamylaminecyclotransferase,32365,-0.0343728711412041,0.0292673970033397,-0.0917369692677498,0.0229912269853416,0.240253237604788
Physical measures,X4270.Volume level set by participant (left),LEO1,RNA polymerase-associated protein LEO1,32350,-0.0736622542644808,0.0627812683590787,-0.196713540248275,0.0493890317193134,0.240704583767457
Physical measures,X4270.Volume level set by participant (left),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,33439,-0.0817121450624873,0.0696817191501776,-0.218288314596835,0.0548640244718608,0.240967989339431
Physical measures,X4270.Volume level set by participant (left),MET,Hepatocyte growth factor receptor,33459,-0.100184773373516,0.0855159042259192,-0.267795945656318,0.0674263989092853,0.241415274354636
Physical measures,X4270.Volume level set by participant (left),DSG2,Desmoglein-2,33441,-0.0744870708002094,0.0635947075144918,-0.199132697528613,0.0501585559281946,0.241518177694784
Physical measures,X4270.Volume level set by participant (left),PCBP2,Poly(rC)-binding protein 2,32350,-0.034229211017183,0.0292430400198021,-0.0915455694559952,0.0230871474216292,0.241831943901125
Physical measures,X4270.Volume level set by participant (left),RP2,Protein XRP2,33386,-0.049116192717102,0.0419955161385217,-0.131427404348604,0.0331950189144006,0.242210091133494
Physical measures,X4270.Volume level set by participant (left),CETN3,Centrin-3,32329,-0.031181327364403,0.0266699139355536,-0.083454358678088,0.0210917039492819,0.242375610953467
Physical measures,X4270.Volume level set by participant (left),PPM1B,Protein phosphatase 1B,32140,-0.0372354590652761,0.0318839034606537,-0.0997279098481574,0.0252569917176052,0.242905499717214
Physical measures,X4270.Volume level set by participant (left),KIAA2013,Uncharacterized protein KIAA2013,32319,-0.0384757753773869,0.0329562182202743,-0.103069963089125,0.0261184123343508,0.243051368212411
Physical measures,X4270.Volume level set by participant (left),PKN3,Serine/threonine-protein kinase N3,32235,-0.0298661232720447,0.025583026627513,-0.0800088554619702,0.0202766089178807,0.243076791336667
Physical measures,X4270.Volume level set by participant (left),NFX1,Transcriptional repressor NF-X1,32122,-0.0362248271240529,0.0310868876383539,-0.0971551268952265,0.0247054726471207,0.243943242579365
Physical measures,X4270.Volume level set by participant (left),PFDN6,Prefoldin subunit 6,32154,0.0350108725930819,0.0300518565705891,-0.0238907662852728,0.0939125114714366,0.244048895910421
Physical measures,X4270.Volume level set by participant (left),HNMT,Histamine N-methyltransferase,33339,0.0442992754146155,0.0381016954413707,-0.0303800476504711,0.118978598479702,0.244999152107626
Physical measures,X4270.Volume level set by participant (left),CCAR2,Cell cycle and apoptosis regulator protein 2,32353,-0.0415475943726417,0.0357557262796534,-0.111628817880762,0.028533629135479,0.245276934277737
Physical measures,X4270.Volume level set by participant (left),CAPG,Macrophage-capping protein,33361,-0.034709550229799,0.0298899152831838,-0.0932937841848393,0.0238746837252413,0.245572918328246
Physical measures,X4270.Volume level set by participant (left),PODXL,Podocalyxin,33386,-0.130567738503817,0.112688800082745,-0.351437786665998,0.0903023096583637,0.246626746252701
Physical measures,X4270.Volume level set by participant (left),TINAGL1,Tubulointerstitial nephritis antigen-like,33402,-0.0892368657499663,0.0770275967907056,-0.240210955459749,0.0617372239598166,0.24668888226081
Physical measures,X4270.Volume level set by participant (left),PSIP1,PC4 and SFRS1-interacting protein,33421,0.0333925287173676,0.0288405757514093,-0.0231349997553947,0.0899200571901299,0.246963624165517
Physical measures,X4270.Volume level set by participant (left),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",32353,-0.0926132156216963,0.0800339053047576,-0.249479670019021,0.0642532387756286,0.247235961002562
Physical measures,X4270.Volume level set by participant (left),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,32235,-0.021415404320356,0.0185172186395099,-0.0577091528537954,0.0148783442130833,0.247506890109259
Physical measures,X4270.Volume level set by participant (left),FZD8,Frizzled-8,32111,-0.0531095342066767,0.0459375580127924,-0.14314714791175,0.0369280794983964,0.247666330058021
Physical measures,X4270.Volume level set by participant (left),ARSB,Arylsulfatase B,33386,-0.0369461573137191,0.0320362673683008,-0.0997372413555887,0.0258449267281504,0.248834397670936
Physical measures,X4270.Volume level set by participant (left),C7orf50,Uncharacterized protein C7orf50,32353,-0.116479325592183,0.10104652650332,-0.31453051753869,0.0815718663543243,0.249056260745944
Physical measures,X4270.Volume level set by participant (left),ITGB2,Integrin beta-2,33347,-0.0710210024315791,0.0616443317899761,-0.191843892739932,0.0498018878767739,0.249307172410085
Physical measures,X4270.Volume level set by participant (left),CHAD,Chondroadherin,32213,-0.0431272329842902,0.0374790292736481,-0.116586130360641,0.0303316643920602,0.249889890434815
Physical measures,X4270.Volume level set by participant (left),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",32142,-0.0313240603012239,0.0272536206158047,-0.0847411567082012,0.0220930361057533,0.250445761969168
Physical measures,X4270.Volume level set by participant (left),IL10,Interleukin-10,33273,0.0242152549501663,0.0210714170047208,-0.0170847223790866,0.0655152322794191,0.250505031932258
Physical measures,X4270.Volume level set by participant (left),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",32350,0.0511558821549954,0.0445336848725107,-0.0361301401951256,0.138441904505116,0.250714151450357
Physical measures,X4270.Volume level set by participant (left),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,33338,-0.0639351449124531,0.0556699457761232,-0.173048238633655,0.0451779488087484,0.250806388200517
Physical measures,X4270.Volume level set by participant (left),CLNS1A,Methylosome subunit pICln,32154,-0.06433425909334,0.0560176697009687,-0.174128891707239,0.0454603735205587,0.250812878942303
Physical measures,X4270.Volume level set by participant (left),TUBB3,Tubulin beta-3 chain,32111,-0.082947954012783,0.0723124122239368,-0.224680281971699,0.0587843739461332,0.251385363395015
Physical measures,X4270.Volume level set by participant (left),ATP5IF1,"ATPase inhibitor, mitochondrial",33481,-0.0183176606617851,0.0159805649344511,-0.0496395679333093,0.013004246609739,0.251723713750244
Physical measures,X4270.Volume level set by participant (left),KIRREL2,Kin of IRRE-like protein 2,33219,-0.049773866282138,0.0434367897089038,-0.13490997411159,0.0353622415473134,0.251871162872315
Physical measures,X4270.Volume level set by participant (left),ADGRB3,Adhesion G protein-coupled receptor B3,33363,-0.0598636630076,0.0522716326652522,-0.162316063031494,0.0425887370162942,0.252139740284175
Physical measures,X4270.Volume level set by participant (left),CARHSP1,Calcium-regulated heat-stable protein 1,33219,-0.0375085660726507,0.0327608063195926,-0.101719746459052,0.0267026143137509,0.252272758203404
Physical measures,X4270.Volume level set by participant (left),RBM17,Splicing factor 45,32350,-0.0306309467760427,0.0267573078618543,-0.0830752701852771,0.0218133766331917,0.252339404798267
Physical measures,X4270.Volume level set by participant (left),CREG1,Protein CREG1,33297,-0.0552554814199652,0.0483048679205351,-0.149933022544214,0.0394220597042835,0.252700001641079
Physical measures,X4270.Volume level set by participant (left),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,32163,-0.0644588445052081,0.0563674376009507,-0.174939022203072,0.0460213331926553,0.252846842563452
Physical measures,X4270.Volume level set by participant (left),SNCG,Gamma-synuclein,33380,0.03011308960076,0.0263402401528287,-0.0215137810987843,0.0817399603003044,0.252971617204482
Physical measures,X4270.Volume level set by participant (left),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,32350,-0.0346256236299526,0.0302946530319228,-0.0940031435725212,0.024751896312616,0.25308921259194
Physical measures,X4270.Volume level set by participant (left),CCL23,C-C motif chemokine 23,33481,0.0475062459985423,0.0416693009887201,-0.034165583939349,0.129178075936434,0.254284131529128
Physical measures,X4270.Volume level set by participant (left),RNF149,E3 ubiquitin-protein ligase RNF149,32163,-0.0778645883235381,0.0683294848686553,-0.211790378666103,0.0560612020190264,0.254510921383381
Physical measures,X4270.Volume level set by participant (left),RRAS,Ras-related protein R-Ras,32154,-0.0181784355412286,0.0159536860477251,-0.0494476601947698,0.0130907891123125,0.254550752596308
Physical measures,X4270.Volume level set by participant (left),HTR1A,5-hydroxytryptamine receptor 1A,32111,-0.0281127352311319,0.0246775725663792,-0.0764807774612352,0.0202553069989714,0.254654634614804
Physical measures,X4270.Volume level set by participant (left),VWC2L,von Willebrand factor C domain-containing protein 2-like,32350,-0.0498643615242244,0.0438302627576578,-0.135771676529234,0.0360429534807849,0.255292958029624
Physical measures,X4270.Volume level set by participant (left),CTSZ,Cathepsin Z,33409,-0.0633979264576369,0.0557624463550985,-0.17269232131363,0.0458964683983562,0.255598511824426
Physical measures,X4270.Volume level set by participant (left),PXDNL,Peroxidasin-like protein,32319,-0.0390719702531269,0.0343795512777458,-0.106455890757509,0.0283119502512548,0.255786738230462
Physical measures,X4270.Volume level set by participant (left),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,32111,-0.0722068089863014,0.0635561053960983,-0.196776775562654,0.0523631575900513,0.255945551319983
Physical measures,X4270.Volume level set by participant (left),LARP1,La-related protein 1,32319,-0.0360507021136767,0.0317372112666724,-0.0982556361963546,0.0261542319690011,0.256027708174829
Physical measures,X4270.Volume level set by participant (left),VSIG10,V-set and immunoglobulin domain-containing protein 10,32319,-0.0622764919668118,0.05487313475765,-0.169827836091806,0.0452748521581823,0.256444392832728
Physical measures,X4270.Volume level set by participant (left),RBPMS2,RNA-binding protein with multiple splicing 2,32163,-0.0223065618998993,0.0196693410018914,-0.0608584702636065,0.016245346463808,0.256797206254675
Physical measures,X4270.Volume level set by participant (left),CPA1,Carboxypeptidase A1,33533,-0.0341645762146104,0.0301339636210338,-0.0932271449118366,0.0248979924826158,0.256926654172394
Physical measures,X4270.Volume level set by participant (left),ENTR1,Endosome-associated-trafficking regulator 1,32163,-0.0410365735631019,0.0362391563282174,-0.112065319966408,0.0299921728402043,0.2575090325068
Physical measures,X4270.Volume level set by participant (left),KLK1,Kallikrein-1,33359,-0.0154131293235976,0.0136301191169886,-0.0421281627928952,0.0113019041457001,0.258163849591168
Physical measures,X4270.Volume level set by participant (left),NEFL,Neurofilament light polypeptide,33199,-0.0483890754135593,0.0427968856043605,-0.132270971198106,0.0354928203709872,0.258225803567697
Physical measures,X4270.Volume level set by participant (left),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,32213,-0.0471962712604228,0.0417564992953517,-0.129039009879312,0.0346464673584665,0.258395872448252
Physical measures,X4270.Volume level set by participant (left),MAX,Protein max,33219,-0.01969258463429,0.0174486881955113,-0.0538920134974921,0.0145068442289121,0.259097621054884
Physical measures,X4270.Volume level set by participant (left),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,33465,-0.0180813897859543,0.0160274295892695,-0.0494951517809226,0.013332372209014,0.259285427112762
Physical measures,X4270.Volume level set by participant (left),CCL18,C-C motif chemokine 18,33273,0.0277809952777517,0.0246295504082587,-0.0204929235224354,0.0760549140779389,0.259370114475623
Physical measures,X4270.Volume level set by participant (left),CPQ,Carboxypeptidase Q,32366,-0.0574042866089529,0.0509389115088375,-0.157244553166274,0.0424359799483685,0.259808756709593
Physical measures,X4270.Volume level set by participant (left),MIF,Macrophage migration inhibitory factor,33421,-0.0305274866102773,0.027161276998882,-0.0837635895280861,0.0227086163075315,0.261071055749362
Physical measures,X4270.Volume level set by participant (left),ELAC1,Zinc phosphodiesterase ELAC protein 1,32350,-0.0276126566754349,0.024616560139327,-0.0758611145485159,0.020635801197646,0.26201961877639
Physical measures,X4270.Volume level set by participant (left),MMP8,Neutrophil collagenase,33493,0.0258398035277403,0.0230802281915285,-0.0193974437276556,0.0710770507831362,0.262929153331922
Physical measures,X4270.Volume level set by participant (left),DTX2,Probable E3 ubiquitin-protein ligase DTX2,32154,0.0330663681485541,0.0295491128886112,-0.024849893113124,0.0909826294102321,0.263161900599619
Physical measures,X4270.Volume level set by participant (left),THBS4,Thrombospondin-4,33409,-0.0426701070674874,0.0381495999086436,-0.117443322888429,0.0321031087534541,0.263385978868888
Physical measures,X4270.Volume level set by participant (left),GNPDA2,Glucosamine-6-phosphate isomerase 2,32213,-0.0634508796395835,0.0567384195838672,-0.174658182023963,0.0477564227447961,0.263471218295885
Physical measures,X4270.Volume level set by participant (left),SIAE,Sialate O-acetylesterase,33446,-0.0415628360562499,0.0371886754440334,-0.114452639926555,0.0313269678140556,0.263758856915675
Physical measures,X4270.Volume level set by participant (left),LIF,Leukemia inhibitory factor,33219,0.0369862049255646,0.033097830076555,-0.0278855420244832,0.101857951875613,0.263819239524581
Physical measures,X4270.Volume level set by participant (left),RAB11FIP3,Rab11 family-interacting protein 3,32365,-0.0213093767016657,0.0190797308070839,-0.0587056490835501,0.0160868956802188,0.264088369702289
Physical measures,X4270.Volume level set by participant (left),MYL4,Myosin light chain 4,32163,-0.0407348652243127,0.0364904812155667,-0.112256208406823,0.030786477958198,0.264322194851412
Physical measures,X4270.Volume level set by participant (left),STX3,Syntaxin-3,32353,-0.0567784383364949,0.0508826506103671,-0.156508433532814,0.0429515568598245,0.264511607646598
Physical measures,X4270.Volume level set by participant (left),ARTN,Artemin,33273,-0.0422617059313399,0.0378852429408953,-0.116516782095495,0.0319933702328149,0.264658506887984
Physical measures,X4270.Volume level set by participant (left),ASAH1,Acid ceramidase,32306,-0.0475121953264641,0.0425948401605284,-0.1309980820411,0.0359736913881715,0.264693977776117
Physical measures,X4270.Volume level set by participant (left),AIF1,Allograft inflammatory factor 1,33232,0.0387428532255733,0.034759085769007,-0.0293849548816804,0.106870661332827,0.265047749301249
Physical measures,X4270.Volume level set by participant (left),TF,Serotransferrin,32398,-0.098898927698418,0.0888557944810422,-0.273056284881261,0.0752584294844247,0.265730373993426
Physical measures,X4270.Volume level set by participant (left),GGT1,Glutathione hydrolase 1 proenzyme,33428,0.0410463931209077,0.0368843184211991,-0.0312468709846426,0.113339657226458,0.265806402833867
Physical measures,X4270.Volume level set by participant (left),SERPINC1,Antithrombin-III,32381,-0.149934902558745,0.134762043566554,-0.414068507949191,0.1141987028317,0.265918298448606
Physical measures,X4270.Volume level set by participant (left),ACP1,Low molecular weight phosphotyrosine protein phosphatase,32140,-0.0500225528032319,0.0450446398601787,-0.138310046929182,0.0382649413227184,0.266813780923162
Physical measures,X4270.Volume level set by participant (left),BCHE,Cholinesterase,32215,-0.0770637215537818,0.0694183169108657,-0.213123622699078,0.058996179591515,0.26697514197255
Physical measures,X4270.Volume level set by participant (left),LPO,Lactoperoxidase,33180,0.033432233291662,0.0301188274859684,-0.0256006685808362,0.0924651351641602,0.267024827792849
Physical measures,X4270.Volume level set by participant (left),LY9,T-lymphocyte surface antigen Ly-9,33330,0.0672461476204407,0.060590575767788,-0.0515113808844238,0.186003676125305,0.267095893988454
Physical measures,X4270.Volume level set by participant (left),GUSB,Beta-glucuronidase,33456,0.0323533457842211,0.029152996299656,-0.0247865269631046,0.0894932185315468,0.267124469737687
Physical measures,X4270.Volume level set by participant (left),MEPE,Matrix extracellular phosphoglycoprotein,33424,-0.0677215536231992,0.0611453433000035,-0.187566426491206,0.0521233192448077,0.268085706050427
Physical measures,X4270.Volume level set by participant (left),EDF1,Endothelial differentiation-related factor 1,32350,-0.0321160874888822,0.0290416710554876,-0.0890377627576378,0.0248055877798734,0.268819845869207
Physical measures,X4270.Volume level set by participant (left),ORM1,Alpha-1-acid glycoprotein 1,32375,0.108738459595508,0.0984063769855197,-0.0841380392961109,0.301614958487126,0.269195740684145
Physical measures,X4270.Volume level set by participant (left),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,32350,-0.0666969518757317,0.0603989048387286,-0.18507880535964,0.0516849016081764,0.269507868180609
Physical measures,X4270.Volume level set by participant (left),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,33434,-0.0606416450172215,0.0549641245215423,-0.168371329079444,0.0470880390450014,0.269928635416134
Physical measures,X4270.Volume level set by participant (left),FH,"Fumarate hydratase, mitochondrial",32111,-0.0270457454216593,0.0245187002448432,-0.075102397901552,0.0210109070582334,0.270033161183278
Physical measures,X4270.Volume level set by participant (left),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,33273,0.0449302172348735,0.0407411184502767,-0.0349223749276689,0.124782809397416,0.270134403518329
Physical measures,X4270.Volume level set by participant (left),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",32353,-0.0236757382192664,0.0215234837015294,-0.065861766274264,0.0185102898357311,0.271367547923803
Physical measures,X4270.Volume level set by participant (left),PITHD1,PITH domain-containing protein 1,32059,-0.0275511638541304,0.025086243087225,-0.0767202003050915,0.0216178725968307,0.272126677293629
Physical measures,X4270.Volume level set by participant (left),IQGAP2,Ras GTPase-activating-like protein IQGAP2,33386,-0.034685062015281,0.0315866997293964,-0.096594993484898,0.0272248694543359,0.272194477833401
Physical measures,X4270.Volume level set by participant (left),PSPN,Persephin,33421,-0.0190812110871275,0.017377980153719,-0.0531420521884167,0.0149796300141618,0.272229228795611
Physical measures,X4270.Volume level set by participant (left),AOC3,Membrane primary amine oxidase,33452,-0.0614911365934988,0.0560379797802156,-0.171325576962721,0.0483433037757238,0.272534480625817
Physical measures,X4270.Volume level set by participant (left),ANGPTL3,Angiopoietin-related protein 3,33409,-0.052319647416222,0.0476801907475263,-0.145772821281374,0.0411335264489296,0.272538183301976
Physical measures,X4270.Volume level set by participant (left),ACRV1,Acrosomal protein SP-10,32140,-0.0622774368710809,0.056768777508627,-0.17354424078799,0.0489893670458281,0.272659687537522
Physical measures,X4270.Volume level set by participant (left),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,32365,-0.0628251359789046,0.0572817458378487,-0.175097357821088,0.0494470858632788,0.272773537497481
Physical measures,X4270.Volume level set by participant (left),NCK2,Cytoplasmic protein NCK2,33481,-0.0187217760874308,0.0170850375073011,-0.0522084496017409,0.0147648974268794,0.273195750864922
Physical measures,X4270.Volume level set by participant (left),ALPI,Intestinal-type alkaline phosphatase,32140,-0.0183981125207829,0.0167992301554053,-0.0513246036253774,0.0145283785838115,0.273473889561546
Physical measures,X4270.Volume level set by participant (left),CPA2,Carboxypeptidase A2,33458,-0.0289788976790017,0.0264774084604778,-0.0808746182615381,0.0229168229035347,0.273775389373887
Physical measures,X4270.Volume level set by participant (left),CD276,CD276 antigen,33424,-0.0518145938064418,0.0473497503236913,-0.144620104440877,0.040990916827993,0.273855015701372
Physical measures,X4270.Volume level set by participant (left),FCRL1,Fc receptor-like protein 1,33434,-0.0420753563431351,0.0384624363449259,-0.11746173157919,0.0333110188929197,0.274013390831446
Physical measures,X4270.Volume level set by participant (left),CFP,Properdin,32398,-0.0971728016917511,0.0888614340216973,-0.271341212374278,0.0769956089907756,0.274193547579712
Physical measures,X4270.Volume level set by participant (left),XIAP,E3 ubiquitin-protein ligase XIAP,32140,-0.0391991327468472,0.0358546261843695,-0.109474200068211,0.0310759345745171,0.274305308288703
Physical measures,X4270.Volume level set by participant (left),SATB1,DNA-binding protein SATB1,32350,-0.0726807002882403,0.0665150168818568,-0.20305013337668,0.0576887328001991,0.274560588534671
Physical measures,X4270.Volume level set by participant (left),ATF4,Cyclic AMP-dependent transcription factor ATF-4,32075,-0.0641628896912446,0.0587332902336336,-0.179280138549167,0.0509543591666773,0.274672086368638
Physical measures,X4270.Volume level set by participant (left),PRG3,Proteoglycan 3,32384,-0.0430882593677319,0.0394890265072071,-0.120486751321858,0.0343102325863941,0.275242178452494
Physical measures,X4270.Volume level set by participant (left),REXO2,"Oligoribonuclease, mitochondrial",32122,-0.0437450255460889,0.0401342150168928,-0.122408086979199,0.0349180358870211,0.27576132596277
Physical measures,X4270.Volume level set by participant (left),LTBP2,Latent-transforming growth factor beta-binding protein 2,33533,-0.058702267141477,0.0539073998669825,-0.164360770880763,0.0469562365978087,0.276206445213722
Physical measures,X4270.Volume level set by participant (left),ISM2,Isthmin-2,32384,-0.0468081658370597,0.0430193200689198,-0.131126033172143,0.0375097014980232,0.276595900585318
Physical measures,X4270.Volume level set by participant (left),PSAP,Prosaposin,32292,-0.0729879989061526,0.0671340827665906,-0.20457080112867,0.0585948033163649,0.276983024113919
Physical measures,X4270.Volume level set by participant (left),L1CAM,Neural cell adhesion molecule L1,33456,0.0653744868164103,0.0601523734565025,-0.0525241651583345,0.183273138791155,0.277147789792904
Physical measures,X4270.Volume level set by participant (left),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,32213,-0.0269558686239908,0.0248417213368584,-0.0756456424442333,0.0217339051962517,0.277909002623589
Physical measures,X4270.Volume level set by participant (left),RPL14,60S ribosomal protein L14,32163,-0.0541069873801363,0.0498954188883604,-0.151902008401323,0.0436880336410501,0.278217890483353
Physical measures,X4270.Volume level set by participant (left),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,33489,-0.0536401703094091,0.0494909324711964,-0.150642397952954,0.0433620573341358,0.278465405295437
Physical measures,X4270.Volume level set by participant (left),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,33452,-0.0486840693288484,0.044929122071966,-0.136745148589902,0.0393770099322049,0.278582358290727
Physical measures,X4270.Volume level set by participant (left),USP25,Ubiquitin carboxyl-terminal hydrolase 25,32319,-0.0325072966586307,0.0300102182716753,-0.0913273244711142,0.0263127311538528,0.278749495304499
Physical measures,X4270.Volume level set by participant (left),CRADD,Death domain-containing protein CRADD,33356,-0.0263207680161148,0.0243061032830054,-0.0739607304508053,0.0213191944185758,0.278887829543478
Physical measures,X4270.Volume level set by participant (left),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,33509,0.0545575036161392,0.0504510924435605,-0.0443266375732394,0.153441644805518,0.27955073565785
Physical measures,X4270.Volume level set by participant (left),SNX5,Sorting nexin-5,32163,-0.0728192858078333,0.0673790383070544,-0.20488220088966,0.0592436292739934,0.279846174821392
Physical measures,X4270.Volume level set by participant (left),CRH,Corticoliberin,33203,0.0218827070409676,0.0203086394231906,-0.0179222262284859,0.0616876403104211,0.281283406986937
Physical measures,X4270.Volume level set by participant (left),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,32140,-0.0284956049561134,0.0264660238903899,-0.0803690117812776,0.0233778018690509,0.281654238909816
Physical measures,X4270.Volume level set by participant (left),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,33421,0.0123541281251746,0.0114873646754516,-0.0101611066387105,0.0348693628890596,0.282200617253565
Physical measures,X4270.Volume level set by participant (left),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,32329,-0.0161083967499876,0.0149800882340617,-0.0454693696887485,0.0132525761887732,0.282264185923535
Physical measures,X4270.Volume level set by participant (left),QDPR,Dihydropteridine reductase,33394,-0.0439376714274504,0.0408911811646099,-0.124084386510086,0.0362090436551851,0.282626581719304
Physical measures,X4270.Volume level set by participant (left),TSPAN8,Tetraspanin-8,32329,-0.0205862021206153,0.0191808154553845,-0.058180600413169,0.0170081961719383,0.283182687287414
Physical measures,X4270.Volume level set by participant (left),ITGAM,Integrin alpha-M,33441,-0.0591108810189027,0.0550847430750061,-0.167076977445915,0.0488552154081092,0.283259601543138
Physical measures,X4270.Volume level set by participant (left),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,32350,-0.0273081104209861,0.0254501528412328,-0.0771904099898023,0.0225741891478302,0.283302211703541
Physical measures,X4270.Volume level set by participant (left),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",33195,0.0397913067120526,0.0371300458518682,-0.032983583157609,0.112566196581714,0.283896050232317
Physical measures,X4270.Volume level set by participant (left),KCTD5,BTB/POZ domain-containing protein KCTD5,32180,-0.0518787079804829,0.0484090212779496,-0.146760389685264,0.0430029737242983,0.283899789952688
Physical measures,X4270.Volume level set by participant (left),NEXN,Nexilin,32381,-0.030526601907208,0.0285464074168751,-0.0864775604442832,0.0254243566298671,0.284936646233824
Physical measures,X4270.Volume level set by participant (left),ADIPOQ,Adiponectin,32398,-0.0308682116351127,0.0288762194966388,-0.0874656018485247,0.0257291785782993,0.285109441648817
Physical measures,X4270.Volume level set by participant (left),CGREF1,Cell growth regulator with EF hand domain protein 1,33434,-0.0435204671749458,0.040733803164287,-0.123358721376948,0.0363177870270568,0.285363616317579
Physical measures,X4270.Volume level set by participant (left),SEC31A,Protein transport protein Sec31A,32163,-0.0292635935615956,0.0274226370190179,-0.0830119621188706,0.0244847749956795,0.285945324502448
Physical measures,X4270.Volume level set by participant (left),IKZF2,Zinc finger protein Helios,33232,-0.0198987564606834,0.0186525084403499,-0.0564576730037692,0.0166601600824024,0.286085194680313
Physical measures,X4270.Volume level set by participant (left),FGF16,Fibroblast growth factor 16,32140,0.0454234955082264,0.0426030567689489,-0.0380784957589135,0.128925486775366,0.286365501960189
Physical measures,X4270.Volume level set by participant (left),UBAC1,Ubiquitin-associated domain-containing protein 1,33386,-0.0528987887518851,0.0496328201081598,-0.150179116163878,0.044381538660108,0.286541696606354
Physical measures,X4270.Volume level set by participant (left),PARK7,Parkinson disease protein 7,33441,-0.0360181926998472,0.0338051784602729,-0.102276342481982,0.0302399570822876,0.286694741598635
Physical measures,X4270.Volume level set by participant (left),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",33386,-0.0599929938291078,0.056358538426699,-0.170455729145438,0.0504697414872221,0.287136418241967
Physical measures,X4270.Volume level set by participant (left),KHK,Ketohexokinase,32163,-0.0339194987841557,0.0319021700806633,-0.0964477521422558,0.0286087545739444,0.287708773307762
Physical measures,X4270.Volume level set by participant (left),C4BPB,C4b-binding protein beta chain,33456,0.0447069938800037,0.042057525220407,-0.0377257555519941,0.127139743312002,0.287812144839521
Physical measures,X4270.Volume level set by participant (left),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,32235,-0.049359909148189,0.0464431998907962,-0.14038858093415,0.0416687626377716,0.287904901663581
Physical measures,X4270.Volume level set by participant (left),PAMR1,Inactive serine protease PAMR1,33441,0.065905017357263,0.0620180503593022,-0.0556503613469694,0.187460396061495,0.28795802373428
Physical measures,X4270.Volume level set by participant (left),ADRA2A,Alpha-2A adrenergic receptor,32122,0.0286648564464681,0.0269819395037138,-0.024219744980811,0.0815494578737472,0.288100310686155
Physical measures,X4270.Volume level set by participant (left),GOLGA3,Golgin subfamily A member 3,32350,-0.0282329014659087,0.0265778238023448,-0.0803254361185046,0.0238596331866871,0.288144313736349
Physical measures,X4270.Volume level set by participant (left),PMS1,PMS1 protein homolog 1,32154,-0.0425095520154156,0.0400268087952516,-0.120962097254109,0.0359429932232775,0.288256735820592
Physical measures,X4270.Volume level set by participant (left),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,33273,-0.0614399251479003,0.0578651333571568,-0.174855586527928,0.051975736232127,0.288365561057261
Physical measures,X4270.Volume level set by participant (left),RAB2B,Ras-related protein Rab-2B,32319,-0.0361937706214702,0.0341545880112216,-0.103136763123465,0.0307492218805241,0.289311601052211
Physical measures,X4270.Volume level set by participant (left),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,33456,-0.0402140407104484,0.037990132677885,-0.114674700759103,0.0342466193382063,0.289838142341603
Physical measures,X4270.Volume level set by participant (left),HEBP1,Heme-binding protein 1,33273,-0.0330522356595117,0.0312269288654399,-0.0942570162357738,0.0281525449167505,0.289877973450913
Physical measures,X4270.Volume level set by participant (left),WDR46,WD repeat-containing protein 46,32319,-0.0625269518094354,0.0590761752466703,-0.178316255292909,0.0532623516740384,0.289900013400981
Physical measures,X4270.Volume level set by participant (left),KAZN,Kazrin,32329,-0.0216032287945284,0.0204300416524782,-0.0616461104333856,0.0184396528443288,0.290350284924773
Physical measures,X4270.Volume level set by participant (left),ADGRG1,Adhesion G-protein coupled receptor G1,33386,-0.0337379196901884,0.0319158875584371,-0.096293059304725,0.0288172199243483,0.290499762523387
Physical measures,X4270.Volume level set by participant (left),KLRK1,NKG2-D type II integral membrane protein,32353,-0.0458207289237256,0.04338959089475,-0.130864327077436,0.0392228692299843,0.29098660717618
Physical measures,X4270.Volume level set by participant (left),PYY,Peptide YY,32122,-0.0231468571643378,0.0219285945008801,-0.0661269023860627,0.0198331880573872,0.291204420687882
Physical measures,X4270.Volume level set by participant (left),IGSF3,Immunoglobulin superfamily member 3,33386,-0.0519387676085569,0.0492485719069107,-0.148465968546102,0.0445884333289881,0.291625464536993
Physical measures,X4270.Volume level set by participant (left),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,33232,0.0149525508058542,0.0141882706118322,-0.0128564595933369,0.0427615612050454,0.291972803310667
Physical measures,X4270.Volume level set by participant (left),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,33451,-0.0298108944773524,0.0282914340503832,-0.0852621052161033,0.0256403162613986,0.292045182560669
Physical measures,X4270.Volume level set by participant (left),JPT2,Jupiter microtubule associated homolog 2,32329,-0.0259065214221193,0.0245985511669949,-0.0741196817094294,0.0223066388651908,0.292294185846111
Physical measures,X4270.Volume level set by participant (left),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,32122,-0.0545303841265276,0.0517938929943341,-0.156046414395423,0.0469856461423672,0.292450147031877
Physical measures,X4270.Volume level set by participant (left),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,32122,0.0442630140203316,0.0420772224381486,-0.0382083419584397,0.126734369999103,0.292856952898263
Physical measures,X4270.Volume level set by participant (left),SUGP1,SURP and G-patch domain-containing protein 1,32329,-0.0525944788531724,0.0500261520620817,-0.150645736894853,0.0454567791885077,0.293134871250823
Physical measures,X4270.Volume level set by participant (left),EVPL,Envoplakin,32235,-0.0603466396152475,0.0574586464191652,-0.172965586596811,0.0522723073663162,0.293630239294433
Physical measures,X4270.Volume level set by participant (left),CXCL5,C-X-C motif chemokine 5,33407,-0.0157231886830095,0.0149721993426887,-0.0450686993946793,0.0136223220286604,0.29367340188095
Physical measures,X4270.Volume level set by participant (left),OMD,Osteomodulin,33481,-0.0390703735387483,0.0372566291701555,-0.112093366712253,0.0339526196347565,0.29435236815704
Physical measures,X4270.Volume level set by participant (left),SOD3,Extracellular superoxide dismutase,32381,-0.034305498188368,0.0327625853982431,-0.0985201655689244,0.0299091691921885,0.295088274100598
Physical measures,X4270.Volume level set by participant (left),TNFSF10,Tumor necrosis factor ligand superfamily member 10,33527,-0.0687140852674997,0.0656434076185284,-0.197375164199815,0.0599469936648159,0.295229794899424
Physical measures,X4270.Volume level set by participant (left),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",33219,-0.0327689355729366,0.0313182069819903,-0.0941526212576376,0.0286147501117645,0.295441150328905
Physical measures,X4270.Volume level set by participant (left),LAG3,Lymphocyte activation gene 3 protein,33386,-0.0444009880668574,0.0424555508995658,-0.127613867830006,0.0388118916962916,0.295671102470309
Physical measures,X4270.Volume level set by participant (left),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,32154,-0.0200037726753046,0.0191343071743129,-0.057507014736958,0.0174994693863488,0.295852416808547
Physical measures,X4270.Volume level set by participant (left),ACP5,Tartrate-resistant acid phosphatase type 5,33456,0.0555500504063986,0.0531819811046898,-0.0486866325587935,0.159786733371591,0.296269378373634
Physical measures,X4270.Volume level set by participant (left),SLC39A14,Zinc transporter ZIP14,33219,-0.0570398772536915,0.0546842460182521,-0.164220999449466,0.0501412449420826,0.296941420286556
Physical measures,X4270.Volume level set by participant (left),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",32213,-0.0218225170957656,0.0209248931390078,-0.0628353076482208,0.0191902734566897,0.29702830046726
Physical measures,X4270.Volume level set by participant (left),LAMTOR5,Ragulator complex protein LAMTOR5,32319,-0.0506929114708099,0.0486616301111779,-0.146069706488719,0.0446838835470987,0.297562881881348
Physical measures,X4270.Volume level set by participant (left),ITM2A,Integral membrane protein 2A,33421,-0.0292717598234437,0.0281320287559141,-0.0844105361850353,0.025867016538148,0.298129384141829
Physical measures,X4270.Volume level set by participant (left),SNX2,Sorting nexin-2,32319,-0.0263202414610175,0.0253088027344843,-0.0759254948206068,0.0232850118985718,0.298388640129308
Physical measures,X4270.Volume level set by participant (left),VCAM1,Vascular cell adhesion protein 1,33435,-0.0663492448251367,0.0638882502064807,-0.191570215229839,0.0588717255795655,0.299055850659803
Physical measures,X4270.Volume level set by participant (left),DTYMK,Thymidylate kinase,32365,-0.0312798303602083,0.0301224935651856,-0.0903199177479721,0.0277602570275555,0.29910583075452
Physical measures,X4270.Volume level set by participant (left),TREML1,Trem-like transcript 1 protein,32381,-0.0392969960186131,0.0378536086505619,-0.113490068973714,0.0348960769364883,0.299240844844743
Physical measures,X4270.Volume level set by participant (left),PMVK,Phosphomevalonate kinase,33197,-0.0173605675785328,0.01673814612502,-0.050167333983572,0.0154461988265063,0.299677959266192
Physical measures,X4270.Volume level set by participant (left),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,33232,-0.030141976730334,0.0290796231898215,-0.0871380381823842,0.0268540847217161,0.299982305792344
Physical measures,X4270.Volume level set by participant (left),PDLIM7,PDZ and LIM domain protein 7,33481,-0.0142373098465172,0.0137539261792868,-0.0411950051579193,0.0127203854648848,0.300628866452337
Physical measures,X4270.Volume level set by participant (left),LGALS9,Galectin-9,33427,0.055758824381804,0.0538947591970007,-0.0498749036443173,0.161392552407925,0.300889650401267
Physical measures,X4270.Volume level set by participant (left),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,33219,-0.0170963314884112,0.0165285039314682,-0.0494921991940889,0.0152995362172666,0.300999033682271
Physical measures,X4270.Volume level set by participant (left),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,32235,-0.0257609147530223,0.0249164433941228,-0.0745971438055029,0.0230753142994583,0.301218730229142
Physical measures,X4270.Volume level set by participant (left),TPBGL,Trophoblast glycoprotein-like,32154,0.0495220925164161,0.047927383517907,-0.0444155791786817,0.143459764211514,0.301508407651269
Physical measures,X4270.Volume level set by participant (left),PTP4A3,Protein tyrosine phosphatase type IVA 3,32140,-0.0401973015379814,0.0389255957923535,-0.116491469290994,0.0360968662150314,0.30179077503898
Physical measures,X4270.Volume level set by participant (left),CDH15,Cadherin-15,33476,-0.0393724363583043,0.03815279609476,-0.114151916704034,0.0354070439874253,0.302115121692364
Physical measures,X4270.Volume level set by participant (left),PHLDB2,Pleckstrin homology-like domain family B member 2,32075,0.0230288353245868,0.0223203646201287,-0.0207190793308653,0.066776749980039,0.30222620962042
Physical measures,X4270.Volume level set by participant (left),SIGLEC6,Sialic acid-binding Ig-like lectin 6,33509,0.0530649096098239,0.0514615318167817,-0.0477996927510682,0.153929511970716,0.302494828620703
Physical measures,X4270.Volume level set by participant (left),FCRL2,Fc receptor-like protein 2,33476,-0.0357306749400537,0.0346791200252525,-0.103701750189549,0.0322404003094413,0.302886299688865
Physical measures,X4270.Volume level set by participant (left),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,32365,-0.0341083852162753,0.0331289085006148,-0.0990410458774802,0.0308242754449297,0.30324544118185
Physical measures,X4270.Volume level set by participant (left),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",32163,-0.0276839809798564,0.0269065726426448,-0.0804208633594403,0.0250529013997274,0.303562299654794
Physical measures,X4270.Volume level set by participant (left),AHSP,Alpha-hemoglobin-stabilizing protein,33422,-0.0194421803765171,0.0188974116394975,-0.0564811071899322,0.017596746436898,0.303588402158786
Physical measures,X4270.Volume level set by participant (left),GH1,Somatotropin,33418,0.0101954498783849,0.00991500622316279,-0.0092379623190142,0.0296288620757839,0.303843641976685
Physical measures,X4270.Volume level set by participant (left),LRP2,Low-density lipoprotein receptor-related protein 2,32154,0.0558540191013676,0.0544062412217246,-0.0507822136932125,0.162490251895948,0.304636155246035
Physical measures,X4270.Volume level set by participant (left),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,33424,0.0604738264733985,0.0589444572712859,-0.0550573097783218,0.176004962725119,0.30494473615512
Physical measures,X4270.Volume level set by participant (left),MTUS1,Microtubule-associated tumor suppressor 1,32235,-0.0376900279247138,0.0367771491059901,-0.109773240172454,0.0343931843230268,0.305479092405057
Physical measures,X4270.Volume level set by participant (left),TXNDC15,Thioredoxin domain-containing protein 15,33456,0.0646665304166196,0.0631142921924327,-0.0590374822805484,0.188370543113788,0.305582291592998
Physical measures,X4270.Volume level set by participant (left),KIAA1549L,UPF0606 protein KIAA1549L,32235,-0.071713857968642,0.0700615147141394,-0.209034426808355,0.0656067108710713,0.306063546586824
Physical measures,X4270.Volume level set by participant (left),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,32350,-0.017025554645786,0.0166866332576099,-0.0497313558307014,0.0156802465391295,0.307612274971955
Physical measures,X4270.Volume level set by participant (left),TOR1AIP1,Torsin-1A-interacting protein 1,32163,-0.0401169142594745,0.039321995253155,-0.117188024955658,0.0369541964367093,0.307658224394597
Physical measures,X4270.Volume level set by participant (left),GRSF1,G-rich sequence factor 1,32033,-0.0266374881497663,0.0261233867880795,-0.0778393262544021,0.0245643499548695,0.30791292673441
Physical measures,X4270.Volume level set by participant (left),ZNRD2,Protein ZNRD2,32329,-0.0291760729949478,0.0286310803207045,-0.0852929904235285,0.026940844433633,0.308217658235959
Physical measures,X4270.Volume level set by participant (left),CCL15,C-C motif chemokine 15,33533,-0.0387527554287741,0.0380381945553842,-0.113307616757327,0.0358021058997789,0.30833203108627
Physical measures,X4270.Volume level set by participant (left),RAB39B,Ras-related protein Rab-39B,32122,-0.0216963936988408,0.0212962219053542,-0.0634369886333351,0.0200442012356534,0.308334468555803
Physical measures,X4270.Volume level set by participant (left),PRSS27,Serine protease 27,33393,-0.0430276573649631,0.0422469402516858,-0.125831660258267,0.0397763455283411,0.308477538935117
Physical measures,X4270.Volume level set by participant (left),NRP1,Neuropilin-1,33475,-0.0625313898806628,0.0614826877222193,-0.183037457816213,0.0579746780548872,0.309153655516488
Physical measures,X4270.Volume level set by participant (left),CD3E,T-cell surface glycoprotein CD3 epsilon chain,32235,-0.0596850914919437,0.0586872795798803,-0.174712159468509,0.0553419764846217,0.309184015369733
Physical measures,X4270.Volume level set by participant (left),HEG1,Protein HEG homolog 1,32213,-0.0793713790854114,0.0781255428814814,-0.232497443133115,0.0737546849622922,0.309686501915652
Physical measures,X4270.Volume level set by participant (left),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,32353,0.032832914437655,0.0323187667853925,-0.0305118684617143,0.0961776973370244,0.309704013126637
Physical measures,X4270.Volume level set by participant (left),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,33452,0.0418486641371465,0.0412080394734926,-0.038919093230899,0.122616421505192,0.309872887582693
Physical measures,X4270.Volume level set by participant (left),BABAM1,BRISC and BRCA1-A complex member 1,32140,-0.068824136467479,0.0677853487015892,-0.201683419922594,0.0640351469876358,0.309983054521861
Physical measures,X4270.Volume level set by participant (left),DBNL,Drebrin-like protein,33481,-0.0198480066917487,0.019579710200473,-0.0582242386846758,0.0185282253011784,0.310751768639598
Physical measures,X4270.Volume level set by participant (left),IDO1,"Indoleamine 2,3-dioxygenase 1",32163,-0.0307864585798777,0.0304222487888364,-0.0904140662059971,0.0288411490462417,0.311583290453404
Physical measures,X4270.Volume level set by participant (left),LONP1,"Lon protease homolog, mitochondrial",32163,-0.0245058655028896,0.0242227930764043,-0.0719825399326421,0.0229708089268628,0.311719871191446
Physical measures,X4270.Volume level set by participant (left),SLC1A4,Neutral amino acid transporter A,32154,-0.0392243769255144,0.0387755113405424,-0.115224379152978,0.0367756253019487,0.311772612132782
Physical measures,X4270.Volume level set by participant (left),LATS1,Serine/threonine-protein kinase LATS1,32140,-0.0252806415278245,0.0249927271233286,-0.0742663866895486,0.0237051036338996,0.311799494032972
Physical measures,X4270.Volume level set by participant (left),PHACTR2,Phosphatase and actin regulator 2,32350,-0.0182469038299966,0.0180545472646604,-0.0536338164687309,0.0171400088087377,0.312212942416295
Physical measures,X4270.Volume level set by participant (left),STEAP4,Metalloreductase STEAP4,32111,0.0270571516930183,0.0267727769719825,-0.0254174911720674,0.0795317945581041,0.312229422524101
Physical measures,X4270.Volume level set by participant (left),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,33386,0.0384672590017637,0.0380883893932787,-0.0361859842090625,0.11312050221259,0.312547988522865
Physical measures,X4270.Volume level set by participant (left),PSME2,Proteasome activator complex subunit 2,33328,-0.0480097588671256,0.0475480863909364,-0.141204008193361,0.0451844904591097,0.312661979146358
Physical measures,X4270.Volume level set by participant (left),LUZP2,Leucine zipper protein 2,32319,-0.045409126615143,0.0450122018740465,-0.133633042288274,0.0428147890579882,0.313092889276372
Physical measures,X4270.Volume level set by participant (left),KRT19,"Keratin, type I cytoskeletal 19",33409,0.026126835567899,0.0259272604905387,-0.0246905949935569,0.0769442661293548,0.31362693593748
Physical measures,X4270.Volume level set by participant (left),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,33434,-0.0351110044757356,0.0348687200854522,-0.103453695843222,0.0332316868917507,0.313986670267237
Physical measures,X4270.Volume level set by participant (left),OGA,Protein O-GlcNAcase,32329,-0.0303714267576406,0.0301630594809437,-0.0894910233402903,0.0287481698250092,0.314009914367775
Physical measures,X4270.Volume level set by participant (left),ATP6AP2,Renin receptor,33232,-0.041563086653216,0.0413221981758756,-0.122554595077932,0.0394284217715002,0.314525313803799
Physical measures,X4270.Volume level set by participant (left),SLMAP,Sarcolemmal membrane-associated protein,32329,-0.024022631462921,0.0239074480759751,-0.0708812296918322,0.0228359667659903,0.315015426240737
Physical measures,X4270.Volume level set by participant (left),EDDM3B,Epididymal secretory protein E3-beta,32319,-0.0470217740701515,0.0468871399976899,-0.138920568465624,0.0448770203253207,0.315953746011294
Physical measures,X4270.Volume level set by participant (left),DGKA,Diacylglycerol kinase alpha,32140,-0.0391486033522091,0.0390533318435055,-0.11569313376548,0.0373959270610616,0.316162923302211
Physical measures,X4270.Volume level set by participant (left),FABP2,"Fatty acid-binding protein, intestinal",33434,-0.0223396903809835,0.0223418089891365,-0.0661296359996912,0.0214502552377241,0.317383345995705
Physical measures,X4270.Volume level set by participant (left),AZI2,5-azacytidine-induced protein 2,32350,-0.0355179812071825,0.0355377287407556,-0.105171929539063,0.0341359671246985,0.317610128786809
Physical measures,X4270.Volume level set by participant (left),CCL17,C-C motif chemokine 17,33412,-0.0192092088485707,0.0192283105559534,-0.0568966975382395,0.018478279841098,0.317818488839571
Physical measures,X4270.Volume level set by participant (left),COL1A1,Collagen alpha-1(I) chain,33533,-0.064909262449947,0.0649754304191355,-0.192261106071453,0.0624425811715587,0.317830209095376
Physical measures,X4270.Volume level set by participant (left),CMIP,C-Maf-inducing protein,32319,-0.0251604014499041,0.0252144418985898,-0.0745807075711401,0.024259904671332,0.318379521530763
Physical measures,X4270.Volume level set by participant (left),LAYN,Layilin,33356,-0.0520831962764411,0.0522392470805155,-0.154472120554251,0.0503057280013693,0.318785415558856
Physical measures,X4270.Volume level set by participant (left),HDAC9,Histone deacetylase 9,32111,-0.0312084953204131,0.0313028365012597,-0.0925620548628822,0.030145064222056,0.318802728098852
Physical measures,X4270.Volume level set by participant (left),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,32319,-0.0424373885031982,0.0425943049783151,-0.125922226260696,0.0410474492542994,0.31912727626274
Physical measures,X4270.Volume level set by participant (left),PLXNB2,Plexin-B2,33476,-0.0727725678725854,0.0730615077283803,-0.215973123020211,0.0704279872750399,0.319254874812116
Physical measures,X4270.Volume level set by participant (left),NT5C1A,Cytosolic 5'-nucleotidase 1A,32353,-0.0608997316006248,0.0611831599005359,-0.180818725005675,0.0590192618044254,0.319588031698401
Physical measures,X4270.Volume level set by participant (left),SART1,U4/U6.U5 tri-snRNP-associated protein 1,32122,-0.0576601375048415,0.0579354404392347,-0.171213600765741,0.0558933257560585,0.319647017658017
Physical measures,X4270.Volume level set by participant (left),TARBP2,RISC-loading complex subunit TARBP2,33219,-0.0229471097403896,0.0230693732444258,-0.0681630812994641,0.022268861818685,0.319909568570506
Physical measures,X4270.Volume level set by participant (left),SPTLC1,Serine palmitoyltransferase 1,32353,-0.0541889657347734,0.0545084275778467,-0.161025483787353,0.052647552317806,0.320185548966193
Physical measures,X4270.Volume level set by participant (left),CDC25A,M-phase inducer phosphatase 1,32075,0.0495831095901367,0.0498759048607925,-0.0481736639370166,0.14733988311729,0.320191379778443
Physical measures,X4270.Volume level set by participant (left),PCDH9,Protocadherin-9,32329,-0.0587415120545019,0.0591115310410261,-0.174600112894913,0.0571170887859093,0.320379841788154
Physical measures,X4270.Volume level set by participant (left),PTGES2,Prostaglandin E synthase 2,32101,-0.0384125623394616,0.03865959666577,-0.114185371804371,0.0373602471254477,0.320444210395302
Physical measures,X4270.Volume level set by participant (left),EBI3_IL27,Interleukin-27,33499,0.0545081379575468,0.0549040375234562,-0.0531037755884274,0.162120051503521,0.320839232759487
Physical measures,X4270.Volume level set by participant (left),PPME1,Protein phosphatase methylesterase 1,33386,-0.0289568347534377,0.0291693231067593,-0.086128708042686,0.0282150385358106,0.320875587531018
Physical measures,X4270.Volume level set by participant (left),SPOCK1,Testican-1,33380,-0.068401949018325,0.068911433711709,-0.203468359093275,0.0666644610566246,0.320928580695946
Physical measures,X4270.Volume level set by participant (left),VAV3,Guanine nucleotide exchange factor VAV3,32111,-0.0213589991119432,0.0215275622657256,-0.0635530211527654,0.020835022928879,0.321146013180177
Physical measures,X4270.Volume level set by participant (left),CPXM2,Inactive carboxypeptidase-like protein X2,32365,-0.0812728937974721,0.0819569215087744,-0.24190845995467,0.0793626723597257,0.321396761574118
Physical measures,X4270.Volume level set by participant (left),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,33232,-0.0237339264074635,0.0239698111943296,-0.0707147563483496,0.0232469035334226,0.322123661016349
Physical measures,X4270.Volume level set by participant (left),ATXN2L,Ataxin-2-like protein,32350,-0.0397705570937731,0.0402164948583144,-0.118594887016069,0.0390537728285231,0.322736714891293
Physical measures,X4270.Volume level set by participant (left),SEMA7A,Semaphorin-7A,33492,-0.0621556212090375,0.0629266875705486,-0.185491928847313,0.0611806864292378,0.32330321455741
Physical measures,X4270.Volume level set by participant (left),CST3,Cystatin-C,33444,0.0626344670860608,0.0634569649693485,-0.0617411842538623,0.187010118425984,0.323650335025142
Physical measures,X4270.Volume level set by participant (left),PSME1,Proteasome activator complex subunit 1,33367,-0.0468221771556468,0.0474431310538215,-0.139810714021137,0.0461663597098433,0.323712761703345
Physical measures,X4270.Volume level set by participant (left),CHMP6,Charged multivesicular body protein 6,32365,-0.0362065414579651,0.0366930764459627,-0.108124971292052,0.0357118883761219,0.323800093433113
Physical measures,X4270.Volume level set by participant (left),GTPBP2,GTP-binding protein 2,32154,-0.0259863645618235,0.0263489082532528,-0.0776302247381991,0.0256574956145521,0.324046025544734
Physical measures,X4270.Volume level set by participant (left),LAMB1,Laminin subunit beta-1,32163,-0.06729241799992,0.0682454746902079,-0.201053548392727,0.0664687123928874,0.324146949944556
Physical measures,X4270.Volume level set by participant (left),LPP,Lipoma-preferred partner,32122,-0.0310986079171633,0.0315546116877604,-0.0929456468251738,0.0307484309908471,0.324385700438678
Physical measures,X4270.Volume level set by participant (left),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,32365,-0.0590522245627527,0.0599247635665183,-0.176504761153129,0.058400312027623,0.324438412965448
Physical measures,X4270.Volume level set by participant (left),MRPS16,"28S ribosomal protein S16, mitochondrial",32140,-0.0662486960953845,0.0672843068038757,-0.198125937430981,0.0656285452402118,0.32484744109308
Physical measures,X4270.Volume level set by participant (left),MYDGF,Myeloid-derived growth factor,32365,-0.0199128474895442,0.0202276382689373,-0.0595590184966613,0.0197333235175729,0.324930512638795
Physical measures,X4270.Volume level set by participant (left),APP,Amyloid-beta precursor protein,33429,-0.0255758356244571,0.0260040154145569,-0.0765437058369885,0.0253920345880743,0.325371161320557
Physical measures,X4270.Volume level set by participant (left),CDHR2,Cadherin-related family member 2,33386,0.0220655906648295,0.0224508895577907,-0.0219381528684404,0.0660693341980993,0.325713728134124
Physical measures,X4270.Volume level set by participant (left),SERPINB5,Serpin B5,33273,0.034942083759662,0.0355662926172509,-0.0347678497701497,0.104652017289474,0.325905440863369
Physical measures,X4270.Volume level set by participant (left),CA4,Carbonic anhydrase 4,33533,-0.0728730768114522,0.0741985874671132,-0.218302308246994,0.0725561546240896,0.326059205524099
Physical measures,X4270.Volume level set by participant (left),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",32140,-0.0418907981076001,0.0426710799970883,-0.125526114901893,0.041744518686693,0.326271653451788
Physical measures,X4270.Volume level set by participant (left),CD2,T-cell surface antigen CD2,32122,0.0523700920173982,0.0533517312052082,-0.0521993011448099,0.156939485179606,0.326327618867155
Physical measures,X4270.Volume level set by participant (left),SWAP70,Switch-associated protein 70,32329,-0.0589430259350092,0.0600635191908335,-0.176667523549043,0.0587814716790244,0.326452857759445
Physical measures,X4270.Volume level set by participant (left),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,33527,-0.0471581453571598,0.0480716192991789,-0.14137851918355,0.0470622284692309,0.326620062561156
Physical measures,X4270.Volume level set by participant (left),CD27,CD27 antigen,33456,0.0420419942210166,0.042919503408417,-0.0420802324594808,0.126164220901514,0.327332383266648
Physical measures,X4270.Volume level set by participant (left),CRLF1,Cytokine receptor-like factor 1,33481,0.0639590424111722,0.0653126135015677,-0.0640536800519006,0.191971764874245,0.327470117583418
Physical measures,X4270.Volume level set by participant (left),MNAT1,CDK-activating kinase assembly factor MAT1,32235,-0.0450721196538227,0.0460339511459549,-0.135298663899894,0.0451544245922488,0.327558031361545
Physical measures,X4270.Volume level set by participant (left),BCL2L15,Bcl-2-like protein 15,32140,0.0328403045367107,0.0335996774347253,-0.0330150632353509,0.0986956723087724,0.32840222606924
Physical measures,X4270.Volume level set by participant (left),TAX1BP1,Tax1-binding protein 1,32353,-0.0298052993954824,0.0305335519656431,-0.0896510612481428,0.030040462457178,0.329020477494887
Physical measures,X4270.Volume level set by participant (left),SCARB2,Lysosome membrane protein 2,33183,-0.0594127589749791,0.0609977712133647,-0.178968390553174,0.0601428726032157,0.330075963932769
Physical measures,X4270.Volume level set by participant (left),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,32329,-0.0193019176525727,0.0198310498411315,-0.0581707753411904,0.019566940036045,0.330425180903931
Physical measures,X4270.Volume level set by participant (left),CHGB,Secretogranin-1,33459,-0.0424701080344124,0.0436430986522042,-0.128010581392733,0.0430703653239078,0.330518259220452
Physical measures,X4270.Volume level set by participant (left),FUS,RNA-binding protein FUS,33228,0.0451597934755945,0.0464084165650489,-0.0458007029919013,0.13612028994309,0.33053296738911
Physical measures,X4270.Volume level set by participant (left),TWF2,Twinfilin-2,32384,-0.0240335246365586,0.0247111079984074,-0.0724672963134372,0.0244002470403199,0.330791851325282
Physical measures,X4270.Volume level set by participant (left),FHIT,Bis(5'-adenosyl)-triphosphatase,33219,-0.0244589749744518,0.0251651366345431,-0.0737826427781562,0.0248646928292527,0.331107774479157
Physical measures,X4270.Volume level set by participant (left),KDM3A,Lysine-specific demethylase 3A,32140,-0.0211027523222057,0.0217453027791838,-0.0637235457694061,0.0215180411249946,0.331852245256337
Physical measures,X4270.Volume level set by participant (left),VASP,Vasodilator-stimulated phosphoprotein,32381,-0.0276088213213587,0.0284602119172219,-0.0833908366791136,0.0281731940363962,0.332033785384403
Physical measures,X4270.Volume level set by participant (left),IDI2,Isopentenyl-diphosphate delta-isomerase 2,33219,0.0363910390626677,0.037514047551633,-0.037136494138533,0.109918572263868,0.332041202515096
Physical measures,X4270.Volume level set by participant (left),CD79B,B-cell antigen receptor complex-associated protein beta chain,33527,0.038578931458932,0.0397773523200784,-0.0393846790884217,0.116542542006286,0.332136264890141
Physical measures,X4270.Volume level set by participant (left),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",32350,-0.0252680284882518,0.0260608401023357,-0.0763472750888298,0.0258112181123261,0.33228636949579
Physical measures,X4270.Volume level set by participant (left),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,32122,-0.0348433830943207,0.0359401319721055,-0.105286041759647,0.035599275571006,0.332334338672351
Physical measures,X4270.Volume level set by participant (left),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",32163,-0.0598881842638908,0.0617850599245241,-0.180986901715958,0.0612105331881764,0.332426542518716
Physical measures,X4270.Volume level set by participant (left),CTHRC1,Collagen triple helix repeat-containing protein 1,32384,-0.0693352209269926,0.0715337826336663,-0.209541434888979,0.0708709930349935,0.33244234895393
Physical measures,X4270.Volume level set by participant (left),ARL13B,ADP-ribosylation factor-like protein 13B,32122,-0.0282013552191429,0.0290975492456201,-0.0852325517405584,0.0288298413022726,0.332475803907119
Physical measures,X4270.Volume level set by participant (left),SEPTIN3,Neuronal-specific septin-3,32350,0.0261173985516884,0.0269558597900296,-0.0267160866367695,0.0789508837401463,0.332627246119882
Physical measures,X4270.Volume level set by participant (left),CDC26,Anaphase-promoting complex subunit CDC26,32309,-0.0277511848985422,0.0286757313222276,-0.0839556182901083,0.0284532484930239,0.333194755543277
Physical measures,X4270.Volume level set by participant (left),ATP5F1D,"ATP synthase subunit delta, mitochondrial",32122,-0.0357717857736011,0.0370071791237185,-0.108305856856089,0.0367622853088872,0.333765787770031
Physical measures,X4270.Volume level set by participant (left),CPM,Carboxypeptidase M,33451,0.0486059795925001,0.05031935788858,-0.0500199618691166,0.147231921054117,0.334095208601415
Physical measures,X4270.Volume level set by participant (left),SHH,Sonic hedgehog protein,32140,-0.0443407549224237,0.0459066138997277,-0.13431771816589,0.0456362083210426,0.334129450127709
Physical measures,X4270.Volume level set by participant (left),PON2,Serum paraoxonase/arylesterase 2,33273,0.0488517510587159,0.050642491686016,-0.0504075326458755,0.148111034763307,0.334751829199688
Physical measures,X4270.Volume level set by participant (left),MAEA,E3 ubiquitin-protein transferase MAEA,33232,0.0428173505618402,0.0444329254069096,-0.0442711832357026,0.129905884359383,0.335252922152311
Physical measures,X4270.Volume level set by participant (left),CCL7,C-C motif chemokine 7,33421,0.0277324948257954,0.0288092512075621,-0.0287336375410263,0.084198627192617,0.3357618922175
Physical measures,X4270.Volume level set by participant (left),CTRB1,Chymotrypsinogen B,33441,-0.0312106542617106,0.0324341434913359,-0.094781575504729,0.0323602669813078,0.335936001001786
Physical measures,X4270.Volume level set by participant (left),OSBPL2,Oxysterol-binding protein-related protein 2,32353,-0.0454029804502752,0.0472090980535522,-0.137932812635238,0.0471268517346871,0.336208575958191
Physical measures,X4270.Volume level set by participant (left),PRKD2,Serine/threonine-protein kinase D2,32122,-0.0403431526248203,0.0419897865722039,-0.12264313430634,0.0419568290566994,0.336690634131975
Physical measures,X4270.Volume level set by participant (left),CBLN1,Cerebellin-1,32111,0.0200531833417702,0.0209360231114205,-0.020981421956614,0.0610877886401545,0.338177955336268
Physical measures,X4270.Volume level set by participant (left),LTB,Lymphotoxin-beta,32319,0.0550539625094307,0.0574986312353321,-0.0576433547118202,0.167751279730682,0.338352951898614
Physical measures,X4270.Volume level set by participant (left),ENPEP,Glutamyl aminopeptidase,32122,-0.0446558759629809,0.0467115484247201,-0.136210510875432,0.0468987589494704,0.339106316448227
Physical measures,X4270.Volume level set by participant (left),CRISP3,Cysteine-rich secretory protein 3,32312,-0.0699426362957577,0.0732542357059408,-0.213520938279402,0.0736356656878862,0.339711728856972
Physical measures,X4270.Volume level set by participant (left),TCL1A,T-cell leukemia/lymphoma protein 1A,33369,0.0177579550125116,0.0186037643914993,-0.018705423194827,0.0542213332198502,0.339838492487426
Physical measures,X4270.Volume level set by participant (left),NADK,NAD kinase,33434,0.0302275078436412,0.0316853838736775,-0.0318758445487667,0.0923308602360491,0.340114888920907
Physical measures,X4270.Volume level set by participant (left),CSF3R,Granulocyte colony-stimulating factor receptor,32140,-0.0599227921398524,0.0628148136823053,-0.183039826957171,0.0631942426774659,0.34013411623702
Physical measures,X4270.Volume level set by participant (left),TPPP2,Tubulin polymerization-promoting protein family member 2,32235,-0.0232652245904047,0.024391778374903,-0.0710731102052146,0.0245426610244053,0.340207333105794
Physical measures,X4270.Volume level set by participant (left),C1QL2,Complement C1q-like protein 2,32140,-0.0454090057008344,0.0476229674548997,-0.138750021912438,0.047932010510769,0.340361402358901
Physical measures,X4270.Volume level set by participant (left),DLG4,Disks large homolog 4,32353,-0.0269664745071957,0.028290351423148,-0.0824155632965658,0.0284826142821744,0.340515920257735
Physical measures,X4270.Volume level set by participant (left),KIF22,Kinesin-like protein KIF22,32122,-0.0163558992520101,0.0171603986850131,-0.0499902806746359,0.0172784821706156,0.340559909563688
Physical measures,X4270.Volume level set by participant (left),SOST,Sclerostin,33418,-0.0425167483233853,0.0446302093974872,-0.12999195874246,0.0449584620956897,0.340795629749985
Physical measures,X4270.Volume level set by participant (left),FGF3,Fibroblast growth factor 3,32140,0.0624042206814669,0.0655644182924035,-0.0661020391716441,0.190910480534578,0.34122829851128
Physical measures,X4270.Volume level set by participant (left),GFRA3,GDNF family receptor alpha-3,33358,-0.0588429949971038,0.0618634493805481,-0.180095355782978,0.0624093657887704,0.341541133583003
Physical measures,X4270.Volume level set by participant (left),SHPK,Sedoheptulokinase,32235,-0.0448384522336751,0.0471491560781359,-0.137250798146821,0.0475738936794713,0.341638172384511
Physical measures,X4270.Volume level set by participant (left),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,32213,-0.0467729036165746,0.0492399308668245,-0.143283168115551,0.0497373608824013,0.342193757869026
Physical measures,X4270.Volume level set by participant (left),RRM2,Ribonucleoside-diphosphate reductase subunit M2,33232,0.0327611763958681,0.034495567912011,-0.0348501367116734,0.10037248950341,0.342280021572307
Physical measures,X4270.Volume level set by participant (left),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,32213,-0.0472106941271574,0.0497429762247161,-0.144706927527601,0.0502855392732862,0.342603045495507
Physical measures,X4270.Volume level set by participant (left),GSAP,Gamma-secretase-activating protein,33232,0.0185132793316583,0.0195300693735934,-0.0197656566405847,0.0567922153039014,0.343187522139795
Physical measures,X4270.Volume level set by participant (left),ANK2,Ankyrin-2,32122,0.0268460020079294,0.0283833133092881,-0.0287852920782753,0.0824772960941341,0.344261283973533
Physical measures,X4270.Volume level set by participant (left),HSBP1,Heat shock factor-binding protein 1,32163,0.0203666567997892,0.0215735976801007,-0.0219175946532082,0.0626509082527865,0.345171273936303
Physical measures,X4270.Volume level set by participant (left),CD14,Monocyte differentiation antigen CD14,33199,0.0404145246619508,0.0428155409606125,-0.0435039356208496,0.124332984944751,0.345235665075794
Physical measures,X4270.Volume level set by participant (left),CDH6,Cadherin-6,33434,-0.0426085381284361,0.0451966613416059,-0.131193994357984,0.0459769181011114,0.345841110200642
Physical measures,X4270.Volume level set by participant (left),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,32384,-0.048321581866966,0.0512572153678288,-0.148785723987911,0.0521425602539785,0.345849072003412
Physical measures,X4270.Volume level set by participant (left),ECE1,Endothelin-converting enzyme 1,33219,-0.0464212356777374,0.0492979904431239,-0.14304529694626,0.0502028255907854,0.346400070851554
Physical measures,X4270.Volume level set by participant (left),ATG16L1,Autophagy-related protein 16-1,32329,-0.0233003099212658,0.0247622213352907,-0.0718342637384356,0.0252336438959041,0.346753186311153
Physical measures,X4270.Volume level set by participant (left),MAN2B2,Epididymis-specific alpha-mannosidase,32365,-0.0312861432845363,0.0332707306825717,-0.0964967754223769,0.0339244888533042,0.347066595015134
Physical measures,X4270.Volume level set by participant (left),CEP164,Centrosomal protein of 164 kDa,33273,-0.0250949298358329,0.0267163777003179,-0.0774590301284561,0.0272691704567903,0.34759792755242
Physical measures,X4270.Volume level set by participant (left),AMOTL2,Angiomotin-like protein 2,32283,-0.0386683340345657,0.0412086004038568,-0.119437190826125,0.0421005227569936,0.348090482986224
Physical measures,X4270.Volume level set by participant (left),SUSD4,Sushi domain-containing protein 4,32319,-0.0414559008056936,0.0442109581243338,-0.128109378729388,0.0451975771180007,0.348435709411684
Physical measures,X4270.Volume level set by participant (left),MINK1,Misshapen-like kinase 1,32353,-0.0208939079919072,0.0222829655286509,-0.064568520428063,0.0227807044442487,0.34844639533262
Physical measures,X4270.Volume level set by participant (left),ALMS1,Alstrom syndrome protein 1,32235,-0.0386615446024846,0.0412332932971852,-0.119478799464968,0.0421557102599984,0.3484640455846
Physical measures,X4270.Volume level set by participant (left),CNST,Consortin,33434,-0.0161172780179018,0.0171944802006741,-0.049818459211223,0.0175839031754193,0.348602805439481
Physical measures,X4270.Volume level set by participant (left),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",32140,-0.0370936026633865,0.0395786489821678,-0.114667754668435,0.0404805493416623,0.348678737232727
Physical measures,X4270.Volume level set by participant (left),GASK1A,Golgi-associated kinase 1A,32122,0.0448979771669826,0.0479061876117282,-0.0489981505520046,0.13879410488597,0.348682009534732
Physical measures,X4270.Volume level set by participant (left),CBLN4,Cerebellin-4,33509,-0.0505088588292881,0.0539240467257454,-0.156199990411749,0.055182272753173,0.348955014110736
Physical measures,X4270.Volume level set by participant (left),BAG4,BAG family molecular chaperone regulator 4,32140,-0.0395166783688049,0.0422325828171408,-0.122292540690401,0.043259183952791,0.34946133204818
Physical measures,X4270.Volume level set by participant (left),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,32140,-0.0409536382312213,0.0437866803738568,-0.126775531763981,0.044868255301538,0.349663619949904
Physical measures,X4270.Volume level set by participant (left),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,33380,-0.0556891949892228,0.0595916575566016,-0.172488843800162,0.0611104538217162,0.350064474601384
Physical measures,X4270.Volume level set by participant (left),CELA3A,Chymotrypsin-like elastase family member 3A,33517,-0.0289653528362789,0.0309964928798396,-0.0897184788807645,0.0317877732082068,0.350085402740035
Physical measures,X4270.Volume level set by participant (left),MB,Myoglobin,33533,0.0322565073919884,0.0345511271172165,-0.035463701757756,0.0999767165417329,0.350541441330123
Physical measures,X4270.Volume level set by participant (left),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,32122,-0.072425827043207,0.0776065880107483,-0.224534739544274,0.0796830854578597,0.350723759457324
Physical measures,X4270.Volume level set by participant (left),SARG,Specifically androgen-regulated gene protein,32329,-0.0178957203123786,0.0191760465651286,-0.0554807715800306,0.0196893309552734,0.350728272260705
Physical measures,X4270.Volume level set by participant (left),TCOF1,Treacle protein,32365,-0.0626728189600439,0.0671773057919951,-0.194340338312354,0.0689947003922664,0.350876170472358
Physical measures,X4270.Volume level set by participant (left),CD82,CD82 antigen,32235,-0.0445333516951651,0.0478806216001641,-0.138379370031487,0.0493126666411565,0.352352649747984
Physical measures,X4270.Volume level set by participant (left),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,33500,-0.0230415554389467,0.0247783099107526,-0.0716070428640218,0.0255239319861283,0.352443394501566
Physical measures,X4270.Volume level set by participant (left),SIT1,Signaling threshold-regulating transmembrane adapter 1,33273,0.0295460315381348,0.031791184032356,-0.0327646891652829,0.0918567522415525,0.352718591645095
Physical measures,X4270.Volume level set by participant (left),NRXN3,Neurexin-3,32154,0.0509587950413699,0.0549105545135711,-0.0566658918052294,0.158583481887969,0.353419654108278
Physical measures,X4270.Volume level set by participant (left),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,33356,-0.0153788241383645,0.0165742257033184,-0.0478643065168685,0.0171066582401395,0.353497120616225
Physical measures,X4270.Volume level set by participant (left),NEO1,Neogenin,32350,-0.0882753204193445,0.0952160439284126,-0.274898766519033,0.0983481256803442,0.353900087866758
Physical measures,X4270.Volume level set by participant (left),GLOD4,Glyoxalase domain-containing protein 4,33413,-0.0466341852394586,0.0503231142501043,-0.145267489169663,0.0519991186907459,0.354109808805496
Physical measures,X4270.Volume level set by participant (left),TBL1X,F-box-like/WD repeat-containing protein TBL1X,33232,-0.0201373299271371,0.0217364381072902,-0.0627407486174259,0.0224660887631518,0.35424703861636
Physical measures,X4270.Volume level set by participant (left),PRAME,Melanoma antigen preferentially expressed in tumors,32075,0.0727437539143985,0.0785435239661727,-0.0812015530592999,0.226689060888097,0.354392936536623
Physical measures,X4270.Volume level set by participant (left),GC,Vitamin D-binding protein,32398,0.0709079801167556,0.0767071865844331,-0.0794381055887332,0.221254065822244,0.355307147320843
Physical measures,X4270.Volume level set by participant (left),CDC37,Hsp90 co-chaperone Cdc37,33456,-0.0199615803535406,0.0215990774455305,-0.0622957721467804,0.0223726114396992,0.355413887645991
Physical measures,X4270.Volume level set by participant (left),SPINK4,Serine protease inhibitor Kazal-type 4,33421,-0.0249661972877534,0.0270143063184986,-0.0779142376720106,0.0279818430965039,0.355415248947321
Physical measures,X4270.Volume level set by participant (left),AREG,Amphiregulin,33386,0.0319894880690789,0.0346591098127686,-0.0359423671639476,0.0999213433021055,0.356045224688564
Physical measures,X4270.Volume level set by participant (left),MNDA,Myeloid cell nuclear differentiation antigen,33420,0.0164475865020352,0.0178579490644001,-0.0185539936641889,0.0514491666682593,0.357063065263894
Physical measures,X4270.Volume level set by participant (left),ECI2,Enoyl-CoA delta isomerase 2,32122,-0.0305065311962618,0.0331325789954375,-0.0954463860273193,0.0344333236347956,0.357214519341478
Physical measures,X4270.Volume level set by participant (left),GRK5,G protein-coupled receptor kinase 5,33273,-0.0320192905188318,0.034787011004531,-0.100201832087713,0.0361632510500491,0.357369042309726
Physical measures,X4270.Volume level set by participant (left),CCN2,CCN family member 2,33441,-0.02767189695867,0.0301040537998927,-0.0866758424064596,0.0313320484891197,0.358011289003481
Physical measures,X4270.Volume level set by participant (left),GIMAP8,GTPase IMAP family member 8,32075,0.0359526999353341,0.0391299883273378,-0.040742077186248,0.112647477056916,0.35822838336507
Physical measures,X4270.Volume level set by participant (left),YAP1,Transcriptional coactivator YAP1,32353,-0.0694323391748929,0.0755889954872806,-0.217586770329963,0.078722091980177,0.358358578762899
Physical measures,X4270.Volume level set by participant (left),IL10RA,Interleukin-10 receptor subunit alpha,33273,-0.0274133934506292,0.0298862820710298,-0.0859905063098476,0.0311637194085893,0.359033210054697
Physical measures,X4270.Volume level set by participant (left),NPHS2,Podocin,32140,-0.0176676904924844,0.0192641472111637,-0.0554254190263652,0.0200900380413965,0.359104304088629
Physical measures,X4270.Volume level set by participant (left),CLEC11A,C-type lectin domain family 11 member A,33417,0.0325969188890792,0.0355811269536873,-0.037142089940148,0.102335927718306,0.359623644127507
Physical measures,X4270.Volume level set by participant (left),TLR4,Toll-like receptor 4,32140,-0.0656843499643976,0.0717409816036907,-0.206296673907631,0.0749279739788362,0.35991783951696
Physical measures,X4270.Volume level set by participant (left),STAM,Signal transducing adapter molecule 1,32319,-0.0458454394856203,0.0500801275086568,-0.144002489402588,0.0523116104313471,0.3599878392275
Physical measures,X4270.Volume level set by participant (left),PRSS53,Serine protease 53,32353,-0.0489612199405722,0.0535760416028111,-0.153970261482082,0.0560478216009376,0.360816167051068
Physical measures,X4270.Volume level set by participant (left),CD86,T-lymphocyte activation antigen CD86,32329,-0.0622289590096721,0.0681019620301737,-0.195708804588813,0.0712508865694684,0.360870096906716
Physical measures,X4270.Volume level set by participant (left),CDH5,Cadherin-5,33533,-0.0506016529762166,0.0553824106614961,-0.159151177872749,0.0579478719203158,0.360910686006447
Physical measures,X4270.Volume level set by participant (left),LPA,Apolipoprotein(a),32213,0.0105072301485964,0.0115010758481048,-0.012034878513689,0.0330493388108819,0.360962438429299
Physical measures,X4270.Volume level set by participant (left),GNLY,Granulysin,33441,0.0305379800927551,0.0334315961791073,-0.0349879484182952,0.0960639086038053,0.361032178445266
Physical measures,X4270.Volume level set by participant (left),TBCB,Tubulin-folding cofactor B,33380,-0.0167878950573729,0.0183798670030863,-0.052812434383422,0.0192366442686762,0.361064757862198
Physical measures,X4270.Volume level set by participant (left),IL24,Interleukin-24,33273,-0.0335160107199323,0.0367074692743858,-0.105462650497728,0.0384306290578638,0.361237541582929
Physical measures,X4270.Volume level set by participant (left),NOTCH1,Neurogenic locus notch homolog protein 1,33533,-0.100453018539073,0.110083745333489,-0.316217159392711,0.115311122314565,0.361522149627361
Physical measures,X4270.Volume level set by participant (left),ZHX2,Zinc fingers and homeoboxes protein 2,32353,0.0601737435975312,0.0659473671003773,-0.0690830959192084,0.189430583114271,0.361559182772905
Physical measures,X4270.Volume level set by participant (left),RHOC,Rho-related GTP-binding protein RhoC,33313,-0.014305130107019,0.0156825580816266,-0.045042943947007,0.0164326837329691,0.361705027416962
Physical measures,X4270.Volume level set by participant (left),AKT2,RAC-beta serine/threonine-protein kinase,32350,-0.0150966641587693,0.0165506897769931,-0.0475360161216758,0.0173426878041373,0.361719122717706
Physical measures,X4270.Volume level set by participant (left),EGFLAM,Pikachurin,32329,0.0584655381754854,0.0641130498571611,-0.0671960395445503,0.184127115895521,0.361842315638432
Physical measures,X4270.Volume level set by participant (left),GOT1,"Aspartate aminotransferase, cytoplasmic",32384,-0.045612576872231,0.050104503554431,-0.143817403838916,0.0525922500944537,0.3626662397893
Physical measures,X4270.Volume level set by participant (left),PLPBP,Pyridoxal phosphate homeostasis protein,33434,-0.024392851942286,0.0268254802703015,-0.0769707932720769,0.028185089387505,0.363207488021559
Physical measures,X4270.Volume level set by participant (left),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,32329,-0.0208945045362539,0.0229825038866997,-0.0659402121541854,0.0241512030816776,0.363299671776756
Physical measures,X4270.Volume level set by participant (left),PPT1,Palmitoyl-protein thioesterase 1,32154,-0.0236697640710225,0.0260387310245437,-0.074705676879128,0.0273661487370831,0.3633672773599
Physical measures,X4270.Volume level set by participant (left),ECM1,Extracellular matrix protein 1,32155,-0.0499780959580803,0.0550004154819227,-0.157778910302649,0.0578227183864882,0.363544446885642
Physical measures,X4270.Volume level set by participant (left),RBP7,Retinoid-binding protein 7,32329,0.0292742112114589,0.0322330949086736,-0.0339026548095413,0.0924510772324591,0.363798484134729
Physical measures,X4270.Volume level set by participant (left),AP1G2,AP-1 complex subunit gamma-like 2,32319,-0.0227759678772013,0.0250849685429748,-0.0719425062214318,0.0263905704670292,0.363930972274762
Physical measures,X4270.Volume level set by participant (left),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",32365,-0.0208359942402082,0.0229733856848224,-0.0658638301824602,0.0241918417020437,0.364454372704093
Physical measures,X4270.Volume level set by participant (left),IL20RB,Interleukin-20 receptor subunit beta,32140,-0.0440569260522796,0.0485802135727635,-0.139274144654896,0.0511602925503368,0.364493228022528
Physical measures,X4270.Volume level set by participant (left),CD40,Tumor necrosis factor receptor superfamily member 5,33427,-0.0316428942615736,0.0349067763351754,-0.100060175878517,0.03677438735537,0.364697101671199
Physical measures,X4270.Volume level set by participant (left),AK2,"Adenylate kinase 2, mitochondrial",32353,-0.0175975750093761,0.0194195851228068,-0.0556599618500774,0.0204648118313252,0.364869992402556
Physical measures,X4270.Volume level set by participant (left),OTOA,Otoancorin,32111,-0.0341724202801594,0.0377325618940972,-0.10812824159259,0.039783401032271,0.365150678666286
Physical measures,X4270.Volume level set by participant (left),LTBP3,Latent-transforming growth factor beta-binding protein 3,33232,0.0290058014244937,0.032049447791577,-0.0338111162469973,0.0918227190959846,0.365472853147412
Physical measures,X4270.Volume level set by participant (left),CD101,Immunoglobulin superfamily member 2,32329,-0.0432325945726262,0.0478637716403063,-0.137045586987626,0.0505803978423741,0.366424817086725
Physical measures,X4270.Volume level set by participant (left),SPESP1,Sperm equatorial segment protein 1,32365,-0.0660975871367853,0.0732427504223062,-0.209653377964505,0.0774582036909348,0.3668477636992
Physical measures,X4270.Volume level set by participant (left),CD28,T-cell-specific surface glycoprotein CD28,33232,0.0444785574620337,0.049406045884837,-0.0523572924722468,0.141314407396314,0.368003688370644
Physical measures,X4270.Volume level set by participant (left),PALM,Paralemmin-1,32281,-0.0625466914714793,0.0696243844177925,-0.199010484930353,0.0739171019873939,0.369029485909844
Physical measures,X4270.Volume level set by participant (left),SDCCAG8,Serologically defined colon cancer antigen 8,32319,-0.0167213915853184,0.0186153114114133,-0.0532074019516885,0.0197646187810518,0.369074396951851
Physical measures,X4270.Volume level set by participant (left),GLA,Alpha-galactosidase A,32192,-0.0510175216323347,0.0568037970423802,-0.1623529638354,0.0603179205707305,0.369141122335803
Physical measures,X4270.Volume level set by participant (left),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,33273,0.038238877906126,0.0425795905422494,-0.0452171195566829,0.121694875368935,0.369179949805592
Physical measures,X4270.Volume level set by participant (left),CHGA,Chromogranin-A,32384,0.0198538793441853,0.0221111082451673,-0.0234838928163426,0.0631916515047132,0.36925852675173
Physical measures,X4270.Volume level set by participant (left),MFAP3,Microfibril-associated glycoprotein 3,33273,0.0319828081615031,0.0356213956534243,-0.0378351273192086,0.101800743642215,0.36928797077939
Physical measures,X4270.Volume level set by participant (left),RAB37,Ras-related protein Rab-37,33273,-0.018652328396385,0.0207914148867449,-0.059403501574405,0.0220988447816351,0.369681065920845
Physical measures,X4270.Volume level set by participant (left),IL34,Interleukin-34,33204,0.043372927451947,0.0483486101004339,-0.0513903483449035,0.138136203248798,0.369696981768702
Physical measures,X4270.Volume level set by participant (left),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,32213,-0.0630939007980614,0.0703877011464534,-0.20105379504511,0.0748659934489872,0.370079378169888
Physical measures,X4270.Volume level set by participant (left),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,32350,-0.025973529749292,0.0289819017556795,-0.0827780571904239,0.0308309976918399,0.370174212435812
Physical measures,X4270.Volume level set by participant (left),CYTL1,Cytokine-like protein 1,32384,-0.0766305249375902,0.0855124097610985,-0.244234848069343,0.0909737981941628,0.370208735296558
Physical measures,X4270.Volume level set by participant (left),AHNAK,Neuroblast differentiation-associated protein AHNAK,32163,-0.0596872194930103,0.0666223021298225,-0.190266931667462,0.0708924926814418,0.370331754132599
Physical measures,X4270.Volume level set by participant (left),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",32365,-0.0247769883581575,0.0276652930517075,-0.0790009627395043,0.0294469860231893,0.370494617283241
Physical measures,X4270.Volume level set by participant (left),MDH1,"Malate dehydrogenase, cytoplasmic",32327,-0.0443820116129952,0.0495967133141273,-0.141591569708685,0.0528275464826943,0.370890404350046
Physical measures,X4270.Volume level set by participant (left),SEMA4C,Semaphorin-4C,33386,-0.0563836832769253,0.0631990657634792,-0.180253852173344,0.0674864856194939,0.372331174588842
Physical measures,X4270.Volume level set by participant (left),SMAD2,Mothers against decapentaplegic homolog 2,32319,-0.0271041502013341,0.0304148692271986,-0.0867172938866433,0.0325089934839751,0.37287703496855
Physical measures,X4270.Volume level set by participant (left),ERCC1,DNA excision repair protein ERCC-1,32075,-0.0558829329273976,0.0629971750609954,-0.179357396046949,0.0675915301921535,0.375068964058788
Physical measures,X4270.Volume level set by participant (left),CA12,Carbonic anhydrase 12,33386,-0.0483583474771009,0.0547132139798536,-0.155596246877614,0.0588795519234121,0.376800259594131
Physical measures,X4270.Volume level set by participant (left),GRN,Progranulin,33399,0.0634490826497249,0.0718720691290694,-0.0774201728432512,0.204318338142701,0.377364908736086
Physical measures,X4270.Volume level set by participant (left),DCDC2C,Doublecortin domain-containing protein 2C,32075,-0.0277041720507412,0.0314105922668665,-0.0892689328937996,0.0338605887923172,0.377804117286558
Physical measures,X4270.Volume level set by participant (left),CD36,Platelet glycoprotein 4,32140,-0.0400500461232398,0.0454118387604198,-0.129057250093663,0.0489571578471829,0.377842446218526
Physical measures,X4270.Volume level set by participant (left),ZNF75D,Zinc finger protein 75D,32235,-0.0273282683999002,0.0309963758218209,-0.0880811650106693,0.0334246282108688,0.377987870799812
Physical measures,X4270.Volume level set by participant (left),SEMA3G,Semaphorin-3G,32213,-0.0409554965946729,0.0464543813099857,-0.132006083962245,0.0500950907728992,0.378005166627607
Physical measures,X4270.Volume level set by participant (left),DXO,Decapping and exoribonuclease protein,32353,-0.0403644752145607,0.0458102921392698,-0.130152647807529,0.049423697378408,0.37827837889851
Physical measures,X4270.Volume level set by participant (left),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,32235,-0.0257998999251749,0.0293024267307803,-0.0832326563175043,0.0316328564671545,0.378632089875121
Physical measures,X4270.Volume level set by participant (left),CKAP4,Cytoskeleton-associated protein 4,33469,-0.0578139063161649,0.0656919260891667,-0.186570081450932,0.0709422688186019,0.378841446995842
Physical measures,X4270.Volume level set by participant (left),CD7,T-cell antigen CD7,32128,-0.0417271936896736,0.0474281939528248,-0.13468645383721,0.051232066457863,0.378996718139209
Physical measures,X4270.Volume level set by participant (left),SKAP2,Src kinase-associated phosphoprotein 2,33481,-0.0145604021463896,0.0165665131992659,-0.0470307680169508,0.0179099637241716,0.379475828602926
Physical measures,X4270.Volume level set by participant (left),PSMC3,26S proteasome regulatory subunit 6A,32075,-0.0573279228390866,0.0652768807484254,-0.185270609106,0.0706147634278272,0.379848201832206
Physical measures,X4270.Volume level set by participant (left),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,33500,-0.028696456507619,0.0326757416360984,-0.0927409101143719,0.0353479970991338,0.379848221083642
Physical measures,X4270.Volume level set by participant (left),CASP2,Caspase-2,33421,-0.0228209718390237,0.0260504230905853,-0.0738798010965709,0.0282378574185235,0.381036782469514
Physical measures,X4270.Volume level set by participant (left),PLG,Plasminogen,32167,-0.0783988295556466,0.0896834201915557,-0.254178333131096,0.0973806740198025,0.382051237454522
Physical measures,X4270.Volume level set by participant (left),GRPEL1,"GrpE protein homolog 1, mitochondrial",33386,-0.0258516732623752,0.0295821195649534,-0.0838326276096839,0.0321292810849335,0.382198808399036
Physical measures,X4270.Volume level set by participant (left),MAVS,Mitochondrial antiviral-signaling protein,33232,-0.0164386703349662,0.0188201664666935,-0.0533261966096854,0.0204488559397531,0.382436072138557
Physical measures,X4270.Volume level set by participant (left),DAB2,Disabled homolog 2,33509,-0.0140933691134464,0.016153158979508,-0.0457535607132822,0.0175668224863893,0.382967652884912
Physical measures,X4270.Volume level set by participant (left),CLEC4C,C-type lectin domain family 4 member C,33421,-0.032644403859772,0.0374227335918178,-0.105992961699735,0.0407041539801908,0.383060032145882
Physical measures,X4270.Volume level set by participant (left),USP28,Ubiquitin carboxyl-terminal hydrolase 28,32353,-0.0439653241131822,0.0504237251336311,-0.142795825375099,0.0548651771487348,0.383279936114348
Physical measures,X4270.Volume level set by participant (left),CYB5A,Cytochrome b5,32075,0.0241214241428237,0.0276651796237346,-0.0301023279196962,0.0783451762053435,0.383287366753166
Physical measures,X4270.Volume level set by participant (left),ANG,Angiogenin,33368,-0.0432952869613093,0.0497069634386298,-0.140720935301024,0.0541303613784051,0.383771880260814
Physical measures,X4270.Volume level set by participant (left),IL9,Interleukin-9,32235,-0.0300974774650945,0.034565865939126,-0.0978465747057815,0.0376516197755924,0.383929391597794
Physical measures,X4270.Volume level set by participant (left),SCRN1,Secernin-1,33421,-0.0267742272376837,0.0307527233470679,-0.0870495649979368,0.0335011105225693,0.383979808971792
Physical measures,X4270.Volume level set by participant (left),MAG,Myelin-associated glycoprotein,32154,-0.0375314178540647,0.0431334967078464,-0.122073071401444,0.0470102356933142,0.384260693339496
Physical measures,X4270.Volume level set by participant (left),NIT1,Deaminated glutathione amidase,32163,-0.0406164496339374,0.0467212973864909,-0.13219019251146,0.0509572932435847,0.384691103404504
Physical measures,X4270.Volume level set by participant (left),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,32111,-0.0305034395273777,0.0350991767665312,-0.0992978259897787,0.0382909469350234,0.384839235587411
Physical measures,X4270.Volume level set by participant (left),SIGLEC9,Sialic acid-binding Ig-like lectin 9,33499,0.049784351413699,0.0573082473881679,-0.0625398134671101,0.162108516294508,0.385027831016832
Physical measures,X4270.Volume level set by participant (left),PRG2,Bone marrow proteoglycan,32384,-0.0327345800585266,0.0377823739538202,-0.106788033008014,0.041318872890961,0.386298057144542
Physical measures,X4270.Volume level set by participant (left),AOC1,Amiloride-sensitive amine oxidase [copper-containing],33273,-0.0263737404924083,0.0304731543702627,-0.0861011230581233,0.0333536420733066,0.386801907096069
Physical measures,X4270.Volume level set by participant (left),DNAJA4,DnaJ homolog subfamily A member 4,32353,-0.02315958981807,0.0267729163463069,-0.0756345058568315,0.0293153262206915,0.38704420925608
Physical measures,X4270.Volume level set by participant (left),ITPA,Inosine triphosphate pyrophosphatase,32122,-0.0258267566176035,0.0298590523979689,-0.0843504993176225,0.0326969860824156,0.387090183159329
Physical measures,X4270.Volume level set by participant (left),ESYT2,Extended synaptotagmin-2,32353,-0.0210085081373139,0.0242960142526592,-0.068628696072526,0.0266116797978982,0.387235501676294
Physical measures,X4270.Volume level set by participant (left),TALDO1,Transaldolase,32349,-0.0394253571449748,0.0456042287923462,-0.128809645577973,0.0499589312880238,0.387333512367051
Physical measures,X4270.Volume level set by participant (left),SRC,Proto-oncogene tyrosine-protein kinase Src,33436,-0.0127740973260505,0.0147795763628249,-0.0417420669971873,0.0161938723450864,0.387442125451583
Physical measures,X4270.Volume level set by participant (left),FCRLB,Fc receptor-like B,33232,0.0248822525061325,0.028793446962949,-0.0315529035412476,0.0813174085535126,0.387521569454309
Physical measures,X4270.Volume level set by participant (left),CLEC3B,Tetranectin,32207,0.0816773453734398,0.0945223468150113,-0.103586454383982,0.266941145130862,0.38755629249509
Physical measures,X4270.Volume level set by participant (left),TMED8,Protein TMED8,32329,-0.0176842326272531,0.0204786723411035,-0.0578224304158159,0.0224539651613097,0.387864794897203
Physical measures,X4270.Volume level set by participant (left),STAB2,Stabilin-2,32384,0.0598398923604976,0.0692981420944105,-0.075984466144547,0.195664250865542,0.38788123108521
Physical measures,X4270.Volume level set by participant (left),CSDE1,Cold shock domain-containing protein E1,32122,-0.0145594980088882,0.0168789569226315,-0.0476422535772458,0.0185232575594695,0.388393867173834
Physical measures,X4270.Volume level set by participant (left),CA11,Carbonic anhydrase-related protein 11,33232,-0.0466018201323506,0.054115599674242,-0.152668395493865,0.0594647552291638,0.389177213305461
Physical measures,X4270.Volume level set by participant (left),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,32075,-0.0410002107531262,0.0477285448166656,-0.134548158593791,0.0525477370875385,0.390351461719181
Physical measures,X4270.Volume level set by participant (left),DBN1,Drebrin,32140,-0.0331100372838551,0.0385474475213265,-0.108663034425655,0.0424429598579448,0.390399082689408
Physical measures,X4270.Volume level set by participant (left),GCC1,GRIP and coiled-coil domain-containing protein 1,32353,-0.0164765708981083,0.0191847640354271,-0.0540787084075455,0.0211255666113288,0.39045692628669
Physical measures,X4270.Volume level set by participant (left),CASQ2,Calsequestrin-2,32122,0.0341494296205044,0.0397939064605783,-0.0438466270422291,0.112145486283238,0.390832460127769
Physical measures,X4270.Volume level set by participant (left),ACTN4,Alpha-actinin-4,33273,0.0456614049411164,0.0532375681024451,-0.0586842285396761,0.150007038421909,0.391086193882502
Physical measures,X4270.Volume level set by participant (left),MSMB,Beta-microseminoprotein,33390,0.0217773737422485,0.0253968231008356,-0.0280003995353894,0.0715551470198864,0.391200359320642
Physical measures,X4270.Volume level set by participant (left),FAM3D,Protein FAM3D,32329,0.0204966033144463,0.0239143462859799,-0.0263755154060743,0.0673687220349669,0.391424553233721
Physical measures,X4270.Volume level set by participant (left),SH2D1A,SH2 domain-containing protein 1A,33421,0.028075504178285,0.0327930947057904,-0.0361989614450642,0.0923499698016341,0.391942818997827
Physical measures,X4270.Volume level set by participant (left),HIF1A,Hypoxia-inducible factor 1-alpha,32140,0.0244605493151385,0.0286090372006098,-0.0316131635980567,0.0805342622283338,0.392581235552127
Physical measures,X4270.Volume level set by participant (left),FLT1,Vascular endothelial growth factor receptor 1,33364,0.0628714424812993,0.0736332240954017,-0.081449676745688,0.207192561708287,0.393213215236976
Physical measures,X4270.Volume level set by participant (left),PGM2,Phosphoglucomutase-2,32154,-0.0281076606173402,0.0329220810667739,-0.0926349395082169,0.0364196182735366,0.393262781667562
Physical measures,X4270.Volume level set by participant (left),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,33386,0.0327355298306694,0.0383941348249929,-0.0425169744263167,0.107988034087656,0.393894050034833
Physical measures,X4270.Volume level set by participant (left),GSTA1,Glutathione S-transferase A1,33420,0.0179387142941265,0.0210434859800385,-0.023306518226749,0.0591839468150021,0.393982018896349
Physical measures,X4270.Volume level set by participant (left),CPLX2,Complexin-2,32075,-0.0558983583503627,0.0655728241764481,-0.184421093736201,0.0726243770354755,0.393984365052085
Physical measures,X4270.Volume level set by participant (left),CPB1,Carboxypeptidase B,33533,-0.0257452104228087,0.0302689417371964,-0.0850723362277136,0.0335819153820962,0.395042504173757
Physical measures,X4270.Volume level set by participant (left),MED21,Mediator of RNA polymerase II transcription subunit 21,32122,-0.0349179499436417,0.0410571635290515,-0.115389990460583,0.0455540905732992,0.395089523604931
Physical measures,X4270.Volume level set by participant (left),CLEC6A,C-type lectin domain family 6 member A,33232,-0.032636703462522,0.0383863953675646,-0.107874038382949,0.0426006314579047,0.395228548063705
Physical measures,X4270.Volume level set by participant (left),CD164L2,CD164 sialomucin-like 2 protein,32154,-0.046681932503555,0.0549141234287706,-0.154313614423945,0.0609497494168353,0.395301634174848
Physical measures,X4270.Volume level set by participant (left),BIN2,Bridging integrator 2,33441,-0.0162702396718764,0.0191504401651425,-0.0538051023955557,0.0212646230518028,0.395569399551724
Physical measures,X4270.Volume level set by participant (left),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,33273,0.0266029777778856,0.0313162857395881,-0.0347769422717071,0.0879828978274783,0.395629868095592
Physical measures,X4270.Volume level set by participant (left),OSTN,Osteocrin,32154,-0.0414510357797736,0.0488341897078735,-0.137166047607206,0.0542639760476584,0.396012421206016
Physical measures,X4270.Volume level set by participant (left),NRGN,Neurogranin,32381,-0.0191988323839023,0.0226825086856899,-0.0636565494078545,0.0252588846400499,0.397346414224173
Physical measures,X4270.Volume level set by participant (left),S100A11,Protein S100-A11,33354,0.0296432569720151,0.0350259934406659,-0.03900769017169,0.0982942041157203,0.397396083743928
Physical measures,X4270.Volume level set by participant (left),INHBC,Inhibin beta C chain,33441,0.0339347820982828,0.0401054174814085,-0.0446718361652779,0.112541400361843,0.397497400238915
Physical measures,X4270.Volume level set by participant (left),SERPINB6,Serpin B6,33467,-0.0248217050354726,0.0293366367312253,-0.0823215130286741,0.0326781029577289,0.397519868772136
Physical measures,X4270.Volume level set by participant (left),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,32075,-0.0674289964403689,0.07973757867519,-0.223714650643741,0.0888566577630035,0.397782183072851
Physical measures,X4270.Volume level set by participant (left),AMPD3,AMP deaminase 3,32353,-0.0225926136747271,0.0267291893783,-0.0749818248561951,0.029796597506741,0.398001755041557
Physical measures,X4270.Volume level set by participant (left),C8B,Complement component C8 beta chain,32398,-0.0538230284749791,0.0637195128198801,-0.178713273601944,0.0710672166519859,0.398311197500256
Physical measures,X4270.Volume level set by participant (left),VEGFA,Vascular endothelial growth factor A,33499,-0.0247207116119465,0.0292887406549031,-0.0821266432955566,0.0326852200716636,0.398672374505838
Physical measures,X4270.Volume level set by participant (left),F13B,Coagulation factor XIII B chain,32353,0.0694995258730323,0.0823807264131474,-0.0919666978967366,0.230965749642801,0.398897173950698
Physical measures,X4270.Volume level set by participant (left),NRCAM,Neuronal cell adhesion molecule,33434,-0.0514550682570302,0.0609952717133002,-0.171005800815099,0.0680956643010383,0.398920412980933
Physical measures,X4270.Volume level set by participant (left),DUSP29,Dual specificity phosphatase 29,32154,-0.0263063025477889,0.0312000154609744,-0.0874583328512988,0.034845727755721,0.399170580997325
Physical measures,X4270.Volume level set by participant (left),ERP44,Endoplasmic reticulum resident protein 44,33374,-0.0585839829005437,0.0695124707437739,-0.194828425558341,0.0776604597572532,0.399371980261572
Physical measures,X4270.Volume level set by participant (left),OTUD7B,OTU domain-containing protein 7B,32350,-0.026790099663964,0.0318166718140268,-0.0891507764194565,0.0355705770915284,0.399805330343603
Physical measures,X4270.Volume level set by participant (left),LZTFL1,Leucine zipper transcription factor-like protein 1,32213,-0.0249736622051598,0.0296908060177424,-0.0831676419999349,0.0332203175896154,0.400304156172233
Physical measures,X4270.Volume level set by participant (left),SNAP25,Synaptosomal-associated protein 25,32111,-0.0376339729719373,0.0448051870055926,-0.125452139502899,0.0501841935590242,0.400964450163013
Physical measures,X4270.Volume level set by participant (left),SKAP1,Src kinase-associated phosphoprotein 1,33356,0.0203522927033506,0.024247196803718,-0.0271722130319366,0.0678767984386378,0.401286034252535
Physical measures,X4270.Volume level set by participant (left),POLR2A,DNA-directed RNA polymerase II subunit RPB1,32140,-0.0585206078138839,0.0697731090045196,-0.195275901462742,0.0782346858349746,0.401648470193309
Physical measures,X4270.Volume level set by participant (left),CASP1,Caspase-1,33219,0.0208781606621338,0.0249117601277234,-0.027948889188204,0.0697052105124715,0.402006088817497
Physical measures,X4270.Volume level set by participant (left),CABP2,Calcium-binding protein 2,32154,-0.0263446856554818,0.0314475222609447,-0.0879818292869333,0.0352924579759698,0.402205635339616
Physical measures,X4270.Volume level set by participant (left),DYNLT3,Dynein light chain Tctex-type 3,32319,0.0380454202387506,0.0454744926701664,-0.0510845853947755,0.127175425872277,0.402824818754708
Physical measures,X4270.Volume level set by participant (left),DNAJB6,DnaJ homolog subfamily B member 6,32123,-0.0210595227163235,0.025182204801001,-0.0704166441262855,0.0282975986936385,0.403020144729329
Physical measures,X4270.Volume level set by participant (left),MMP13,Collagenase 3,33219,-0.0446174660820173,0.05347413966478,-0.149426779824986,0.0601918476609515,0.40409264462189
Physical measures,X4270.Volume level set by participant (left),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,32122,-0.032155609558756,0.0385599758339117,-0.107733162193223,0.0434219430757109,0.404356802660538
Physical measures,X4270.Volume level set by participant (left),YJU2,Splicing factor YJU2,32319,-0.0525732988163446,0.0630931218567275,-0.176235817655531,0.0710892200228413,0.404720520442851
Physical measures,X4270.Volume level set by participant (left),EGF,Pro-epidermal growth factor,33421,-0.0143066466303889,0.0171701729212157,-0.0479601855559716,0.0193468922951938,0.404739078559416
Physical measures,X4270.Volume level set by participant (left),CILP,Cartilage intermediate layer protein 1,32384,-0.0309532571741853,0.0371490342268942,-0.103765364258898,0.0418588499105273,0.404746690335159
Physical measures,X4270.Volume level set by participant (left),FOS,Proto-oncogene c-Fos,32059,0.0489051555432626,0.0587040184703263,-0.066154720658577,0.163965031745102,0.404825663996039
Physical measures,X4270.Volume level set by participant (left),GLB1,Beta-galactosidase,33380,-0.036193246398495,0.0435040423938674,-0.121461169490475,0.0490746766934852,0.405458669444809
Physical measures,X4270.Volume level set by participant (left),ADH1B,All-trans-retinol dehydrogenase,32213,-0.0232287178281763,0.0279356332248102,-0.0779825589488043,0.0315251232924517,0.405711992676666
Physical measures,X4270.Volume level set by participant (left),SCGB2A2,Mammaglobin-A,32122,-0.0538457181732611,0.0648203229724196,-0.180893551199203,0.0732021148526812,0.406173561908242
Physical measures,X4270.Volume level set by participant (left),DIPK1C,Divergent protein kinase domain 1C,32154,-0.0388345917259202,0.0467804880687758,-0.130524348340721,0.0528551648888803,0.406482505388908
Physical measures,X4270.Volume level set by participant (left),PMCH,Pro-MCH,32122,-0.0206571135387406,0.024923320765595,-0.0695068222393067,0.0281925951618255,0.407228282376867
Physical measures,X4270.Volume level set by participant (left),TNIP1,TNFAIP3-interacting protein 1,32353,-0.0196635020286396,0.0237358834516205,-0.0661858335938159,0.0268588295365366,0.407452434789352
Physical measures,X4270.Volume level set by participant (left),MAPRE3,Microtubule-associated protein RP/EB family member 3,32075,-0.0114455971781365,0.0138663608349618,-0.0386236644146616,0.0157324700583887,0.409157975590275
Physical measures,X4270.Volume level set by participant (left),DUOX2,Dual oxidase 2,33273,-0.0192966165137799,0.0233971795900471,-0.0651550885102723,0.0265618554827124,0.409540879796489
Physical measures,X4270.Volume level set by participant (left),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,33386,0.0462283952620279,0.0561383729273713,-0.0638028156756199,0.156259606199676,0.410261449275195
Physical measures,X4270.Volume level set by participant (left),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",32163,-0.0238176742066464,0.0289335250971811,-0.0805273833971214,0.0328920349838286,0.410427668013371
Physical measures,X4270.Volume level set by participant (left),ALDH2,"Aldehyde dehydrogenase, mitochondrial",32319,-0.0299886373063759,0.0364378245588293,-0.101406773441681,0.0414294988289295,0.41052814696766
Physical measures,X4270.Volume level set by participant (left),AMBP,Protein AMBP,33499,0.0718802561137109,0.0873647717787566,-0.099354696572652,0.243115208800074,0.410666072484453
Physical measures,X4270.Volume level set by participant (left),ELOB,Elongin-B,32122,0.0411674658699634,0.050063415330288,-0.0569568281774012,0.139291759917328,0.410928118195283
Physical measures,X4270.Volume level set by participant (left),MANF,Mesencephalic astrocyte-derived neurotrophic factor,33481,-0.0122962453692308,0.0149741129164392,-0.0416455066854517,0.0170530159469901,0.411572915092049
Physical measures,X4270.Volume level set by participant (left),CDC42BPB,Serine/threonine-protein kinase MRCK beta,32329,-0.0158884637379833,0.0193546534511559,-0.0538235845022489,0.0220466570262822,0.411721351452475
Physical measures,X4270.Volume level set by participant (left),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",32235,-0.0225303607667166,0.0274676422774868,-0.0763669396305908,0.0313062180971575,0.412098168892317
Physical measures,X4270.Volume level set by participant (left),IFNGR2,Interferon gamma receptor 2,33380,-0.0273086475807136,0.0333420378612108,-0.0926590417886869,0.0380417466272596,0.41278229787467
Physical measures,X4270.Volume level set by participant (left),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",32163,-0.0341130273993428,0.0416666414729409,-0.115779644686307,0.0475535898876214,0.412975401101538
Physical measures,X4270.Volume level set by participant (left),GAL,Galanin peptides,33481,-0.0224408949226841,0.027428567416711,-0.0762008870594377,0.0313190972140695,0.413288716332303
Physical measures,X4270.Volume level set by participant (left),ERP29,Endoplasmic reticulum resident protein 29,32213,-0.0145773811453508,0.0178336145884147,-0.0495312657386435,0.020376503447942,0.413719064733068
Physical measures,X4270.Volume level set by participant (left),PLA2G4A,Cytosolic phospholipase A2,33481,-0.0166705743711942,0.0204063821441235,-0.0566670833736764,0.0233259346312879,0.413990312718921
Physical measures,X4270.Volume level set by participant (left),ECSCR,Endothelial cell-specific chemotaxis regulator,32111,0.0324215700743091,0.0397769474121516,-0.045541246853508,0.110384387002126,0.41504934394139
Physical measures,X4270.Volume level set by participant (left),SCN2B,Sodium channel subunit beta-2,32154,-0.0540622274910324,0.0663294199074642,-0.184067890509662,0.0759434355275975,0.415065158634565
Physical measures,X4270.Volume level set by participant (left),MTPN,Myotrophin,33273,-0.0450377120461131,0.055295864177976,-0.153417605834946,0.0633421817427199,0.415388534364719
Physical measures,X4270.Volume level set by participant (left),CNPY2,Protein canopy homolog 2,33273,0.0234590420362398,0.0288193434148423,-0.0330268710568511,0.0799449551293308,0.415665013003138
Physical measures,X4270.Volume level set by participant (left),SERPINA6,Corticosteroid-binding globulin,32398,0.0875456744273761,0.107566944864294,-0.12328553750664,0.298376886361392,0.415742946631676
Physical measures,X4270.Volume level set by participant (left),ITGAL,Integrin alpha-L,32140,-0.0379774815189614,0.0466923111227243,-0.129494411319501,0.0535394482815781,0.416039052321688
Physical measures,X4270.Volume level set by participant (left),TMPRSS11B,Transmembrane protease serine 11B,32111,0.0215105880466496,0.0264476148488638,-0.0303267370571235,0.0733479131504227,0.41605526890644
Physical measures,X4270.Volume level set by participant (left),DDR1,Epithelial discoidin domain-containing receptor 1,33500,-0.061025426709788,0.0750363819187096,-0.208096735270459,0.0860458818508827,0.416080185432629
Physical measures,X4270.Volume level set by participant (left),CDAN1,Codanin-1,32353,-0.0629290078789537,0.0774232998766959,-0.214678675637278,0.0888206598793703,0.416362050758129
Physical measures,X4270.Volume level set by participant (left),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,33380,-0.0156776940321079,0.0193052340796953,-0.0535159528283107,0.0221605647640948,0.416758484854705
Physical measures,X4270.Volume level set by participant (left),DDX4,Probable ATP-dependent RNA helicase DDX4,32140,0.0304796166369764,0.037550299843547,-0.0431189710563757,0.104078204330328,0.416988349367474
Physical measures,X4270.Volume level set by participant (left),LCN2,Neutrophil gelatinase-associated lipocalin,33171,0.0373968709153834,0.0460843572869962,-0.0529284693671292,0.127722211197896,0.417108039562299
Physical measures,X4270.Volume level set by participant (left),WFDC1,WAP four-disulfide core domain protein 1,32154,-0.0303462046891589,0.0375137506634909,-0.103873155989601,0.0431807466112832,0.418577244136581
Physical measures,X4270.Volume level set by participant (left),BMP6,Bone morphogenetic protein 6,33247,-0.0323656818714261,0.0400291569672337,-0.110822829527204,0.0460914657843519,0.418794374291261
Physical measures,X4270.Volume level set by participant (left),POSTN,Periostin,32384,-0.0423254384272252,0.052347136751015,-0.144925826459215,0.0602749496047642,0.418796523781829
Physical measures,X4270.Volume level set by participant (left),RAB33A,Ras-related protein Rab-33A,32122,-0.0249422211808421,0.0308751481692386,-0.0854575115925499,0.0355730692308656,0.419206984104983
Physical measures,X4270.Volume level set by participant (left),HARS1,"Histidine--tRNA ligase, cytoplasmic",33441,-0.0189510128760772,0.0234806018463265,-0.0649729924948771,0.0270709667427227,0.419634671180366
Physical measures,X4270.Volume level set by participant (left),TNC,Tenascin,33452,0.0290803357763093,0.03606684743194,-0.0416106851902931,0.0997713567429117,0.42009700843475
Physical measures,X4270.Volume level set by participant (left),TOP1,DNA topoisomerase 1,32329,-0.0150273012357313,0.018655100340914,-0.0515912979039227,0.02153669543246,0.420536424764736
Physical measures,X4270.Volume level set by participant (left),CTSL,Cathepsin L1,33434,-0.0572101660585682,0.071090326196931,-0.196547205404553,0.0821268732874165,0.420983432279422
Physical measures,X4270.Volume level set by participant (left),IGSF8,Immunoglobulin superfamily member 8,33434,0.0463890913230587,0.0577245054759477,-0.0667509394097987,0.159529122055916,0.421632496121666
Physical measures,X4270.Volume level set by participant (left),PFDN4,Prefoldin subunit 4,32075,-0.030388749664627,0.0378207116074409,-0.104517344415211,0.0437398450859572,0.421713794366665
Physical measures,X4270.Volume level set by participant (left),IL11,Interleukin-11,33273,-0.0216774745769859,0.0270079466862255,-0.0746130500819878,0.0312581009280161,0.422208406674214
Physical measures,X4270.Volume level set by participant (left),DAG1,Dystroglycan,33481,-0.029223596501569,0.036410560640477,-0.100588295356904,0.042141102353766,0.422219470243578
Physical measures,X4270.Volume level set by participant (left),GIP,Gastric inhibitory polypeptide,32163,-0.0327311740017611,0.0408164932091057,-0.112731500691608,0.0472691526880861,0.4226294596925
Physical measures,X4270.Volume level set by participant (left),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",33456,-0.0391768660483439,0.0489166142360462,-0.135053429950994,0.0566996978543066,0.423216008970155
Physical measures,X4270.Volume level set by participant (left),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,33380,0.0335774335650474,0.0419303539491204,-0.0486060601752285,0.115760927305323,0.423274194287168
Physical measures,X4270.Volume level set by participant (left),ITGB1BP2,Integrin beta-1-binding protein 2,33273,-0.0130747742146382,0.0163712790045435,-0.0451624810635436,0.0190129326342671,0.424520130484888
Physical measures,X4270.Volume level set by participant (left),CXADR,Coxsackievirus and adenovirus receptor,33421,-0.026127928621918,0.0327290751425357,-0.090276915901288,0.0380210586574521,0.424712103232712
Physical measures,X4270.Volume level set by participant (left),CST5,Cystatin-D,33290,-0.0252269461200157,0.0316198037728553,-0.087201761514812,0.0367478692747806,0.424995766550036
Physical measures,X4270.Volume level set by participant (left),WNT9A,Protein Wnt-9a,33273,-0.0490562452973121,0.0615225996106095,-0.169640540534107,0.0715280499394826,0.425257929556554
Physical measures,X4270.Volume level set by participant (left),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,32235,0.0218650490197018,0.02746904740989,-0.0319742839036826,0.0757043819430862,0.426062938493113
Physical measures,X4270.Volume level set by participant (left),MGLL,Monoglyceride lipase,33468,-0.016401231129588,0.0206135521624212,-0.0568037933679336,0.0240013311087577,0.426254803998344
Physical measures,X4270.Volume level set by participant (left),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,33452,-0.0329003334130394,0.0413716872130575,-0.113988840350632,0.0481881735245534,0.426496111126226
Physical measures,X4270.Volume level set by participant (left),LDLR,Low-density lipoprotein receptor,33445,0.0267646217576804,0.0336734521785758,-0.0392353445123282,0.092764588027689,0.426734213272098
Physical measures,X4270.Volume level set by participant (left),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,32122,-0.040180173194055,0.0505741354602091,-0.139305478696065,0.0589451323079548,0.426940246437485
Physical measures,X4270.Volume level set by participant (left),NECTIN4,Nectin-4,33456,0.0453979984502091,0.057176606045213,-0.0666681493984084,0.157464146298827,0.427218671725335
Physical measures,X4270.Volume level set by participant (left),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,33207,0.0255473254035449,0.0322330393156908,-0.0376294316552091,0.0887240824622989,0.428042907326117
Physical measures,X4270.Volume level set by participant (left),PAK4,Serine/threonine-protein kinase PAK 4,33219,0.023493159535083,0.0296675108097076,-0.034655161651944,0.0816414807221099,0.428451078009754
Physical measures,X4270.Volume level set by participant (left),CDH1,Cadherin-1,33133,-0.0357782868168088,0.0452333061304031,-0.124435566832399,0.0528789931987813,0.428981841370928
Physical measures,X4270.Volume level set by participant (left),NPPB,Natriuretic peptides B,33273,-0.0106690874914309,0.0134989541374667,-0.0371270376008657,0.0157888626180039,0.429336469970448
Physical measures,X4270.Volume level set by participant (left),CEP152,Centrosomal protein of 152 kDa,32075,0.0386448387249464,0.0489048187392747,-0.057208606004032,0.134498283453925,0.429432569776053
Physical measures,X4270.Volume level set by participant (left),SFRP4,Secreted frizzled-related protein 4,32213,-0.0376944209930057,0.0477911913478328,-0.131365156034758,0.0559763140487467,0.430293018058748
Physical measures,X4270.Volume level set by participant (left),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,32347,-0.020197037394557,0.0256440697416625,-0.0704594140882156,0.0300653392991015,0.430959659421882
Physical measures,X4270.Volume level set by participant (left),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,32028,-0.0597977611670306,0.0759436269699281,-0.20864727002809,0.0890517476940284,0.431074320739196
Physical measures,X4270.Volume level set by participant (left),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,32398,-0.0797726025316164,0.101407599019372,-0.278531496609586,0.118986291546353,0.431508432404134
Physical measures,X4270.Volume level set by participant (left),ANXA5,Annexin A5,33199,0.0441176850580063,0.0560843941526581,-0.0658077274812036,0.154043097597216,0.431519621689372
Physical measures,X4270.Volume level set by participant (left),IST1,IST1 homolog,32264,-0.017010177260664,0.0216322779724991,-0.0594094420867623,0.0253890875654342,0.431696197259138
Physical measures,X4270.Volume level set by participant (left),ITGA6,Integrin alpha-6,33421,-0.0245260666083548,0.0312022371577929,-0.0856824514376288,0.0366303182209192,0.431867452324439
Physical measures,X4270.Volume level set by participant (left),RALY,RNA-binding protein Raly,32319,-0.0326161937946699,0.0415176904840634,-0.113990867143434,0.0487584795540944,0.432126998468758
Physical measures,X4270.Volume level set by participant (left),CD248,Endosialin,32384,-0.0392356123763792,0.0499757338866402,-0.137188050794194,0.0587168260414357,0.432422341691068
Physical measures,X4270.Volume level set by participant (left),BHLHE40,Class E basic helix-loop-helix protein 40,32111,0.0223795700694902,0.0285111251249141,-0.0335022351753416,0.0782613753143219,0.432512058847638
Physical measures,X4270.Volume level set by participant (left),PXN,Paxillin,33219,0.0269414518023621,0.0343312930166842,-0.0403478825103388,0.0942307861150631,0.43262189137465
Physical measures,X4270.Volume level set by participant (left),NELL1,Protein kinase C-binding protein NELL1,33456,-0.0322172568096573,0.0410836199760511,-0.112741151962718,0.0483066383434028,0.432950797860488
Physical measures,X4270.Volume level set by participant (left),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",32163,-0.0180703062296353,0.0230543971382959,-0.0632569246206953,0.0271163121614247,0.433174691377089
Physical measures,X4270.Volume level set by participant (left),MPI,Mannose-6-phosphate isomerase,33386,-0.0165121371443816,0.0210735564158583,-0.0578163077194639,0.0247920334307007,0.433326318940144
Physical measures,X4270.Volume level set by participant (left),CSPG4,Chondroitin sulfate proteoglycan 4,32384,-0.0469647644197456,0.0599806354059583,-0.164526809815424,0.0705972809759326,0.433651212844005
Physical measures,X4270.Volume level set by participant (left),MAPK13,Mitogen-activated protein kinase 13,32075,0.038962064727923,0.0498111661063165,-0.0586678208404574,0.136591950296303,0.434124055363773
Physical measures,X4270.Volume level set by participant (left),MEGF11,Multiple epidermal growth factor-like domains protein 11,32122,-0.0457375238491767,0.0584757037640133,-0.160349903226643,0.0688748555282895,0.434143021313663
Physical measures,X4270.Volume level set by participant (left),KIF1C,Kinesin-like protein KIF1C,32122,-0.0461460256005894,0.058998782173642,-0.161783638660928,0.0694915874597489,0.434149303157882
Physical measures,X4270.Volume level set by participant (left),KRT5,"Keratin, type II cytoskeletal 5",33219,-0.027669035429724,0.0353855767642456,-0.0970247658876453,0.0416866950281973,0.43427698007645
Physical measures,X4270.Volume level set by participant (left),PPCDC,Phosphopantothenoylcysteine decarboxylase,33500,-0.0286768739490832,0.0366898114604451,-0.100588904411556,0.0432351565133891,0.434468265156041
Physical measures,X4270.Volume level set by participant (left),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",32163,-0.0610590946579042,0.0781233694608859,-0.214180898801241,0.092062709485432,0.434489727404404
Physical measures,X4270.Volume level set by participant (left),F9,Coagulation factor IX,33435,0.073565499883713,0.0941506938183829,-0.110969860000317,0.258100859767743,0.434611927358038
Physical measures,X4270.Volume level set by participant (left),ICAM2,Intercellular adhesion molecule 2,33533,-0.042794769858433,0.0547900900479778,-0.150183346352469,0.0645938066356035,0.434783042879093
Physical measures,X4270.Volume level set by participant (left),LETM1,Mitochondrial proton/calcium exchanger protein,32350,-0.0304835900975772,0.0390617144277052,-0.107044550375879,0.046077370180725,0.435181452731606
Physical measures,X4270.Volume level set by participant (left),OPHN1,Oligophrenin-1,32353,-0.0152539117421466,0.0195618670973723,-0.0535951712529963,0.0230873477687032,0.435544979955141
Physical measures,X4270.Volume level set by participant (left),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",32353,-0.0280780035660678,0.0360236582455765,-0.0986843737273977,0.042528366595262,0.435748444759162
Physical measures,X4270.Volume level set by participant (left),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,32163,-0.0306823787499307,0.03939896135091,-0.107904342997714,0.0465395854978529,0.436144358599912
Physical measures,X4270.Volume level set by participant (left),DFFA,DNA fragmentation factor subunit alpha,33527,-0.0208570222140788,0.0268034522747376,-0.0733917886725645,0.031677744244407,0.436502733843542
Physical measures,X4270.Volume level set by participant (left),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,33421,0.0221486632859743,0.0284701277152042,-0.0336527870358259,0.0779501136077745,0.436612237689547
Physical measures,X4270.Volume level set by participant (left),INHBB,Inhibin beta B chain,32213,-0.0311838921070051,0.0400989284193177,-0.109777791808868,0.0474100075948577,0.436784966399994
Physical measures,X4270.Volume level set by participant (left),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,32213,-0.0263810951855719,0.0339311036345478,-0.0928860583092856,0.0401238679381419,0.43689341494159
Physical measures,X4270.Volume level set by participant (left),TCN1,Transcobalamin-1,32203,-0.0466317480806722,0.0599868945395565,-0.164206061378203,0.0709425652168585,0.43696683759354
Physical measures,X4270.Volume level set by participant (left),LTBR,Tumor necrosis factor receptor superfamily member 3,33369,-0.0491434288954665,0.0632416424113065,-0.173097048021627,0.0748101902306943,0.43713579967861
Physical measures,X4270.Volume level set by participant (left),MFGE8,Lactadherin,33441,-0.0323649732352667,0.0416674618791757,-0.114033198518451,0.0493032520479176,0.437329952401412
Physical measures,X4270.Volume level set by participant (left),RBP2,Retinol-binding protein 2,33386,-0.0176296639349721,0.0227015409576656,-0.0621246842119966,0.0268653563420525,0.437424538936377
Physical measures,X4270.Volume level set by participant (left),CRKL,Crk-like protein,33454,-0.0134341423088354,0.017301757503605,-0.0473455870159011,0.0204773023982303,0.437497165722278
Physical measures,X4270.Volume level set by participant (left),TSLP,Thymic stromal lymphopoietin,33273,0.0214506082590331,0.0276403286041005,-0.0327244358050039,0.0756256523230701,0.437733202309543
Physical measures,X4270.Volume level set by participant (left),GART,Trifunctional purine biosynthetic protein adenosine-3,32350,-0.0554065265159294,0.0714259233041906,-0.195401336192143,0.0845882831602841,0.437937486782447
Physical measures,X4270.Volume level set by participant (left),PENK,Proenkephalin-A,32213,0.0517303852349672,0.0667758414327781,-0.0791502639732779,0.182611034443212,0.438548164611658
Physical measures,X4270.Volume level set by participant (left),LCN15,Lipocalin-15,32350,-0.024474631634944,0.0316128459465175,-0.0864358096901183,0.0374865464202303,0.438836341426047
Physical measures,X4270.Volume level set by participant (left),PAPPA,Pappalysin-1,33273,-0.0287401341507916,0.037131747916539,-0.101518360067208,0.0440380917656249,0.438948973311075
Physical measures,X4270.Volume level set by participant (left),RILPL2,RILP-like protein 2,32365,-0.0163565301571323,0.0211346146165302,-0.0577803748055315,0.0250673144912668,0.439000413492919
Physical measures,X4270.Volume level set by participant (left),SLITRK6,SLIT and NTRK-like protein 6,33273,-0.0390099919538116,0.0504256148027602,-0.137844196967221,0.0598242130595983,0.439179472417258
Physical measures,X4270.Volume level set by participant (left),PKD2,Polycystin-2,32122,-0.026553842486947,0.0343567562481953,-0.0938930847334098,0.0407853997595159,0.439613907810908
Physical measures,X4270.Volume level set by participant (left),DUSP3,Dual specificity protein phosphatase 3,33219,-0.0155247720098469,0.0201118661800622,-0.0549440297227689,0.0238944857030751,0.440182027630024
Physical measures,X4270.Volume level set by participant (left),PDIA4,Protein disulfide-isomerase A4,32384,-0.0256013319841189,0.033168306289012,-0.0906112123105823,0.0394085483423446,0.440219584294135
Physical measures,X4270.Volume level set by participant (left),DIABLO,"Diablo homolog, mitochondrial",33393,-0.0124663107473635,0.0162062603695456,-0.0442305810716728,0.0192979595769458,0.441778242710602
Physical measures,X4270.Volume level set by participant (left),DOCK9,Dedicator of cytokinesis protein 9,32111,0.0132691855760223,0.0172700460757722,-0.0205801047324912,0.0471184758845358,0.44231172193474
Physical measures,X4270.Volume level set by participant (left),DOC2B,Double C2-like domain-containing protein beta,32154,-0.0434540593237172,0.0565621628193577,-0.154315898449658,0.0674077798022238,0.442360370016046
Physical measures,X4270.Volume level set by participant (left),AGR3,Anterior gradient protein 3,33224,-0.0227815793898993,0.0296976780649872,-0.0809890283972743,0.0354258696174757,0.443032894470225
Physical measures,X4270.Volume level set by participant (left),GRIK2,"Glutamate receptor ionotropic, kainate 2",32350,0.0371107799693142,0.0483862555177669,-0.0577262808455088,0.131947840784137,0.443122611024237
Physical measures,X4270.Volume level set by participant (left),CD99L2,CD99 antigen-like protein 2,33441,0.0563308487570488,0.0735080231200056,-0.0877448765581621,0.20040657407226,0.443504590182112
Physical measures,X4270.Volume level set by participant (left),REG3A,Regenerating islet-derived protein 3-alpha,33533,0.0213577203893949,0.0278743015994455,-0.0332759107455182,0.075991351524308,0.44356804282346
Physical measures,X4270.Volume level set by participant (left),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,32122,-0.0541797341036047,0.0707431583442281,-0.192836324458292,0.0844768562510825,0.443779998470709
Physical measures,X4270.Volume level set by participant (left),LGALS3BP,Galectin-3-binding protein,32398,-0.0492654986619734,0.064436801080989,-0.175561628780712,0.077030631456765,0.444559099676326
Physical measures,X4270.Volume level set by participant (left),COMP,Cartilage oligomeric matrix protein,33301,-0.0397338128891138,0.052011272621867,-0.141675907227973,0.0622082814497454,0.444919693015692
Physical measures,X4270.Volume level set by participant (left),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,33421,-0.0340296855527464,0.0445745592539801,-0.121395821690547,0.0533364505850546,0.445225345428331
Physical measures,X4270.Volume level set by participant (left),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,33456,-0.0386414659385109,0.0506633930569088,-0.137941716330052,0.0606587844530303,0.445656477107159
Physical measures,X4270.Volume level set by participant (left),EIF4E,Eukaryotic translation initiation factor 4E,32140,-0.0183608956286239,0.0240903637984257,-0.0655780086735382,0.0288562174162905,0.445983349807762
Physical measures,X4270.Volume level set by participant (left),DBH,Dopamine beta-hydroxylase,32364,-0.0137616552490519,0.0180561358783179,-0.0491516815705549,0.0216283710724511,0.445987550436499
Physical measures,X4270.Volume level set by participant (left),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,33380,-0.0169187077607375,0.0222278788630816,-0.0604853503323774,0.0266479348109025,0.446588723281362
Physical measures,X4270.Volume level set by participant (left),MZT1,Mitotic-spindle organizing protein 1,33232,-0.0241566301989933,0.0318473916807383,-0.0865775178932404,0.0382642574952539,0.448164871888601
Physical measures,X4270.Volume level set by participant (left),TGFB1,Transforming growth factor beta-1 proprotein,33509,-0.034378080651702,0.0453396868153355,-0.12324386680976,0.0544877055063557,0.448330796966938
Physical measures,X4270.Volume level set by participant (left),SLK,STE20-like serine/threonine-protein kinase,32235,0.0192130866823029,0.0253392893812088,-0.0304519205048664,0.0688780938694722,0.448334445964623
Physical measures,X4270.Volume level set by participant (left),LAT,Linker for activation of T-cells family member 1,33527,-0.0172905266754292,0.022810738617018,-0.0619995743647845,0.0274185210139261,0.448471018417634
Physical measures,X4270.Volume level set by participant (left),USP8,Ubiquitin carboxyl-terminal hydrolase 8,33273,-0.0142935779083476,0.0188860383051153,-0.0513102129863735,0.0227230571696783,0.449170112140976
Physical measures,X4270.Volume level set by participant (left),DEFB116,Beta-defensin 116,32111,-0.0195706593901656,0.0258926941976482,-0.070320340017556,0.0311790212372249,0.449770112506418
Physical measures,X4270.Volume level set by participant (left),CTNNA1,Catenin alpha-1,32111,-0.0409064951382255,0.054175615423091,-0.147090701367484,0.0652777110910329,0.450228955518531
Physical measures,X4270.Volume level set by participant (left),BRSK2,Serine/threonine-protein kinase BRSK2,32350,-0.0364935025219504,0.0483372043195576,-0.131234422988283,0.0582474179443826,0.450284992504551
Physical measures,X4270.Volume level set by participant (left),SLITRK2,SLIT and NTRK-like protein 2,33509,0.0337753359689856,0.0447521304655727,-0.0539388397435369,0.121489511681508,0.450436525388938
Physical measures,X4270.Volume level set by participant (left),GH2,Growth hormone variant,33232,-0.00791221224632571,0.0104910512568366,-0.0284746727097255,0.0126502482170741,0.450757302878099
Physical measures,X4270.Volume level set by participant (left),SOX9,Transcription factor SOX-9,32154,-0.0571167269028579,0.07573502123319,-0.20555736851991,0.0913239147141946,0.450773020878494
Physical measures,X4270.Volume level set by participant (left),CHMP1A,Charged multivesicular body protein 1a,33380,-0.0175802082339692,0.0233359991828383,-0.0633187666323324,0.0281583501643939,0.451258636124233
Physical measures,X4270.Volume level set by participant (left),PTPRM,Receptor-type tyrosine-protein phosphatase mu,33407,-0.0524488294904796,0.0696668501262983,-0.188995855738024,0.0840981967570651,0.451558634067665
Physical measures,X4270.Volume level set by participant (left),OLFM4,Olfactomedin-4,31868,0.0126567980589505,0.0168131133084151,-0.0202969040255431,0.0456105001434441,0.451598073436565
Physical measures,X4270.Volume level set by participant (left),MFAP4,Microfibril-associated glycoprotein 4,32213,-0.0483313048560671,0.0642049013651058,-0.174172911531674,0.0775103018195402,0.451613025417782
Physical measures,X4270.Volume level set by participant (left),ESAM,Endothelial cell-selective adhesion molecule,33533,-0.0417363860821119,0.0554988002781296,-0.150514034627246,0.0670412624630221,0.452056596619296
Physical measures,X4270.Volume level set by participant (left),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,33467,-0.020075674455481,0.0267053539996118,-0.0724181682947202,0.0322668193837581,0.452222745747804
Physical measures,X4270.Volume level set by participant (left),DDX25,ATP-dependent RNA helicase DDX25,32154,-0.0363506860824043,0.0484528334223059,-0.131318239590124,0.0586168674253153,0.453140152439914
Physical measures,X4270.Volume level set by participant (left),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,32154,-0.0352298974735976,0.0469627490350788,-0.127276885582352,0.0568170906351569,0.453177145530117
Physical measures,X4270.Volume level set by participant (left),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,32163,-0.0361746395704682,0.0482282938741176,-0.130702095563739,0.0583528164228023,0.453234900778098
Physical measures,X4270.Volume level set by participant (left),LAP3,Cytosol aminopeptidase,33273,0.0268930754407055,0.035857548856481,-0.0433877203179972,0.0971738711994082,0.453276162045092
Physical measures,X4270.Volume level set by participant (left),TIE1,Tyrosine-protein kinase receptor Tie-1,33533,0.0308454150577569,0.041131627860813,-0.0497725755494366,0.11146340566495,0.453322546355683
Physical measures,X4270.Volume level set by participant (left),GMFG,Glia maturation factor gamma,32365,-0.0216441234989588,0.0288713528466353,-0.078231975078364,0.0349437280804464,0.45347292890077
Physical measures,X4270.Volume level set by participant (left),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,33232,-0.0174667904240621,0.0233155900709473,-0.0631653469631187,0.0282317661149945,0.453789046080242
Physical measures,X4270.Volume level set by participant (left),NOTCH2,Neurogenic locus notch homolog protein 2,32384,-0.067836519601858,0.0906342961004362,-0.245479739958713,0.109806700754997,0.454202453257566
Physical measures,X4270.Volume level set by participant (left),AGRP,Agouti-related protein,33527,-0.0238235696870844,0.0318343560060277,-0.0862189074588987,0.0385717680847299,0.454262233984513
Physical measures,X4270.Volume level set by participant (left),CLIC5,Chloride intracellular channel protein 5,32154,-0.0449374243962793,0.0600574957388766,-0.162650116044478,0.0727752672519189,0.454338225294798
Physical measures,X4270.Volume level set by participant (left),TMEM132A,Transmembrane protein 132A,32163,-0.023273397504692,0.0311407614847149,-0.0843092900147333,0.0377624950053493,0.454868344959277
Physical measures,X4270.Volume level set by participant (left),DRAXIN,Draxin,33380,-0.0294868967793928,0.0395312839116286,-0.106968213246185,0.0479944196873994,0.455739644033156
Physical measures,X4270.Volume level set by participant (left),UPK3A,Uroplakin-3a,32111,0.0306105504778355,0.0410556465258463,-0.0498585167128233,0.111079617668494,0.455939913819235
Physical measures,X4270.Volume level set by participant (left),MBL2,Mannose-binding protein C,32284,0.0139413010342611,0.0187434231131969,-0.0227958082676047,0.050678410336127,0.457021644096194
Physical measures,X4270.Volume level set by participant (left),TFPI2,Tissue factor pathway inhibitor 2,33416,-0.0327482835309349,0.0440425177174012,-0.119071618257041,0.0535750511951715,0.457161805244345
Physical measures,X4270.Volume level set by participant (left),SRPK2,SRSF protein kinase 2,33421,0.015613372551204,0.0210016301475688,-0.0255498225380307,0.0567765676404388,0.457237101691303
Physical measures,X4270.Volume level set by participant (left),HS1BP3,HCLS1-binding protein 3,32163,-0.0175399894628711,0.0236008917839206,-0.0637977373593554,0.0287177584336132,0.457388212005212
Physical measures,X4270.Volume level set by participant (left),ANKRD54,Ankyrin repeat domain-containing protein 54,33232,-0.0226048297049693,0.030427558857481,-0.0822428450656321,0.0370331856556934,0.457558203830873
Physical measures,X4270.Volume level set by participant (left),KLK7,Kallikrein-7,32002,0.0389463196123388,0.0524442059421549,-0.0638443240342847,0.141736963258962,0.457732540775271
Physical measures,X4270.Volume level set by participant (left),APPL2,DCC-interacting protein 13-beta,32213,-0.0138187688772609,0.0186146104576709,-0.0503034053742959,0.0226658676197741,0.457890855737109
Physical measures,X4270.Volume level set by participant (left),PLA2G10,Group 10 secretory phospholipase A2,33380,-0.0215217219927407,0.0290128200524818,-0.078386849295605,0.0353434053101236,0.458227787738445
Physical measures,X4270.Volume level set by participant (left),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,33441,0.0336417318682327,0.0455082640969876,-0.055554465761863,0.122837929498328,0.459777880733018
Physical measures,X4270.Volume level set by participant (left),FARSA,Phenylalanine--tRNA ligase alpha subunit,32154,0.0221681656731536,0.0300061773881834,-0.0366439420076859,0.0809802733539932,0.460059031984916
Physical measures,X4270.Volume level set by participant (left),FGR,Tyrosine-protein kinase Fgr,33219,0.0235958169837485,0.0319534424812845,-0.0390329302795691,0.0862245642470661,0.460264666004113
Physical measures,X4270.Volume level set by participant (left),PAEP,Glycodelin,33380,-0.0094989839621286,0.0128654472921453,-0.0347152606547334,0.0157172927304762,0.460331547231987
Physical measures,X4270.Volume level set by participant (left),FCRL6,Fc receptor-like protein 6,33421,-0.0187069804453421,0.0253566600447147,-0.0684060341329828,0.0309920732422987,0.460683184663724
Physical measures,X4270.Volume level set by participant (left),TIMP3,Metalloproteinase inhibitor 3,33481,-0.00972661211126174,0.0131933878129482,-0.0355856522246403,0.0161324280021168,0.460999314064012
Physical measures,X4270.Volume level set by participant (left),INSL3,Insulin-like 3,32353,0.0242772515732409,0.0329697137084572,-0.0403433872953353,0.088897890441817,0.46153954124651
Physical measures,X4270.Volume level set by participant (left),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,32154,0.0269390154864125,0.0366003248488395,-0.044797621217313,0.098675652190138,0.461733561056044
Physical measures,X4270.Volume level set by participant (left),GBP4,Guanylate-binding protein 4,33219,-0.0266306014120295,0.0362063571528426,-0.097595061431601,0.044333858607542,0.462040838751358
Physical measures,X4270.Volume level set by participant (left),KRT17,"Keratin, type I cytoskeletal 17",32122,0.0392054200785649,0.0533268097064692,-0.0653151269461148,0.143725967103245,0.462245329637835
Physical measures,X4270.Volume level set by participant (left),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,32163,-0.0199167961195256,0.0270963983828276,-0.0730257369498677,0.0331921447108165,0.462340654733533
Physical measures,X4270.Volume level set by participant (left),ARFIP1,Arfaptin-1,32350,-0.0216071496402438,0.0294487458031432,-0.0793266914144046,0.0361123921339169,0.463140865270627
Physical measures,X4270.Volume level set by participant (left),CXCL8,Interleukin-8,33367,0.0189741415526771,0.0258921956852954,-0.031774561990502,0.0697228450958561,0.463691671365755
Physical measures,X4270.Volume level set by participant (left),PDCL2,Phosducin-like protein 2,32075,0.0279878462131752,0.0381943977643845,-0.0468731734050184,0.102848865831369,0.463719067389862
Physical measures,X4270.Volume level set by participant (left),TJP3,Tight junction protein ZO-3,32111,-0.0350072860200104,0.0478211139143676,-0.128736669292171,0.05872209725215,0.464162505481202
Physical measures,X4270.Volume level set by participant (left),SMC3,Structural maintenance of chromosomes protein 3,32075,0.0265857396453082,0.0363809279228691,-0.0447208790835152,0.0978923583741316,0.464948013305089
Physical measures,X4270.Volume level set by participant (left),CCL21,C-C motif chemokine 21,33481,0.0288214027055454,0.0394423844560896,-0.0484856708283901,0.106128476239481,0.464968179438621
Physical measures,X4270.Volume level set by participant (left),PSG1,Pregnancy-specific beta-1-glycoprotein 1,33380,0.0109912231487548,0.015045069555858,-0.0184971131807269,0.0404795594782366,0.465071305689913
Physical measures,X4270.Volume level set by participant (left),TPSG1,Tryptase gamma,32140,-0.0537361469605902,0.0735649511684599,-0.197923451250772,0.0904511573295911,0.465132212576599
Physical measures,X4270.Volume level set by participant (left),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",33273,-0.0106237412891679,0.0145495040288677,-0.0391407691857485,0.0178932866074128,0.465300217071444
Physical measures,X4270.Volume level set by participant (left),VIM,Vimentin,33273,0.0108574733498745,0.0148845901494758,-0.0183163233430982,0.0400312700428471,0.465749552770846
Physical measures,X4270.Volume level set by participant (left),MARS1,"Methionine--tRNA ligase, cytoplasmic",32192,-0.0181041544860242,0.0248240928755327,-0.0667593765220682,0.0305510675500198,0.465841639404466
Physical measures,X4270.Volume level set by participant (left),ADAMTSL4,ADAMTS-like protein 4,32163,-0.0647643396296376,0.088806297702037,-0.23882468312563,0.109296003866355,0.465854746637621
Physical measures,X4270.Volume level set by participant (left),CSF1,Macrophage colony-stimulating factor 1,33481,0.0458341544145659,0.062961910801826,-0.0775711907570131,0.169239499586145,0.466653049289875
Physical measures,X4270.Volume level set by participant (left),BRAP,BRCA1-associated protein,32260,-0.0147014267732046,0.0201997574543178,-0.0542929513836676,0.0248900978372583,0.466756544181749
Physical measures,X4270.Volume level set by participant (left),NTF4,Neurotrophin-4,33232,0.0307014755522881,0.0421956082001346,-0.0520019165199757,0.113404867624552,0.466878599254465
Physical measures,X4270.Volume level set by participant (left),NUDC,Nuclear migration protein nudC,33527,-0.0205401043022671,0.0282536807019155,-0.0759173184780215,0.0348371098734873,0.46725168651523
Physical measures,X4270.Volume level set by participant (left),RBP5,Retinol-binding protein 5,33386,0.0233915460697013,0.0322247326474019,-0.0397689299192064,0.0865520220586089,0.467926467279423
Physical measures,X4270.Volume level set by participant (left),CR1,Complement receptor type 1,32345,-0.0413876806287065,0.057039769572849,-0.153185628991491,0.0704102677340776,0.468109585790027
Physical measures,X4270.Volume level set by participant (left),CWC15,Spliceosome-associated protein CWC15 homolog,32284,-0.0246971423769059,0.0340413366982047,-0.091418162305387,0.0420238775515753,0.468164280862796
Physical measures,X4270.Volume level set by participant (left),CIT,Citron Rho-interacting kinase,32154,0.0305876526222798,0.0421997280445533,-0.0521238143450448,0.113299119589604,0.468578011087011
Physical measures,X4270.Volume level set by participant (left),CPE,Carboxypeptidase E,33458,-0.0331822849748832,0.0457961969479643,-0.122942830992893,0.0565782610431268,0.468738254972403
Physical measures,X4270.Volume level set by participant (left),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,32194,-0.0329192084242484,0.0454620229872021,-0.122024773479165,0.0561863566306678,0.469024104819464
Physical measures,X4270.Volume level set by participant (left),KLB,Beta-klotho,33219,0.017405327094568,0.0240402113571351,-0.0297134871654168,0.0645241413545528,0.46907959345252
Physical measures,X4270.Volume level set by participant (left),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,33468,-0.0172144219546503,0.0237894769997083,-0.0638417968740786,0.0294129529647781,0.469320920804134
Physical measures,X4270.Volume level set by participant (left),SKIV2L,Helicase SKI2W,32122,-0.0350088899678509,0.0483922778692939,-0.129857754591667,0.0598399746559652,0.469431921772601
Physical measures,X4270.Volume level set by participant (left),SCRIB,Protein scribble homolog,32163,-0.0158047809444115,0.0218487202651772,-0.0586282726641588,0.0270187107753359,0.469472518799537
Physical measures,X4270.Volume level set by participant (left),CERT,Ceramide transfer protein,33219,-0.0217229827487472,0.0301298175312587,-0.0807774251100142,0.0373314596125198,0.470941318561287
Physical measures,X4270.Volume level set by participant (left),NGF,Beta-nerve growth factor,33380,0.100432900261398,0.139321561906125,-0.172637361074607,0.373503161597404,0.471007650266424
Physical measures,X4270.Volume level set by participant (left),IFT20,Intraflagellar transport protein 20 homolog,32154,-0.0332877343460971,0.0461873197413309,-0.123814881039106,0.0572394123469115,0.47110889257521
Physical measures,X4270.Volume level set by participant (left),LYPD3,Ly6/PLAUR domain-containing protein 3,33392,-0.0357126180434829,0.0495562868975877,-0.132842940362755,0.0614177042757889,0.471145222931114
Physical measures,X4270.Volume level set by participant (left),ABRAXAS2,BRISC complex subunit Abraxas 2,32122,-0.0230755489188381,0.032052322986517,-0.0858981019724114,0.0397470041347352,0.471587735553954
Physical measures,X4270.Volume level set by participant (left),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,33232,0.0199207309623897,0.0276952753971039,-0.034362008815934,0.0742034707407134,0.471985936469243
Physical measures,X4270.Volume level set by participant (left),BMP4,Bone morphogenetic protein 4,33363,-0.0237000004312601,0.0329652502048132,-0.0883118908326939,0.0409118899701737,0.47219743034986
Physical measures,X4270.Volume level set by participant (left),BRME1,Break repair meiotic recombinase recruitment factor 1,32111,-0.0332236289370383,0.0462300019610124,-0.123834432780623,0.0573871749065459,0.472372690190408
Physical measures,X4270.Volume level set by participant (left),S100A12,Protein S100-A12,33304,0.0168807597816117,0.0235106775633291,-0.0292001682425132,0.0629616878057366,0.472773795090615
Physical measures,X4270.Volume level set by participant (left),VSIG4,V-set and immunoglobulin domain-containing protein 4,33429,0.032326242090481,0.0450257829433887,-0.0559242924785608,0.120576776659523,0.472807063141154
Physical measures,X4270.Volume level set by participant (left),SPINK2,Serine protease inhibitor Kazal-type 2,32213,-0.0380944644078194,0.0530635355380636,-0.142098994062424,0.0659100652467852,0.472838795612337
Physical measures,X4270.Volume level set by participant (left),LCP1,Plastin-2,32384,0.0299514623979311,0.0417390279673644,-0.0518570324181031,0.111759957213965,0.473031955073378
Physical measures,X4270.Volume level set by participant (left),MSTN,Growth/differentiation factor 8,33273,-0.0248418755789824,0.0346265388412234,-0.0927098917077803,0.0430261405498154,0.473132132079393
Physical measures,X4270.Volume level set by participant (left),ANGPTL7,Angiopoietin-related protein 7,33509,-0.0339334320598025,0.0473075901256755,-0.126656308706127,0.0587894445865215,0.473211454174767
Physical measures,X4270.Volume level set by participant (left),RNASE3,Eosinophil cationic protein,33379,0.0108199954536828,0.0150910542051494,-0.0187584707884099,0.0403984616957756,0.473404735271115
Physical measures,X4270.Volume level set by participant (left),RALB,Ras-related protein Ral-B,32140,-0.0482365726770397,0.0672948158329678,-0.180134411709657,0.0836612663555772,0.473522516416736
Physical measures,X4270.Volume level set by participant (left),CACYBP,Calcyclin-binding protein,32192,-0.0148253661771756,0.0206910854203153,-0.0553798936009936,0.0257291612466424,0.473698224141492
Physical measures,X4270.Volume level set by participant (left),SUGT1,Protein SGT1 homolog,33232,-0.0166978714967831,0.0233154710869144,-0.0623961948271353,0.029000451833569,0.47390462896445
Physical measures,X4270.Volume level set by participant (left),CCL11,Eotaxin,33527,0.0322529223084718,0.0450396592253473,-0.056024809773209,0.120530654390153,0.473947729480844
Physical measures,X4270.Volume level set by participant (left),DNAJB8,DnaJ homolog subfamily B member 8,33273,-0.0221504199394756,0.0309611953075528,-0.0828343627422791,0.0385335228633279,0.474365275752977
Physical measures,X4270.Volume level set by participant (left),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,33453,-0.0458827606234131,0.0643149305521561,-0.171940024505639,0.0801745032588129,0.475612070061714
Physical measures,X4270.Volume level set by participant (left),VWA5A,von Willebrand factor A domain-containing protein 5A,32075,0.0171639674120137,0.0240763183926626,-0.0300256166376049,0.0643535514616324,0.475930496262619
Physical measures,X4270.Volume level set by participant (left),IL18RAP,Interleukin-18 receptor accessory protein,33311,0.00710677877266777,0.00997929731855916,-0.0124526439717082,0.0266662015170437,0.476389278624962
Physical measures,X4270.Volume level set by participant (left),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,33533,-0.0536688495631368,0.0754211015976827,-0.201494208694595,0.0941565095683213,0.476737413843844
Physical measures,X4270.Volume level set by participant (left),PECAM1,Platelet endothelial cell adhesion molecule,33441,-0.0405616213747215,0.0570205670913199,-0.152321932873708,0.0711986901242655,0.476885394083937
Physical measures,X4270.Volume level set by participant (left),REPS1,RalBP1-associated Eps domain-containing protein 1,32140,-0.0362778916458427,0.0510226475955908,-0.136282280933201,0.0637264976415152,0.477096229254814
Physical measures,X4270.Volume level set by participant (left),CTRL,Chymotrypsin-like protease CTRL-1,32353,-0.0213894428939087,0.0300919032184553,-0.0803695732020811,0.0375906874142638,0.47722673779627
Physical measures,X4270.Volume level set by participant (left),CMC1,COX assembly mitochondrial protein homolog,32365,-0.0160088134768589,0.0225619275773889,-0.0602301915285411,0.0282125645748233,0.478004210763364
Physical measures,X4270.Volume level set by participant (left),CCL8,C-C motif chemokine 8,33499,-0.0199853327997247,0.0281722159062842,-0.0752028759760417,0.0352322103765923,0.478095393575488
Physical measures,X4270.Volume level set by participant (left),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",32154,-0.0180226184316521,0.0254132977569817,-0.0678326820353363,0.0317874451720321,0.478233868551294
Physical measures,X4270.Volume level set by participant (left),HPCAL1,Hippocalcin-like protein 1,33527,-0.0173052197622707,0.0244143448622687,-0.0651573356923174,0.030546896167776,0.478458368178906
Physical measures,X4270.Volume level set by participant (left),FBLN2,Fibulin-2,32384,-0.045133447615439,0.0636872467256173,-0.169960451197649,0.0796935559667708,0.478548107566544
Physical measures,X4270.Volume level set by participant (left),SOD2,"Superoxide dismutase [Mn], mitochondrial",33441,-0.0335999153884696,0.0474134104724663,-0.126530199914504,0.0593303691375644,0.478554819551206
Physical measures,X4270.Volume level set by participant (left),XPNPEP2,Xaa-Pro aminopeptidase 2,33456,0.0137470620852691,0.019403311856886,-0.0242834291542275,0.0517775533247657,0.478659058044466
Physical measures,X4270.Volume level set by participant (left),CLEC4M,C-type lectin domain family 4 member M,32374,0.0291768584260239,0.0413377298670372,-0.0518450921133689,0.110198808965417,0.480322922532742
Physical measures,X4270.Volume level set by participant (left),HMOX1,Heme oxygenase 1,33317,-0.0260468582406332,0.0369587063954817,-0.0984859227757773,0.0463922062945109,0.480980814859423
Physical measures,X4270.Volume level set by participant (left),IL15RA,Interleukin-15 receptor subunit alpha,33273,-0.0344455738520938,0.0489335402175659,-0.130355312678523,0.0614641649743355,0.481497667373686
Physical measures,X4270.Volume level set by participant (left),CDH2,Cadherin-2,33434,-0.0330432667798051,0.0469513298659283,-0.125067873317025,0.0589813397574144,0.48158989956263
Physical measures,X4270.Volume level set by participant (left),COL24A1,Collagen alpha-1(XXIV) chain,32329,-0.0248488834900468,0.0353139400300665,-0.0940642059489771,0.0443664389688835,0.481667522012709
Physical measures,X4270.Volume level set by participant (left),TACC3,Transforming acidic coiled-coil-containing protein 3,33386,-0.0108957154259298,0.0154949417016744,-0.0412658011612117,0.019474370309352,0.481962621943012
Physical measures,X4270.Volume level set by participant (left),FMNL1,Formin-like protein 1,33219,0.021137169759435,0.0300699510330782,-0.0377999342653982,0.0800742737842682,0.482115991821092
Physical measures,X4270.Volume level set by participant (left),RGMA,Repulsive guidance molecule A,33500,-0.0389218555416884,0.0554311467071659,-0.147566903087734,0.0697231920043569,0.48259383838682
Physical measures,X4270.Volume level set by participant (left),ACHE,Acetylcholinesterase,32213,-0.0454151510849103,0.0646905793081405,-0.172208686528866,0.0813783843590452,0.482677431050017
Physical measures,X4270.Volume level set by participant (left),SETMAR,Histone-lysine N-methyltransferase SETMAR,33352,-0.0416745100793259,0.0595046772721932,-0.158303677532824,0.0749546573741727,0.483722771696977
Physical measures,X4270.Volume level set by participant (left),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,33317,-0.0490421997407284,0.0700767667981897,-0.18639266266518,0.0883082631837235,0.484048495288143
Physical measures,X4270.Volume level set by participant (left),SPP1,Osteopontin,33515,0.0240563111054179,0.0344039614431573,-0.0433754533231705,0.0914880755340063,0.48442572585495
Physical measures,X4270.Volume level set by participant (left),OLR1,Oxidized low-density lipoprotein receptor 1,33343,0.0199581131428049,0.0285487671769241,-0.0359974705239664,0.0759136968095762,0.484515054828066
Physical measures,X4270.Volume level set by participant (left),ESPL1,Separin,32075,-0.0241523886001156,0.0345934825488962,-0.0919556143959521,0.043650837195721,0.48508754667201
Physical measures,X4270.Volume level set by participant (left),IL4,Interleukin-4,33273,-0.0137599391234159,0.0197105700686136,-0.0523926564578985,0.0248727782110666,0.485133378211476
Physical measures,X4270.Volume level set by participant (left),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",32122,-0.0289566527311283,0.0415470619733618,-0.110388894198917,0.0524755887366608,0.485848770749067
Physical measures,X4270.Volume level set by participant (left),KRT6C,"Keratin, type II cytoskeletal 6C",32122,0.0345377592600974,0.0495727838865865,-0.062624897157612,0.131700415677807,0.486006620904557
Physical measures,X4270.Volume level set by participant (left),CRELD2,Protein disulfide isomerase CRELD2,33468,-0.0232316231013932,0.0333631283360559,-0.0886233546400628,0.0421601084372765,0.486242473940407
Physical measures,X4270.Volume level set by participant (left),B4GAT1,"Beta-1,4-glucuronyltransferase 1",33441,-0.0495017239101248,0.0710979335655297,-0.188853673698563,0.0898502258783135,0.48629215764517
Physical measures,X4270.Volume level set by participant (left),SCGB1A1,Uteroglobin,33454,0.0213283598181811,0.0307362834809123,-0.038914755804407,0.0815714754407692,0.48775359755741
Physical measures,X4270.Volume level set by participant (left),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,32329,-0.0312630608162967,0.0452240551578376,-0.119902208925658,0.0573760872930649,0.489401975954343
Physical measures,X4270.Volume level set by participant (left),WFDC2,WAP four-disulfide core domain protein 2,32979,0.0340180387705175,0.0492776317786355,-0.0625661195156082,0.130602197056643,0.490002786633894
Physical measures,X4270.Volume level set by participant (left),CNPY4,Protein canopy homolog 4,33386,-0.016443665210342,0.0238650127314332,-0.063219090163951,0.030331759743267,0.490823461874925
Physical measures,X4270.Volume level set by participant (left),ERBB3,Receptor tyrosine-protein kinase erbB-3,33398,-0.0633205927325829,0.0920438564724972,-0.243726551418677,0.117085365953512,0.491508804325749
Physical measures,X4270.Volume level set by participant (left),CXCL12,Stromal cell-derived factor 1,33273,-0.0294650078089021,0.0429111157720302,-0.113570794722081,0.0546407791042772,0.492320043394998
Physical measures,X4270.Volume level set by participant (left),SIRPB1,Signal-regulatory protein beta-1,33410,0.0261616824692209,0.0381906763350518,-0.0486920431474805,0.101015408085922,0.493343985189314
Physical measures,X4270.Volume level set by participant (left),LRP1,Prolow-density lipoprotein receptor-related protein 1,33386,-0.0453275877603239,0.0662189858929298,-0.175116800110466,0.0844616245898185,0.493670655731573
Physical measures,X4270.Volume level set by participant (left),CD200,OX-2 membrane glycoprotein,33421,-0.0448564714563696,0.0656237179921613,-0.173478958721006,0.0837660158082665,0.494283007584096
Physical measures,X4270.Volume level set by participant (left),RSPO1,R-spondin-1,33380,-0.0334019317117877,0.0488929826485056,-0.129232177702859,0.0624283142792833,0.494520872170606
Physical measures,X4270.Volume level set by participant (left),FCRL5,Fc receptor-like protein 5,33441,0.0207338856028945,0.0303695928881469,-0.0387905164578734,0.0802582876636624,0.494802280603272
Physical measures,X4270.Volume level set by participant (left),ITGA2,Integrin alpha-2,32213,-0.041067433308652,0.0602026889973895,-0.159064703743536,0.0769298371262315,0.495162697510398
Physical measures,X4270.Volume level set by participant (left),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,32365,-0.0188253416778895,0.0276062522668933,-0.0729335961210003,0.0352829127652213,0.495307531349904
Physical measures,X4270.Volume level set by participant (left),KLK6,Kallikrein-6,33440,-0.0391886526666875,0.0574817254223126,-0.15185283449442,0.0734755291610453,0.495409266682936
Physical measures,X4270.Volume level set by participant (left),NOS2,"Nitric oxide synthase, inducible",32122,0.0351934423301342,0.0516384484145351,-0.0660179165623546,0.136404801222623,0.495553216655404
Physical measures,X4270.Volume level set by participant (left),BRDT,Bromodomain testis-specific protein,32122,0.0385713711374987,0.0566020102445457,-0.0723685689418108,0.149511311216808,0.495608144725291
Physical measures,X4270.Volume level set by participant (left),DOK1,Docking protein 1,32353,-0.0108036433408561,0.0158555006406306,-0.041880424596492,0.0202731379147798,0.495650162245323
Physical measures,X4270.Volume level set by participant (left),EPHA1,Ephrin type-A receptor 1,33467,0.0345089824047007,0.0506913582865989,-0.0648460798370331,0.133864044646434,0.496036692454272
Physical measures,X4270.Volume level set by participant (left),SHISA5,Protein shisa-5,32384,-0.0527780071923164,0.0775338079353324,-0.204744270745568,0.0991882563609351,0.496075139110127
Physical measures,X4270.Volume level set by participant (left),CXCL13,C-X-C motif chemokine 13,33500,0.0182370228233378,0.0268305587392681,-0.0343508723056276,0.0708249179523033,0.496704937004468
Physical measures,X4270.Volume level set by participant (left),CPTP,Ceramide-1-phosphate transfer protein,32122,-0.0333857600268533,0.0491611041176603,-0.129741524097467,0.0629700040437609,0.49708914818894
Physical measures,X4270.Volume level set by participant (left),CTAG1A_CTAG1B,Cancer/testis antigen 1,32216,-0.0274165073638869,0.0403862272369102,-0.106573512748231,0.0517404980204572,0.497248177769608
Physical measures,X4270.Volume level set by participant (left),RNASE10,Inactive ribonuclease-like protein 10,32163,0.0288716852228779,0.0425479588374625,-0.0545223140985487,0.112265684544305,0.497431967629219
Physical measures,X4270.Volume level set by participant (left),COX6B1,Cytochrome c oxidase subunit 6B1,32365,-0.0416901165539166,0.0614620640187408,-0.162155762030649,0.0787755289228154,0.497597230592085
Physical measures,X4270.Volume level set by participant (left),TMED1,Transmembrane emp24 domain-containing protein 1,32235,0.0253792718233099,0.0374243506499909,-0.0479724554506723,0.0987309990972921,0.497697633103791
Physical measures,X4270.Volume level set by participant (left),LRP2BP,LRP2-binding protein,32154,-0.0163370772503351,0.0240949139030366,-0.0635631085002869,0.0308889539996168,0.497772975349513
Physical measures,X4270.Volume level set by participant (left),SHD,SH2 domain-containing adapter protein D,32110,-0.0160827776118539,0.0237317742989397,-0.0625970552377758,0.030431500014068,0.497988977168233
Physical measures,X4270.Volume level set by participant (left),DDI2,Protein DDI1 homolog 2,32213,-0.0170199258686443,0.0251605310204724,-0.0663345666687703,0.0322947149314816,0.498773011859041
Physical measures,X4270.Volume level set by participant (left),MANSC4,MANSC domain-containing protein 4,32122,-0.0211148633342071,0.0312274997975858,-0.0823207629374752,0.040091036269061,0.49895789438457
Physical measures,X4270.Volume level set by participant (left),CA6,Carbonic anhydrase 6,33415,-0.0183961234390232,0.0272286672919418,-0.071764311331229,0.0349720644531827,0.499301912485357
Physical measures,X4270.Volume level set by participant (left),FGF5,Fibroblast growth factor 5,33273,-0.0359583586749299,0.0532512304377489,-0.140330770332918,0.068414052983058,0.499529099629567
Physical measures,X4270.Volume level set by participant (left),EHBP1,EH domain-binding protein 1,32365,-0.0179990239823187,0.0266690664314063,-0.0702703941878751,0.0342723462232377,0.499757333698222
Physical measures,X4270.Volume level set by participant (left),CFI,Complement factor I,32398,-0.0654623470643454,0.0973636678547849,-0.256295136059724,0.125370441931033,0.501381214546754
Physical measures,X4270.Volume level set by participant (left),TANK,TRAF family member-associated NF-kappa-B activator,33273,-0.0174196128595928,0.0259116815269897,-0.0682065086524926,0.0333672829333069,0.501430256097677
Physical measures,X4270.Volume level set by participant (left),SLIT2,Slit homolog 2 protein,33219,-0.0230263418827565,0.0342707387013304,-0.090196989737364,0.044144305971851,0.501668182095389
Physical measures,X4270.Volume level set by participant (left),CLC,Galectin-10,33420,-0.016289528059747,0.0243121006577913,-0.0639412453490178,0.0313621892295239,0.502864018613425
Physical measures,X4270.Volume level set by participant (left),NENF,Neudesin,32319,-0.0118036992418585,0.0176241111337289,-0.0463469570639671,0.0227395585802501,0.503038615567262
Physical measures,X4270.Volume level set by participant (left),CLINT1,Clathrin interactor 1,32075,-0.029692199651024,0.0443474576871463,-0.116613216717831,0.0572288174157827,0.503174194696879
Physical measures,X4270.Volume level set by participant (left),MYH7B,Myosin-7B,32075,0.0309192595407889,0.04618583293637,-0.0596049730144964,0.121443492096074,0.503226626834819
Physical measures,X4270.Volume level set by participant (left),ADGRD1,Adhesion G-protein coupled receptor D1,32213,0.0376527825801669,0.0562752224092749,-0.0726466533420118,0.147952218502346,0.503462579725795
Physical measures,X4270.Volume level set by participant (left),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,32111,-0.0229621950923867,0.0343432201853324,-0.0902749066556381,0.0443505164708647,0.50376492095442
Physical measures,X4270.Volume level set by participant (left),VSTM1,V-set and transmembrane domain-containing protein 1,33219,-0.0244649627695371,0.036647106754281,-0.0962932920079279,0.0473633664688536,0.504417785604645
Physical measures,X4270.Volume level set by participant (left),PEBP1,Phosphatidylethanolamine-binding protein 1,33441,-0.0202262137292673,0.0303029050182079,-0.0796199075649549,0.0391674801064202,0.504490503018098
Physical measures,X4270.Volume level set by participant (left),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,32122,-0.0249436000989605,0.0373931398469831,-0.0982341541990474,0.0483469540011263,0.504751624812632
Physical measures,X4270.Volume level set by participant (left),CTRC,Chymotrypsin-C,33438,-0.0183192653405626,0.0274715911574089,-0.072163584009084,0.0355250533279589,0.50488892051232
Physical measures,X4270.Volume level set by participant (left),CALY,Neuron-specific vesicular protein calcyon,32122,0.0362243890005632,0.0543417722307925,-0.0702854845717901,0.142734262572917,0.505045803567352
Physical measures,X4270.Volume level set by participant (left),CIRBP,Cold-inducible RNA-binding protein,32329,-0.014620167148571,0.021943373177809,-0.0576291785770767,0.0283888442799347,0.50525934121298
Physical measures,X4270.Volume level set by participant (left),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",32329,-0.00976382112356557,0.0146603271930437,-0.0384980624219313,0.0189704201748001,0.505428726817283
Physical measures,X4270.Volume level set by participant (left),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,32140,-0.0297271042333957,0.0446441352805359,-0.117229609383246,0.0577754009164547,0.505515416120298
Physical measures,X4270.Volume level set by participant (left),AMFR,E3 ubiquitin-protein ligase AMFR,33219,-0.0174990250002901,0.0262996792009201,-0.0690463962340934,0.0340483462335132,0.505831196736816
Physical measures,X4270.Volume level set by participant (left),NOS1,"Nitric oxide synthase, brain",33219,-0.0238622319151639,0.0359346977507094,-0.0942942395065543,0.0465697756762265,0.506679414489912
Physical measures,X4270.Volume level set by participant (left),UNC79,Protein unc-79 homolog,32075,-0.024383441850151,0.0367437460868246,-0.0964011841803272,0.0476343004800252,0.506961346544349
Physical measures,X4270.Volume level set by participant (left),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,33481,-0.0117422094639342,0.0177328344043989,-0.0464985648965561,0.0230141459686877,0.507877069842663
Physical measures,X4270.Volume level set by participant (left),AKR1B10,Aldo-keto reductase family 1 member B10,32154,-0.0226876876335135,0.034279530052009,-0.0898755665354512,0.0445001912684241,0.508091267483953
Physical measures,X4270.Volume level set by participant (left),BTN3A2,Butyrophilin subfamily 3 member A2,33421,-0.0305272169270502,0.0461700412334033,-0.121020497744521,0.0599660638904202,0.50850680505991
Physical measures,X4270.Volume level set by participant (left),SMPD3,Sphingomyelin phosphodiesterase 3,32140,-0.0224895053405464,0.034013442708998,-0.0891558530501826,0.0441768423690897,0.508507332150857
Physical measures,X4270.Volume level set by participant (left),WASHC3,WASH complex subunit 3,32353,-0.0170326420935091,0.0257872701300429,-0.0675756915483932,0.033510407361375,0.508948545917638
Physical measures,X4270.Volume level set by participant (left),RGMB,RGM domain family member B,33500,-0.0446252954986836,0.0675891304081754,-0.177099991098707,0.0878494001013401,0.509114285028732
Physical measures,X4270.Volume level set by participant (left),TBC1D23,TBC1 domain family member 23,33386,-0.012606514300864,0.0191009900892862,-0.0500444548758649,0.024831426274137,0.509275524352335
Physical measures,X4270.Volume level set by participant (left),PLA2G1B,Phospholipase A2,33518,-0.0274804761454539,0.0416709260207629,-0.109155491146149,0.0541945388552414,0.509614603259424
Physical measures,X4270.Volume level set by participant (left),P4HB,Protein disulfide-isomerase,33387,-0.0300575691710443,0.0455973782960658,-0.119428430631333,0.0593132922892447,0.509787475212453
Physical measures,X4270.Volume level set by participant (left),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",32350,-0.0176358001010971,0.0267571022479871,-0.0700797205071519,0.0348081203049576,0.509846122748222
Physical measures,X4270.Volume level set by participant (left),SCG3,Secretogranin-3,33453,-0.0337879834488921,0.0512974180734735,-0.1343309228729,0.0667549559751159,0.51012564309584
Physical measures,X4270.Volume level set by participant (left),HYAL1,Hyaluronidase-1,33368,0.0505079062153113,0.0766918865656391,-0.0998081914533413,0.200824003883964,0.510181150944028
Physical measures,X4270.Volume level set by participant (left),EPHB6,Ephrin type-B receptor 6,33356,-0.0373212784297341,0.0567219272915411,-0.148496255921155,0.0738536990616865,0.510574968955648
Physical measures,X4270.Volume level set by participant (left),SEMA6C,Semaphorin-6C,32140,-0.0507582037230372,0.077183991688788,-0.202038827433062,0.100522419986987,0.510798146170588
Physical measures,X4270.Volume level set by participant (left),ANGPT2,Angiopoietin-2,33509,0.0292973557422295,0.0445751365194062,-0.0580699118358067,0.116664623320266,0.51103187915216
Physical measures,X4270.Volume level set by participant (left),PDAP1,28 kDa heat- and acid-stable phosphoprotein,32365,-0.0140272135395602,0.0213498099494723,-0.0558728410405259,0.0278184139614054,0.51118833410181
Physical measures,X4270.Volume level set by participant (left),CORO6,Coronin-6,32111,-0.0355666017745526,0.0541866601605434,-0.141772455689218,0.0706392521401124,0.511604584325449
Physical measures,X4270.Volume level set by participant (left),ANGPTL2,Angiopoietin-related protein 2,33438,0.0284917420965716,0.0434378732865269,-0.0566464895450212,0.113629973738164,0.511892809121757
Physical measures,X4270.Volume level set by participant (left),GAGE2A,G antigen 2A,32075,-0.0217600650231995,0.0331749346488559,-0.0867829369349571,0.0432628068885582,0.511896142036222
Physical measures,X4270.Volume level set by participant (left),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",32384,-0.021470518812416,0.0328194390135403,-0.0857966192789549,0.042855581654123,0.513001114579464
Physical measures,X4270.Volume level set by participant (left),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,32111,-0.0209135221071498,0.0319705699029579,-0.0835758391169472,0.0417487949026476,0.513035347185131
Physical measures,X4270.Volume level set by participant (left),NHLRC3,NHL repeat-containing protein 3,32001,0.0419977613140445,0.0642360976048495,-0.0839049899914606,0.16790051261955,0.513258575710059
Physical measures,X4270.Volume level set by participant (left),MAGEA3,Melanoma-associated antigen 3,32235,0.0155083555228813,0.0237347888637529,-0.0310118306500743,0.0620285416958369,0.513516540315512
Physical measures,X4270.Volume level set by participant (left),DEFB103A_DEFB103B,Beta-defensin 103,32086,0.0333277753455698,0.0510486164080243,-0.0667275128141579,0.133383063505297,0.513863987375031
Physical measures,X4270.Volume level set by participant (left),NCLN,Nicalin,33273,-0.0208438515395724,0.0319343803603499,-0.0834352370458582,0.0417475339667133,0.513961034214942
Physical measures,X4270.Volume level set by participant (left),AGT,Angiotensinogen,32381,0.0466942519251866,0.0715760771507982,-0.0935948592903779,0.186983363140751,0.514179931244689
Physical measures,X4270.Volume level set by participant (left),CBX2,Chromobox protein homolog 2,32122,0.0337679479662389,0.0517810912883976,-0.0677229909590203,0.135258886891498,0.514337547940696
Physical measures,X4270.Volume level set by participant (left),CA9,Carbonic anhydrase 9,33509,-0.0246382068342441,0.0378476333483378,-0.0988195681969861,0.0495431545284979,0.515073283128243
Physical measures,X4270.Volume level set by participant (left),CCL2,C-C motif chemokine 2,33363,0.0219747518063871,0.033812963241957,-0.0442986561478487,0.0882481597606228,0.515779174148632
Physical measures,X4270.Volume level set by participant (left),IFNL1,Interferon lambda-1,33219,0.0263278985472597,0.0405130320806276,-0.0530776443307703,0.10573344142529,0.515798103738317
Physical measures,X4270.Volume level set by participant (left),IGFBP6,Insulin-like growth factor-binding protein 6,33353,-0.0405941776695929,0.0624761876685695,-0.163047505499989,0.0818591501608033,0.515867652861438
Physical measures,X4270.Volume level set by participant (left),FST,Follistatin,33468,0.0213042678064874,0.0327935987328195,-0.0429711857098389,0.0855797213228136,0.515936727934128
Physical measures,X4270.Volume level set by participant (left),SERPINA7,Thyroxine-binding globulin,32398,0.0692948260612197,0.10666616441309,-0.139770856188437,0.278360508310877,0.515942247977172
Physical measures,X4270.Volume level set by participant (left),THY1,Thy-1 membrane glycoprotein,33500,-0.0402300385352281,0.0619603682488677,-0.161672360303009,0.0812122832325525,0.516169614033982
Physical measures,X4270.Volume level set by participant (left),LCAT,Phosphatidylcholine-sterol acyltransferase,32381,-0.0572275990279931,0.0881393057724172,-0.229980638341931,0.115525440285945,0.516172480875442
Physical measures,X4270.Volume level set by participant (left),ATP1B4,Protein ATP1B4,32075,-0.0302392203031423,0.046636855071829,-0.121647456243927,0.0611690156376425,0.516747423940083
Physical measures,X4270.Volume level set by participant (left),NDRG1,Protein NDRG1,33219,-0.0161837599822203,0.0249698978764959,-0.0651247598201522,0.0327572398557117,0.516917331566036
Physical measures,X4270.Volume level set by participant (left),HSPA1A,Heat shock 70 kDa protein 1A,33467,-0.0161885437364339,0.0249988758350917,-0.0651863403732137,0.0328092529003459,0.517279039642433
Physical measures,X4270.Volume level set by participant (left),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,33424,0.0275558704504545,0.0426011122387967,-0.0559423095375869,0.111054050438496,0.517755593781493
Physical measures,X4270.Volume level set by participant (left),HSPB1,Heat shock protein beta-1,33260,-0.0174768897752939,0.0270417001702886,-0.0704786221090595,0.0355248425584718,0.518105788328114
Physical measures,X4270.Volume level set by participant (left),SIGLEC10,Sialic acid-binding Ig-like lectin 10,33421,-0.0340809589867686,0.0527382060369343,-0.13744784281916,0.0692859248456226,0.518147590757846
Physical measures,X4270.Volume level set by participant (left),RAB27B,Ras-related protein Rab-27B,32365,-0.0163682283941387,0.0253319180169577,-0.0660187877073759,0.0332823309190984,0.518200717667048
Physical measures,X4270.Volume level set by participant (left),ELAVL4,ELAV-like protein 4,32111,-0.0153178312072515,0.0237137361749035,-0.0617967541100623,0.0311610916955593,0.518332644903914
Physical measures,X4270.Volume level set by participant (left),PGLYRP4,Peptidoglycan recognition protein 4,32122,-0.0196772438078468,0.0304628460383905,-0.0793844220430922,0.0400299344273986,0.518335992748819
Physical measures,X4270.Volume level set by participant (left),NAAA,N-acylethanolamine-hydrolyzing acid amidase,33334,-0.0189398704031417,0.0293497123450345,-0.0764653065994094,0.038585565793126,0.518738406645658
Physical measures,X4270.Volume level set by participant (left),RBM25,RNA-binding protein 25,32075,-0.0284603087100886,0.0441352063930877,-0.11496531324054,0.0580446958203633,0.519047907827798
Physical measures,X4270.Volume level set by participant (left),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,32350,-0.0154956869678591,0.0240428724305694,-0.0626197169317752,0.031628342996057,0.51926848100775
Physical measures,X4270.Volume level set by participant (left),PQBP1,Polyglutamine-binding protein 1,33232,0.0213056897875335,0.0330614456496607,-0.0434947436858014,0.0861061232608684,0.519315391321732
Physical measures,X4270.Volume level set by participant (left),PRDX6,Peroxiredoxin-6,33509,-0.0171052312718415,0.0265730054688643,-0.0691883219908156,0.0349778594471325,0.519781714116619
Physical measures,X4270.Volume level set by participant (left),TSPAN7,Tetraspanin-7,32111,-0.0142694046575563,0.0222251468815713,-0.057830692545436,0.0292918832303233,0.520867271415194
Physical measures,X4270.Volume level set by participant (left),AFP,Alpha-fetoprotein,33352,0.0162883326759574,0.0254059643526624,-0.0335073574552608,0.0660840228071757,0.5214596799644
Physical measures,X4270.Volume level set by participant (left),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,32384,0.00907096677644033,0.0141598608850233,-0.0186823605582053,0.0368242941110859,0.521793773911689
Physical measures,X4270.Volume level set by participant (left),HJV,Hemojuvelin,32350,0.0265552294788606,0.0415592371451832,-0.0549008753256984,0.10801133428342,0.522859048361868
Physical measures,X4270.Volume level set by participant (left),WAS,Wiskott-Aldrich syndrome protein,33273,-0.0161490028587294,0.0253217635979376,-0.065779659510687,0.0334816537932283,0.52365175405183
Physical measures,X4270.Volume level set by participant (left),CEMIP2,Cell surface hyaluronidase,32140,-0.0378151067766518,0.0593264888458605,-0.154095024914538,0.0784648113612348,0.523878895746317
Physical measures,X4270.Volume level set by participant (left),DTD1,D-aminoacyl-tRNA deacylase 1,32213,-0.015233223850338,0.023912202939874,-0.062101141612491,0.031634693911815,0.524112299737905
Physical measures,X4270.Volume level set by participant (left),PRKG1,cGMP-dependent protein kinase 1,32213,-0.0103781761481907,0.0163091190535148,-0.0423440494930797,0.0215876971966982,0.524572360141236
Physical measures,X4270.Volume level set by participant (left),PFDN2,Prefoldin subunit 2,33219,-0.0202852216507242,0.0318987446688587,-0.0828067612016872,0.0422363179002389,0.524841658272635
Physical measures,X4270.Volume level set by participant (left),TXLNA,Alpha-taxilin,33380,-0.0132829040203145,0.0208936776980602,-0.0542345123085124,0.0276687042678835,0.524963531027941
Physical measures,X4270.Volume level set by participant (left),TYMP,Thymidine phosphorylase,33371,-0.0167571015674864,0.0264404903188559,-0.068580462592444,0.0350662594574712,0.526249363724667
Physical measures,X4270.Volume level set by participant (left),RPE,Ribulose-phosphate 3-epimerase,32235,-0.0184271373430859,0.0290867337996382,-0.0754371355903768,0.038582860904205,0.526410284356191
Physical measures,X4270.Volume level set by participant (left),CD209,CD209 antigen,33439,0.0278500230208134,0.0439975383724331,-0.0583851521891554,0.114085198230782,0.526755969843959
Physical measures,X4270.Volume level set by participant (left),PRSS22,Brain-specific serine protease 4,32140,-0.0352922322137157,0.0557628525326943,-0.144587423177797,0.0740029587503651,0.52681868276783
Physical measures,X4270.Volume level set by participant (left),CLEC4D,C-type lectin domain family 4 member D,33421,0.0176076449689135,0.0278438277943348,-0.0369662575079827,0.0721815474458098,0.527160234921596
Physical measures,X4270.Volume level set by participant (left),ISM1,Isthmin-1,33421,0.0274154439797502,0.043363804498044,-0.0575776128364162,0.112408500795916,0.527259559743565
Physical measures,X4270.Volume level set by participant (left),STC2,Stanniocalcin-2,33429,0.0383229023649529,0.0607008861371408,-0.0806508344638431,0.157296639193749,0.527834265202296
Physical measures,X4270.Volume level set by participant (left),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",33384,0.016035373409474,0.0254104853338337,-0.03376917784484,0.0658399246637879,0.528021755430109
Physical measures,X4270.Volume level set by participant (left),AP2B1,AP-2 complex subunit beta,32154,-0.0258269321881684,0.040944738100691,-0.106078618865523,0.0544247544891859,0.528206135426394
Physical measures,X4270.Volume level set by participant (left),ANXA2,Annexin A2,32014,0.0179294746792328,0.0284442593507707,-0.0378212736482777,0.0736802230067433,0.528493046372617
Physical measures,X4270.Volume level set by participant (left),SELENOP,Selenoprotein P,32398,-0.0541802356519453,0.0859900964553432,-0.222720824704418,0.114360353400527,0.528663444993155
Physical measures,X4270.Volume level set by participant (left),REG4,Regenerating islet-derived protein 4,33453,0.0229308323934227,0.0364057951419847,-0.0484245260848674,0.0942861908717127,0.528797177563962
Physical measures,X4270.Volume level set by participant (left),NPTX1,Neuronal pentraxin-1,33441,-0.0275934127076642,0.0438144277401454,-0.113469691078349,0.0582828656630207,0.528855106228645
Physical measures,X4270.Volume level set by participant (left),AK1,Adenylate kinase isoenzyme 1,33434,-0.0168662574297501,0.0267899629859381,-0.0693745848821888,0.0356420700226886,0.528989521669144
Physical measures,X4270.Volume level set by participant (left),SLC34A3,Sodium-dependent phosphate transport protein 2C,32075,-0.0252792599229476,0.0402209934302589,-0.104112407046255,0.0535538872003599,0.529689332488178
Physical measures,X4270.Volume level set by participant (left),PLSCR3,Phospholipid scramblase 3,32337,-0.0207350812744925,0.0330226799302252,-0.0854595339377339,0.0439893713887489,0.530084853834122
Physical measures,X4270.Volume level set by participant (left),MARCO,Macrophage receptor MARCO,33434,0.041069665572889,0.0656567959755752,-0.0876176545392383,0.169756985685016,0.531645458486599
Physical measures,X4270.Volume level set by participant (left),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,33273,0.025815840991751,0.041307910884764,-0.0551476643423866,0.106779346325888,0.53201270365565
Physical measures,X4270.Volume level set by participant (left),FUCA1,Tissue alpha-L-fucosidase,33492,-0.0130988757386857,0.0209632005462847,-0.0541867488094038,0.0279889973320323,0.532084664476197
Physical measures,X4270.Volume level set by participant (left),CSNK1D,Casein kinase I isoform delta,32140,-0.0198655646282647,0.0318198888382058,-0.0822325467511481,0.0425014174946187,0.532440696749916
Physical measures,X4270.Volume level set by participant (left),ID4,DNA-binding protein inhibitor ID-4,32235,-0.0282810260478871,0.0453183760997991,-0.117105043203493,0.060542991107719,0.532611692139724
Physical measures,X4270.Volume level set by participant (left),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,32154,-0.0400867550299722,0.0642500048290676,-0.166016764494945,0.0858432544350002,0.532699713837599
Physical measures,X4270.Volume level set by participant (left),ANPEP,Aminopeptidase N,33424,-0.0380252578439788,0.0611042814682433,-0.157789649521736,0.081739133833778,0.533759757664297
Physical measures,X4270.Volume level set by participant (left),CD160,CD160 antigen,33527,-0.0232323723923607,0.0373399090853726,-0.0964185941996909,0.0499538494149695,0.533835141716003
Physical measures,X4270.Volume level set by participant (left),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",32350,-0.0141285776199086,0.0227174829585083,-0.0586548442185848,0.0303976889787676,0.534008940735081
Physical measures,X4270.Volume level set by participant (left),PSMD5,26S proteasome non-ATPase regulatory subunit 5,32154,-0.0220617506672714,0.0355715379232906,-0.091781964996921,0.0476584636623782,0.535139243599527
Physical measures,X4270.Volume level set by participant (left),MITD1,MIT domain-containing protein 1,33380,-0.011699980612271,0.0188815770319381,-0.0487078715948696,0.0253079103703276,0.535503661226135
Physical measures,X4270.Volume level set by participant (left),RAD23B,UV excision repair protein RAD23 homolog B,33232,-0.0243363752477241,0.0392927884089521,-0.10135024052927,0.0526774900338221,0.535695405742545
Physical measures,X4270.Volume level set by participant (left),NAPRT,Nicotinate phosphoribosyltransferase,32353,-0.036541532106378,0.0590558857342827,-0.152291068145572,0.0792080039328161,0.5360910695961
Physical measures,X4270.Volume level set by participant (left),CNTN3,Contactin-3,33441,-0.0302530921190382,0.0489227622989421,-0.126141706224965,0.0656355219868882,0.536337394487437
Physical measures,X4270.Volume level set by participant (left),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",32111,0.0378654135074242,0.0613701042108908,-0.0824199907459217,0.15815081776077,0.537252437178499
Physical measures,X4270.Volume level set by participant (left),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,32235,-0.0191519003593034,0.0310441662388918,-0.0799984661875312,0.0416946654689245,0.537302714212899
Physical measures,X4270.Volume level set by participant (left),PDIA3,Protein disulfide-isomerase A3,32213,-0.0487248017960768,0.0790081889936871,-0.203580852223704,0.10613124863155,0.537446946498472
Physical measures,X4270.Volume level set by participant (left),NPL,N-acetylneuraminate lyase,32365,0.0284128395510553,0.0460847241538408,-0.0619132197904728,0.118738898892583,0.537559306155119
Physical measures,X4270.Volume level set by participant (left),VIT,Vitrin,32365,0.0329475186762297,0.0534471839996556,-0.0718089619630954,0.137703999315555,0.537615276307479
Physical measures,X4270.Volume level set by participant (left),DNMBP,Dynamin-binding protein,33380,-0.0170560793843934,0.0276766973792016,-0.0713024062476285,0.0371902474788417,0.537737748583898
Physical measures,X4270.Volume level set by participant (left),GAD1,Glutamate decarboxylase 1,32075,-0.0485545199185512,0.078840954149351,-0.203082790051279,0.105973750214177,0.538009253514924
Physical measures,X4270.Volume level set by participant (left),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",32350,-0.0169524464681377,0.0275336155040722,-0.0709183328561192,0.0370134399198438,0.538110300135987
Physical measures,X4270.Volume level set by participant (left),DTNB,Dystrobrevin beta,32299,-0.0285654801149795,0.0464876326634608,-0.119681240135363,0.0625502799054037,0.538919423851135
Physical measures,X4270.Volume level set by participant (left),STIP1,Stress-induced-phosphoprotein 1,33421,-0.0168431511040704,0.0274398250555711,-0.0706252082129897,0.0369389060048489,0.539348944455166
Physical measures,X4270.Volume level set by participant (left),SELE,E-selectin,33533,0.0209654844698017,0.0341818337160389,-0.0460309096136347,0.087961878553238,0.539659208227633
Physical measures,X4270.Volume level set by participant (left),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,32381,-0.0253646648402354,0.0413557777601763,-0.106421989250181,0.0556926595697102,0.539676948381269
Physical measures,X4270.Volume level set by participant (left),MORF4L1,Mortality factor 4-like protein 1,32235,0.0294236030727004,0.0480431350228239,-0.0647409415720345,0.123588147717435,0.540263681885534
Physical measures,X4270.Volume level set by participant (left),CIAPIN1,Anamorsin,33456,-0.0176081008044984,0.0287821885749505,-0.0740211904114014,0.0388049888024046,0.540704902716793
Physical measures,X4270.Volume level set by participant (left),HTRA2,"Serine protease HTRA2, mitochondrial",33456,-0.0173740863853953,0.0284207608629251,-0.0730787776767284,0.0383306049059378,0.541005360319836
Physical measures,X4270.Volume level set by participant (left),BIRC2,Baculoviral IAP repeat-containing protein 2,33232,-0.0177145191082708,0.0289793742763209,-0.0745140926898598,0.0390850544733182,0.541029895605783
Physical measures,X4270.Volume level set by participant (left),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",32213,-0.014262662744138,0.023337173732873,-0.0600035232605691,0.0314781977722932,0.541113960194859
Physical measures,X4270.Volume level set by participant (left),BCL2L1,Bcl-2-like protein 1,32353,-0.0128475781979643,0.0210403617541269,-0.0540866872360531,0.0283915308401245,0.541471503108625
Physical measures,X4270.Volume level set by participant (left),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,33380,-0.0370266971848393,0.0607634085434152,-0.156122977929933,0.0820695835602546,0.542302375353624
Physical measures,X4270.Volume level set by participant (left),STX5,Syntaxin-5,32140,0.0299588700621105,0.0492658541007233,-0.0666022039753072,0.126519944099528,0.543135028007192
Physical measures,X4270.Volume level set by participant (left),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,32140,-0.0204293149366959,0.0336505451474124,-0.0863843834256242,0.0455257535522324,0.543801125752628
Physical measures,X4270.Volume level set by participant (left),GFER,FAD-linked sulfhydryl oxidase ALR,33232,-0.0171033791471762,0.0281796152953366,-0.072335425126036,0.0381286668316835,0.543905407701605
Physical measures,X4270.Volume level set by participant (left),PAM,Peptidyl-glycine alpha-amidating monooxygenase,33486,-0.036581939728051,0.0602833144789458,-0.154737236106785,0.0815733566506828,0.543976613357464
Physical measures,X4270.Volume level set by participant (left),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,32329,-0.0229729543027265,0.0378824532091829,-0.0972225625927249,0.051276653987272,0.544248518715815
Physical measures,X4270.Volume level set by participant (left),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,33500,-0.0184059657639892,0.0303789922513379,-0.0779487905766116,0.0411368590486331,0.544610913549493
Physical measures,X4270.Volume level set by participant (left),XG,Glycoprotein Xg,33476,0.0349258614685861,0.0576790662777686,-0.0781251084358403,0.147976831373013,0.544848389961962
Physical measures,X4270.Volume level set by participant (left),PLIN3,Perilipin-3,33434,-0.0249146855526057,0.0411642079427059,-0.105596533120309,0.0557671620150978,0.545027408573647
Physical measures,X4270.Volume level set by participant (left),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,32329,-0.0551258477315172,0.0912091088677308,-0.23389570111227,0.123644005649235,0.5456019829057
Physical measures,X4270.Volume level set by participant (left),CRNN,Cornulin,33144,0.0160472844304592,0.0265738200326214,-0.0360374028334787,0.068131971694397,0.545942044086603
Physical measures,X4270.Volume level set by participant (left),NUP50,Nuclear pore complex protein Nup50,32122,-0.0372162837898408,0.0616411595189025,-0.15803295644689,0.0836003888672081,0.546023049606986
Physical measures,X4270.Volume level set by participant (left),SYAP1,Synapse-associated protein 1,32213,-0.0219670474488928,0.0363985166060552,-0.093308139996761,0.0493740450989753,0.546183844481823
Physical measures,X4270.Volume level set by participant (left),MIA,Melanoma-derived growth regulatory protein,33456,0.0279600953187843,0.0463850743348691,-0.0629546503775592,0.118874841015128,0.546668802165417
Physical measures,X4270.Volume level set by participant (left),DENR,Density-regulated protein,32140,-0.0221807677692483,0.0368468068973504,-0.094400509288055,0.0500389737495584,0.547210141875252
Physical measures,X4270.Volume level set by participant (left),PMM2,Phosphomannomutase 2,32122,-0.0205852207108655,0.0342471174718486,-0.0877095709556888,0.0465391295339578,0.547805186049333
Physical measures,X4270.Volume level set by participant (left),CD80,T-lymphocyte activation antigen CD80,32365,-0.0355559551186957,0.0593893878902637,-0.151959155383613,0.0808472451462212,0.549395395010577
Physical measures,X4270.Volume level set by participant (left),CNTN1,Contactin-1,33533,-0.0367766222051052,0.0615946221220528,-0.157502081564329,0.0839488371541184,0.550472055902536
Physical measures,X4270.Volume level set by participant (left),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",33386,0.0112917523006483,0.0189151865847193,-0.0257820134054016,0.0483655180066982,0.55054418896828
Physical measures,X4270.Volume level set by participant (left),TAFA5,Chemokine-like protein TAFA-5,33386,0.0295656665108666,0.0495311402321991,-0.0675153683442437,0.126646701365977,0.550582148576583
Physical measures,X4270.Volume level set by participant (left),CLASP1,CLIP-associating protein 1,32075,0.0165399490405427,0.0277183373244385,-0.0377879921153568,0.0708678901964422,0.550715370204322
Physical measures,X4270.Volume level set by participant (left),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",33421,0.0219508784944377,0.0368217654878733,-0.050219781861794,0.0941215388506694,0.551097638418899
Physical measures,X4270.Volume level set by participant (left),PON1,Serum paraoxonase/arylesterase 1,32381,-0.0437197166232784,0.0733675612605168,-0.187520136693891,0.100080703447334,0.551259168597866
Physical measures,X4270.Volume level set by participant (left),NUB1,NEDD8 ultimate buster 1,33421,0.0128283210575421,0.0215326009770025,-0.0293755768573828,0.055032218972467,0.551348785697757
Physical measures,X4270.Volume level set by participant (left),TDP1,Tyrosyl-DNA phosphodiesterase 1,32319,-0.0176169945197728,0.0296010616477475,-0.0756350753493579,0.0404010863098122,0.551762079464764
Physical measures,X4270.Volume level set by participant (left),IL1A,Interleukin-1 alpha,33273,0.0187697841225636,0.0315507545615399,-0.0430696948180545,0.0806092630631818,0.551920492130397
Physical measures,X4270.Volume level set by participant (left),GHR,Growth hormone receptor,32213,0.0411843119911108,0.0692476349019586,-0.094541052416728,0.17690967639895,0.552034879139611
Physical measures,X4270.Volume level set by participant (left),RNF31,E3 ubiquitin-protein ligase RNF31,32140,-0.0317980885057427,0.0534815701100881,-0.136621965921515,0.07302578891003,0.55215405038902
Physical measures,X4270.Volume level set by participant (left),TFRC,Transferrin receptor protein 1,33462,-0.0251226566146336,0.0422668459878593,-0.107965674750838,0.0577203615215706,0.552271508016233
Physical measures,X4270.Volume level set by participant (left),LMNB2,Lamin-B2,32353,-0.0433250635284724,0.0729235934846526,-0.186255306758391,0.0996051797014466,0.552451639472219
Physical measures,X4270.Volume level set by participant (left),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,32329,-0.0105208657599242,0.0177293505624066,-0.0452703928622412,0.0242286613423928,0.55292037685446
Physical measures,X4270.Volume level set by participant (left),TNR,Tenascin-R,33380,-0.0241764460250723,0.04074578725889,-0.104038189052497,0.055685297002352,0.552963076621916
Physical measures,X4270.Volume level set by participant (left),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,33500,0.0227350616565988,0.0383327835674352,-0.0523971941355743,0.0978673174487718,0.553131019334584
Physical measures,X4270.Volume level set by participant (left),IGFL4,Insulin growth factor-like family member 4,32140,0.0154228236611928,0.02602997586783,-0.035595929039754,0.0664415763621397,0.553531634056722
Physical measures,X4270.Volume level set by participant (left),VAMP8,Vesicle-associated membrane protein 8,32140,-0.0142351392042162,0.0240490416733348,-0.0613712608839523,0.03290098247552,0.553920724834922
Physical measures,X4270.Volume level set by participant (left),NBL1,Neuroblastoma suppressor of tumorigenicity 1,33456,-0.0391933615150784,0.066263279160806,-0.169069388670258,0.0906826656401015,0.554214138752793
Physical measures,X4270.Volume level set by participant (left),ANXA11,Annexin A11,33413,0.016244066989437,0.0274699983180844,-0.0375971297140085,0.0700852636928825,0.554308574106061
Physical measures,X4270.Volume level set by participant (left),IL1B,Interleukin-1 beta,33237,0.0173302226884741,0.0293380514635847,-0.0401723581801519,0.0748328035571001,0.554731265286363
Physical measures,X4270.Volume level set by participant (left),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,33421,-0.00876493319049313,0.0148770230838606,-0.03792389843486,0.0203940320538737,0.555769409657276
Physical measures,X4270.Volume level set by participant (left),NFIC,Nuclear factor 1 C-type,32350,-0.0273317235354883,0.0464547004622747,-0.118382936441547,0.0637194893705701,0.556312769133738
Physical measures,X4270.Volume level set by participant (left),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,32111,-0.0189352027523519,0.0322383392258836,-0.0821223476350837,0.0442519421303799,0.556985691951148
Physical measures,X4270.Volume level set by participant (left),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,33434,-0.0124360935988297,0.0211806720146465,-0.0539502107475369,0.0290780235498774,0.557122106841123
Physical measures,X4270.Volume level set by participant (left),RGS8,Regulator of G-protein signaling 8,33273,-0.016028065550545,0.0273209978255585,-0.0695772212886398,0.0375210901875497,0.557448841525355
Physical measures,X4270.Volume level set by participant (left),GLO1,Lactoylglutathione lyase,33273,0.0177863329097561,0.0303408365238622,-0.0416817066770139,0.0772543724965261,0.557744288473427
Physical measures,X4270.Volume level set by participant (left),DCUN1D1,DCN1-like protein 1,32111,0.0151602111449525,0.0258743686783721,-0.0355535514646569,0.0658739737545619,0.55794911808245
Physical measures,X4270.Volume level set by participant (left),MMP10,Stromelysin-2,33426,0.0167051788970774,0.0285357378685762,-0.039224867325332,0.0726352251194867,0.558285081329188
Physical measures,X4270.Volume level set by participant (left),HGF,Hepatocyte growth factor,33527,0.0291109411510199,0.0497942888843484,-0.0684858650623031,0.126707747364343,0.558815039761879
Physical measures,X4270.Volume level set by participant (left),IL18BP,Interleukin-18-binding protein,33452,-0.0335356594615095,0.0573643011916938,-0.145969689797229,0.0788983708742104,0.558825633654125
Physical measures,X4270.Volume level set by participant (left),FES,Tyrosine-protein kinase Fes/Fps,33232,0.0220517786179776,0.0377473531144089,-0.0519330334862639,0.0960365907222191,0.55910478658163
Physical measures,X4270.Volume level set by participant (left),PPL,Periplakin,32140,-0.0367571746195813,0.0629351613013404,-0.160110090770208,0.0865957415310458,0.559204951988867
Physical measures,X4270.Volume level set by participant (left),GLP1R,Glucagon-like peptide 1 receptor,32111,-0.0301416577955685,0.0517149635380107,-0.131502986330069,0.0712196707389326,0.560016768704043
Physical measures,X4270.Volume level set by participant (left),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,32329,-0.0355853536857258,0.0610598587651515,-0.155262676865423,0.0840919694939712,0.560048294646264
Physical measures,X4270.Volume level set by participant (left),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",32365,-0.0221835506772998,0.0381194658229915,-0.0968977036903632,0.0525306023357636,0.560618225390631
Physical measures,X4270.Volume level set by participant (left),OGN,Mimecan,33441,0.0254609803538936,0.0437868383424082,-0.0603612227972264,0.111283183505014,0.560934508791852
Physical measures,X4270.Volume level set by participant (left),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",33386,-0.0239745280238908,0.0412391981642354,-0.104803356425792,0.0568543003780105,0.561017296315443
Physical measures,X4270.Volume level set by participant (left),ACP6,Lysophosphatidic acid phosphatase type 6,33499,-0.0147449896926082,0.0253788291162417,-0.064487494760442,0.0349975153752256,0.561257852997608
Physical measures,X4270.Volume level set by participant (left),IL22RA1,Interleukin-22 receptor subunit alpha-1,33273,-0.0219839454333613,0.0378527740418126,-0.096175382555314,0.0522074916885913,0.561406937964936
Physical measures,X4270.Volume level set by participant (left),IL18R1,Interleukin-18 receptor 1,33527,0.0303004098815147,0.0521830981948699,-0.0719784625804303,0.13257928234346,0.561486992781315
Physical measures,X4270.Volume level set by participant (left),SERPINA1,Alpha-1-antitrypsin,32209,-0.138234309803147,0.239007578716239,-0.606689164086976,0.330220544480682,0.563032562698153
Physical measures,X4270.Volume level set by participant (left),CTSD,Cathepsin D,32811,0.0280850184240274,0.0486145381041245,-0.0671994762600565,0.123369513108111,0.563476692679068
Physical measures,X4270.Volume level set by participant (left),SERPINA9,Serpin A9,33327,-0.0139337988734626,0.0241711059165076,-0.0613091664698176,0.0334415687228924,0.564315480263584
Physical measures,X4270.Volume level set by participant (left),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,33500,0.0366328263886619,0.0637622485779075,-0.0883411808240367,0.161606833601361,0.565628780246628
Physical measures,X4270.Volume level set by participant (left),VSTM2B,V-set and transmembrane domain-containing protein 2B,32235,-0.0258075561271817,0.0449201979482147,-0.113851144105683,0.0622360318513192,0.565632521340201
Physical measures,X4270.Volume level set by participant (left),CD59,CD59 glycoprotein,33101,0.046920348537463,0.0817074132434068,-0.113226181419614,0.20706687849454,0.565814683458939
Physical measures,X4270.Volume level set by participant (left),MILR1,Allergin-1,33273,-0.0199798145088998,0.0347936097162875,-0.0881752895528232,0.0482156605350236,0.565821373239916
Physical measures,X4270.Volume level set by participant (left),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,33509,0.0261232518534663,0.0455348321377389,-0.063125019136502,0.115371522843435,0.566186287326393
Physical measures,X4270.Volume level set by participant (left),RANGAP1,Ran GTPase-activating protein 1,33232,0.0198827283211437,0.0346859351203042,-0.0481017045146525,0.08786716115694,0.56650932513717
Physical measures,X4270.Volume level set by participant (left),PLB1,"Phospholipase B1, membrane-associated",32353,0.0188555473261795,0.0329219097343126,-0.0456713957530733,0.0833824904054322,0.566840082257638
Physical measures,X4270.Volume level set by participant (left),BID,BH3-interacting domain death agonist,33421,-0.014678864109766,0.0256370235047136,-0.0649274301790047,0.0355697019594728,0.566953573933796
Physical measures,X4270.Volume level set by participant (left),LAMP1,Lysosome-associated membrane glycoprotein 1,32161,0.0379206908059237,0.0662308924308303,-0.0918918583585036,0.167733239970351,0.566964148838434
Physical measures,X4270.Volume level set by participant (left),THPO,Thrombopoietin,33273,-0.0264333257629414,0.0461701410301676,-0.11692680218207,0.0640601506561871,0.566984386158468
Physical measures,X4270.Volume level set by participant (left),HSPA2,Heat shock-related 70 kDa protein 2,32319,-0.0334688241774552,0.0584928101851067,-0.148114732140264,0.0811770837853539,0.567211665798686
Physical measures,X4270.Volume level set by participant (left),MENT,Protein MENT,32213,0.0542808484865778,0.0949704252976753,-0.131861185096866,0.240422882070021,0.567639854098043
Physical measures,X4270.Volume level set by participant (left),SPON2,Spondin-2,33401,0.0290342845212659,0.0508386693771542,-0.0706095074579562,0.128678076500488,0.567941932260115
Physical measures,X4270.Volume level set by participant (left),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,32122,-0.0196833512797631,0.0344939743349181,-0.0872915409762026,0.0479248384166764,0.568266125870738
Physical measures,X4270.Volume level set by participant (left),CST7,Cystatin-F,33440,0.0105510464338542,0.0185029448271612,-0.0257147254273816,0.0468168182950901,0.568531857051612
Physical measures,X4270.Volume level set by participant (left),MUCL3,Mucin-like protein 3,32075,0.0249760111982791,0.0438014557393861,-0.0608748420509177,0.110826864447476,0.568552347320737
Physical measures,X4270.Volume level set by participant (left),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,33249,0.0132034300383077,0.0231636214200031,-0.0321972679448984,0.0586041280215138,0.568687403753292
Physical measures,X4270.Volume level set by participant (left),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,32154,0.02347011997403,0.0411758887874279,-0.0572346220493288,0.104174861997389,0.568696580580821
Physical measures,X4270.Volume level set by participant (left),IL2RA,Interleukin-2 receptor subunit alpha,33342,0.0248381000058078,0.0436108719967341,-0.060639209107791,0.110315409119407,0.569004688955425
Physical measures,X4270.Volume level set by participant (left),AXL,Tyrosine-protein kinase receptor UFO,33452,-0.0358348110916652,0.062940681994972,-0.15919854780181,0.0875289256184798,0.569137880382988
Physical measures,X4270.Volume level set by participant (left),CLEC5A,C-type lectin domain family 5 member A,33393,-0.0342359838044976,0.0601479010074141,-0.152125869779029,0.083653902170034,0.569236996229838
Physical measures,X4270.Volume level set by participant (left),ABHD14B,Protein ABHD14B,33344,-0.0173335874769871,0.0304752557972493,-0.0770650888395957,0.0423979138856216,0.569522680547326
Physical measures,X4270.Volume level set by participant (left),IL1RL1,Interleukin-1 receptor-like 1,33492,-0.0215261637035566,0.038013182939878,-0.0960320022657174,0.0529796748586042,0.571216470446247
Physical measures,X4270.Volume level set by participant (left),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,32350,-0.0190703857830565,0.0337932952327053,-0.0853052444391589,0.047164472873046,0.572549314578182
Physical measures,X4270.Volume level set by participant (left),ITGB1BP1,Integrin beta-1-binding protein 1,33232,0.0240214759767652,0.0426729848617486,-0.0596175743522621,0.107660526305793,0.573503749557378
Physical measures,X4270.Volume level set by participant (left),HAO1,Hydroxyacid oxidase 1,33509,0.00743342921473166,0.0132169477867295,-0.0184717884472582,0.0333386468767215,0.573846219172404
Physical measures,X4270.Volume level set by participant (left),IGSF21,Immunoglobulin superfamily member 21,32163,-0.0296160236161399,0.0526670610591871,-0.132843463292147,0.0736114160598668,0.573910721058884
Physical measures,X4270.Volume level set by participant (left),PTGDS,Prostaglandin-H2 D-isomerase,33313,0.0339080889432793,0.0603634998021905,-0.084404370669014,0.152220548555573,0.574313072006726
Physical measures,X4270.Volume level set by participant (left),PSCA,Prostate stem cell antigen,32329,0.00431651035237859,0.00769061990040345,-0.0107571046524122,0.0193901253571693,0.574629805938489
Physical measures,X4270.Volume level set by participant (left),ARHGEF10,Rho guanine nucleotide exchange factor 10,32350,-0.0124061627483668,0.0221224243044064,-0.0557661143850034,0.0309537888882697,0.574952661149615
Physical measures,X4270.Volume level set by participant (left),ANXA1,Annexin A1,32156,0.0253557507272522,0.0452187190048496,-0.063272938522253,0.113984439976757,0.57499402945558
Physical measures,X4270.Volume level set by participant (left),TJAP1,Tight junction-associated protein 1,33456,-0.0122013364493397,0.0217613607602043,-0.0548536035393401,0.0304509306406608,0.575024123263086
Physical measures,X4270.Volume level set by participant (left),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",33356,-0.0102717577959645,0.018365158214003,-0.0462674678954103,0.0257239523034813,0.575966430326881
Physical measures,X4270.Volume level set by participant (left),EP300,Histone acetyltransferase p300,32140,-0.0383841743612356,0.0687514129858743,-0.173136943813549,0.0963685950910779,0.576653222880555
Physical measures,X4270.Volume level set by participant (left),PPP3R1,Calcineurin subunit B type 1,33380,-0.0237426265869587,0.0425793556854309,-0.107198163730403,0.0597129105564857,0.57712548013693
Physical measures,X4270.Volume level set by participant (left),PLXNB3,Plexin-B3,33420,-0.0206239721239924,0.0369957479286958,-0.0931356380642362,0.0518876938162514,0.577221145416649
Physical measures,X4270.Volume level set by participant (left),PCNA,Proliferating cell nuclear antigen,32075,-0.0175144457123367,0.0314369817812551,-0.0791309300035967,0.0441020385789234,0.577455843278331
Physical measures,X4270.Volume level set by participant (left),RAP1A,Ras-related protein Rap-1A,32140,-0.0159034089872616,0.0285464520359612,-0.0718544549777455,0.0400476370032224,0.57747101047726
Physical measures,X4270.Volume level set by participant (left),WASL,Neural Wiskott-Aldrich syndrome protein,32140,-0.018069615288463,0.0324460989892919,-0.0816639693074751,0.0455247387305491,0.577603911780975
Physical measures,X4270.Volume level set by participant (left),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",32075,-0.0225165130793099,0.0404479088832646,-0.101794414490508,0.0567613883318887,0.577762919183151
Physical measures,X4270.Volume level set by participant (left),LBR,Delta(14)-sterol reductase LBR,33500,0.0147549783130725,0.0265383567709417,-0.0372602009579732,0.0667701575841182,0.57823357300283
Physical measures,X4270.Volume level set by participant (left),PDIA5,Protein disulfide-isomerase A5,32075,-0.0182132885561857,0.0327657289392269,-0.0824341172770704,0.046007540164699,0.578320162570501
Physical measures,X4270.Volume level set by participant (left),IL17F,Interleukin-17F,33273,-0.0120577273192298,0.0217088054009081,-0.0546069859050096,0.0304915312665501,0.578614493238853
Physical measures,X4270.Volume level set by participant (left),H2AP,Huntingtin-interacting protein M,32075,-0.0237005792135162,0.0426770830433827,-0.107347661978546,0.0599465035515139,0.578673812752695
Physical measures,X4270.Volume level set by participant (left),ENAH,Protein enabled homolog,33273,-0.0205045151141176,0.0369693654657991,-0.0929644714270839,0.0519554411988486,0.579158205415589
Physical measures,X4270.Volume level set by participant (left),VIPR1,Vasoactive intestinal polypeptide receptor 1,32163,-0.0444911065191844,0.0802846080054018,-0.201848938209772,0.112866725171403,0.579480414037217
Physical measures,X4270.Volume level set by participant (left),SMAD1,Mothers against decapentaplegic homolog 1,33232,-0.0124616783968649,0.0224979446840654,-0.056557649977633,0.0316342931839032,0.579659362600917
Physical measures,X4270.Volume level set by participant (left),AHCY,Adenosylhomocysteinase,33434,-0.014501757427076,0.0262525379397333,-0.0659567317889534,0.0369532169348013,0.580691851330804
Physical measures,X4270.Volume level set by participant (left),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,33380,-0.0105456036104439,0.0190952904783959,-0.0479723729480998,0.0268811657272121,0.580782679764939
Physical measures,X4270.Volume level set by participant (left),PRDX2,Peroxiredoxin-2,32225,-0.0171184771023601,0.0309984874894777,-0.0778755125817364,0.0436385583770162,0.580802636591965
Physical measures,X4270.Volume level set by participant (left),PROCR,Endothelial protein C receptor,32122,-0.0313568117423429,0.0568221252659252,-0.142728177263556,0.0800145537788704,0.581072976070148
Physical measures,X4270.Volume level set by participant (left),GPKOW,G-patch domain and KOW motifs-containing protein,33219,0.0365484078223832,0.0662585859942987,-0.0933184207264424,0.166415236371209,0.581234723144888
Physical measures,X4270.Volume level set by participant (left),DKK1,Dickkopf-related protein 1,33500,-0.0158578079804646,0.0288288516707624,-0.0723623572551589,0.0406467412942296,0.582286811414558
Physical measures,X4270.Volume level set by participant (left),PCSK9,Proprotein convertase subtilisin/kexin type 9,33533,0.0234890970409556,0.0427062732572577,-0.0602151985432695,0.107193392625181,0.582322518053539
Physical measures,X4270.Volume level set by participant (left),RTKN2,Rhotekin-2,32122,0.0217316565058904,0.0395628561670464,-0.0558115415815206,0.0992748545933013,0.582819407074528
Physical measures,X4270.Volume level set by participant (left),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,32365,-0.0146387181146982,0.0266841542965995,-0.0669396605360332,0.0376622243066368,0.583300843363168
Physical measures,X4270.Volume level set by participant (left),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,33386,-0.0106051424639352,0.0193430957033793,-0.0485176100425586,0.0273073251146881,0.583523656133137
Physical measures,X4270.Volume level set by participant (left),MCFD2,Multiple coagulation factor deficiency protein 2,33399,-0.022132685922332,0.0403727149835648,-0.101263207290119,0.056997835445455,0.58356208135116
Physical measures,X4270.Volume level set by participant (left),FRMD4B,FERM domain-containing protein 4B,32122,-0.0147904701097894,0.0269806006879443,-0.0676724474581601,0.0380915072385814,0.583578053734872
Physical measures,X4270.Volume level set by participant (left),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,32365,-0.0123441609542191,0.0225567915998417,-0.056555472489909,0.0318671505814707,0.584223745544979
Physical measures,X4270.Volume level set by participant (left),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,32235,0.020615485354767,0.0376775645840513,-0.0532325412299735,0.0944635119395075,0.584287623625372
Physical measures,X4270.Volume level set by participant (left),TPD52L2,Tumor protein D54,32213,-0.0106600162049324,0.0194834341247987,-0.0488475470895379,0.0275275146796732,0.584303577746146
Physical measures,X4270.Volume level set by participant (left),CDH3,Cadherin-3,33500,-0.0264853257813318,0.0484213501962071,-0.121391172165898,0.0684205206032341,0.584408582020667
Physical measures,X4270.Volume level set by participant (left),MFAP5,Microfibrillar-associated protein 5,33533,-0.0227420677894925,0.0416208905898725,-0.104319013345643,0.0588348777666577,0.584797616490656
Physical measures,X4270.Volume level set by participant (left),AP3B1,AP-3 complex subunit beta-1,32329,-0.0147614338523486,0.0270309920868648,-0.0677421783426036,0.0382193106379064,0.58501752627381
Physical measures,X4270.Volume level set by participant (left),HGFAC,Hepatocyte growth factor activator,32292,-0.0374729634057882,0.068648963411111,-0.172024931691566,0.0970790048799894,0.585175307125609
Physical measures,X4270.Volume level set by participant (left),THBS2,Thrombospondin-2,33441,0.0259887847111689,0.047611176877007,-0.0673291219677649,0.119306691390103,0.585179368872288
Physical measures,X4270.Volume level set by participant (left),IL17RB,Interleukin-17 receptor B,33307,0.0182547498134428,0.0334470549267502,-0.0473014778429876,0.0838109774698733,0.585230593288645
Physical measures,X4270.Volume level set by participant (left),MYH4,Myosin-4,32122,-0.0230706875541865,0.042291024549495,-0.105961095671197,0.0598197205628236,0.585410370775062
Physical measures,X4270.Volume level set by participant (left),MEGF9,Multiple epidermal growth factor-like domains protein 9,33492,0.0443301667364078,0.0813205381406461,-0.115058088019259,0.203718421492074,0.58567839442662
Physical measures,X4270.Volume level set by participant (left),BAX,Apoptosis regulator BAX,33204,-0.0111101066420372,0.0203841839283202,-0.0510631071415448,0.0288428938574704,0.58574290179163
Physical measures,X4270.Volume level set by participant (left),EPO,Erythropoietin,33421,0.0118276715278445,0.0217137079105749,-0.0307311959768824,0.0543865390325714,0.585966606451248
Physical measures,X4270.Volume level set by participant (left),RANBP2,E3 SUMO-protein ligase RanBP2,32111,-0.0331492776811679,0.0610647337083421,-0.152836155749518,0.0865376003871826,0.587245650588405
Physical measures,X4270.Volume level set by participant (left),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,33219,-0.0191311714861109,0.0352484170797048,-0.0882180689623323,0.0499557259901105,0.587313925883275
Physical measures,X4270.Volume level set by participant (left),ART5,Ecto-ADP-ribosyltransferase 5,32111,-0.0175873708244175,0.0324053086523334,-0.0811017757829909,0.0459270341341559,0.587330713656214
Physical measures,X4270.Volume level set by participant (left),AGER,Advanced glycosylation end product-specific receptor,33417,-0.0231064986371508,0.0425895633107058,-0.106582042726134,0.0603690454518326,0.587460746251194
Physical measures,X4270.Volume level set by participant (left),PACS2,Phosphofurin acidic cluster sorting protein 2,32122,-0.0187169451191563,0.034600434735017,-0.0865337971997896,0.0490999069614769,0.588560950258148
Physical measures,X4270.Volume level set by participant (left),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,32213,-0.0515233675919027,0.0952862778005704,-0.238284472081021,0.135237736897215,0.588714874332045
Physical measures,X4270.Volume level set by participant (left),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,32213,-0.0162759681892845,0.0301054957856813,-0.0752827399292198,0.0427308035506507,0.588777377732787
Physical measures,X4270.Volume level set by participant (left),SELP,P-selectin,33452,-0.0162669050833775,0.0301153794066824,-0.075293048720475,0.0427592385537199,0.589105062664872
Physical measures,X4270.Volume level set by participant (left),FXN,"Frataxin, mitochondrial",33509,-0.0133294149198636,0.0246893867934624,-0.0617206130350498,0.0350617831953227,0.589290030591597
Physical measures,X4270.Volume level set by participant (left),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,32140,-0.0251925599894212,0.0467026751804215,-0.116729803343047,0.0663446833642049,0.589609713802175
Physical measures,X4270.Volume level set by participant (left),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,32319,-0.0133556225997426,0.024776382041052,-0.0619173314002044,0.0352060862007193,0.589870012945255
Physical measures,X4270.Volume level set by participant (left),SCAMP3,Secretory carrier-associated membrane protein 3,33386,-0.0111173916477199,0.0206950427148868,-0.051679675368898,0.0294448920734581,0.591142363718829
Physical measures,X4270.Volume level set by participant (left),ZNF174,Zinc finger protein 174,32140,-0.0290228300395864,0.05405864201017,-0.13497776837952,0.0769321083003467,0.591368268302698
Physical measures,X4270.Volume level set by participant (left),EZR,Ezrin,33500,0.0384633097796445,0.0716536941651786,-0.101977930784106,0.178904550343395,0.591422765884169
Physical measures,X4270.Volume level set by participant (left),TMPRSS5,Transmembrane protease serine 5,33334,-0.0246308186225054,0.0459261754806405,-0.114646122564561,0.06538448531955,0.591755477488392
Physical measures,X4270.Volume level set by participant (left),SMARCA2,Probable global transcription activator SNF2L2,33219,0.0132080605333473,0.0246709696553326,-0.0351470399911046,0.0615631610577992,0.592408637401678
Physical measures,X4270.Volume level set by participant (left),ARHGAP25,Rho GTPase-activating protein 25,33232,-0.0162208503388797,0.0303041548083481,-0.0756169937632421,0.0431752930854826,0.592477974922863
Physical measures,X4270.Volume level set by participant (left),TIA1,Nucleolysin TIA-1 isoform p40,33219,-0.00813504825061375,0.015216494188419,-0.0379593768599149,0.0216892803586874,0.592925934598957
Physical measures,X4270.Volume level set by participant (left),MPRIP,Myosin phosphatase Rho-interacting protein,32305,-0.024861056343507,0.0465031293440257,-0.116007189857797,0.0662850771707834,0.592934435048741
Physical measures,X4270.Volume level set by participant (left),CPXM1,Probable carboxypeptidase X1,33456,-0.0135756901649352,0.0254018057963812,-0.0633632295258424,0.036211849195972,0.593051737332386
Physical measures,X4270.Volume level set by participant (left),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,33421,0.0107944247690274,0.0202124574646539,-0.0288219918616942,0.050410841399749,0.593321487147533
Physical measures,X4270.Volume level set by participant (left),RNF4,E3 ubiquitin-protein ligase RNF4,32235,0.0159975381681161,0.0299773275983399,-0.0427580239246301,0.0747531002608623,0.593595784478806
Physical measures,X4270.Volume level set by participant (left),AIDA,"Axin interactor, dorsalization-associated protein",32154,-0.0124506603076656,0.0233722637863104,-0.058260297328834,0.0333589767135027,0.594249075315154
Physical measures,X4270.Volume level set by participant (left),CCL13,C-C motif chemokine 13,33512,0.0131137119195801,0.0246543800277059,-0.0352088729347235,0.0614362967738836,0.594806977945054
Physical measures,X4270.Volume level set by participant (left),LY96,Lymphocyte antigen 96,33380,0.0256820186827607,0.0482988646470163,-0.0689837560253913,0.120347793390913,0.594925335977896
Physical measures,X4270.Volume level set by participant (left),FGL1,Fibrinogen-like protein 1,32381,-0.0165505952805986,0.0311524887059966,-0.0776094731443521,0.0445082825831548,0.595241850191958
Physical measures,X4270.Volume level set by participant (left),SNRPB2,U2 small nuclear ribonucleoprotein B'',32353,-0.0270876810409132,0.0510272283919682,-0.127101048689171,0.0729256866073446,0.595539327327833
Physical measures,X4270.Volume level set by participant (left),CD200R1,Cell surface glycoprotein CD200 receptor 1,33391,0.0269424337655738,0.0507812556709216,-0.0725888273494325,0.12647369488058,0.595737849883736
Physical measures,X4270.Volume level set by participant (left),CNTN5,Contactin-5,33435,-0.0243724138534538,0.0459428940104356,-0.114420486113908,0.0656756584069999,0.595782823457224
Physical measures,X4270.Volume level set by participant (left),HIP1R,Huntingtin-interacting protein 1-related protein,32332,-0.0266003616400151,0.0503004453114669,-0.12518923445049,0.0719885111704599,0.596938600097161
Physical measures,X4270.Volume level set by participant (left),ARHGEF5,Rho guanine nucleotide exchange factor 5,32111,-0.0145250438080568,0.0275260624522681,-0.0684761262145023,0.0394260385983887,0.597734449492343
Physical measures,X4270.Volume level set by participant (left),GZMA,Granzyme A,33527,-0.0259022745420208,0.0490901026794302,-0.122118875793704,0.0703143267096623,0.597756857382141
Physical measures,X4270.Volume level set by participant (left),NFYA,Nuclear transcription factor Y subunit alpha,32122,-0.0296162915496943,0.0561449306401753,-0.139660355604438,0.0804277725050493,0.597863650748068
Physical measures,X4270.Volume level set by participant (left),SIRT1,NAD-dependent protein deacetylase sirtuin-1,32140,-0.0121237207943292,0.0230235285230769,-0.0572498366995599,0.0330023951109014,0.598500748192417
Physical measures,X4270.Volume level set by participant (left),VEGFB,Vascular endothelial growth factor B,32140,-0.0375188055354969,0.0712639963809832,-0.177196238442224,0.10215862737123,0.598572504585991
Physical measures,X4270.Volume level set by participant (left),IL15,Interleukin-15,33421,0.0272445506141868,0.0517622198067689,-0.0742094002070803,0.128698501435454,0.598664694936986
Physical measures,X4270.Volume level set by participant (left),DSC2,Desmocollin-2,33343,-0.0278366894262541,0.0529068036802273,-0.1315340246395,0.0758606457869915,0.598800077693336
Physical measures,X4270.Volume level set by participant (left),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",32111,-0.0193715811200109,0.0368240317755135,-0.0915466834000174,0.0528035211599956,0.598863059518743
Physical measures,X4270.Volume level set by participant (left),SERPINA3,Alpha-1-antichymotrypsin,32363,-0.071983472734895,0.137005830258247,-0.34051490004106,0.19654795457127,0.599316792170392
Physical measures,X4270.Volume level set by participant (left),KLRD1,Natural killer cells antigen CD94,33527,0.0196944756311418,0.0375071802566267,-0.0538195976718465,0.0932085489341302,0.599536603255913
Physical measures,X4270.Volume level set by participant (left),CPA4,Carboxypeptidase A4,32057,-0.0245515084029153,0.0468045181493808,-0.116288363975702,0.0671853471698711,0.599908400203139
Physical measures,X4270.Volume level set by participant (left),TMOD4,Tropomodulin-4,32075,0.0263385397074377,0.0502267723644584,-0.0721059341269007,0.124783013541776,0.60002086710236
Physical measures,X4270.Volume level set by participant (left),FGF19,Fibroblast growth factor 19,33481,0.0120711853396698,0.0230219107657438,-0.033051759761188,0.0571941304405276,0.600058682018108
Physical measures,X4270.Volume level set by participant (left),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,32329,0.0130282479971596,0.0248677512630147,-0.0357125444783494,0.0617690404726685,0.600361914033904
Physical measures,X4270.Volume level set by participant (left),DDA1,DET1- and DDB1-associated protein 1,32122,0.0252714680015319,0.0482730152121917,-0.0693436418143638,0.119886577817428,0.600633633551502
Physical measures,X4270.Volume level set by participant (left),NAGK,N-acetyl-D-glucosamine kinase,32142,-0.0193667732611584,0.0370875066534003,-0.092058286301823,0.0533247397795063,0.601552190903688
Physical measures,X4270.Volume level set by participant (left),ARHGAP1,Rho GTPase-activating protein 1,33232,-0.0205189431466763,0.039315637693927,-0.0975775930267733,0.0565397067334206,0.601751147709007
Physical measures,X4270.Volume level set by participant (left),TGFBI,Transforming growth factor-beta-induced protein ig-h3,33327,-0.0338758055957384,0.0649333888620655,-0.161145247765387,0.0933936365739099,0.601891640572334
Physical measures,X4270.Volume level set by participant (left),AFAP1,Actin filament-associated protein 1,32213,-0.0121050166979701,0.023233747383123,-0.0576431615688911,0.0334331281729509,0.602374616373864
Physical measures,X4270.Volume level set by participant (left),EFCAB2,Dynein regulatory complex protein 8,32235,-0.0308465309128375,0.0593032057020278,-0.147080814088812,0.0853877522631369,0.602974202040979
Physical measures,X4270.Volume level set by participant (left),DLGAP5,Disks large-associated protein 5,32350,0.0190932345178972,0.0367324167585852,-0.0529023023289298,0.0910887713647241,0.603222784373242
Physical measures,X4270.Volume level set by participant (left),MSRA,Mitochondrial peptide methionine sulfoxide reductase,33456,-0.0128468041205829,0.0247530514569587,-0.0613627849762218,0.0356691767350561,0.603774334488127
Physical measures,X4270.Volume level set by participant (left),KLK11,Kallikrein-11,33366,0.0302480674136201,0.058340728601904,-0.0840997606461117,0.144595895473352,0.604141467898315
Physical measures,X4270.Volume level set by participant (left),BCR,Breakpoint cluster region protein,33421,0.0104641922120256,0.0201848164646431,-0.0290980480586749,0.0500264324827261,0.604178759422005
Physical measures,X4270.Volume level set by participant (left),DDX53,Probable ATP-dependent RNA helicase DDX53,32154,0.0294853840452328,0.0569123519281129,-0.0820628257338684,0.141033593824334,0.604414487611396
Physical measures,X4270.Volume level set by participant (left),STAT2,Signal transducer and activator of transcription 2,32140,-0.0140005544449735,0.0270571877449856,-0.0670326424251454,0.0390315335351983,0.604861789424245
Physical measures,X4270.Volume level set by participant (left),CA3,Carbonic anhydrase 3,33529,-0.0136167161649333,0.0263214600632338,-0.0652067778888716,0.0379733455590049,0.60494279440845
Physical measures,X4270.Volume level set by participant (left),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,32319,-0.0215711240580896,0.0416989462990843,-0.103301058804295,0.0601588106881157,0.604956966152691
Physical measures,X4270.Volume level set by participant (left),TADA3,Transcriptional adapter 3,32319,-0.0271116597419048,0.0526629908489506,-0.130331121805848,0.0761078023220384,0.606697273994207
Physical measures,X4270.Volume level set by participant (left),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,32122,0.0502268298307641,0.0975704033039755,-0.141011160645028,0.241464820306556,0.606724913762156
Physical measures,X4270.Volume level set by participant (left),ANGPT1,Angiopoietin-1,33420,-0.0103706165148755,0.0201496959404017,-0.0498640205580629,0.0291227875283118,0.606790345032598
Physical measures,X4270.Volume level set by participant (left),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,33232,-0.0138322752560336,0.0269210743822422,-0.0665975810452284,0.0389330305331611,0.607398860315266
Physical measures,X4270.Volume level set by participant (left),CD109,CD109 antigen,33441,-0.0267616700872604,0.0520943909708554,-0.128866676390137,0.0753433362156161,0.607463893691442
Physical measures,X4270.Volume level set by participant (left),SDK2,Protein sidekick-2,32213,-0.0264320160959942,0.0515208062854057,-0.127412796415389,0.074548764223401,0.607940913208211
Physical measures,X4270.Volume level set by participant (left),VASN,Vasorin,33236,-0.0331338906937848,0.0645862585971265,-0.159722957544153,0.0934551761565832,0.607951879067459
Physical measures,X4270.Volume level set by participant (left),ASPSCR1,Tether containing UBX domain for GLUT4,32350,-0.0155466820641179,0.0303400617699774,-0.0750132031332736,0.0439198390050378,0.608375406668983
Physical measures,X4270.Volume level set by participant (left),NCAN,Neurocan core protein,33500,-0.0233934082835696,0.0457292511366004,-0.113022740511306,0.0662359239441672,0.608969138607084
Physical measures,X4270.Volume level set by participant (left),NUMB,Protein numb homolog,32140,-0.0131717759056807,0.0257537134935809,-0.0636490543530992,0.0373055025417378,0.609049621479101
Physical measures,X4270.Volume level set by participant (left),OBP2B,Odorant-binding protein 2b,33351,-0.0134580274236538,0.0263136383889595,-0.0650327586660144,0.0381167038187068,0.609050891345367
Physical measures,X4270.Volume level set by participant (left),CD83,CD83 antigen,33421,-0.0268142693156278,0.0524382030112946,-0.129593147217765,0.0759646085865097,0.609118668816032
Physical measures,X4270.Volume level set by participant (left),PI16,Peptidase inhibitor 16,32381,0.0406096807866759,0.0794282888986022,-0.115069765454584,0.196289127027936,0.609172905137008
Physical measures,X4270.Volume level set by participant (left),ARF6,ADP-ribosylation factor 6,32329,-0.0102139157562115,0.0199841984970694,-0.0493829448104674,0.0289551132980445,0.609295649702618
Physical measures,X4270.Volume level set by participant (left),BST2,Bone marrow stromal antigen 2,33500,0.0167805010877011,0.0329111821609967,-0.0477254159478525,0.0812864181232548,0.610153349553082
Physical measures,X4270.Volume level set by participant (left),TGFBR2,TGF-beta receptor type-2,33456,-0.0283594414510831,0.0556374037009308,-0.137408752704907,0.0806898698027412,0.610260840904665
Physical measures,X4270.Volume level set by participant (left),EHD3,EH domain-containing protein 3,32163,0.00937770925899512,0.0184105121357376,-0.0267068945270506,0.0454623130450408,0.610509511169742
Physical measures,X4270.Volume level set by participant (left),ACOT13,Acyl-coenzyme A thioesterase 13,32329,-0.00931239705608022,0.0182913228775878,-0.0451633898961523,0.0265385957839919,0.610685493083043
Physical measures,X4270.Volume level set by participant (left),DPY30,Protein dpy-30 homolog,33480,0.015062190766733,0.0295934423816893,-0.0429409563013781,0.073065337834844,0.610785306644251
Physical measures,X4270.Volume level set by participant (left),POMC,Pro-opiomelanocortin,32163,0.0150554892411296,0.0296050654957267,-0.0429704391304949,0.073081417612754,0.611086188507856
Physical measures,X4270.Volume level set by participant (left),CD1C,T-cell surface glycoprotein CD1c,33456,-0.0362139197259274,0.0712420334446446,-0.175848305277431,0.103420465825576,0.611239737576097
Physical measures,X4270.Volume level set by participant (left),SELPLG,P-selectin glycoprotein ligand 1,33421,-0.0306124400129382,0.0603542365785563,-0.148906743706908,0.087681863681032,0.612018004667593
Physical measures,X4270.Volume level set by participant (left),ATP6V1F,V-type proton ATPase subunit F,33195,0.013320454602873,0.0262724040901426,-0.0381734574138064,0.0648143666195525,0.612158376617527
Physical measures,X4270.Volume level set by participant (left),TXNDC5,Thioredoxin domain-containing protein 5,33500,-0.013145264812599,0.0259441451182196,-0.0639957892443093,0.0377052596191113,0.612394817204829
Physical measures,X4270.Volume level set by participant (left),NTproBNP,N-terminal prohormone of brain natriuretic peptide,33434,0.00900059007461206,0.0177723698992259,-0.0258332549278708,0.0438344350770949,0.612562167375652
Physical measures,X4270.Volume level set by participant (left),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,32075,0.0186114085701042,0.0367917694215613,-0.0535004594961559,0.0907232766363643,0.612971015795096
Physical measures,X4270.Volume level set by participant (left),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,33232,-0.00878539173911223,0.0173917908653501,-0.0428733018351984,0.0253025183569739,0.613469052755514
Physical measures,X4270.Volume level set by participant (left),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,33441,0.0336049835915315,0.0669751189839444,-0.0976662496169995,0.164876216800063,0.615853394973184
Physical measures,X4270.Volume level set by participant (left),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",32329,-0.0102033701621247,0.0203477640262286,-0.0500849876535328,0.0296782473292833,0.616069034356109
Physical measures,X4270.Volume level set by participant (left),LRG1,Leucine-rich alpha-2-glycoprotein,32398,-0.0388158468340301,0.0774100677275298,-0.190539579579988,0.112907885911928,0.616081367831695
Physical measures,X4270.Volume level set by participant (left),ZBP1,Z-DNA-binding protein 1,32140,0.0240283722372714,0.0479750377719702,-0.0700027017957902,0.118059446270333,0.616489943657821
Physical measures,X4270.Volume level set by participant (left),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,32350,-0.0103844041950933,0.0207548864161451,-0.0510639815707377,0.0302951731805512,0.616852884616582
Physical measures,X4270.Volume level set by participant (left),ELOA,Elongin-A,33386,0.0177027041544775,0.0354445147701106,-0.0517685447949393,0.0871739531038942,0.61747587302277
Physical measures,X4270.Volume level set by participant (left),KRT8,"Keratin, type II cytoskeletal 8",32111,-0.016363348822855,0.032764652729242,-0.0805820681721693,0.0478553705264594,0.617497325494885
Physical measures,X4270.Volume level set by participant (left),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",33232,0.0108109125334827,0.0216523508296237,-0.0316276950925797,0.053249520159545,0.617584025658437
Physical measures,X4270.Volume level set by participant (left),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,33439,-0.0171847619700173,0.034438185006757,-0.084683604583261,0.0503140806432263,0.617789399863753
Physical measures,X4270.Volume level set by participant (left),RASA1,Ras GTPase-activating protein 1,33219,0.0274143297463766,0.0549383091630281,-0.0802647562131585,0.135093415705912,0.617790453604742
Physical measures,X4270.Volume level set by participant (left),PKLR,Pyruvate kinase PKLR,33454,-0.0122869182864409,0.0246443276677373,-0.0605898005152061,0.0360159639423242,0.618094648348687
Physical measures,X4270.Volume level set by participant (left),UROS,Uroporphyrinogen-III synthase,32154,-0.014420409523923,0.028930162865042,-0.0711235287394054,0.0422827096915594,0.618177004740923
Physical measures,X4270.Volume level set by participant (left),GIPC3,PDZ domain-containing protein GIPC3,32329,-0.0105815164311496,0.0212746611412368,-0.0522798522679738,0.0311168194056746,0.61893746450261
Physical measures,X4270.Volume level set by participant (left),CNDP1,Beta-Ala-His dipeptidase,33452,-0.0176082558201293,0.0354464289462823,-0.0870832565548426,0.0518667449145839,0.619372675793367
Physical measures,X4270.Volume level set by participant (left),PGF,Placenta growth factor,33527,0.0327044129244165,0.0659337881427779,-0.0965258118354281,0.161934637684261,0.619893008672904
Physical measures,X4270.Volume level set by participant (left),RRP15,RRP15-like protein,32111,-0.0107379194766098,0.021696169584476,-0.0532624118621828,0.0317865729089631,0.620669128281139
Physical measures,X4270.Volume level set by participant (left),RAB6B,Ras-related protein Rab-6B,33219,0.0183062553474393,0.0371561677829417,-0.0545198335071264,0.091132344202005,0.622248113600462
Physical measures,X4270.Volume level set by participant (left),KLF4,Krueppel-like factor 4,32111,-0.0257127401733546,0.0522037898968454,-0.128032168371172,0.0766066880244624,0.622347911172445
Physical measures,X4270.Volume level set by participant (left),FADD,FAS-associated death domain protein,33434,-0.0116347808731727,0.0236326746638456,-0.0579548232143102,0.0346852614679648,0.622506900772852
Physical measures,X4270.Volume level set by participant (left),NACC1,Nucleus accumbens-associated protein 1,32319,-0.0175568225400206,0.0356996237495776,-0.0875280850891926,0.0524144400091515,0.62287946212794
Physical measures,X4270.Volume level set by participant (left),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,32329,-0.0337637645415637,0.0687127667290411,-0.168440787330484,0.100913258247357,0.623174642372305
Physical measures,X4270.Volume level set by participant (left),SCIN,Adseverin,32111,0.0132424356082153,0.0269680810937035,-0.0396150033354436,0.0660998745518743,0.62341146919905
Physical measures,X4270.Volume level set by participant (left),LTA4H,Leukotriene A-4 hydrolase,33509,-0.0156935405243073,0.0319717523906992,-0.0783581752100779,0.0469710941614632,0.623539885158524
Physical measures,X4270.Volume level set by participant (left),SOX2,Transcription factor SOX-2,32331,0.0427394499939491,0.0871588360469652,-0.128091868658103,0.213570768646001,0.623890862655475
Physical measures,X4270.Volume level set by participant (left),TGM2,Protein-glutamine gamma-glutamyltransferase 2,33427,-0.0110007009776472,0.022461268589841,-0.0550247874137356,0.0330233854584413,0.624313505424783
Physical measures,X4270.Volume level set by participant (left),SORD,Sorbitol dehydrogenase,33475,0.0130103619191724,0.0265899257234294,-0.0391058924987493,0.0651266163370941,0.624643581198469
Physical measures,X4270.Volume level set by participant (left),IL16,Pro-interleukin-16,33527,0.0213872923660414,0.0438110241232692,-0.0644823149155662,0.107256899647649,0.625440184285184
Physical measures,X4270.Volume level set by participant (left),BTLA,B- and T-lymphocyte attenuator,32075,0.0107304312523319,0.0219999308430702,-0.0323894332000856,0.0538502957047494,0.625742091297026
Physical measures,X4270.Volume level set by participant (left),ANGPTL4,Angiopoietin-related protein 4,33468,0.0181396542982805,0.0372319528909381,-0.0548349733679583,0.0911142819645192,0.626123756073349
Physical measures,X4270.Volume level set by participant (left),FDX2,"Ferredoxin-2, mitochondrial",32122,-0.0172353394794175,0.0353985775814167,-0.0866165515389943,0.0521458725801593,0.626347681070906
Physical measures,X4270.Volume level set by participant (left),BACH1,Transcription regulator protein BACH1,33421,0.012211026153618,0.0250960646251486,-0.0369772605116733,0.0613993128189093,0.62657402079506
Physical measures,X4270.Volume level set by participant (left),HYOU1,Hypoxia up-regulated protein 1,33533,0.0390760131646667,0.0803436249203267,-0.118397491679174,0.196549518008507,0.626722911901634
Physical measures,X4270.Volume level set by participant (left),IDUA,Alpha-L-iduronidase,33509,-0.0180623589877479,0.0371459387303537,-0.0908683988992411,0.0547436809237452,0.626798901796801
Physical measures,X4270.Volume level set by participant (left),CXCL1,Growth-regulated alpha protein,33410,-0.00878644455295809,0.0180749013319215,-0.0442132511635243,0.0266403620576081,0.626898943467333
Physical measures,X4270.Volume level set by participant (left),SSNA1,Sjoegren syndrome nuclear autoantigen 1,32329,-0.0192312230597151,0.0397112529910327,-0.0970652789221391,0.0586028328027089,0.628203184118731
Physical measures,X4270.Volume level set by participant (left),NRP2,Neuropilin-2,33441,0.0284017046051778,0.0587107316000439,-0.0866713293309083,0.143474738541264,0.628570398629511
Physical measures,X4270.Volume level set by participant (left),GPNMB,Transmembrane glycoprotein NMB,33164,-0.0301169808279593,0.0622623319988119,-0.152151151545631,0.0919171898897121,0.628603079138539
Physical measures,X4270.Volume level set by participant (left),DLL1,Delta-like protein 1,33456,-0.0286391322227968,0.059316285541946,-0.144899051885011,0.0876207874394174,0.629234773371612
Physical measures,X4270.Volume level set by participant (left),TOP1MT,"DNA topoisomerase I, mitochondrial",32075,0.0191935904495814,0.0397861649024435,-0.0587872927592078,0.0971744736583707,0.629522387782711
Physical measures,X4270.Volume level set by participant (left),GIGYF2,GRB10-interacting GYF protein 2,32350,-0.0122300908778461,0.025392484447935,-0.0619993603957987,0.0375391786401065,0.630073525837578
Physical measures,X4270.Volume level set by participant (left),DEFB4A_DEFB4B,Beta-defensin 4A,33302,0.00571884342150551,0.0118940462354124,-0.0175934871999028,0.0290311740429138,0.630659425255122
Physical measures,X4270.Volume level set by participant (left),PPIB,Peptidyl-prolyl cis-trans isomerase B,33396,-0.00904015750375248,0.0188127984281108,-0.0459132424228496,0.0278329274153447,0.630860690636348
Physical measures,X4270.Volume level set by participant (left),TBCC,Tubulin-specific chaperone C,33380,-0.0108188488427391,0.0225649856064411,-0.0550462206313637,0.0334085229458854,0.631628182278746
Physical measures,X4270.Volume level set by participant (left),KYAT1,Kynurenine--oxoglutarate transaminase 1,33406,-0.0149144331085218,0.03111676440614,-0.0759032913445563,0.0460744251275126,0.631733092959034
Physical measures,X4270.Volume level set by participant (left),CCDC28A,Coiled-coil domain-containing protein 28A,32154,0.0339844956541496,0.070920862318791,-0.105020394490681,0.17298938579898,0.631817803293656
Physical measures,X4270.Volume level set by participant (left),KLK10,Kallikrein-10,33432,0.0208473464065332,0.0435424797140926,-0.0644959138330883,0.106190606646155,0.63210553323484
Physical measures,X4270.Volume level set by participant (left),ACY1,Aminoacylase-1,33434,-0.0138863474907782,0.0290285650811387,-0.0707823350498101,0.0430096400682536,0.632399685755985
Physical measures,X4270.Volume level set by participant (left),LGALS4,Galectin-4,33424,0.0155953989235483,0.0327822216144449,-0.0486577554407636,0.0798485532878603,0.634280230445756
Physical measures,X4270.Volume level set by participant (left),TTN,Titin,32122,-0.0138499145698599,0.0291160780677133,-0.070917427582578,0.0432175984428583,0.63431644865692
Physical measures,X4270.Volume level set by participant (left),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,32122,0.0179635800070883,0.0377836901899525,-0.0560924527652185,0.0920196127793952,0.634492547750982
Physical measures,X4270.Volume level set by participant (left),MORN4,MORN repeat-containing protein 4,32075,0.0124158959344304,0.0261169479772692,-0.0387733221010172,0.063605113969878,0.634518280624825
Physical measures,X4270.Volume level set by participant (left),IL13,Interleukin-13,33273,0.0169251431322753,0.0356317931935262,-0.0529131715270361,0.0867634577915866,0.63479790999122
Physical measures,X4270.Volume level set by participant (left),ADGRV1,Adhesion G-protein coupled receptor V1,32111,-0.014209327276023,0.0299418934238487,-0.0728954383867665,0.0444767838347204,0.635111721393791
Physical measures,X4270.Volume level set by participant (left),PCYT2,Ethanolamine-phosphate cytidylyltransferase,32329,-0.0129408085197144,0.0272710754997236,-0.0663921164991727,0.0405104994597439,0.635138697086966
Physical measures,X4270.Volume level set by participant (left),MESD,LRP chaperone MESD,33441,-0.00698723362576693,0.014727400559699,-0.035852938722777,0.0218784714712432,0.635199363460602
Physical measures,X4270.Volume level set by participant (left),PSAPL1,Proactivator polypeptide-like 1,32329,0.0186730321686655,0.03941490855512,-0.0585801885993697,0.0959262529367007,0.635687361597105
Physical measures,X4270.Volume level set by participant (left),GGH,Gamma-glutamyl hydrolase,33263,-0.0241768877585703,0.0511809466833948,-0.124491543258024,0.0761377677408836,0.63666683214806
Physical measures,X4270.Volume level set by participant (left),MCEMP1,Mast cell-expressed membrane protein 1,32140,-0.0104313865168264,0.0220990688797715,-0.0537455615211786,0.0328827884875258,0.636919971447872
Physical measures,X4270.Volume level set by participant (left),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,32213,0.0250231392754995,0.0531253899785943,-0.0791026250825453,0.129148903633544,0.637639453163884
Physical measures,X4270.Volume level set by participant (left),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",33489,-0.010728978231508,0.0227790856764066,-0.0553759861572649,0.0339180296942489,0.637651202134092
Physical measures,X4270.Volume level set by participant (left),IL21R,Interleukin-21 receptor,32140,0.017511558564709,0.0372130044861964,-0.0554259302282359,0.0904490473576539,0.637956678922486
Physical measures,X4270.Volume level set by participant (left),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",33374,-0.011524442831339,0.0246422447353373,-0.0598232425126002,0.0367743568499222,0.640031901235384
Physical measures,X4270.Volume level set by participant (left),NIT2,Omega-amidase NIT2,32341,-0.0129412860643786,0.0276841131658581,-0.0672021478694605,0.0413195757407033,0.640181898163542
Physical measures,X4270.Volume level set by participant (left),ATG4A,Cysteine protease ATG4A,33232,-0.013726511908808,0.0294129134435965,-0.0713758222582573,0.0439227984406412,0.640738150372584
Physical measures,X4270.Volume level set by participant (left),SPON1,Spondin-1,33453,-0.0249963072441327,0.0536136166970998,-0.130078995970448,0.0800863814821829,0.641061753811268
Physical measures,X4270.Volume level set by participant (left),NECTIN2,Nectin-2,33418,-0.0281872695279514,0.0605323076573701,-0.146830592536397,0.0904560534804939,0.641472625407991
Physical measures,X4270.Volume level set by participant (left),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,33232,-0.0216853890654545,0.0466463361671439,-0.113112207953057,0.0697414298221475,0.642022166149936
Physical measures,X4270.Volume level set by participant (left),FURIN,Furin,33456,-0.0234352962780317,0.0504465985371479,-0.122310629410842,0.0754400368547781,0.642260311495249
Physical measures,X4270.Volume level set by participant (left),COLEC12,Collectin-12,33424,-0.0323082496236569,0.0696291007371669,-0.168781287068504,0.10416478782119,0.642655437525979
Physical measures,X4270.Volume level set by participant (left),SH3GL3,Endophilin-A3,32185,-0.0112833239964008,0.0243536337838163,-0.0590164462126808,0.0364497982198791,0.643153988947086
Physical measures,X4270.Volume level set by participant (left),CLSTN1,Calsyntenin-1,33219,-0.0155992619039858,0.0337030117178984,-0.0816571648710668,0.0504586410630951,0.643487146860452
Physical measures,X4270.Volume level set by participant (left),BSND,Barttin,32075,-0.0288655995968012,0.062507482362631,-0.151380265027558,0.0936490658339555,0.644242015574706
Physical measures,X4270.Volume level set by participant (left),SYTL4,Synaptotagmin-like protein 4,32365,-0.0122664130872034,0.026564761289903,-0.0643333452154133,0.0398005190410064,0.644269675968069
Physical measures,X4270.Volume level set by participant (left),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,33332,0.0178890881130236,0.0387572605439152,-0.0580751425530501,0.0938533187790974,0.644402884544558
Physical measures,X4270.Volume level set by participant (left),PRL,Prolactin,33500,-0.01025623688577,0.0222265664140929,-0.0538203070573921,0.0333078332858521,0.64449373007889
Physical measures,X4270.Volume level set by participant (left),TNFSF13,Tumor necrosis factor ligand superfamily member 13,33481,-0.0296067032417419,0.0641721085680763,-0.155384036035172,0.0961706295516877,0.644548564294797
Physical measures,X4270.Volume level set by participant (left),UPK3BL1,Uroplakin-3b-like protein 1,32215,-0.0159499406677769,0.0345865603583423,-0.0837395989701278,0.051839717634574,0.644696690396267
Physical measures,X4270.Volume level set by participant (left),F7,Coagulation factor VII,33439,-0.0267457624182071,0.0581208641227409,-0.140662656098779,0.0871711312623652,0.645401827662474
Physical measures,X4270.Volume level set by participant (left),GBP2,Guanylate-binding protein 2,33273,0.0132726638760084,0.0288846645272867,-0.0433412785974734,0.0698866063494903,0.645882489750057
Physical measures,X4270.Volume level set by participant (left),ARHGAP5,Rho GTPase-activating protein 5,32075,-0.0120588483897262,0.0262509546033858,-0.0635107194123624,0.03939302263291,0.645983031217543
Physical measures,X4270.Volume level set by participant (left),INSL4,Early placenta insulin-like peptide,32319,-0.0160465798702328,0.0349506337094329,-0.0845498219407212,0.0524566622002556,0.646159761999517
Physical measures,X4270.Volume level set by participant (left),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",33232,-0.0100175919189674,0.02182889382649,-0.0528022238188879,0.0327670399809531,0.646307060480321
Physical measures,X4270.Volume level set by participant (left),ITGB5,Integrin beta-5,33456,0.0209363476579579,0.0458500152308036,-0.0689296821944171,0.110802377510333,0.647950300988931
Physical measures,X4270.Volume level set by participant (left),PLA2G7,Platelet-activating factor acetylhydrolase,33441,-0.0247571380005973,0.0543098702223822,-0.131204483636466,0.0816902076352719,0.648509078176968
Physical measures,X4270.Volume level set by participant (left),CRHR1,Corticotropin-releasing factor receptor 1,33273,0.0125079389783316,0.027449740296453,-0.0412935520027163,0.0663094299593795,0.648640723784621
Physical measures,X4270.Volume level set by participant (left),LYN,Tyrosine-protein kinase Lyn,33386,-0.00979639027852854,0.0215391611420142,-0.0520131461168764,0.0324203655598193,0.649251498561649
Physical measures,X4270.Volume level set by participant (left),CEP20,Centrosomal protein 20,33232,0.0113148662295576,0.0249506582475031,-0.0375884239355484,0.0602181563946636,0.65020737835415
Physical measures,X4270.Volume level set by participant (left),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,33195,0.0177112288948711,0.0391014630822385,-0.0589276387463164,0.0943500965360585,0.650591916148464
Physical measures,X4270.Volume level set by participant (left),PDCD6,Programmed cell death protein 6,33434,-0.0110434841853939,0.0244260905530888,-0.058918621669448,0.0368316532986601,0.651194633873864
Physical measures,X4270.Volume level set by participant (left),LACTB2,Endoribonuclease LACTB2,33434,-0.0123359065922762,0.0272885911029785,-0.0658215451541142,0.0411497319695617,0.651241269370264
Physical measures,X4270.Volume level set by participant (left),MAGED1,Melanoma-associated antigen D1,33232,-0.0165967379776557,0.0367270766633373,-0.0885818082377968,0.0553883322824855,0.651356662845613
Physical measures,X4270.Volume level set by participant (left),NFKB1,Nuclear factor NF-kappa-B p105 subunit,32122,-0.0133106197795148,0.0294582793572915,-0.0710488473198061,0.0444276077607765,0.65139236573581
Physical measures,X4270.Volume level set by participant (left),CGN,Cingulin,32154,-0.0222688344155621,0.0492878293938278,-0.118872980027464,0.0743353111963403,0.651417127612941
Physical measures,X4270.Volume level set by participant (left),CCL5,C-C motif chemokine 5,33452,-0.00755444248880111,0.0167389425365514,-0.0403627698604419,0.0252538848828396,0.651777432330476
Physical measures,X4270.Volume level set by participant (left),GOLM2,Protein GOLM2,33500,0.0341150684526994,0.0756522557270397,-0.114163352772298,0.182393489677697,0.652039408918318
Physical measures,X4270.Volume level set by participant (left),RCC1,Regulator of chromosome condensation,32319,-0.0169587817190358,0.0376270778860579,-0.0907078543757094,0.0567902909376377,0.652213271145003
Physical measures,X4270.Volume level set by participant (left),KLRF1,Killer cell lectin-like receptor subfamily F member 1,32140,-0.0203109254709225,0.0450767149820517,-0.108661286835744,0.0680394358938988,0.652300849649003
Physical measures,X4270.Volume level set by participant (left),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,33421,-0.00804840074405277,0.0178894218768867,-0.0431116676227507,0.0270148661346452,0.652795445816843
Physical measures,X4270.Volume level set by participant (left),GKN1,Gastrokine-1,33075,0.0280804099610407,0.0624275645736577,-0.0942776166033284,0.15043843652541,0.652860291833629
Physical measures,X4270.Volume level set by participant (left),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,32198,-0.0188184467708295,0.0419117164904091,-0.100965411092031,0.0633285175503724,0.653442741196582
Physical measures,X4270.Volume level set by participant (left),RWDD1,RWD domain-containing protein 1,33500,-0.0127884487374043,0.0284849706951544,-0.068618991299907,0.0430420938250984,0.65347541376064
Physical measures,X4270.Volume level set by participant (left),F10,Coagulation factor X,32381,-0.0351776176690072,0.0784972170190939,-0.189032163026431,0.118676927688417,0.654065561263673
Physical measures,X4270.Volume level set by participant (left),PDCD1LG2,Programmed cell death 1 ligand 2,33386,0.0244746933556396,0.0547083743034308,-0.0827537202790848,0.131703106990364,0.654621316570698
Physical measures,X4270.Volume level set by participant (left),APRT,Adenine phosphoribosyltransferase,33367,-0.0175392355341396,0.0392782644746865,-0.0945246339045251,0.0594461628362458,0.655219558655245
Physical measures,X4270.Volume level set by participant (left),COPB2,Coatomer subunit beta',32122,-0.0211820519854205,0.047443070791702,-0.114170470737156,0.0718063667663153,0.65526819322406
Physical measures,X4270.Volume level set by participant (left),AFM,Afamin,32398,-0.0466221461160926,0.104555609631676,-0.251551140994178,0.158306848761993,0.655676110426695
Physical measures,X4270.Volume level set by participant (left),ACSL1,Long-chain-fatty-acid--CoA ligase 1,32122,-0.0232076553074037,0.0520793788086114,-0.125283237772282,0.0788679271574746,0.65588375344895
Physical measures,X4270.Volume level set by participant (left),CLSPN,Claspin,33195,-0.0223525659547359,0.0502369372263763,-0.120816962918433,0.0761118310089617,0.656372074720865
Physical measures,X4270.Volume level set by participant (left),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,32235,0.0116090885584896,0.0261241918274586,-0.0395943274233293,0.0628125045403085,0.656779672368914
Physical measures,X4270.Volume level set by participant (left),EDA2R,Tumor necrosis factor receptor superfamily member 27,33509,-0.0218839891725371,0.0492609882198013,-0.118435526083348,0.0746675477382734,0.656875469992493
Physical measures,X4270.Volume level set by participant (left),LECT2,Leukocyte cell-derived chemotaxin-2,32365,-0.0132063953825638,0.0297956649231074,-0.0716058986318542,0.0451931078667267,0.657609978511462
Physical measures,X4270.Volume level set by participant (left),BSG,Basigin,33509,-0.0384603146263617,0.0868093434409806,-0.208606627770684,0.13168599851796,0.65774486201934
Physical measures,X4270.Volume level set by participant (left),DOK2,Docking protein 2,33434,-0.00645499363275214,0.0145868109822628,-0.0350451431579872,0.0221351558924829,0.658121733636547
Physical measures,X4270.Volume level set by participant (left),ITGB7,Integrin beta-7,33509,0.0167053226749151,0.0378145631701939,-0.0574112211386651,0.0908218664884952,0.658666523516633
Physical measures,X4270.Volume level set by participant (left),SIGLEC15,Sialic acid-binding Ig-like lectin 15,33219,0.00941347397939048,0.0213206799106896,-0.0323750586455611,0.051202006604342,0.658848585623523
Physical measures,X4270.Volume level set by participant (left),TREML2,Trem-like transcript 2 protein,33441,0.0231699836926454,0.0524917696347522,-0.0797138847914689,0.12605385217676,0.658932455136683
Physical measures,X4270.Volume level set by participant (left),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,33424,0.0251040212659079,0.056926190923269,-0.0864713129436993,0.136679355475515,0.659229081240574
Physical measures,X4270.Volume level set by participant (left),CRYBB1,Beta-crystallin B1,32365,-0.013883368157274,0.0315001637716347,-0.075623689149678,0.0478569528351299,0.659413601912012
Physical measures,X4270.Volume level set by participant (left),FYB1,FYN-binding protein 1,33422,0.00843486198490438,0.0191418854735549,-0.0290832335432633,0.0459529575130721,0.659477394255817
Physical measures,X4270.Volume level set by participant (left),LELP1,Late cornified envelope-like proline-rich protein 1,32111,-0.0116589181278091,0.0264885919487763,-0.0635765583474106,0.0402587220917924,0.659841869599792
Physical measures,X4270.Volume level set by participant (left),ERMAP,Erythroid membrane-associated protein,32140,-0.0199670177754779,0.0453733544115994,-0.108898792422213,0.0689647568712569,0.659905717141498
Physical measures,X4270.Volume level set by participant (left),MAMDC4,Apical endosomal glycoprotein,32319,-0.0164126515980459,0.0373084446634434,-0.089537203138395,0.0567118999423031,0.66000868045601
Physical measures,X4270.Volume level set by participant (left),SFTPD,Pulmonary surfactant-associated protein D,33434,0.011408415418158,0.0259338590835412,-0.0394219483855828,0.0622387792218988,0.660017029080583
Physical measures,X4270.Volume level set by participant (left),PDGFA,Platelet-derived growth factor subunit A,33533,-0.010404621201443,0.0236623189024384,-0.0567827662502222,0.0359735238473362,0.660155698967188
Physical measures,X4270.Volume level set by participant (left),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,33490,-0.0253367793705274,0.0577366441870677,-0.13850060197718,0.0878270432361253,0.660792606156333
Physical measures,X4270.Volume level set by participant (left),CX3CL1,Fractalkine,33380,-0.0222491485513861,0.0507264578033483,-0.121673005845949,0.0771747087431766,0.660954525077302
Physical measures,X4270.Volume level set by participant (left),RNASE6,Ribonuclease K6,32311,-0.0303289667057383,0.0691913130276856,-0.165943940240002,0.105286006828526,0.661155588817179
Physical measures,X4270.Volume level set by participant (left),RETN,Resistin,33387,-0.0173481256169829,0.0395991712593593,-0.0949625012853272,0.0602662500513613,0.661329354959502
Physical measures,X4270.Volume level set by participant (left),FCAR,Immunoglobulin alpha Fc receptor,33421,0.0160290681114934,0.0367742148630727,-0.0560483930201291,0.0881065292431159,0.662935802882223
Physical measures,X4270.Volume level set by participant (left),CEP350,Centrosome-associated protein 350,32075,-0.0237623909170166,0.0545814727944013,-0.130742077594043,0.0832172957600099,0.66331611738624
Physical measures,X4270.Volume level set by participant (left),TAGLN3,Transgelin-3,32075,0.0144197378714016,0.0331864760224461,-0.0506257551325929,0.079465230875396,0.663933015680497
Physical measures,X4270.Volume level set by participant (left),GJA8,Gap junction alpha-8 protein,32075,-0.0143748825853101,0.0330855786695205,-0.0792226167775703,0.0504728516069501,0.663955281642006
Physical measures,X4270.Volume level set by participant (left),EPB41L5,Band 4.1-like protein 5,32154,-0.0135150194817197,0.0311931613878277,-0.0746536158018621,0.0476235768384226,0.664831735654496
Physical measures,X4270.Volume level set by participant (left),WARS,"Tryptophan--tRNA ligase, cytoplasmic",33441,-0.0202176651436253,0.0467517683155609,-0.111851131042125,0.0714158007548741,0.665426892478403
Physical measures,X4270.Volume level set by participant (left),EDAR,Tumor necrosis factor receptor superfamily member EDAR,33421,-0.00817070778586894,0.0189340322092217,-0.0452814109159435,0.0289399953442056,0.666089393568387
Physical measures,X4270.Volume level set by participant (left),CHP1,Calcineurin B homologous protein 1,32111,-0.0118237872347872,0.0274049639133326,-0.0655375165049191,0.0418899420353447,0.666155589238505
Physical measures,X4270.Volume level set by participant (left),ARHGEF1,Rho guanine nucleotide exchange factor 1,32353,-0.00998244330717571,0.023137755446008,-0.0553324439813515,0.035367557367,0.66616369938688
Physical measures,X4270.Volume level set by participant (left),CLIP2,CAP-Gly domain-containing linker protein 2,33421,-0.00682999376024554,0.0158720587148654,-0.0379392288413817,0.0242792413208906,0.666976455909743
Physical measures,X4270.Volume level set by participant (left),C9,Complement component C9,32381,-0.0177481556519723,0.0412801385716655,-0.0986572272524367,0.0631609159484921,0.667247929338025
Physical measures,X4270.Volume level set by participant (left),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,33493,0.0271837548864923,0.0633642104460943,-0.0970100975878524,0.151377607360837,0.667927608511621
Physical measures,X4270.Volume level set by participant (left),DPT,Dermatopontin,33533,0.0274103052431796,0.063914352413504,-0.0978618254872883,0.152682435973648,0.668035332231913
Physical measures,X4270.Volume level set by participant (left),CD72,B-cell differentiation antigen CD72,32213,-0.0208657609684347,0.0486594604682479,-0.116238303486201,0.0745067815493311,0.668071945244694
Physical measures,X4270.Volume level set by participant (left),GPR101,Probable G-protein coupled receptor 101,32111,-0.0133716692123135,0.031191745078301,-0.0745074895657835,0.0477641511411565,0.668159032794369
Physical measures,X4270.Volume level set by participant (left),GIT1,ARF GTPase-activating protein GIT1,32140,-0.00957135520122571,0.022327528045907,-0.0533333101712035,0.0341905997687521,0.668168442720021
Physical measures,X4270.Volume level set by participant (left),GBA,Lysosomal acid glucosylceramidase,32154,0.0161553475479034,0.0377022710661054,-0.0577411037416633,0.09005179883747,0.668300580582547
Physical measures,X4270.Volume level set by participant (left),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,33232,0.0166613052937003,0.0390580095806171,-0.0598923934843093,0.0932150040717099,0.669696856787243
Physical measures,X4270.Volume level set by participant (left),KDR,Vascular endothelial growth factor receptor 2,33456,0.0285627089261788,0.0669605701456881,-0.10268000855937,0.159805426411728,0.66970995029994
Physical measures,X4270.Volume level set by participant (left),STC1,Stanniocalcin-1,33500,0.0176352913538476,0.0413638412883107,-0.0634378375712414,0.0987084202789366,0.669866187465823
Physical measures,X4270.Volume level set by participant (left),CCL26,C-C motif chemokine 26,33421,-0.00791571797445355,0.0185849667270878,-0.0443422527595457,0.0285108168106386,0.670176013883746
Physical measures,X4270.Volume level set by participant (left),RPS10,40S ribosomal protein S10,32122,0.019929284888464,0.0468520690571657,-0.0719007704635807,0.111759340240509,0.670581706337732
Physical measures,X4270.Volume level set by participant (left),SPARC,SPARC,33456,-0.0103758966050818,0.0243954479012956,-0.0581909744916213,0.0374391812814576,0.670612845586103
Physical measures,X4270.Volume level set by participant (left),KHDC3L,KH domain-containing protein 3,32075,0.0127733249387698,0.0301048177170755,-0.0462321177866981,0.0717787676642378,0.671362631611862
Physical measures,X4270.Volume level set by participant (left),MLLT1,Protein ENL,32075,0.0119861246314181,0.0282579139629055,-0.0433993867358767,0.0673716359987129,0.671454708264521
Physical measures,X4270.Volume level set by participant (left),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,33380,-0.0103186694886355,0.0243739951551614,-0.0580916999927519,0.0374543610154809,0.672051956602453
Physical measures,X4270.Volume level set by participant (left),CCL4,C-C motif chemokine 4,33440,0.0104389193839624,0.0246659640913148,-0.0379063702350146,0.0587842090029395,0.672151094479807
Physical measures,X4270.Volume level set by participant (left),STXBP3,Syntaxin-binding protein 3,33232,-0.0165002206221049,0.0390044102593704,-0.0929488647304709,0.0599484234862612,0.67228027789494
Physical measures,X4270.Volume level set by participant (left),VASH1,Tubulinyl-Tyr carboxypeptidase 1,33421,0.00922875992739653,0.0218283165677114,-0.0335547405453179,0.0520122604001109,0.672459761211173
Physical measures,X4270.Volume level set by participant (left),PADI2,Protein-arginine deiminase type-2,33273,0.0130132977759467,0.0307834242889176,-0.0473222138303319,0.0733488093822252,0.672497338445179
Physical measures,X4270.Volume level set by participant (left),BAG3,BAG family molecular chaperone regulator 3,33363,0.018246554860845,0.0431701869590218,-0.0663670115788376,0.102860121300528,0.67254942726225
Physical measures,X4270.Volume level set by participant (left),MATN2,Matrilin-2,33453,-0.0242181615248026,0.057463753319433,-0.136847118030891,0.088410794981286,0.673435785566645
Physical measures,X4270.Volume level set by participant (left),PPM1F,Protein phosphatase 1F,32365,-0.0166508945040944,0.0395969002533635,-0.0942608190006869,0.0609590299924981,0.67412431238137
Physical measures,X4270.Volume level set by participant (left),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,33380,-0.00700354152716211,0.0166722673560005,-0.0396811855449231,0.0256741024905989,0.674443458129479
Physical measures,X4270.Volume level set by participant (left),CHM,Rab proteins geranylgeranyltransferase component A 1,32154,-0.0140960133032017,0.033563167071145,-0.0798798207626459,0.0516877941562425,0.674508423464466
Physical measures,X4270.Volume level set by participant (left),FLI1,Friend leukemia integration 1 transcription factor,33232,-0.00707903187814864,0.0168928646211556,-0.0401890465356136,0.0260309827793163,0.675186516564637
Physical measures,X4270.Volume level set by participant (left),NPPC,C-type natriuretic peptide,33421,0.0168978974640833,0.0403402446101166,-0.0621689819717453,0.0959647768999119,0.675310683326567
Physical measures,X4270.Volume level set by participant (left),GPR15L,Protein GPR15L,32329,0.013770548036933,0.0329445086440211,-0.0508006889053483,0.0783417849792143,0.675964209703099
Physical measures,X4270.Volume level set by participant (left),DCTD,Deoxycytidylate deaminase,32213,-0.00933949247951226,0.0223775475046987,-0.0531994855887217,0.0345205006296972,0.67642668143816
Physical measures,X4270.Volume level set by participant (left),GPR37,Prosaposin receptor GPR37,33273,0.0109001555064117,0.026126711891791,-0.0403081998014987,0.062108510814322,0.676539725738029
Physical measures,X4270.Volume level set by participant (left),FAM13A,Protein FAM13A,32329,-0.0126371722524268,0.0303242238687968,-0.0720726510352686,0.046798306530415,0.676883446158392
Physical measures,X4270.Volume level set by participant (left),SLC28A1,Sodium/nucleoside cotransporter 1,32075,-0.0139395228438096,0.0334511177155819,-0.0795037135663502,0.0516246678787309,0.676899924150782
Physical measures,X4270.Volume level set by participant (left),NSFL1C,NSFL1 cofactor p47,33500,-0.0111083708123836,0.0266961964857867,-0.0634329159245255,0.0412161742997583,0.677344414856604
Physical measures,X4270.Volume level set by participant (left),RAB10,Ras-related protein Rab-10,32365,-0.0154611068235968,0.03722230252078,-0.0884168197643256,0.0574946061171319,0.677880777367583
Physical measures,X4270.Volume level set by participant (left),TPM3,Tropomyosin alpha-3 chain,32122,-0.0195133263970099,0.0469859176146411,-0.111605724921706,0.0725790721276867,0.677932757260795
Physical measures,X4270.Volume level set by participant (left),MRPL28,"39S ribosomal protein L28, mitochondrial",32350,-0.0233879055638321,0.0563158173837341,-0.133766907635951,0.0869910965082868,0.677934281016455
Physical measures,X4270.Volume level set by participant (left),TP53,Cellular tumor antigen p53,33232,-0.0172080787771077,0.0414361038453402,-0.0984228423139745,0.0640066847597591,0.677938373092907
Physical measures,X4270.Volume level set by participant (left),NT5C3A,Cytosolic 5'-nucleotidase 3A,33413,-0.00867924977552583,0.020946210876274,-0.0497338230930228,0.0323753235419712,0.678621174658895
Physical measures,X4270.Volume level set by participant (left),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,32122,-0.0128759381515949,0.0310808354208749,-0.0737943755765097,0.0480424992733198,0.678686075409005
Physical measures,X4270.Volume level set by participant (left),DNAJC21,DnaJ homolog subfamily C member 21,32353,0.0208350691659882,0.0503671223812849,-0.0778844907013303,0.119554629033307,0.679131371030522
Physical measures,X4270.Volume level set by participant (left),GID8,Glucose-induced degradation protein 8 homolog,32350,0.0251388403119058,0.0607813872140247,-0.0939926786275826,0.144270359251394,0.679182421792687
Physical measures,X4270.Volume level set by participant (left),ICA1,Islet cell autoantigen 1,33273,0.00938778634291944,0.0227568059936835,-0.0352155534047002,0.0539911260905391,0.679963563996887
Physical measures,X4270.Volume level set by participant (left),CLEC2L,C-type lectin domain family 2 member L,32154,-0.0159555028767211,0.0386907847366247,-0.0917894409605055,0.0598784352070634,0.680068669444061
Physical measures,X4270.Volume level set by participant (left),SPINT3,Kunitz-type protease inhibitor 3,32329,0.00634301312451619,0.0153905266557853,-0.0238224191208231,0.0365084453698555,0.680249865977937
Physical measures,X4270.Volume level set by participant (left),TSHB,Thyrotropin subunit beta,33434,0.00841655287875895,0.0204250516426419,-0.0316165483408191,0.048449654098337,0.680297887261989
Physical measures,X4270.Volume level set by participant (left),ADAMTSL5,ADAMTS-like protein 5,32365,-0.0210838288729666,0.0511662192967964,-0.121369618694687,0.0792019609487542,0.680302650745228
Physical measures,X4270.Volume level set by participant (left),CD99,CD99 antigen,33441,-0.0371776035682908,0.090228394126291,-0.214025256055821,0.13967004891924,0.680320777803799
Physical measures,X4270.Volume level set by participant (left),FAS,Tumor necrosis factor receptor superfamily member 6,33492,-0.0221142166666231,0.053699218028954,-0.127364684003373,0.0831362506701269,0.680483793962013
Physical measures,X4270.Volume level set by participant (left),CEBPA,CCAAT/enhancer-binding protein alpha,32140,-0.0211541753935194,0.0514125233544405,-0.121922721168223,0.0796143703811839,0.680747046137492
Physical measures,X4270.Volume level set by participant (left),NPHS1,Nephrin,32140,-0.0243104002002517,0.0591274547413709,-0.140200211493339,0.0915794110928353,0.680972188081532
Physical measures,X4270.Volume level set by participant (left),SEMA4D,Semaphorin-4D,33500,-0.0236865496386025,0.0576201416414744,-0.136622027255892,0.0892489279786872,0.681022826927129
Physical measures,X4270.Volume level set by participant (left),S100A4,Protein S100-A4,33456,-0.0132448714965327,0.032251437247758,-0.0764576885021383,0.0499679455090729,0.68132035212358
Physical measures,X4270.Volume level set by participant (left),TDO2,"Tryptophan 2,3-dioxygenase",32154,-0.0218182989042014,0.0533666114371076,-0.126416857320932,0.0827802595125295,0.682669919565902
Physical measures,X4270.Volume level set by participant (left),IFNLR1,Interferon lambda receptor 1,33421,-0.0184532672586885,0.0451571339341578,-0.106961249769638,0.0700547152522608,0.682809469318955
Physical measures,X4270.Volume level set by participant (left),SERPINF2,Alpha-2-antiplasmin,32218,-0.059657073521919,0.146621230731054,-0.347034685754785,0.227720538710947,0.684108209058838
Physical measures,X4270.Volume level set by participant (left),GRAP2,GRB2-related adapter protein 2,33434,-0.00575059475566845,0.0141353952533638,-0.0334559694522614,0.0219547799409245,0.684148164857307
Physical measures,X4270.Volume level set by participant (left),LGMN,Legumain,33481,-0.0197247919569724,0.0485295251420466,-0.114842661235384,0.075393077321439,0.684422131977439
Physical measures,X4270.Volume level set by participant (left),ENDOU,Poly(U)-specific endoribonuclease,31754,-0.0169139835693586,0.0417059745626981,-0.0986576937122469,0.0648297265735297,0.68508294729904
Physical measures,X4270.Volume level set by participant (left),TXNDC9,Thioredoxin domain-containing protein 9,32353,-0.0152790139038246,0.0377172382139278,-0.089204800803123,0.0586467729954739,0.685419641407224
Physical measures,X4270.Volume level set by participant (left),TBC1D17,TBC1 domain family member 17,33219,-0.0148079723699682,0.0366031698254342,-0.0865501852278192,0.0569342404878827,0.685814976524104
Physical measures,X4270.Volume level set by participant (left),STAT5B,Signal transducer and activator of transcription 5B,33386,-0.00538821293183816,0.0133445459383638,-0.0315435229710311,0.0207670971073548,0.686386807927436
Physical measures,X4270.Volume level set by participant (left),AHNAK2,Protein AHNAK2,32163,-0.0291397169226119,0.0721912275127602,-0.170634522847622,0.112355089002398,0.686484081052095
Physical measures,X4270.Volume level set by participant (left),IL1RAP,Interleukin-1 receptor accessory protein,33441,-0.0163781959049013,0.0406158659625078,-0.0959852931914166,0.063228901381614,0.68677666798656
Physical measures,X4270.Volume level set by participant (left),MAP2,Microtubule-associated protein 2,32353,-0.0171281667279658,0.0425736951143706,-0.100572609152132,0.0663162756962006,0.687460847386148
Physical measures,X4270.Volume level set by participant (left),CCL16,C-C motif chemokine 16,33533,0.0125845328253528,0.0312866883193565,-0.0487373762805859,0.0739064419312916,0.687522161670809
Physical measures,X4270.Volume level set by participant (left),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,33232,-0.0110504778976732,0.0275093739556951,-0.0649688508508357,0.0428678950554892,0.687915611471168
Physical measures,X4270.Volume level set by participant (left),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",32075,0.014087793331278,0.0350756456920458,-0.0546604722251318,0.0828360588876878,0.687960020181552
Physical measures,X4270.Volume level set by participant (left),CST6,Cystatin-M,33194,0.0148527073104175,0.0370709175936826,-0.0578062911732005,0.0875117057940355,0.688682772193882
Physical measures,X4270.Volume level set by participant (left),CDKN1A,Cyclin-dependent kinase inhibitor 1,33386,-0.00685699206655499,0.0171290324761212,-0.0404298957197526,0.0267159115866426,0.688934808343567
Physical measures,X4270.Volume level set by participant (left),MYOM2,Myomesin-2,32122,0.0170694265658073,0.0426565634409457,-0.0665374377784462,0.100676290910061,0.689050234516505
Physical measures,X4270.Volume level set by participant (left),TXNL1,Thioredoxin-like protein 1,32094,0.00825116533798443,0.0206613900063627,-0.0322451590744864,0.0487474897504552,0.689645095123398
Physical measures,X4270.Volume level set by participant (left),FBP1,"Fructose-1,6-bisphosphatase 1",33434,0.0092685441831781,0.023229012029263,-0.0362603193941775,0.0547974077605337,0.689897351967087
Physical measures,X4270.Volume level set by participant (left),CEP112,Centrosomal protein of 112 kDa,32122,-0.0188936045971938,0.0474478072815864,-0.111891306869103,0.0741040976747155,0.690495597367377
Physical measures,X4270.Volume level set by participant (left),IL25,Interleukin-25,32050,-0.0235929356173752,0.0593555629628533,-0.139929839024568,0.0927439677898172,0.691021144229731
Physical measures,X4270.Volume level set by participant (left),TPRKB,EKC/KEOPS complex subunit TPRKB,32075,0.0122677101372951,0.0309300590788486,-0.0483552056572482,0.0728906259318383,0.691653321793094
Physical measures,X4270.Volume level set by participant (left),TPPP3,Tubulin polymerization-promoting protein family member 3,33219,0.0172472420634582,0.0435476087775887,-0.0681060711406157,0.102600555267532,0.692074199773357
Physical measures,X4270.Volume level set by participant (left),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,33456,-0.00727796724854718,0.0184038310083704,-0.0433494760249532,0.0287935415278589,0.692513279745564
Physical measures,X4270.Volume level set by participant (left),RNASE4,Ribonuclease 4,32126,0.0299729597751447,0.0759284021152977,-0.118846708370839,0.178792627921128,0.693036205293264
Physical measures,X4270.Volume level set by participant (left),CA13,Carbonic anhydrase 13,33357,-0.00681975812037343,0.017291084101539,-0.0407102829593899,0.0270707667186431,0.693288593928852
Physical measures,X4270.Volume level set by participant (left),C9orf40,Uncharacterized protein C9orf40,32329,-0.00917011854549013,0.0232936710410717,-0.0548257137859907,0.0364854766950104,0.693832212123466
Physical measures,X4270.Volume level set by participant (left),MDK,Midkine,33444,-0.0132264677706269,0.033673656541182,-0.0792268345913437,0.0527738990500898,0.694488462706625
Physical measures,X4270.Volume level set by participant (left),LPL,Lipoprotein lipase,33434,-0.0145766458521688,0.0371447717812764,-0.0873803985434705,0.058227106839133,0.694751368239644
Physical measures,X4270.Volume level set by participant (left),CEND1,Cell cycle exit and neuronal differentiation protein 1,32111,-0.0136670824585985,0.0348772798517527,-0.0820265509680339,0.0546923860508369,0.695171049854952
Physical measures,X4270.Volume level set by participant (left),RGCC,Regulator of cell cycle RGCC,32350,-0.0105006342274785,0.0268040764893739,-0.0630366241466514,0.0420353556916945,0.695249731483623
Physical measures,X4270.Volume level set by participant (left),CHEK2,Serine/threonine-protein kinase Chk2,33273,0.0196881192930651,0.0503241328011575,-0.0789471809972036,0.118323419583334,0.695639495517884
Physical measures,X4270.Volume level set by participant (left),LGALS7_LGALS7B,Galectin-7,33411,0.0173321914024319,0.0443065907872505,-0.0695087265405791,0.104173109345443,0.695667837586614
Physical measures,X4270.Volume level set by participant (left),SIRT2,NAD-dependent protein deacetylase sirtuin-2,33386,-0.00813649493230442,0.0208202804607391,-0.048944244635353,0.0326712547707442,0.695956905663712
Physical measures,X4270.Volume level set by participant (left),CCL25,C-C motif chemokine 25,33527,0.013445545523775,0.0344059960675585,-0.0539902067686396,0.0808812978161897,0.695961078183523
Physical measures,X4270.Volume level set by participant (left),TP73,Tumor protein p73,32154,0.02274572103014,0.0582516691109467,-0.0914275504273155,0.136918992487595,0.696197403719819
Physical measures,X4270.Volume level set by participant (left),CDHR5,Cadherin-related family member 5,33434,-0.0172412759596801,0.0441815313969112,-0.103837077497626,0.0693545255782657,0.69637043227946
Physical measures,X4270.Volume level set by participant (left),NMRK2,Nicotinamide riboside kinase 2,32075,0.0186441921595669,0.0478412123445331,-0.0751245840357179,0.112412968354852,0.696761996144772
Physical measures,X4270.Volume level set by participant (left),PDCD5,Programmed cell death protein 5,33500,-0.0117575806432824,0.030201729620772,-0.0709529706999955,0.0474378094134306,0.697062242716677
Physical measures,X4270.Volume level set by participant (left),MANSC1,MANSC domain-containing protein 1,33456,0.0241286206056219,0.0620403613680192,-0.0974704876756956,0.14572772888694,0.697345918335411
Physical measures,X4270.Volume level set by participant (left),CDCP1,CUB domain-containing protein 1,33380,0.013837580934684,0.0356407923026869,-0.0560183719785823,0.0836935338479503,0.697839395634775
Physical measures,X4270.Volume level set by participant (left),NLGN2,Neuroligin-2,32111,0.0167036240082461,0.0432572233078217,-0.0680805336750845,0.101487781691577,0.699398927014127
Physical measures,X4270.Volume level set by participant (left),MGMT,Methylated-DNA--protein-cysteine methyltransferase,33421,-0.00564646197357226,0.0146497191850435,-0.0343599115762576,0.0230669876291131,0.699926955899688
Physical measures,X4270.Volume level set by participant (left),BGN,Biglycan,33221,-0.00569296789552172,0.0147866898680794,-0.0346748800369574,0.0232889442459139,0.700242131738126
Physical measures,X4270.Volume level set by participant (left),TGFB2,Transforming growth factor beta-2 proprotein,32319,0.0141430298419241,0.0367540888107744,-0.0578949842271937,0.0861810439110418,0.700394866704043
Physical measures,X4270.Volume level set by participant (left),FRZB,Secreted frizzled-related protein 3,33349,-0.024942130077568,0.0649832514226219,-0.152309302865907,0.102425042710771,0.701118089682814
Physical measures,X4270.Volume level set by participant (left),PGA4,Pepsin A-4,32381,-0.0111065876656638,0.0289988268331921,-0.0679442882587204,0.0457311129273927,0.701729089296616
Physical measures,X4270.Volume level set by participant (left),ADA2,Adenosine deaminase 2,33319,-0.0160790598999204,0.0419820952117844,-0.0983639665150177,0.066205846715177,0.701730406312655
Physical measures,X4270.Volume level set by participant (left),FABP1,"Fatty acid-binding protein, liver",33424,0.00707592004605032,0.0185102288125635,-0.029204128426574,0.0433559685186747,0.702269565790712
Physical measures,X4270.Volume level set by participant (left),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,32329,0.0193435554985338,0.0506668075410498,-0.0799633872819239,0.118650498278992,0.702635124734372
Physical measures,X4270.Volume level set by participant (left),FOXJ3,Forkhead box protein J3,32140,-0.0174846804748819,0.0458373937930214,-0.107325972309204,0.07235661135944,0.702879804223696
Physical measures,X4270.Volume level set by participant (left),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,33273,0.0132026338759798,0.0346484992925521,-0.0547084247374223,0.0811136924893818,0.703179113159086
Physical measures,X4270.Volume level set by participant (left),SIL1,Nucleotide exchange factor SIL1,32163,0.0219710747416137,0.0578156764688079,-0.0913476511372498,0.135289800620477,0.703941535357342
Physical measures,X4270.Volume level set by participant (left),MTR,Methionine synthase,32122,0.0117516097712629,0.031044010515884,-0.0490946508398698,0.0725978703823955,0.705034941020503
Physical measures,X4270.Volume level set by participant (left),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,32154,0.014020805825234,0.0370495172637795,-0.0585962480117739,0.0866378596622418,0.705118472121451
Physical measures,X4270.Volume level set by participant (left),EEF1D,Elongation factor 1-delta,32365,-0.00840764118008931,0.022244035314771,-0.0520059503970404,0.0351906680368618,0.705460913256014
Physical measures,X4270.Volume level set by participant (left),LGALS8,Galectin-8,33500,-0.0108205825901208,0.0287340875517826,-0.0671393941916147,0.045498229011373,0.706497175598253
Physical measures,X4270.Volume level set by participant (left),LMNB1,Lamin-B1,32310,0.0132869975250514,0.0353186302498884,-0.0559375177647299,0.0825115128148327,0.706775664177835
Physical measures,X4270.Volume level set by participant (left),IL5RA,Interleukin-5 receptor subunit alpha,33421,0.0116625115660382,0.0310310212038455,-0.049158289993499,0.0724833131255753,0.707049231122275
Physical measures,X4270.Volume level set by participant (left),NCAM2,Neural cell adhesion molecule 2,33441,-0.0239822813546015,0.0639008240309989,-0.149227896455359,0.101263333746156,0.707442708589956
Physical measures,X4270.Volume level set by participant (left),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,33467,-0.012326655183446,0.0329131264440282,-0.0768363830137413,0.0521830726468493,0.708025589557443
Physical measures,X4270.Volume level set by participant (left),CES2,Cocaine esterase,33386,-0.0118883057048496,0.0317816132954733,-0.0741802677639773,0.0504036563542782,0.708366791409824
Physical measures,X4270.Volume level set by participant (left),POF1B,Protein POF1B,32140,0.0164380168327462,0.0439465331115973,-0.0696971880659845,0.102573221731477,0.708380549094227
Physical measures,X4270.Volume level set by participant (left),CDHR1,Cadherin-related family member 1,33219,0.0151667958549698,0.0406972540100774,-0.0645998220047818,0.0949334137147215,0.709400331844388
Physical measures,X4270.Volume level set by participant (left),PKD1,Polycystin-1,32365,-0.0285894782522846,0.0767277676729638,-0.178975902891294,0.121796946386724,0.709449248232676
Physical measures,X4270.Volume level set by participant (left),LY75,Lymphocyte antigen 75,33421,-0.0165458681518744,0.04440836603923,-0.103586265588765,0.0704945292850165,0.709466529170796
Physical measures,X4270.Volume level set by participant (left),DBI,Acyl-CoA-binding protein,33397,-0.00844952783663113,0.0226802490599439,-0.0529028159941211,0.0360037603208588,0.709492186996102
Physical measures,X4270.Volume level set by participant (left),UPB1,Beta-ureidopropionase,32365,0.00815253648963721,0.0219391727201037,-0.0348482420417661,0.0511533150210405,0.710202681861205
Physical measures,X4270.Volume level set by participant (left),BRK1,Protein BRICK1,33219,-0.0148415872334864,0.0400416197736503,-0.093323161989841,0.0636399875228682,0.710904201264393
Physical measures,X4270.Volume level set by participant (left),TEF,Thyrotroph embryonic factor,32122,0.0176092706377957,0.0476818443967027,-0.0758471443797416,0.111065685655333,0.711908611306152
Physical measures,X4270.Volume level set by participant (left),YTHDF3,YTH domain-containing family protein 3,33273,-0.00791594401867348,0.0214439149969911,-0.049946017412776,0.0341141293754291,0.712027468651111
Physical measures,X4270.Volume level set by participant (left),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,32365,-0.009605705810279,0.0260654492553165,-0.0606939863506994,0.0414825747301414,0.712493496657391
Physical measures,X4270.Volume level set by participant (left),LRP11,Low-density lipoprotein receptor-related protein 11,33434,-0.0180048342903319,0.0490347509526918,-0.114112946157608,0.0781032775769439,0.713489539775913
Physical measures,X4270.Volume level set by participant (left),CDC27,Cell division cycle protein 27 homolog,33232,-0.0102771423507129,0.02800685723252,-0.0651705825264521,0.0446162978250262,0.71366446576367
Physical measures,X4270.Volume level set by participant (left),GZMH,Granzyme H,33273,0.00840980291793554,0.0229699527160435,-0.0366113044055097,0.0534309102413808,0.71428289363968
Physical measures,X4270.Volume level set by participant (left),NARS1,"Asparagine--tRNA ligase, cytoplasmic",32350,-0.0163910058917473,0.0448148558611879,-0.104228123379676,0.0714461115961811,0.714561891911791
Physical measures,X4270.Volume level set by participant (left),SIGLEC7,Sialic acid-binding Ig-like lectin 7,33434,0.0222536879352753,0.0609149942104899,-0.0971397007172849,0.141647076587835,0.714878432531957
Physical measures,X4270.Volume level set by participant (left),EIF5A,Eukaryotic translation initiation factor 5A-1,33273,0.0211843683519573,0.0582225337183604,-0.0929317977360292,0.135300534439944,0.715977470811684
Physical measures,X4270.Volume level set by participant (left),TIMP4,Metalloproteinase inhibitor 4,33441,-0.0154393047227059,0.0424382550460046,-0.0986182846128749,0.0677396751674632,0.716011213681393
Physical measures,X4270.Volume level set by participant (left),CD300A,CMRF35-like molecule 8,32213,-0.0252754079249819,0.0695147625717082,-0.16152434256553,0.110973526715566,0.716168350465975
Physical measures,X4270.Volume level set by participant (left),PROC,Vitamin K-dependent protein C,33435,0.0244598654217716,0.067347025801705,-0.10754030514957,0.156460035993113,0.716470406539112
Physical measures,X4270.Volume level set by participant (left),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,33380,0.0103549860657043,0.0285658347705497,-0.0456340500845731,0.0663440222159816,0.716990381807149
Physical measures,X4270.Volume level set by participant (left),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,33380,0.0157976542472098,0.0436703605851035,-0.0697962524995931,0.101391560994013,0.717549112015286
Physical measures,X4270.Volume level set by participant (left),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,32163,0.0201801834463398,0.0557948860818454,-0.0891777932740772,0.129538160166757,0.7175972165406
Physical measures,X4270.Volume level set by participant (left),CENPJ,Centromere protein J,32235,0.0100609853087262,0.0278307736102023,-0.0444873309672702,0.0646093015847227,0.717731207489419
Physical measures,X4270.Volume level set by participant (left),CALB1,Calbindin,33386,0.015267823557322,0.0422598699836735,-0.0675615216106782,0.0980971687253221,0.717895545505679
Physical measures,X4270.Volume level set by participant (left),CDK1,Cyclin-dependent kinase 1,32075,-0.0201131897945418,0.0556941558496326,-0.129273735259822,0.0890473556707382,0.718007456983153
Physical measures,X4270.Volume level set by participant (left),IGLON5,IgLON family member 5,32075,-0.00843769680891263,0.0233694456127108,-0.0542418102098258,0.0373664165920005,0.718067009973927
Physical measures,X4270.Volume level set by participant (left),FLT3,Receptor-type tyrosine-protein kinase FLT3,33232,-0.0216190951070482,0.0599478634191775,-0.139116907408636,0.0958787171945396,0.718383526971475
Physical measures,X4270.Volume level set by participant (left),GIMAP7,GTPase IMAP family member 7,32213,-0.0227757047507468,0.0633297220418965,-0.146901959952864,0.10135055045137,0.719128475813263
Physical measures,X4270.Volume level set by participant (left),PDCD1,Programmed cell death protein 1,33496,0.0145005759779819,0.040414628348777,-0.064712095585621,0.0937132475415847,0.719756657396524
Physical measures,X4270.Volume level set by participant (left),RBKS,Ribokinase,33221,-0.0118169999875204,0.0329411945507358,-0.0763817413069625,0.0527477413319217,0.719805602892495
Physical measures,X4270.Volume level set by participant (left),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,33232,-0.0133593457979251,0.0372427507286883,-0.0863551372261542,0.059636445630304,0.71982070088261
Physical measures,X4270.Volume level set by participant (left),PTN,Pleiotrophin,33273,-0.0124782152123649,0.0348460902398108,-0.0807765520823941,0.0558201216576643,0.720280694935518
Physical measures,X4270.Volume level set by participant (left),REG3G,Regenerating islet-derived protein 3-gamma,32319,-0.0179300223655127,0.0501210927103719,-0.116167364077842,0.0803073193468164,0.720551936398569
Physical measures,X4270.Volume level set by participant (left),STX1B,Syntaxin-1B,32154,-0.0170456248853577,0.0476516454344795,-0.110442849936938,0.0763516001662222,0.720567723165366
Physical measures,X4270.Volume level set by participant (left),METAP1,Methionine aminopeptidase 1,33219,0.0205467469362038,0.0575504862982311,-0.0922522062083291,0.133345700080737,0.721084488409446
Physical measures,X4270.Volume level set by participant (left),CFH,Complement factor H,31886,0.0314462879098384,0.0884412158438526,-0.141898495144113,0.20479107096379,0.722179101868265
Physical measures,X4270.Volume level set by participant (left),CEP85,Centrosomal protein of 85 kDa,33232,0.00962676066304172,0.0271999640345637,-0.0436851688447031,0.0629386901707866,0.723403223285263
Physical measures,X4270.Volume level set by participant (left),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,33386,0.0147710213797571,0.0417632704647755,-0.0670849887312028,0.096627031490717,0.723583689506218
Physical measures,X4270.Volume level set by participant (left),SNX9,Sorting nexin-9,33434,-0.00928333175548472,0.0262988099550396,-0.0608289992673623,0.0422623357563929,0.724100950242239
Physical measures,X4270.Volume level set by participant (left),DAAM1,Disheveled-associated activator of morphogenesis 1,32213,-0.00869477429664084,0.0247491732596002,-0.0572031538854572,0.0398136052921755,0.725361022690752
Physical measures,X4270.Volume level set by participant (left),PODXL2,Podocalyxin-like protein 2,33456,0.0215567931342983,0.0619032142479932,-0.0997735067917684,0.142887093060365,0.72767273012415
Physical measures,X4270.Volume level set by participant (left),SMAD3,Mothers against decapentaplegic homolog 3,32319,-0.0140642457320628,0.0405263789489568,-0.0934959484720182,0.0653674570078926,0.728571088862445
Physical measures,X4270.Volume level set by participant (left),ADGRE1,Adhesion G protein-coupled receptor E1,32329,-0.012690940119968,0.0366119655006138,-0.084450392501171,0.0590685122612351,0.728875806938276
Physical measures,X4270.Volume level set by participant (left),DNM1,Dynamin-1,32329,-0.00622824188369433,0.0180283492260233,-0.0415638063667,0.0291073225993114,0.729750785798023
Physical measures,X4270.Volume level set by participant (left),UNC5D,Netrin receptor UNC5D,32140,0.0258896973873007,0.0750066843681005,-0.121123403974176,0.172902798748778,0.729979623947763
Physical measures,X4270.Volume level set by participant (left),FZD10,Frizzled-10,32154,-0.0116175322593477,0.0336858995068567,-0.0776418952927868,0.0544068307740913,0.730195363720847
Physical measures,X4270.Volume level set by participant (left),BLNK,B-cell linker protein,32140,0.0187666186293617,0.0544499156166401,-0.0879552159792529,0.125488453237976,0.730360657094532
Physical measures,X4270.Volume level set by participant (left),CALCA,Calcitonin,33356,-0.0110233133793574,0.032045244720313,-0.0738319930311708,0.051785366272456,0.730860297684237
Physical measures,X4270.Volume level set by participant (left),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,32111,-0.00956265073186103,0.0278232824810299,-0.0640962843946797,0.0449709829309576,0.7310870653141
Physical measures,X4270.Volume level set by participant (left),SGSH,N-sulphoglucosamine sulphohydrolase,32235,-0.0123617180839358,0.0361133128698491,-0.08314381130884,0.0584203751409685,0.732131650687895
Physical measures,X4270.Volume level set by participant (left),DRG2,Developmentally-regulated GTP-binding protein 2,33386,0.0108912787621671,0.0318704218504804,-0.0515747480647745,0.0733573055891086,0.732557422089132
Physical measures,X4270.Volume level set by participant (left),ESM1,Endothelial cell-specific molecule 1,33424,-0.0170841759639907,0.0500296977919247,-0.115142383636163,0.0809740317081817,0.732749735447479
Physical measures,X4270.Volume level set by participant (left),ERBIN,Erbin,33386,-0.0059871358925375,0.0175370547061867,-0.0403597631166634,0.0283854913315884,0.732811132749349
Physical measures,X4270.Volume level set by participant (left),CXCL9,C-X-C motif chemokine 9,33481,-0.00874184147624233,0.0256085367253275,-0.0589345734578842,0.0414508905053995,0.732837256331548
Physical measures,X4270.Volume level set by participant (left),NOP56,Nucleolar protein 56,32122,0.00614637343229759,0.0180104773042367,-0.0291541620840063,0.0414469089486015,0.732912279921972
Physical measures,X4270.Volume level set by participant (left),REG1A,Lithostathine-1-alpha,33340,-0.0124919528430956,0.0366455468722087,-0.0843172247126247,0.0593333190264334,0.733197486183163
Physical measures,X4270.Volume level set by participant (left),CLEC10A,C-type lectin domain family 10 member A,33380,-0.0163475232423648,0.04802406556908,-0.110474691757762,0.077779645273032,0.73356127113529
Physical measures,X4270.Volume level set by participant (left),DNER,Delta and Notch-like epidermal growth factor-related receptor,33422,-0.023674864770157,0.0698267453457992,-0.160535285647923,0.113185556107609,0.734578851599969
Physical measures,X4270.Volume level set by participant (left),AMN,Protein amnionless,33273,0.0124706774720491,0.0368243679650726,-0.0597050837394932,0.0846464386835913,0.734879320888172
Physical measures,X4270.Volume level set by participant (left),CHRDL1,Chordin-like protein 1,33468,0.0193138516248343,0.057061599787808,-0.0925268839592693,0.131154587208938,0.7350141165157
Physical measures,X4270.Volume level set by participant (left),CADPS,Calcium-dependent secretion activator 1,32154,-0.016175910744178,0.0479181216084148,-0.110095429096671,0.077743607608315,0.735693460632318
Physical measures,X4270.Volume level set by participant (left),COL18A1,Collagen alpha-1(XVIII) chain,33454,0.0254609155332279,0.075479404359121,-0.122478717010649,0.173400548077105,0.735881525889733
Physical measures,X4270.Volume level set by participant (left),CRHBP,Corticotropin-releasing factor-binding protein,33424,0.020577101362567,0.0610531502159736,-0.0990870730607412,0.140241275785875,0.736097749129257
Physical measures,X4270.Volume level set by participant (left),CD93,Complement component C1q receptor,33069,-0.0188409688419524,0.0560091913897432,-0.128618983965849,0.0909370462819444,0.736584486011811
Physical measures,X4270.Volume level set by participant (left),CCDC80,Coiled-coil domain-containing protein 80,33434,0.0163805628144081,0.0488318822829043,-0.0793299264600843,0.112091052088901,0.737294915444235
Physical measures,X4270.Volume level set by participant (left),BTN1A1,Butyrophilin subfamily 1 member A1,32313,0.0162750097332742,0.0487731752167471,-0.07932041369155,0.111870433158098,0.738624119208185
Physical measures,X4270.Volume level set by participant (left),FCN1,Ficolin-1,32364,0.0116674555616562,0.0350992886505302,-0.0571271501933831,0.0804620613166955,0.739586325065423
Physical measures,X4270.Volume level set by participant (left),GFRA1,GDNF family receptor alpha-1,33499,0.0206745170613933,0.0622303077961271,-0.101296886219016,0.142645920341802,0.739726423100302
Physical measures,X4270.Volume level set by participant (left),TRIM40,E3 ubiquitin ligase TRIM40,32154,0.00933048199160705,0.028107701673355,-0.0457606132881687,0.0644215772713828,0.739932546853677
Physical measures,X4270.Volume level set by participant (left),STX8,Syntaxin-8,33421,-0.0112588772263734,0.0339458671034294,-0.0777927767490949,0.0552750222963481,0.740145062856367
Physical measures,X4270.Volume level set by participant (left),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,33468,-0.00677314794190736,0.0204243543573756,-0.0468048824823634,0.0332585865985487,0.740183055259664
Physical measures,X4270.Volume level set by participant (left),THAP12,52 kDa repressor of the inhibitor of the protein kinase,32059,-0.00729500304703459,0.0220012984618705,-0.0504175480323007,0.0358275419382315,0.740221997235034
Physical measures,X4270.Volume level set by participant (left),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,33232,-0.0134057666961534,0.0404578346587775,-0.0927031226273573,0.0658915892350505,0.740386859050863
Physical measures,X4270.Volume level set by participant (left),CRTAP,Cartilage-associated protein,32154,-0.0130842137364901,0.0397351235592826,-0.0909650559126841,0.0647966284397039,0.741948599400732
Physical measures,X4270.Volume level set by participant (left),GRP,Gastrin-releasing peptide,32163,-0.0124207124538235,0.0379379685501397,-0.0867791308120973,0.0619377059044504,0.743377814602014
Physical measures,X4270.Volume level set by participant (left),SRP14,Signal recognition particle 14 kDa protein,33386,0.00986822204615838,0.0301722794403832,-0.0492694456569927,0.0690058897493095,0.74362825643897
Physical measures,X4270.Volume level set by participant (left),MRC1,Macrophage mannose receptor 1,32381,0.0221707517959132,0.0677892057333103,-0.110696091441375,0.155037595033201,0.743635446286859
Physical measures,X4270.Volume level set by participant (left),IL12B,Interleukin-12 subunit beta,33527,0.0103621154786982,0.0318043670405575,-0.0519744439207945,0.0726986748781909,0.744577181379442
Physical measures,X4270.Volume level set by participant (left),CLEC1B,C-type lectin domain family 1 member B,33500,0.005851860568917,0.0179724418706233,-0.0293741254975048,0.0410778466353388,0.744733133610288
Physical measures,X4270.Volume level set by participant (left),PLAUR,Urokinase plasminogen activator surface receptor,33355,0.0210732592188276,0.0648099742488092,-0.105954290308839,0.148100808746494,0.745071733951675
Physical measures,X4270.Volume level set by participant (left),CXCL17,C-X-C motif chemokine 17,33527,0.0129610651741491,0.0398800423707232,-0.0652038178724684,0.0911259482207665,0.745187590396919
Physical measures,X4270.Volume level set by participant (left),MPHOSPH8,M-phase phosphoprotein 8,33273,0.00767268658013706,0.0237076830467031,-0.0387943721914009,0.0541397453516751,0.74622044635503
Physical measures,X4270.Volume level set by participant (left),RNF41,E3 ubiquitin-protein ligase NRDP1,33232,-0.00888451898353357,0.027544727407307,-0.0628721847018553,0.0451031467347881,0.747044651257146
Physical measures,X4270.Volume level set by participant (left),ITGA5,Integrin alpha-5,33441,-0.0225810391530882,0.0700498392172636,-0.159878724018925,0.114716645712748,0.747189937545368
Physical measures,X4270.Volume level set by participant (left),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,32319,-0.00611435136026421,0.0189713907492802,-0.0432982772288533,0.0310695745083249,0.747239106434697
Physical measures,X4270.Volume level set by participant (left),ZNF830,Zinc finger protein 830,32319,-0.00774153378056518,0.024038817837546,-0.0548576167421553,0.0393745491810249,0.747428654923483
Physical measures,X4270.Volume level set by participant (left),DSCAM,Down syndrome cell adhesion molecule,32350,-0.0181927409322708,0.0565036010599937,-0.128939799009859,0.0925543171453169,0.747480239170268
Physical measures,X4270.Volume level set by participant (left),IL31RA,Interleukin-31 receptor subunit alpha,32121,-0.0166307093855417,0.051737864120377,-0.118036923061481,0.0847755042903972,0.747884414795321
Physical measures,X4270.Volume level set by participant (left),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",32122,0.0105425594822206,0.0330287896635844,-0.0541938682584048,0.075278987222846,0.749588837121949
Physical measures,X4270.Volume level set by participant (left),IKBKG,NF-kappa-B essential modulator,33421,0.00651639079196859,0.0204184748265709,-0.0335038198681104,0.0465366014520476,0.74962634890724
Physical measures,X4270.Volume level set by participant (left),SDHB,Succinate dehydrogenase,32329,-0.00936006845269126,0.0293557853069725,-0.0668974076543574,0.0481772707489748,0.749849330415084
Physical measures,X4270.Volume level set by participant (left),CSPG5,Chondroitin sulfate proteoglycan 5,32111,-0.013235425741319,0.0416893129971132,-0.0949464792156609,0.0684756277330229,0.750889842098229
Physical measures,X4270.Volume level set by participant (left),CD46,Membrane cofactor protein,33320,0.0198415182979716,0.0624978040093299,-0.102654177560315,0.142337214156258,0.750890343575345
Physical measures,X4270.Volume level set by participant (left),IL22,Interleukin-22,32319,0.00987386297045733,0.0311169194423573,-0.0511152991365631,0.0708630250774777,0.751013077342057
Physical measures,X4270.Volume level set by participant (left),TLR3,Toll-like receptor 3,33527,0.00889988863665223,0.0280868119136727,-0.0461502627141463,0.0639500399874508,0.75134898262009
Physical measures,X4270.Volume level set by participant (left),SMOC2,SPARC-related modular calcium-binding protein 2,33481,-0.0142282707962808,0.0449811113150342,-0.102391248973748,0.0739347073811861,0.751769550717033
Physical measures,X4270.Volume level set by participant (left),CINP,Cyclin-dependent kinase 2-interacting protein,32235,-0.0138939934937982,0.0439626199379422,-0.100060728572165,0.0722727415845685,0.751979812302565
Physical measures,X4270.Volume level set by participant (left),CASP3,Caspase-3,33533,-0.00651079768334906,0.0206037505024861,-0.0468941486682218,0.0338725533015237,0.752009311540508
Physical measures,X4270.Volume level set by participant (left),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,33453,-0.0166068395995338,0.0526424740962551,-0.119786088828194,0.0865724096291263,0.75241620391665
Physical measures,X4270.Volume level set by participant (left),DDX39A,ATP-dependent RNA helicase DDX39A,32140,0.0289141964915727,0.0917385751661885,-0.150893410834157,0.208721803817302,0.752633279588448
Physical measures,X4270.Volume level set by participant (left),PRSS2,Trypsin-2,33452,-0.0108500775989098,0.0344395817388643,-0.0783516578070839,0.0566515026092643,0.752733480162153
Physical measures,X4270.Volume level set by participant (left),PTX3,Pentraxin-related protein PTX3,33421,-0.0111866820841758,0.0355732451137286,-0.0809102425070839,0.0585368783387323,0.753172190171152
Physical measures,X4270.Volume level set by participant (left),HMCN2,Hemicentin-2,32194,0.0111091264354512,0.0354442791248444,-0.0583616606492438,0.0805799135201463,0.753966170110899
Physical measures,X4270.Volume level set by participant (left),REST,RE1-silencing transcription factor,32075,0.018322483050179,0.0585126281189367,-0.0963622680629369,0.133007234163295,0.754184965119025
Physical measures,X4270.Volume level set by participant (left),FABP5,Fatty acid-binding protein 5,33463,0.00794919150507074,0.0255004940741737,-0.0420317768803096,0.0579301598904511,0.755255251102081
Physical measures,X4270.Volume level set by participant (left),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,32398,-0.0220460959435958,0.0708162501490488,-0.160845946235731,0.11675375434854,0.755570032405861
Physical measures,X4270.Volume level set by participant (left),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,32122,-0.0188515243390678,0.0605698750630202,-0.137568479462587,0.0998654307844518,0.755629695036462
Physical measures,X4270.Volume level set by participant (left),WIF1,Wnt inhibitory factor 1,33509,-0.0153073312668555,0.0491844707448792,-0.111708893926819,0.0810942313931077,0.755638376701369
Physical measures,X4270.Volume level set by participant (left),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,33112,0.0148893045562707,0.047992029533181,-0.079175073328764,0.108953682441305,0.756381845845883
Physical measures,X4270.Volume level set by participant (left),NT5E,5'-nucleotidase,33456,0.00924863338019716,0.0299054687367555,-0.0493660853438435,0.0678633521042379,0.757129181610759
Physical measures,X4270.Volume level set by participant (left),SFRP1,Secreted frizzled-related protein 1,33345,-0.0119922507763597,0.0388348167681725,-0.0881084916419779,0.0641239900892584,0.757479742406223
Physical measures,X4270.Volume level set by participant (left),ENO1,Alpha-enolase,33427,-0.00716313818818202,0.0232372889138036,-0.052708224459237,0.0383819480828729,0.757891279887128
Physical measures,X4270.Volume level set by participant (left),SERPINF1,Pigment epithelium-derived factor,32249,-0.0239262202600247,0.0778506107318285,-0.176513417294409,0.128660976774359,0.758596581610822
Physical measures,X4270.Volume level set by participant (left),TMPRSS15,Enteropeptidase,33386,0.00583336101080642,0.0189820291859485,-0.0313714161936527,0.0430381382152655,0.758614845867701
Physical measures,X4270.Volume level set by participant (left),SNAP23,Synaptosomal-associated protein 23,33434,-0.00643489849983903,0.0209467749502517,-0.0474905774023324,0.0346207804026543,0.758696480857808
Physical measures,X4270.Volume level set by participant (left),SCN2A,Sodium channel protein type 2 subunit alpha,32111,-0.0129357816881774,0.0421082592902094,-0.0954679698969878,0.069596406520633,0.758697251795956
Physical measures,X4270.Volume level set by participant (left),ACTN2,Alpha-actinin-2,32122,0.0109339720388957,0.0356175672752847,-0.0588764598206623,0.0807444038984537,0.758864982624683
Physical measures,X4270.Volume level set by participant (left),CASC3,Protein CASC3,32154,0.0153408312106169,0.0500086720842943,-0.0826761660745999,0.113357828495834,0.75903175021684
Physical measures,X4270.Volume level set by participant (left),SERPINB1,Leukocyte elastase inhibitor,33404,-0.00630211235195365,0.0205732441264707,-0.0466256708398361,0.0340214461359288,0.759363838657439
Physical measures,X4270.Volume level set by participant (left),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,33441,0.0189580637080835,0.0619997770639523,-0.102561499337263,0.14047762675343,0.759782042055566
Physical measures,X4270.Volume level set by participant (left),GBP1,Guanylate-binding protein 1,32334,0.00950848308767761,0.0311508662815595,-0.0515472148241791,0.0705641809995343,0.760191611932698
Physical measures,X4270.Volume level set by participant (left),GAD2,Glutamate decarboxylase 2,32140,-0.0140586905662203,0.0460655141926302,-0.104347098383776,0.0762297172513349,0.760230435924232
Physical measures,X4270.Volume level set by participant (left),B4GALT1,"Beta-1,4-galactosyltransferase 1",33481,-0.0186467857277906,0.0613622767877087,-0.1389168482317,0.101623276776118,0.76122610827845
Physical measures,X4270.Volume level set by participant (left),CD48,CD48 antigen,33468,0.0179225373461376,0.0590757792314577,-0.0978659899475195,0.133711064639795,0.76160564414631
Physical measures,X4270.Volume level set by participant (left),CD6,T-cell differentiation antigen CD6,33509,0.00984270538905735,0.032451053753706,-0.0537613599682063,0.073446770746321,0.761661152026638
Physical measures,X4270.Volume level set by participant (left),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,33380,0.00749926046187224,0.0247615691853903,-0.0410334151414927,0.0560319360652372,0.762004487749551
Physical measures,X4270.Volume level set by participant (left),TNFSF8,Tumor necrosis factor ligand superfamily member 8,32384,-0.0169331353893114,0.0559843690422972,-0.126662498712214,0.0927962279335911,0.762307951341303
Physical measures,X4270.Volume level set by participant (left),RNF5,E3 ubiquitin-protein ligase RNF5,32163,-0.0089681801393732,0.0296666045818132,-0.0671147251197271,0.0491783648409807,0.762432419317547
Physical measures,X4270.Volume level set by participant (left),RFC4,Replication factor C subunit 4,32319,0.0291003482530384,0.0963007323364504,-0.159649087126404,0.217849783632481,0.762521313670591
Physical measures,X4270.Volume level set by participant (left),F2R,Proteinase-activated receptor 1,33468,-0.0091066186471108,0.0301492930811403,-0.0681992330861457,0.0499859957919241,0.762620292925984
Physical measures,X4270.Volume level set by participant (left),SLAMF8,SLAM family member 8,33232,-0.0101891488841318,0.0337688091835457,-0.0763760148838813,0.0559977171156177,0.76286310184057
Physical measures,X4270.Volume level set by participant (left),TCTN3,Tectonic-3,32365,-0.0204686776042116,0.0679561660698936,-0.153662763101203,0.11272540789278,0.763266760983303
Physical measures,X4270.Volume level set by participant (left),ZCCHC8,Zinc finger CCHC domain-containing protein 8,32122,0.00958221888712268,0.0318292002836106,-0.0528030136687542,0.0719674514429995,0.763383617385998
Physical measures,X4270.Volume level set by participant (left),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,32329,0.00851016190123353,0.0283484074581527,-0.0470527167167457,0.0640730405192128,0.764033337571655
Physical measures,X4270.Volume level set by participant (left),ANXA3,Annexin A3,33493,0.00779888951992501,0.025991014506906,-0.0431434989136108,0.0587412779534608,0.764137535890092
Physical measures,X4270.Volume level set by participant (left),TMSB10,Thymosin beta-10,33441,0.00702158222589879,0.0235233971281286,-0.0390842761452333,0.0531274405970309,0.765333402971789
Physical measures,X4270.Volume level set by participant (left),TCN2,Transcobalamin-2,33515,-0.0171245009239186,0.0573835450194935,-0.129596249162126,0.0953472473142886,0.76538809458457
Physical measures,X4270.Volume level set by participant (left),COL9A1,Collagen alpha-1(IX) chain,33421,-0.0108329047677767,0.0363175865111843,-0.0820153743296979,0.0603495647941446,0.765494381908949
Physical measures,X4270.Volume level set by participant (left),SERPINB8,Serpin B8,33527,0.00908049870777431,0.0305033251385002,-0.0507060185636861,0.0688670159792347,0.765947497675521
Physical measures,X4270.Volume level set by participant (left),SAT1,Diamine acetyltransferase 1,32122,-0.0122424882571614,0.0414475538982115,-0.0934796938976558,0.0689947173833331,0.767716956377455
Physical measures,X4270.Volume level set by participant (left),SLC44A4,Choline transporter-like protein 4,32154,-0.00822328394144334,0.0279152279996804,-0.0629371308208168,0.0464905629379302,0.768322244398303
Physical measures,X4270.Volume level set by participant (left),OSCAR,Osteoclast-associated immunoglobulin-like receptor,33453,-0.0151767904210169,0.0515644456428774,-0.116243103881057,0.0858895230390228,0.768515101473877
Physical measures,X4270.Volume level set by participant (left),CBLIF,Cobalamin binding intrinsic factor,33418,-0.00687791629778755,0.0233815378435214,-0.0527057304710895,0.0389498978755144,0.76864235403031
Physical measures,X4270.Volume level set by participant (left),FOLH1,Glutamate carboxypeptidase 2,32140,-0.00541291752776212,0.0184062202026,-0.0414891091248581,0.0306632740693339,0.768704039078382
Physical measures,X4270.Volume level set by participant (left),PALLD,Palladin,32140,-0.0141093123676053,0.0480443099268827,-0.108276159824295,0.0800575350890848,0.769015786020016
Physical measures,X4270.Volume level set by participant (left),VWA1,von Willebrand factor A domain-containing protein 1,33499,0.0120754169754766,0.0411446541360622,-0.0685681051312052,0.0927189390821585,0.769156745640845
Physical measures,X4270.Volume level set by participant (left),CXCL6,C-X-C motif chemokine 6,33527,0.00665811842379628,0.0227004481476102,-0.0378347599455197,0.0511509967931122,0.76929697061296
Physical measures,X4270.Volume level set by participant (left),MASP1,Mannan-binding lectin serine protease 1,33356,-0.0214250926593837,0.0731628010970285,-0.16482418280956,0.121973997490792,0.769650254657257
Physical measures,X4270.Volume level set by participant (left),DPP7,Dipeptidyl peptidase 2,33369,0.00869339053312231,0.0297881329333473,-0.0496913500162383,0.067078131082483,0.770415191497961
Physical measures,X4270.Volume level set by participant (left),IGF2R,Cation-independent mannose-6-phosphate receptor,33441,0.0221785113257066,0.0760706516061282,-0.126919965822305,0.171276988473718,0.770636304665705
Physical measures,X4270.Volume level set by participant (left),MME,Neprilysin,33386,0.00618926540210661,0.0213009791014497,-0.0355606536367347,0.0479391844409479,0.771392702495005
Physical measures,X4270.Volume level set by participant (left),AARSD1,Alanyl-tRNA editing protein Aarsd1,33386,-0.00889231927858849,0.0306147209707031,-0.0688971723811666,0.0511125338239897,0.771471905526417
Physical measures,X4270.Volume level set by participant (left),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,32235,-0.0083804683577152,0.0288575268565722,-0.0649412209965967,0.0481802842811663,0.771511554306811
Physical measures,X4270.Volume level set by participant (left),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",33352,0.0124568257190824,0.0429151875450443,-0.0716569418692044,0.0965705933073692,0.771619407599974
Physical measures,X4270.Volume level set by participant (left),SEL1L,Protein sel-1 homolog 1,32163,-0.0183246877569672,0.0634173195237387,-0.142622634023495,0.105973258509561,0.772624354629896
Physical measures,X4270.Volume level set by participant (left),CDKL5,Cyclin-dependent kinase-like 5,32111,-0.0112257429963147,0.0388691564935595,-0.0874092897236913,0.0649578037310619,0.772735742093248
Physical measures,X4270.Volume level set by participant (left),NPTX2,Neuronal pentraxin-2,32384,-0.0171707310755465,0.0597093604468613,-0.134201077551395,0.0998596154003015,0.773682013023197
Physical measures,X4270.Volume level set by participant (left),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,33380,-0.0146509516964215,0.0509597126503588,-0.114531988491125,0.0852300850982817,0.77373566142125
Physical measures,X4270.Volume level set by participant (left),LAMA1,Laminin subunit alpha-1,32122,0.0103998925410273,0.0362482763662111,-0.0606467291367464,0.0814465142188011,0.774191107847875
Physical measures,X4270.Volume level set by participant (left),DCUN1D2,DCN1-like protein 2,32075,0.00702730473697695,0.0245550561720988,-0.0411006053603366,0.0551552148342905,0.77474371296382
Physical measures,X4270.Volume level set by participant (left),HAVCR1,Hepatitis A virus cellular receptor 1,33499,0.00811706035056118,0.0283914084290578,-0.0475301001703922,0.0637642208715146,0.774962430235036
Physical measures,X4270.Volume level set by participant (left),TNF,Tumor necrosis factor,33258,0.012375735685133,0.0434298332057341,-0.0727467373981058,0.0974982087683718,0.775682012663509
Physical measures,X4270.Volume level set by participant (left),SNAP29,Synaptosomal-associated protein 29,33456,-0.00559724762684233,0.0196902145178217,-0.0441900680817728,0.0329955728280882,0.776213502755804
Physical measures,X4270.Volume level set by participant (left),ZPR1,Zinc finger protein ZPR1,32111,0.00592431579619456,0.0208729482298454,-0.0349866627343025,0.0468352943266916,0.776550287570097
Physical measures,X4270.Volume level set by participant (left),METAP2,Methionine aminopeptidase 2,33499,-0.00899924614283705,0.0318168672170161,-0.0713603058881886,0.0533618136025145,0.777302025857553
Physical measures,X4270.Volume level set by participant (left),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",32365,0.00770250845703853,0.027302817041293,-0.0458110129438957,0.0612160298579727,0.77786343632455
Physical measures,X4270.Volume level set by participant (left),SULT1A1,Sulfotransferase 1A1,33500,-0.00393722474279313,0.0139659384756204,-0.0313104641550091,0.0234360146694228,0.778014192999468
Physical measures,X4270.Volume level set by participant (left),BCL2,Apoptosis regulator Bcl-2,32329,0.0106141981931933,0.0377234621306828,-0.0633237875829451,0.0845521839693316,0.778435083268082
Physical measures,X4270.Volume level set by participant (left),CDC123,Cell division cycle protein 123 homolog,32075,0.00884142493169997,0.0315763007000645,-0.0530481244404264,0.0707309743038263,0.779483629549925
Physical measures,X4270.Volume level set by participant (left),MYBPC1,"Myosin-binding protein C, slow-type",32365,-0.00848171985721379,0.0303203775554978,-0.0679096598659895,0.0509462201515619,0.779686897060621
Physical measures,X4270.Volume level set by participant (left),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,33380,-0.00939454748041486,0.0336322475127515,-0.0753137526054079,0.0565246576445782,0.779996876514283
Physical measures,X4270.Volume level set by participant (left),DAPK2,Death-associated protein kinase 2,32140,-0.0103631256226556,0.0371349542480307,-0.0831476359487957,0.0624213847034846,0.780201219701903
Physical measures,X4270.Volume level set by participant (left),RNASEH2A,Ribonuclease H2 subunit A,32350,-0.0105785935238685,0.0382940129041876,-0.0856348588160761,0.0644776717683392,0.782365845010307
Physical measures,X4270.Volume level set by participant (left),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,31941,-0.00562100622805346,0.0203535591861094,-0.0455139822328279,0.034271969776721,0.782426488015793
Physical measures,X4270.Volume level set by participant (left),ENO3,Beta-enolase,32163,0.00988734990127296,0.0358496744532329,-0.0603780120270635,0.0801527118296094,0.782708869604906
Physical measures,X4270.Volume level set by participant (left),VPS53,Vacuolar protein sorting-associated protein 53 homolog,33386,-0.00620318634229728,0.0225259289214312,-0.0503540070283024,0.0379476343437079,0.783030813829383
Physical measures,X4270.Volume level set by participant (left),HHEX,Hematopoietically-expressed homeobox protein HHEX,32353,-0.00749741661363922,0.0272607974115747,-0.0609285795403257,0.0459337463130472,0.783303779992399
Physical measures,X4270.Volume level set by participant (left),TREM2,Triggering receptor expressed on myeloid cells 2,33424,0.00929353884814452,0.0338223921042504,-0.0569983496761863,0.0755854273724754,0.783495638118905
Physical measures,X4270.Volume level set by participant (left),STX16,Syntaxin-16,33232,-0.00785917266967726,0.028681533144217,-0.0640749776323426,0.0483566322929881,0.78407947920157
Physical measures,X4270.Volume level set by participant (left),RNASET2,Ribonuclease T2,33492,-0.0174332457989383,0.0637821702941096,-0.142446299575393,0.107579807977516,0.78460983698047
Physical measures,X4270.Volume level set by participant (left),RARRES1,Retinoic acid receptor responder protein 1,33232,-0.0133419334395374,0.0490443930476139,-0.109468943812861,0.0827850769337858,0.785599280533567
Physical measures,X4270.Volume level set by participant (left),DNAJB1,DnaJ homolog subfamily B member 1,33386,-0.00574418434822322,0.0211221206823131,-0.047143540885557,0.0356551721891105,0.785665891115984
Physical measures,X4270.Volume level set by participant (left),FTCD,Formimidoyltransferase-cyclodeaminase,32333,-0.00660326935240468,0.0243739595558119,-0.0543762300817959,0.0411696913769866,0.786463565558447
Physical measures,X4270.Volume level set by participant (left),TOP2B,DNA topoisomerase 2-beta,32140,-0.00739574219848706,0.0273023738776766,-0.0609083949987331,0.046116910601759,0.786488485338266
Physical measures,X4270.Volume level set by participant (left),ATP2B4,Plasma membrane calcium-transporting ATPase 4,32122,-0.0085779838545244,0.0317236667888409,-0.0707563707606526,0.0536004030516038,0.786862137432181
Physical measures,X4270.Volume level set by participant (left),MSLNL,Mesothelin-like protein,32154,0.0144514079568256,0.0534646070249816,-0.0903392218121384,0.11924203772579,0.786937794164071
Physical measures,X4270.Volume level set by participant (left),NECTIN1,Nectin-1,32140,-0.0173981770311834,0.0645127801085629,-0.143843226043967,0.1090468719816,0.787409270548473
Physical measures,X4270.Volume level set by participant (left),CD33,Myeloid cell surface antigen CD33,33456,0.00584769782612818,0.0217804284104831,-0.0368419418584188,0.0485373375106751,0.788332896538746
Physical measures,X4270.Volume level set by participant (left),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,33505,0.0169110402030654,0.0629947654206758,-0.106558700021459,0.14038078042759,0.788357909817934
Physical measures,X4270.Volume level set by participant (left),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",32365,-0.0177945165705636,0.066448124925076,-0.148032841423713,0.112443808282585,0.788863627589429
Physical measures,X4270.Volume level set by participant (left),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,33232,-0.00545175351159769,0.0203890649114153,-0.0454143207379717,0.0345108137147764,0.789178146706277
Physical measures,X4270.Volume level set by participant (left),KLK3,Prostate-specific antigen,32384,0.00913063761279532,0.0341603126582811,-0.0578235751974357,0.0760848504230263,0.789254468035695
Physical measures,X4270.Volume level set by participant (left),IL2RB,Interleukin-2 receptor subunit beta,33273,0.012186918502281,0.045611432705841,-0.0772114896011674,0.101585326605729,0.789329127023577
Physical measures,X4270.Volume level set by participant (left),ICAM5,Intercellular adhesion molecule 5,33434,-0.010316655916476,0.0386141925576387,-0.0860004733294478,0.0653671614964957,0.789342373771285
Physical measures,X4270.Volume level set by participant (left),PRDX5,"Peroxiredoxin-5, mitochondrial",33527,-0.00717042805690658,0.0268458138714906,-0.0597882232450282,0.0454473671312151,0.789400786352885
Physical measures,X4270.Volume level set by participant (left),SHBG,Sex hormone-binding globulin,32381,-0.00971433854275349,0.0364110378726517,-0.0810799727731507,0.0616512956876437,0.789632767159204
Physical measures,X4270.Volume level set by participant (left),TSPAN1,Tetraspanin-1,33273,0.0149374872120195,0.0560683729164782,-0.0949565237042779,0.124831498128317,0.789925408824633
Physical measures,X4270.Volume level set by participant (left),STK11,Serine/threonine-protein kinase STK11,33273,-0.00678870772610218,0.0254926405906731,-0.0567542832838214,0.043176867831617,0.790013869670965
Physical measures,X4270.Volume level set by participant (left),SCPEP1,Retinoid-inducible serine carboxypeptidase,32128,-0.0110132661326517,0.041433741562446,-0.0922233995950458,0.0701968673297424,0.790397082702801
Physical measures,X4270.Volume level set by participant (left),IL4R,Interleukin-4 receptor subunit alpha,33421,-0.0122774265106211,0.0462004226114154,-0.102830254828995,0.0782754018077532,0.790443461037698
Physical measures,X4270.Volume level set by participant (left),NPR1,Atrial natriuretic peptide receptor 1,32122,0.0134966218021165,0.0509147070704585,-0.0862962040559821,0.113289447660215,0.790952671917177
Physical measures,X4270.Volume level set by participant (left),PGLYRP1,Peptidoglycan recognition protein 1,33474,0.0105928795139831,0.0400987985550514,-0.0680007656539175,0.0891865246818838,0.791655348826296
Physical measures,X4270.Volume level set by participant (left),PGR,Progesterone receptor,32140,-0.00512047218005769,0.0194001186987881,-0.0431447048296824,0.032903760469567,0.791833037060549
Physical measures,X4270.Volume level set by participant (left),GGA1,ADP-ribosylation factor-binding protein GGA1,33219,0.0065372192116954,0.0248155104097856,-0.0421011811914843,0.0551756196148751,0.792223211080284
Physical measures,X4270.Volume level set by participant (left),MORF4L2,Mortality factor 4-like protein 2,32075,-0.0140334148233072,0.05329824782614,-0.118497980562542,0.0904311509159272,0.792326678750351
Physical measures,X4270.Volume level set by participant (left),DENND2B,DENN domain-containing protein 2B,32122,0.0108493822588911,0.0412056207403381,-0.0699136343921716,0.0916123989099539,0.792327513975893
Physical measures,X4270.Volume level set by participant (left),ULBP2,UL16-binding protein 2,33380,-0.0122808595811254,0.0468306588991301,-0.10406895102342,0.0795072318611695,0.793142673092619
Physical measures,X4270.Volume level set by participant (left),AKT3,RAC-gamma serine/threonine-protein kinase,33193,-0.00819853698804498,0.0312825040136958,-0.0695122448548888,0.0531151708787988,0.793265491578689
Physical measures,X4270.Volume level set by participant (left),CD84,SLAM family member 5,33421,-0.0147504923088174,0.0563294817759604,-0.1251562765897,0.0956552919720651,0.793434652484458
Physical measures,X4270.Volume level set by participant (left),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,32140,0.00920318497412609,0.0352505582601554,-0.0598879092157784,0.0782942791640306,0.794038483698978
Physical measures,X4270.Volume level set by participant (left),INSL5,Insulin-like peptide INSL5,32329,-0.00566405406377685,0.0217857815965321,-0.0483641859929798,0.0370360778654261,0.794879392950402
Physical measures,X4270.Volume level set by participant (left),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,32122,-0.0072498952273043,0.0278884828422553,-0.0619113215981247,0.0474115311435161,0.794901464220779
Physical measures,X4270.Volume level set by participant (left),IL13RA2,Interleukin-13 receptor subunit alpha-2,32111,-0.018395860173064,0.070811462449171,-0.157186326573439,0.120394606227311,0.795035470222595
Physical measures,X4270.Volume level set by participant (left),FGFR2,Fibroblast growth factor receptor 2,33456,0.0208230024874972,0.0803227546670016,-0.136609596659826,0.17825560163482,0.795454734914965
Physical measures,X4270.Volume level set by participant (left),FOXO1,Forkhead box protein O1,33421,-0.0055094092833652,0.0213064796319334,-0.0472701093619547,0.0362512907952242,0.795965984026303
Physical measures,X4270.Volume level set by participant (left),AMOT,Angiomotin,32213,-0.0124033352342626,0.0480026914870863,-0.106488610548952,0.0816819400804265,0.796114077428745
Physical measures,X4270.Volume level set by participant (left),VNN2,Vascular non-inflammatory molecule 2,33386,-0.00977934081393342,0.0379169536061092,-0.0840965698819074,0.0645378882540406,0.796478659807029
Physical measures,X4270.Volume level set by participant (left),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,32154,-0.00973442082460882,0.0377447596503732,-0.0837141497393404,0.0642453080901227,0.796490010577807
Physical measures,X4270.Volume level set by participant (left),COMMD1,COMM domain-containing protein 1,32163,-0.00864591250764886,0.0338608009810445,-0.0750130824304961,0.0577212574151984,0.798469702195979
Physical measures,X4270.Volume level set by participant (left),FOLR1,Folate receptor alpha,33427,-0.0157137749701052,0.0615939956899193,-0.136438006522347,0.105010456582137,0.798637333457528
Physical measures,X4270.Volume level set by participant (left),CEP43,Centrosomal protein 43,33216,-0.00674548000414515,0.0264453564873757,-0.0585783787194015,0.0450874187111112,0.798673184020602
Physical measures,X4270.Volume level set by participant (left),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,33386,0.0110894474528365,0.043542575416559,-0.0742540003636192,0.0964328952692922,0.798975696580522
Physical measures,X4270.Volume level set by participant (left),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",33273,0.00644579120230681,0.0253819389128606,-0.0433028090669,0.0561943914715136,0.799538651783717
Physical measures,X4270.Volume level set by participant (left),PARD3,Partitioning defective 3 homolog,32235,0.0069514084297439,0.0274738365282857,-0.046897311165696,0.0608001280251838,0.800260053099973
Physical measures,X4270.Volume level set by participant (left),CPB2,Carboxypeptidase B2,32381,-0.0222126352184104,0.0879700681072982,-0.194633968708715,0.150208698271894,0.800659465935817
Physical measures,X4270.Volume level set by participant (left),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,33527,0.0114350515889569,0.0453109244190729,-0.0773743602724259,0.10024446345034,0.800761936346429
Physical measures,X4270.Volume level set by participant (left),IL5,Interleukin-5,33273,-0.00307635658565993,0.0121902725525076,-0.0269692907885748,0.020816577617255,0.800767466661597
Physical measures,X4270.Volume level set by participant (left),PLA2G2A,"Phospholipase A2, membrane associated",33381,0.0073395652446957,0.0292025682350066,-0.0498974684959172,0.0645765989853086,0.801562550716041
Physical measures,X4270.Volume level set by participant (left),IGFBP7,Insulin-like growth factor-binding protein 7,33533,-0.0148580029676644,0.0591197449715992,-0.130732703111999,0.10101669717667,0.801572027195329
Physical measures,X4270.Volume level set by participant (left),APOL1,Apolipoprotein L1,32381,-0.0073208914223107,0.029144271809398,-0.0644436641687308,0.0498018813241094,0.801669966269675
Physical measures,X4270.Volume level set by participant (left),LBP,Lipopolysaccharide-binding protein,33452,0.00731947708150184,0.0291873883277796,-0.0498878040409461,0.0645267582039498,0.801993538805067
Physical measures,X4270.Volume level set by participant (left),IGFBP1,Insulin-like growth factor-binding protein 1,33529,0.0036025678993372,0.0143924881174709,-0.0246067088109059,0.0318118446095803,0.802354139469902
Physical measures,X4270.Volume level set by participant (left),MATN3,Matrilin-3,33363,-0.0139829065495198,0.0560483366548116,-0.123837646392951,0.0958718332939109,0.802995710013318
Physical measures,X4270.Volume level set by participant (left),SLAMF7,SLAM family member 7,33421,-0.00751050632336861,0.0301081016878832,-0.0665223856316196,0.0515013729848824,0.803017390384354
Physical measures,X4270.Volume level set by participant (left),PREB,Prolactin regulatory element-binding protein,33273,0.0147755124999123,0.05931472664506,-0.101481351724405,0.13103237672423,0.803286439221043
Physical measures,X4270.Volume level set by participant (left),TGFBR3,Transforming growth factor beta receptor type 3,33533,-0.0119196551060288,0.0479576913611805,-0.105916730173943,0.0820774199618849,0.803718206628627
Physical measures,X4270.Volume level set by participant (left),UBQLN3,Ubiquilin-3,32122,0.0109801845681542,0.0441865084077368,-0.0756253719110099,0.0975857410473184,0.803757075405454
Physical measures,X4270.Volume level set by participant (left),BTC,Probetacellulin,33232,-0.00597493396242424,0.0240483079186346,-0.053109617482948,0.0411597495580995,0.803787822453017
Physical measures,X4270.Volume level set by participant (left),NPY,Pro-neuropeptide Y,33509,-0.00635364421909749,0.025679431453513,-0.056685329867983,0.043978041429788,0.804587623798125
Physical measures,X4270.Volume level set by participant (left),MYO9B,Unconventional myosin-IXb,33273,-0.00616150173099508,0.0249937751110345,-0.0551493009486227,0.0428262974866325,0.805284338773263
Physical measures,X4270.Volume level set by participant (left),SMNDC1,Survival of motor neuron-related-splicing factor 30,32329,0.00872406141335406,0.0355323994900508,-0.0609194415871456,0.0783675644138537,0.806057026942734
Physical measures,X4270.Volume level set by participant (left),FABP3,"Fatty acid-binding protein, heart",32365,0.0101080639189198,0.0412553140504478,-0.070752351619958,0.0909684794577976,0.806453178182829
Physical measures,X4270.Volume level set by participant (left),CGA,Glycoprotein hormones alpha chain,33441,-0.00468453780433386,0.0191467488593851,-0.0422121655687286,0.0328430899600609,0.806721477677956
Physical measures,X4270.Volume level set by participant (left),COL6A3,Collagen alpha-3(VI) chain,33533,-0.0124846148269763,0.0510529395086883,-0.112548376264005,0.0875791466100528,0.806816196727899
Physical measures,X4270.Volume level set by participant (left),VTCN1,V-set domain-containing T-cell activation inhibitor 1,33232,0.0126450557471337,0.0517746996306104,-0.0888333555288626,0.11412346702313,0.807056594774105
Physical measures,X4270.Volume level set by participant (left),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",32290,-0.00466802606938923,0.019132280785339,-0.0421672964086537,0.0328312442698752,0.80724734626797
Physical measures,X4270.Volume level set by participant (left),SERPINI2,Serpin I2,32329,0.00847632706985954,0.0348487946323827,-0.0598273104096106,0.0767799645493297,0.807832346859976
Physical measures,X4270.Volume level set by participant (left),DAND5,DAN domain family member 5,32140,0.0090171959818425,0.0371455134972396,-0.063788010472747,0.081822402436432,0.80820299305362
Physical measures,X4270.Volume level set by participant (left),APOH,Beta-2-glycoprotein 1,33441,-0.0124043831507383,0.0514913694415175,-0.113327467256113,0.088518700954636,0.80963642846758
Physical measures,X4270.Volume level set by participant (left),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,32398,-0.0239388136771873,0.0994131879269285,-0.218788662013967,0.170911034659593,0.809715424348552
Physical measures,X4270.Volume level set by participant (left),YES1,Tyrosine-protein kinase Yes,33386,0.00385391922148598,0.0160223697279228,-0.0275499254452428,0.0352577638882147,0.809922093623196
Physical measures,X4270.Volume level set by participant (left),ARHGEF12,Rho guanine nucleotide exchange factor 12,33421,0.00429237860187922,0.0179484320794803,-0.0308865482739022,0.0394713054776606,0.810994259898859
Physical measures,X4270.Volume level set by participant (left),ATF2,Cyclic AMP-dependent transcription factor ATF-2,33219,0.00604215340026543,0.025294534758328,-0.0435351347260575,0.0556194415265883,0.811210506139985
Physical measures,X4270.Volume level set by participant (left),GP1BA,Platelet glycoprotein Ib alpha chain,33358,-0.012789511557743,0.0537325976738476,-0.118105402998484,0.0925263798829983,0.811869924277879
Physical measures,X4270.Volume level set by participant (left),GUK1,Guanylate kinase,32122,-0.0117285944894562,0.0496093314550025,-0.108962884141261,0.0855056951623487,0.813113776576577
Physical measures,X4270.Volume level set by participant (left),SEPTIN7,Septin-7,32235,0.00883967881485368,0.0373910357022894,-0.0644467511616336,0.0821261087913409,0.813119431466271
Physical measures,X4270.Volume level set by participant (left),LRRC59,Leucine-rich repeat-containing protein 59,32365,-0.00986049208723952,0.0419135194614381,-0.0920109902316581,0.0722900060571791,0.81401455692178
Physical measures,X4270.Volume level set by participant (left),ARMCX2,Armadillo repeat-containing X-linked protein 2,32111,0.00761536324257726,0.0324272754313858,-0.0559420966029389,0.0711728230880934,0.814335804626821
Physical measures,X4270.Volume level set by participant (left),MTDH,Protein LYRIC,32140,-0.00543132301246365,0.023147563275852,-0.0508005470331336,0.0399379010082063,0.814495123675114
Physical measures,X4270.Volume level set by participant (left),SHMT1,"Serine hydroxymethyltransferase, cytosolic",33468,-0.00478242266869098,0.0204344944498592,-0.044834031790415,0.035269186453033,0.814961764050185
Physical measures,X4270.Volume level set by participant (left),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",33421,-0.004370342115473,0.0187256408189507,-0.0410725981206164,0.0323319138896704,0.815465364933638
Physical measures,X4270.Volume level set by participant (left),EPHX2,Bifunctional epoxide hydrolase 2,33273,-0.00633899226439389,0.0273841641218689,-0.0600119539432568,0.0473339694144691,0.816944286750292
Physical measures,X4270.Volume level set by participant (left),CTSF,Cathepsin F,33456,0.00983772059116965,0.0425312527642458,-0.0735235348267522,0.0931989760090915,0.817082587365868
Physical measures,X4270.Volume level set by participant (left),SLC16A1,Monocarboxylate transporter 1,33219,0.00666735112898188,0.0289159468351808,-0.0500079046679725,0.0633426069259363,0.817648850196436
Physical measures,X4270.Volume level set by participant (left),NPDC1,Neural proliferation differentiation and control protein 1,33434,-0.0131585085721502,0.0571253808263348,-0.125124254991766,0.0988072378474661,0.817829450145923
Physical measures,X4270.Volume level set by participant (left),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,33421,-0.00415107180792695,0.0180678811101101,-0.0395641187837427,0.0312619751678888,0.818292307445776
Physical measures,X4270.Volume level set by participant (left),BAG6,Large proline-rich protein BAG6,33273,-0.0111245285216097,0.0484810932475313,-0.106147471286771,0.0838984142435517,0.818515816950731
Physical measures,X4270.Volume level set by participant (left),RELT,Tumor necrosis factor receptor superfamily member 19L,33441,0.0151240865669162,0.0659669228744007,-0.114171082266909,0.144419255400742,0.818666052132035
Physical measures,X4270.Volume level set by participant (left),TDRKH,Tudor and KH domain-containing protein,33219,-0.00457266945690355,0.0199536808833847,-0.0436818839883377,0.0345365450745306,0.818746638396233
Physical measures,X4270.Volume level set by participant (left),CCL27,C-C motif chemokine 27,33434,0.00668325356048951,0.0292627641439354,-0.0506717641616239,0.0640382712826029,0.819350100444929
Physical measures,X4270.Volume level set by participant (left),DCTN6,Dynactin subunit 6,33219,-0.0056666069111993,0.0248319033961194,-0.0543371375675934,0.0430039237451948,0.819497132233224
Physical measures,X4270.Volume level set by participant (left),SCARB1,Scavenger receptor class B member 1,33219,-0.00677783385706088,0.0297194099407754,-0.0650278773409806,0.0514722096268588,0.819604256639924
Physical measures,X4270.Volume level set by participant (left),CREB3,Cyclic AMP-responsive element-binding protein 3,32075,-0.00831432545610598,0.0365064898452072,-0.079867045552712,0.0632383946405001,0.819847297707546
Physical measures,X4270.Volume level set by participant (left),CBS,Cystathionine beta-synthase,32163,-0.00935616877508746,0.0411317468873183,-0.0899743926742313,0.0712620551240564,0.820065644583657
Physical measures,X4270.Volume level set by participant (left),CD63,CD63 antigen,33363,-0.00769267163915306,0.033855361447033,-0.0740491800753376,0.0586638367970315,0.820256595335283
Physical measures,X4270.Volume level set by participant (left),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",33273,-0.00424150445665583,0.0187199924733133,-0.0409326897043498,0.0324496807910382,0.820758565055126
Physical measures,X4270.Volume level set by participant (left),PTPRB,Receptor-type tyrosine-protein phosphatase beta,32365,-0.0153754319643505,0.0678711481187275,-0.148402882277056,0.117652018348355,0.820788428022659
Physical measures,X4270.Volume level set by participant (left),NLGN1,Neuroligin-1,32154,0.00669486655881522,0.0295560342716007,-0.0512349606135222,0.0646246937311526,0.820807395450008
Physical measures,X4270.Volume level set by participant (left),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",33365,0.00385184060969788,0.0170216115651525,-0.029510518058001,0.0372141992773967,0.820980146638845
Physical measures,X4270.Volume level set by participant (left),FBN2,Fibrillin-2,32154,-0.0076850529529024,0.0339610540324044,-0.074248718856415,0.0588786129506102,0.820981744521526
Physical measures,X4270.Volume level set by participant (left),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,33434,-0.00597632694301731,0.0264297986051751,-0.0577787322091605,0.0458260783231259,0.821112621983838
Physical measures,X4270.Volume level set by participant (left),ARHGAP45,Rho GTPase-activating protein 45,32213,-0.00581368667597637,0.0257424948090152,-0.0562689765016462,0.0446416031496935,0.821331764485053
Physical measures,X4270.Volume level set by participant (left),COL9A2,Collagen alpha-2(IX) chain,32235,-0.00957124392208288,0.0423899199672538,-0.0926554870579003,0.0735129992137346,0.821370247637648
Physical measures,X4270.Volume level set by participant (left),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",32353,-0.0116689611590395,0.0517169874512128,-0.113034256563417,0.0896963342453377,0.821494182345715
Physical measures,X4270.Volume level set by participant (left),CD55,Complement decay-accelerating factor,33134,-0.0159589377899596,0.070788574059216,-0.154704542946023,0.122786667366104,0.821638330963272
Physical measures,X4270.Volume level set by participant (left),KEL,Kell blood group glycoprotein,33219,-0.0113852293905804,0.0505704294786513,-0.110503271168737,0.0877328123875761,0.821878645230862
Physical measures,X4270.Volume level set by participant (left),DCTN1,Dynactin subunit 1,33509,-0.00611378907645236,0.027255389150818,-0.0595343518120557,0.047306773659151,0.822517367925809
Physical measures,X4270.Volume level set by participant (left),CRISP2,Cysteine-rich secretory protein 2,33509,-0.00632585935704526,0.0282216339231454,-0.0616402618464103,0.0489885431323198,0.822646193721179
Physical measures,X4270.Volume level set by participant (left),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,32111,0.00835193673868512,0.0373083469310024,-0.0647724232460797,0.0814762967234499,0.822870333214924
Physical measures,X4270.Volume level set by participant (left),EGFL7,Epidermal growth factor-like protein 7,33232,-0.0097936375429428,0.0438249712958084,-0.0956905812827273,0.0761033061968416,0.823173665658471
Physical measures,X4270.Volume level set by participant (left),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,32319,-0.0130987324291535,0.0586512821814079,-0.128055245504713,0.101857780646406,0.823282602423765
Physical measures,X4270.Volume level set by participant (left),SDC1,Syndecan-1,33434,0.00977643469428894,0.043980088150037,-0.0764245380797837,0.0959774074683615,0.824091406152175
Physical measures,X4270.Volume level set by participant (left),IL12A_IL12B,Interleukin-12,33386,0.00496690535342308,0.0224272240955827,-0.038990453873919,0.0489242645807652,0.824733360430714
Physical measures,X4270.Volume level set by participant (left),IL1R1,Interleukin-1 receptor type 1,33428,-0.017089985958324,0.077167052357391,-0.16833740857881,0.134157436662162,0.82473356191979
Physical measures,X4270.Volume level set by participant (left),SERPINA12,Serpin A12,33151,-0.00329157735858725,0.0148949903615194,-0.0324857584671652,0.0259026037499907,0.825108887099303
Physical measures,X4270.Volume level set by participant (left),TET2,Methylcytosine dioxygenase TET2,32212,-0.00445527549292937,0.0201654823317849,-0.0439796208632278,0.0350690698773691,0.825148293752883
Physical measures,X4270.Volume level set by participant (left),SHC1,SHC-transforming protein 1,32075,0.00390164927650159,0.0176867829865027,-0.0307644453770437,0.0385677439300469,0.825412234768352
Physical measures,X4270.Volume level set by participant (left),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,33386,-0.0134528156645441,0.0610233416787636,-0.133058565354921,0.106152934025833,0.825522940363163
Physical measures,X4270.Volume level set by participant (left),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",32122,-0.00675968086907205,0.0309388061175506,-0.0673997408594712,0.0538803791213271,0.827056661154493
Physical measures,X4270.Volume level set by participant (left),C1R,Complement C1r subcomponent,32398,-0.0212210120084651,0.097164360563129,-0.211663158712198,0.169221134695268,0.827120545332987
Physical measures,X4270.Volume level set by participant (left),APCS,Serum amyloid P-component,32330,0.0118820237771873,0.0547049092886373,-0.0953395984285418,0.119103645982916,0.828056437967354
Physical measures,X4270.Volume level set by participant (left),PBLD,Phenazine biosynthesis-like domain-containing protein,33219,0.00781289657221641,0.0360188295616083,-0.0627840093685358,0.0784098025129687,0.828282402683904
Physical measures,X4270.Volume level set by participant (left),FN1,Fibronectin,32398,-0.0163092545766183,0.0752422179944941,-0.163784001845827,0.13116549269259,0.828403527839021
Physical measures,X4270.Volume level set by participant (left),MAPK9,Mitogen-activated protein kinase 9,33421,-0.00864313647519709,0.0399016733533492,-0.0868504162477615,0.0695641432973673,0.828516536158313
Physical measures,X4270.Volume level set by participant (left),FUOM,Fucose mutarotase,32213,-0.00700131101519574,0.0323519690480678,-0.0704111703494086,0.0564085483190171,0.82867334663814
Physical measures,X4270.Volume level set by participant (left),AMBN,Ameloblastin,33273,0.0128147405961168,0.0594358093720432,-0.103679445773088,0.129308926965321,0.829299557106632
Physical measures,X4270.Volume level set by participant (left),CORO1A,Coronin-1A,33227,-0.0040895820101384,0.0190001842883948,-0.0413299432153922,0.0331507791951154,0.829585934516017
Physical measures,X4270.Volume level set by participant (left),SPINT2,Kunitz-type protease inhibitor 2,33481,0.00852905735227057,0.0398372038809491,-0.0695518622543896,0.0866099769589307,0.830475634522108
Physical measures,X4270.Volume level set by participant (left),LRRC25,Leucine-rich repeat-containing protein 25,33386,0.00944900642447758,0.0443813653350254,-0.0775384696321721,0.0964364824811273,0.83140606505612
Physical measures,X4270.Volume level set by participant (left),EVI5,Ecotropic viral integration site 5 protein homolog,32140,0.00500319362718512,0.023568558203714,-0.0411911804520943,0.0511975677064646,0.831892238451418
Physical measures,X4270.Volume level set by participant (left),F11R,Junctional adhesion molecule A,33441,0.00649376698078195,0.030664706913216,-0.0536090585691214,0.0665965925306853,0.832293770293339
Physical measures,X4270.Volume level set by participant (left),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,32319,-0.0107588219845049,0.051149311141134,-0.111011471821128,0.0894938278521177,0.83340660968759
Physical measures,X4270.Volume level set by participant (left),STK4,Serine/threonine-protein kinase 4,33434,0.00431681773908932,0.0205241726999653,-0.0359105607528427,0.0445441962310213,0.833416092700076
Physical measures,X4270.Volume level set by participant (left),MEP1B,Meprin A subunit beta,33434,-0.00304239778861477,0.0144669770583405,-0.0313976728229621,0.0253128772457325,0.833438710887789
Physical measures,X4270.Volume level set by participant (left),NTF3,Neurotrophin-3,33421,-0.0100892416466337,0.0480176541574627,-0.104203843795261,0.0840253605019931,0.83358249377104
Physical measures,X4270.Volume level set by participant (left),VPS37A,Vacuolar protein sorting-associated protein 37A,33386,-0.00471444372720355,0.0224842920033676,-0.048783656053804,0.0393547685993968,0.833924392662133
Physical measures,X4270.Volume level set by participant (left),NCR1,Natural cytotoxicity triggering receptor 1,33406,-0.01005004428542,0.0479812030456981,-0.104093202254988,0.0839931136841484,0.834095527362421
Physical measures,X4270.Volume level set by participant (left),GZMB,Granzyme B,33421,-0.00583401712635891,0.0280548687932347,-0.0608215599610989,0.0491535257083811,0.835272531892454
Physical measures,X4270.Volume level set by participant (left),ANKRA2,Ankyrin repeat family A protein 2,32075,-0.00751033565130654,0.0363300505099397,-0.0787172346507883,0.0636965633481752,0.836230027202437
Physical measures,X4270.Volume level set by participant (left),PRKCQ,Protein kinase C theta type,33273,-0.0077313589571607,0.0374092120768284,-0.0810534146277444,0.065590696713423,0.836272420365213
Physical measures,X4270.Volume level set by participant (left),NUDT16,U8 snoRNA-decapping enzyme,32322,-0.00485935214585437,0.0236153062119805,-0.0511453523213362,0.0414266480296275,0.836974888787446
Physical measures,X4270.Volume level set by participant (left),CLMP,CXADR-like membrane protein,33509,-0.0179110136838991,0.0871110274224842,-0.188648627431968,0.15282660006417,0.83709915381329
Physical measures,X4270.Volume level set by participant (left),CTBS,Di-N-acetylchitobiase,32254,-0.0143951782890637,0.0700947467108542,-0.151780881842338,0.122990525264211,0.837290421460258
Physical measures,X4270.Volume level set by participant (left),PVR,Poliovirus receptor,33500,-0.00965192765806704,0.0471327316682345,-0.102032081727807,0.0827282264116725,0.837747181327694
Physical measures,X4270.Volume level set by participant (left),CEP290,Centrosomal protein of 290 kDa,32235,0.00788427375265837,0.0385416953346253,-0.0676574491032072,0.083425996608524,0.837917519399472
Physical measures,X4270.Volume level set by participant (left),BANK1,B-cell scaffold protein with ankyrin repeats,33421,0.00361018897074781,0.0176540646605783,-0.0309917777639857,0.0382121557054813,0.837970410244714
Physical measures,X4270.Volume level set by participant (left),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",33273,-0.00622366339380175,0.0304365802816769,-0.0658793607458884,0.0534320339582849,0.837983357952722
Physical measures,X4270.Volume level set by participant (left),HLA_E,,33421,0.012003858553319,0.0587831378695401,-0.10321109167098,0.127218808777618,0.838197302502442
Physical measures,X4270.Volume level set by participant (left),CR2,Complement receptor type 2,33452,0.00753600633027359,0.0369101509812771,-0.0648078895930295,0.0798799022535767,0.83822398481536
Physical measures,X4270.Volume level set by participant (left),MED18,Mediator of RNA polymerase II transcription subunit 18,33232,-0.0048929894156811,0.024069958746013,-0.0520701085578665,0.0422841297265043,0.838919334081177
Physical measures,X4270.Volume level set by participant (left),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,32122,-0.0060514736819246,0.029976509763749,-0.0648054328188727,0.0527024854550235,0.840020695246838
Physical measures,X4270.Volume level set by participant (left),SUSD1,Sushi domain-containing protein 1,33273,0.00742130834516834,0.0368015411107236,-0.0647097122318499,0.0795523289221866,0.840189108262235
Physical measures,X4270.Volume level set by participant (left),RPA2,Replication protein A 32 kDa subunit,32140,-0.0132903007211792,0.0660276608993607,-0.142704516083926,0.116123914641568,0.840481969725194
Physical measures,X4270.Volume level set by participant (left),C3,Complement C3,31956,0.00777569049441486,0.0388758991159291,-0.0684210717728062,0.0839724527616359,0.841475729725604
Physical measures,X4270.Volume level set by participant (left),ABL1,Tyrosine-protein kinase ABL1,33386,-0.00503208205454941,0.0252958332403254,-0.0546119152055871,0.0445477510964883,0.842322588406023
Physical measures,X4270.Volume level set by participant (left),HCLS1,Hematopoietic lineage cell-specific protein,33527,-0.00645807171045979,0.0326374877851556,-0.0704275477693648,0.0575114043484453,0.843149004421368
Physical measures,X4270.Volume level set by participant (left),ATOX1,Copper transport protein ATOX1,33456,-0.00493848702392133,0.0250420832144718,-0.054020970124286,0.0441439960764434,0.84366960204883
Physical measures,X4270.Volume level set by participant (left),GPD1,Glycerol-3-phosphate dehydrogenase,32319,-0.00759083206642741,0.0386166891533109,-0.0832795428069167,0.0680978786740619,0.844170152395387
Physical measures,X4270.Volume level set by participant (left),SPINK5,Serine protease inhibitor Kazal-type 5,33441,0.0105979832140221,0.0540043735608343,-0.0952505889652131,0.116446555393257,0.844424368312744
Physical measures,X4270.Volume level set by participant (left),NID2,Nidogen-2,33441,-0.00457109445417152,0.0233735229384991,-0.0503831994136297,0.0412410105052867,0.844953356260604
Physical measures,X4270.Volume level set by participant (left),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,33533,-0.0113764980249589,0.0584944550500062,-0.126025629922971,0.103272633873053,0.845797762131013
Physical measures,X4270.Volume level set by participant (left),WASF3,Wiskott-Aldrich syndrome protein family member 3,33219,0.0039810251565584,0.0204929032689908,-0.0361850652506636,0.0441471155637804,0.845973988439042
Physical measures,X4270.Volume level set by participant (left),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",32163,-0.0107325589905629,0.0555132742635251,-0.119538576547072,0.0980734585659462,0.846703120442973
Physical measures,X4270.Volume level set by participant (left),TPSAB1,Tryptase alpha/beta-1,33505,0.00626168722432141,0.032460101155113,-0.0573601110397001,0.069883485488343,0.847038387591241
Physical measures,X4270.Volume level set by participant (left),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,33273,0.00579188330631595,0.030200473284854,-0.0534010443319979,0.0649848109446298,0.847918005876092
Physical measures,X4270.Volume level set by participant (left),TCL1B,T-cell leukemia/lymphoma protein 1B,33273,0.00410699986452696,0.0214251107613184,-0.0378862172276572,0.0461002169567111,0.847988707980257
Physical measures,X4270.Volume level set by participant (left),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,33273,0.00396521456948764,0.0207284982875247,-0.0366626420740608,0.0445930712130361,0.848300526802938
Physical measures,X4270.Volume level set by participant (left),MLN,Promotilin,33421,-0.00368703992147923,0.0194610650269337,-0.0418307273742693,0.0344566475313109,0.849738743948687
Physical measures,X4270.Volume level set by participant (left),CD4,T-cell surface glycoprotein CD4,33407,0.010876814765859,0.0574386916595359,-0.101703020886831,0.123456650418549,0.849811907819311
Physical measures,X4270.Volume level set by participant (left),RABGAP1L,Rab GTPase-activating protein 1-like,33273,0.0056164214570521,0.0297693401011617,-0.0527314851412249,0.0639643280553291,0.850360018572179
Physical measures,X4270.Volume level set by participant (left),FEN1,Flap endonuclease 1,33232,0.00544468945445217,0.0288872461185988,-0.0511743129380015,0.0620636918469058,0.850504171645027
Physical measures,X4270.Volume level set by participant (left),CD74,HLA class II histocompatibility antigen gamma chain,33500,-0.0093394718059063,0.0496654926193423,-0.106683837339817,0.0880048937280047,0.850843632789879
Physical measures,X4270.Volume level set by participant (left),ESR1,Estrogen receptor,32140,0.00643998182254351,0.0342732131363673,-0.0607355159247364,0.0736154795698234,0.850958972672769
Physical measures,X4270.Volume level set by participant (left),CA8,Carbonic anhydrase-related protein,32140,-0.0154805497648866,0.0826229293471318,-0.177421491285265,0.146460391755492,0.851380313990523
Physical measures,X4270.Volume level set by participant (left),BPIFA2,BPI fold-containing family A member 2,31885,-0.00359951233865466,0.0192397843162922,-0.0413094895985875,0.0341104649212781,0.851597577378678
Physical measures,X4270.Volume level set by participant (left),GIPR,Gastric inhibitory polypeptide receptor,32140,-0.00804148130993614,0.0431930280483186,-0.0926998162846407,0.0766168536647684,0.852312091541626
Physical measures,X4270.Volume level set by participant (left),QPCT,Glutaminyl-peptide cyclotransferase,33436,-0.0117525445282698,0.0634576152358586,-0.136129470390553,0.112624381334013,0.85307395111483
Physical measures,X4270.Volume level set by participant (left),MYOM3,Myomesin-3,32213,-0.00410085966657181,0.0221789774591158,-0.0475716554864387,0.0393699361532951,0.853313480602497
Physical measures,X4270.Volume level set by participant (left),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,33527,0.00336279211651419,0.0182045214527829,-0.0323180699309402,0.0390436541639686,0.853450507562638
Physical measures,X4270.Volume level set by participant (left),RASSF2,Ras association domain-containing protein 2,33232,0.00618197586969214,0.0335827803461694,-0.0596402736087999,0.0720042253481842,0.853953601637014
Physical measures,X4270.Volume level set by participant (left),FSHB,Follitropin subunit beta,32163,0.00533054781498648,0.0289807450311387,-0.0514717124460454,0.0621328080760184,0.854069976411588
Physical measures,X4270.Volume level set by participant (left),MORC3,MORC family CW-type zinc finger protein 3,32353,-0.0130611826465277,0.0712354374995089,-0.152682640145565,0.12656027485251,0.854526292199377
Physical measures,X4270.Volume level set by participant (left),MFAP3L,Microfibrillar-associated protein 3-like,32154,-0.00562024081773375,0.0307404315060124,-0.0658714865695181,0.0546310049340506,0.854937046547815
Physical measures,X4270.Volume level set by participant (left),IRAK1,Interleukin-1 receptor-associated kinase 1,33273,0.00471380060597688,0.025783472765952,-0.045821806015289,0.0552494072272428,0.854941446245853
Physical measures,X4270.Volume level set by participant (left),DCXR,L-xylulose reductase,33456,-0.00614382853474257,0.0336628385458658,-0.0721229920846396,0.0598353350151545,0.85518606108105
Physical measures,X4270.Volume level set by participant (left),PDGFC,Platelet-derived growth factor C,33232,-0.0108997757454187,0.0597243537591769,-0.127959509113405,0.106159957622568,0.855193502623309
Physical measures,X4270.Volume level set by participant (left),ARSA,Arylsulfatase A,33441,-0.00709394627300068,0.0388726607786401,-0.0832843613991353,0.069096468853134,0.855200816081184
Physical measures,X4270.Volume level set by participant (left),CELA2A,Chymotrypsin-like elastase family member 2A,32384,0.00606467389761115,0.033555585496212,-0.0597042736749645,0.0718336214701868,0.856580083763214
Physical measures,X4270.Volume level set by participant (left),HSD17B3,Testosterone 17-beta-dehydrogenase 3,32122,-0.00758362128640754,0.042102279278617,-0.0901040886724968,0.0749368460996817,0.857060162078665
Physical measures,X4270.Volume level set by participant (left),MYOC,Myocilin,33441,-0.00672351352277295,0.0373445521213829,-0.0799188356806834,0.0664718086351374,0.857125217929606
Physical measures,X4270.Volume level set by participant (left),AXIN1,Axin-1,33421,-0.00346900741175044,0.0192739069819407,-0.0412458650963541,0.0343078502728532,0.85716868599257
Physical measures,X4270.Volume level set by participant (left),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,33219,-0.00501771800958423,0.0279300522395873,-0.0597606203991754,0.0497251843800069,0.857429137440645
Physical measures,X4270.Volume level set by participant (left),DSG4,Desmoglein-4,33349,0.00622695864054551,0.0347163902387786,-0.0618171662274606,0.0742710835085517,0.857653991942021
Physical measures,X4270.Volume level set by participant (left),DCC,Netrin receptor DCC,32154,0.0169657495884027,0.0947548700243611,-0.168753795659345,0.20268529483615,0.857904063717944
Physical measures,X4270.Volume level set by participant (left),IPCEF1,Interactor protein for cytohesin exchange factors 1,33363,0.00371724212685391,0.0207647969325372,-0.036981759860919,0.0444162441146268,0.857928784695818
Physical measures,X4270.Volume level set by participant (left),AKR7L,Aflatoxin B1 aldehyde reductase member 4,32140,-0.00511601153569736,0.0286179440431524,-0.061207181860276,0.0509751587888813,0.858123517432173
Physical measures,X4270.Volume level set by participant (left),MMP1,Interstitial collagenase,33050,0.00340794409821525,0.0191395928913089,-0.0341056579687502,0.0409215461651807,0.858682177518488
Physical measures,X4270.Volume level set by participant (left),KIFBP,KIF-binding protein,33386,-0.00389108833704408,0.0218877042355942,-0.0467909886388088,0.0390088119647206,0.858903651861516
Physical measures,X4270.Volume level set by participant (left),SCN3B,Sodium channel subunit beta-3,32111,0.00804999000680673,0.0453694155368517,-0.0808740644454227,0.0969740444590361,0.859173700556844
Physical measures,X4270.Volume level set by participant (left),JUN,Transcription factor AP-1,33273,-0.00578088674236987,0.0326279914234841,-0.0697317499323988,0.058169976447659,0.85937446302989
Physical measures,X4270.Volume level set by participant (left),CAPS,Calcyphosin,32353,0.0038355488350449,0.0217007172875536,-0.0386978570485601,0.0463689547186499,0.859711213255525
Physical measures,X4270.Volume level set by participant (left),CA2,Carbonic anhydrase 2,33405,-0.00417349928472974,0.0236602793686074,-0.0505476468472002,0.0422006482777407,0.859989472666391
Physical measures,X4270.Volume level set by participant (left),ADAMTSL2,ADAMTS-like protein 2,32384,-0.0114330388057821,0.0650283463840246,-0.13888859771847,0.116022520106906,0.860442807089183
Physical measures,X4270.Volume level set by participant (left),S100G,Protein S100-G,32350,-0.00770551215041674,0.0438847179129134,-0.093719559259727,0.0783085349588935,0.860624240672102
Physical measures,X4270.Volume level set by participant (left),MUC13,Mucin-13,33219,-0.00622180223455921,0.035448754489088,-0.0757013610331717,0.0632577565640533,0.860678727969407
Physical measures,X4270.Volume level set by participant (left),CPVL,Probable serine carboxypeptidase CPVL,33506,-0.00740898908520678,0.0423405464128509,-0.0903964600543947,0.0755784818839811,0.861094803849955
Physical measures,X4270.Volume level set by participant (left),HMMR,Hyaluronan mediated motility receptor,32055,-0.00724761825678682,0.0416760855178157,-0.0889327458717056,0.0744375093581319,0.861945912536153
Physical measures,X4270.Volume level set by participant (left),MOCS2,Molybdopterin synthase catalytic subunit,32213,-0.00529614495088766,0.0306029380950713,-0.0652779036172274,0.0546856137154521,0.862608768158016
Physical measures,X4270.Volume level set by participant (left),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,32350,0.0115297119169823,0.0666975843956482,-0.119197553498488,0.142256977332453,0.862761574065798
Physical measures,X4270.Volume level set by participant (left),FCN2,Ficolin-2,33347,0.00715887991631152,0.0414948195072724,-0.0741709663179423,0.0884887261505654,0.863028997116401
Physical measures,X4270.Volume level set by participant (left),HTR1B,5-hydroxytryptamine receptor 1B,32111,-0.0079333491645023,0.0462513268339033,-0.0985859497589529,0.0827192514299483,0.863813972276426
Physical measures,X4270.Volume level set by participant (left),IGFBP3,Insulin-like growth factor-binding protein 3,33452,0.0106858496018606,0.0628905252765038,-0.112579579940087,0.133951279143808,0.865083230600062
Physical measures,X4270.Volume level set by participant (left),ASS1,Argininosuccinate synthase,32122,-0.00432894891032377,0.0254819781076214,-0.0542736260012617,0.0456157281806142,0.865106817416283
Physical measures,X4270.Volume level set by participant (left),WASF1,Wiskott-Aldrich syndrome protein family member 1,33273,-0.00315309154765746,0.018637817917315,-0.0396832146655949,0.03337703157028,0.865661240662233
Physical measures,X4270.Volume level set by participant (left),LSP1,Lymphocyte-specific protein 1,33421,0.00735120150258688,0.0435012526589853,-0.0779112537090243,0.0926136567141981,0.865809678625511
Physical measures,X4270.Volume level set by participant (left),ASAH2,Neutral ceramidase,33380,0.00556043607974909,0.0330926844498026,-0.059301225441864,0.0704220976013622,0.866566520688441
Physical measures,X4270.Volume level set by participant (left),RNASE1,Ribonuclease pancreatic,32381,0.0134745339730298,0.0803113857015498,-0.143935782002008,0.170884849948067,0.866761718377898
Physical measures,X4270.Volume level set by participant (left),KLRB1,Killer cell lectin-like receptor subfamily B member 1,33527,-0.00772560722025605,0.0460868285259973,-0.0980557911312107,0.0826045766906986,0.866876873263007
Physical measures,X4270.Volume level set by participant (left),HMOX2,Heme oxygenase 2,33219,0.00664487041307713,0.0397091903762579,-0.0711851427243883,0.0844748835505426,0.867107691116748
Physical measures,X4270.Volume level set by participant (left),GP1BB,Platelet glycoprotein Ib beta chain,32122,-0.00509910607546472,0.0306325314225853,-0.065138867663732,0.0549406555128025,0.867798966166165
Physical measures,X4270.Volume level set by participant (left),KCNIP4,Kv channel-interacting protein 4,33219,0.00558926149058975,0.0338019181390204,-0.0606624980618902,0.0718410210430697,0.868669657924013
Physical measures,X4270.Volume level set by participant (left),IZUMO1,Izumo sperm-egg fusion protein 1,32075,0.00699341668480974,0.0428078026309351,-0.076909876471823,0.0908967098414425,0.870233183835412
Physical measures,X4270.Volume level set by participant (left),NUCB2,Nucleobindin-2,33493,-0.0075807860591095,0.0467072396584308,-0.0991269757896338,0.0839654036714148,0.87106985324093
Physical measures,X4270.Volume level set by participant (left),SLAMF1,Signaling lymphocytic activation molecule,33273,0.00472514350301374,0.0291366436251361,-0.052382678002253,0.0618329650082805,0.871174239698821
Physical measures,X4270.Volume level set by participant (left),COMT,Catechol O-methyltransferase,33195,0.00353562412357515,0.0218459586605428,-0.0392824548510887,0.0463537030982389,0.871432920071301
Physical measures,X4270.Volume level set by participant (left),F12,Coagulation factor XII,32398,-0.0074104191010966,0.0461671062096367,-0.0978979472719846,0.0830771090697914,0.872481091283163
Physical measures,X4270.Volume level set by participant (left),DPP10,Inactive dipeptidyl peptidase 10,33421,-0.00816046458845727,0.0509157257585542,-0.107955287075224,0.091634357898309,0.87266888743048
Physical measures,X4270.Volume level set by participant (left),VCPKMT,Protein-lysine methyltransferase METTL21D,32075,-0.00365058441666976,0.022835869488016,-0.0484088886131812,0.0411077197798417,0.872994135834647
Physical measures,X4270.Volume level set by participant (left),FOLR3,Folate receptor gamma,33429,-0.00146570601107141,0.00918260424457472,-0.0194636103304379,0.0165321983082951,0.873185840981863
Physical measures,X4270.Volume level set by participant (left),CD244,Natural killer cell receptor 2B4,33527,0.0103250956416668,0.064738598585763,-0.116562557586429,0.137212748869762,0.87328715888113
Physical measures,X4270.Volume level set by participant (left),CLEC4A,C-type lectin domain family 4 member A,33421,-0.00803280428281329,0.0503944390113647,-0.106805904745088,0.0907402961794614,0.873358412572359
Physical measures,X4270.Volume level set by participant (left),MYBPC2,"Myosin-binding protein C, fast-type",32163,-0.00384783157952349,0.0242533280352664,-0.0513843545286456,0.0436886913695986,0.873947454860167
Physical measures,X4270.Volume level set by participant (left),CNTNAP2,Contactin-associated protein-like 2,33421,0.00676127994736209,0.0426660748816899,-0.0768642268207502,0.0903867867154743,0.874090266362654
Physical measures,X4270.Volume level set by participant (left),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,33453,0.00927077526604615,0.0585387239937976,-0.105465123761797,0.12400667429389,0.874168838933586
Physical measures,X4270.Volume level set by participant (left),HBQ1,Hemoglobin subunit theta-1,33509,-0.00429545881349947,0.0271250545799986,-0.0574605657902967,0.0488696481632977,0.874178546281253
Physical measures,X4270.Volume level set by participant (left),TSPAN15,Tetraspanin-15,32122,0.00636242482235859,0.0402483813283147,-0.0725244025811383,0.0852492522258555,0.874398692582282
Physical measures,X4270.Volume level set by participant (left),MUC2,Mucin-2,32384,-0.00341404012553241,0.0216507587755348,-0.0458495273255806,0.0390214470745158,0.874707571985976
Physical measures,X4270.Volume level set by participant (left),CREBZF,CREB/ATF bZIP transcription factor,32075,0.0122487569900142,0.0780543775804777,-0.140737823067722,0.165235337047751,0.87530736924125
Physical measures,X4270.Volume level set by participant (left),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,32319,0.0031602324221359,0.0202316864684938,-0.0364938730561119,0.0428143379003837,0.875877711130633
Physical measures,X4270.Volume level set by participant (left),PRSS8,Prostasin,33393,0.00672553488027172,0.0432455520105904,-0.0780357470604854,0.0914868168210288,0.876415143657332
Physical measures,X4270.Volume level set by participant (left),KRT18,"Keratin, type I cytoskeletal 18",33386,0.00350207355064955,0.0225247164154506,-0.0406463706236336,0.0476505177249327,0.876448860894627
Physical measures,X4270.Volume level set by participant (left),FXYD5,FXYD domain-containing ion transport regulator 5,33273,-0.00426537725936408,0.0275587008525667,-0.0582804309303949,0.0497496764116667,0.877002834237047
Physical measures,X4270.Volume level set by participant (left),TRAF2,TNF receptor-associated factor 2,33421,0.00389634580574964,0.0251849612476973,-0.0454661782397371,0.0532588698512364,0.877054040322225
Physical measures,X4270.Volume level set by participant (left),HEXIM1,Protein HEXIM1,33421,0.00341153556152631,0.0220762045866214,-0.0398578254282517,0.0466808965513043,0.877191777573726
Physical measures,X4270.Volume level set by participant (left),USP47,Ubiquitin carboxyl-terminal hydrolase 47,32122,0.00357762281433826,0.0231608268302669,-0.0418175977729849,0.0489728434016614,0.87724425448521
Physical measures,X4270.Volume level set by participant (left),PTPRS,Receptor-type tyrosine-protein phosphatase S,33533,0.0109068309069309,0.070735785007346,-0.127735307707467,0.149548969521329,0.877462460170185
Physical measures,X4270.Volume level set by participant (left),CSH1,Chorionic somatomammotropin hormone 1,32381,-0.0081610404153906,0.0531004173726683,-0.112237858465821,0.0959157776350393,0.877857529210018
Physical measures,X4270.Volume level set by participant (left),SORCS2,VPS10 domain-containing receptor SorCS2,33232,0.00744690330470501,0.0486481688021214,-0.087903507547453,0.102797314156863,0.878341273850626
Physical measures,X4270.Volume level set by participant (left),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,33500,0.00576089186947322,0.0377042514995772,-0.068139441069698,0.0796612248086445,0.878566052159861
Physical measures,X4270.Volume level set by participant (left),CHCHD6,MICOS complex subunit MIC25,32319,-0.0102719315719454,0.0674146002972889,-0.142404548154632,0.121860685010741,0.878899389744858
Physical measures,X4270.Volume level set by participant (left),CRX,Cone-rod homeobox protein,33273,0.00242687038012819,0.0160743732553305,-0.0290789012003195,0.0339326419605759,0.879996835257101
Physical measures,X4270.Volume level set by participant (left),EXOSC10,Exosome component 10,32122,0.00480882489396522,0.0319523499625141,-0.0578177810325625,0.0674354308204929,0.880374203013167
Physical measures,X4270.Volume level set by participant (left),BTD,Biotinidase,32398,0.0144590702715636,0.0961375896931956,-0.1739706055271,0.202888746070227,0.880453050699974
Physical measures,X4270.Volume level set by participant (left),VWC2,Brorin,33339,-0.00674201535545707,0.0449833282655146,-0.0949093387558657,0.0814253080449515,0.880864199813291
Physical measures,X4270.Volume level set by participant (left),VCAN,Versican core protein,33500,-0.00845073688314721,0.0564755838323845,-0.119142881194621,0.102241407428326,0.881055749092067
Physical measures,X4270.Volume level set by participant (left),CLEC14A,C-type lectin domain family 14 member A,33441,-0.00832468410248153,0.0557322197094995,-0.117559834733101,0.100910466528138,0.881265566389797
Physical measures,X4270.Volume level set by participant (left),ATXN2,Ataxin-2,32111,0.00266002736727121,0.0178635668070374,-0.0323525635745221,0.0376726183090645,0.881630178649
Physical measures,X4270.Volume level set by participant (left),CHRDL2,Chordin-like protein 2,33434,-0.00434904573883619,0.0292811646441397,-0.06174012844135,0.0530420369636776,0.881930155437168
Physical measures,X4270.Volume level set by participant (left),CD69,Early activation antigen CD69,33386,0.00304181139600648,0.0205151562923791,-0.0371678949370565,0.0432515177290695,0.882131915340711
Physical measures,X4270.Volume level set by participant (left),CCL24,C-C motif chemokine 24,33468,-0.00307836923332696,0.0207714021930328,-0.0437903175316713,0.0376335790650174,0.882186445189704
Physical measures,X4270.Volume level set by participant (left),C1S,Complement C1s subcomponent,32398,0.0138144046988039,0.0932631689569862,-0.168981406456889,0.196610215854497,0.882249590802456
Physical measures,X4270.Volume level set by participant (left),SPRR3,Small proline-rich protein 3,32353,0.00408952215485768,0.0276190190007784,-0.050043755086668,0.0582227993963834,0.882292047441641
Physical measures,X4270.Volume level set by participant (left),EPHB4,Ephrin type-B receptor 4,33533,-0.01038176876645,0.0701254034577652,-0.14782755954367,0.12706402201077,0.882309941581952
Physical measures,X4270.Volume level set by participant (left),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",32163,-0.00424884041124864,0.028703391555025,-0.0605074878590976,0.0520098070366003,0.882326336341925
Physical measures,X4270.Volume level set by participant (left),TLR2,Toll-like receptor 2,32235,0.01279487076758,0.0866473572516222,-0.1570339494456,0.18262369098076,0.8826101727974
Physical measures,X4270.Volume level set by participant (left),CYTH3,Cytohesin-3,32075,0.00403741004206816,0.0273486630571169,-0.0495659695498809,0.0576407896340173,0.882640792901576
Physical measures,X4270.Volume level set by participant (left),CD22,B-cell receptor CD22,33527,-0.00626084042364494,0.0427864131724798,-0.0901222102417054,0.0776005293944155,0.88366589578817
Physical measures,X4270.Volume level set by participant (left),DNAJA2,DnaJ homolog subfamily A member 2,33487,-0.00319508027589592,0.0221575573122636,-0.0466238926079325,0.0402337320561407,0.885347165363182
Physical measures,X4270.Volume level set by participant (left),SLC27A4,Long-chain fatty acid transport protein 4,33219,0.00321842406187767,0.0223210954023767,-0.0405309229267806,0.0469677710505359,0.885355687072383
Physical measures,X4270.Volume level set by participant (left),KCNH2,Potassium voltage-gated channel subfamily H member 2,32154,0.00365344191683231,0.0254265792039495,-0.0461826533229086,0.0534895371565733,0.885752235258875
Physical measures,X4270.Volume level set by participant (left),VSNL1,Visinin-like protein 1,32353,-0.00792862593067173,0.0552296048681979,-0.11617865147234,0.100321399610996,0.8858535378297
Physical measures,X4270.Volume level set by participant (left),PADI4,Protein-arginine deiminase type-4,33204,-0.00357604636582248,0.0251294632955162,-0.0528297944250343,0.0456777016933893,0.886842434038205
Physical measures,X4270.Volume level set by participant (left),CSF2,Granulocyte-macrophage colony-stimulating factor,32122,0.00809939192160957,0.0571806290034949,-0.10397464092524,0.12017342476846,0.887363565498567
Physical measures,X4270.Volume level set by participant (left),CXCL11,C-X-C motif chemokine 11,33500,0.00304899199569815,0.0215352580812054,-0.0391601138434643,0.0452580978348606,0.887413812406437
Physical measures,X4270.Volume level set by participant (left),FOSB,Protein fosB,33219,-0.00620773162674187,0.043856304128369,-0.092166087718345,0.0797506244648613,0.887441026265432
Physical measures,X4270.Volume level set by participant (left),ANXA4,Annexin A4,33393,0.00349989488489342,0.0248689226894278,-0.0452431935863851,0.052242983356172,0.888083512370043
Physical measures,X4270.Volume level set by participant (left),PBK,Lymphokine-activated killer T-cell-originated protein kinase,32075,-0.00940082308704496,0.0669098360345759,-0.140544101714814,0.121742455540724,0.888268770907173
Physical measures,X4270.Volume level set by participant (left),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",33533,0.00841186240033203,0.059983408186029,-0.109155617644285,0.125979342444949,0.888476256065895
Physical measures,X4270.Volume level set by participant (left),EPHA10,Ephrin type-A receptor 10,33219,-0.00374865889550706,0.0267548649113181,-0.0561881941216906,0.0486908763306765,0.888575272578117
Physical measures,X4270.Volume level set by participant (left),DMD,Dystrophin,32163,-0.00515218821353859,0.0369217951811549,-0.0775189067686021,0.0672145303415249,0.889024507783558
Physical measures,X4270.Volume level set by participant (left),MMP3,Stromelysin-1,33441,0.00494083199878823,0.0356768681915463,-0.0649858296566426,0.0748674936542191,0.889857548645586
Physical measures,X4270.Volume level set by participant (left),LYPD1,Ly6/PLAUR domain-containing protein 1,33219,-0.00383815563720417,0.0277198787507533,-0.0581691179886807,0.0504928067142723,0.889878316126538
Physical measures,X4270.Volume level set by participant (left),AKR1C4,Aldo-keto reductase family 1 member C4,33273,0.00448099953801108,0.0323640467899726,-0.0589525321703352,0.0679145312463573,0.889883127983138
Physical measures,X4270.Volume level set by participant (left),KYNU,Kynureninase,33527,-0.00525658581520905,0.0380114209910719,-0.0797589709577101,0.069245799327292,0.890014580313011
Physical measures,X4270.Volume level set by participant (left),PLTP,Phospholipid transfer protein,33491,-0.00702546638359789,0.0508975013431198,-0.106784569016113,0.092733636248917,0.890218474977442
Physical measures,X4270.Volume level set by participant (left),DHPS,Deoxyhypusine synthase,32319,0.00660162013873109,0.0479407217204161,-0.0873621944332844,0.100565434710747,0.890478031897975
Physical measures,X4270.Volume level set by participant (left),NPC2,NPC intracellular cholesterol transporter 2,32232,-0.00876441524989801,0.0644648656625032,-0.135115551948404,0.117586721448608,0.891859216096092
Physical measures,X4270.Volume level set by participant (left),GFAP,Glial fibrillary acidic protein,33215,-0.00519313233828101,0.0382826245797154,-0.0802270765145232,0.0698408118379612,0.892099145650697
Physical measures,X4270.Volume level set by participant (left),IL10RB,Interleukin-10 receptor subunit beta,33481,-0.00818800440447235,0.0606559876331764,-0.127073740165498,0.110697731356553,0.892622104741014
Physical measures,X4270.Volume level set by participant (left),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,33232,0.00185681770923591,0.01377117600677,-0.0251346872640333,0.0288483226825051,0.892746504085259
Physical measures,X4270.Volume level set by participant (left),SAMD9L,Sterile alpha motif domain-containing protein 9-like,33421,0.00328957231871022,0.0245460548389379,-0.044820695165608,0.0513998398030285,0.893392665060263
Physical measures,X4270.Volume level set by participant (left),CA1,Carbonic anhydrase 1,33215,-0.00364542370176386,0.0275350174595847,-0.0576140579225498,0.0503232105190221,0.894677062424461
Physical measures,X4270.Volume level set by participant (left),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,33127,-0.00265454665850495,0.0200769680440342,-0.042005404024812,0.0366963107078021,0.894814533816585
Physical measures,X4270.Volume level set by participant (left),TGOLN2,Trans-Golgi network integral membrane protein 2,32381,-0.0101310194020546,0.0766849831202206,-0.160433586317687,0.140171547513578,0.894898924712474
Physical measures,X4270.Volume level set by participant (left),RBP1,Retinol-binding protein 1,32154,-0.00367697285681868,0.0280187296362617,-0.0585936829438916,0.0512397372302542,0.895594677004799
Physical measures,X4270.Volume level set by participant (left),FAM171A2,Protein FAM171A2,32350,0.00161247244059966,0.0123026059509945,-0.0225006352233496,0.0257255801045489,0.895725209252596
Physical measures,X4270.Volume level set by participant (left),LRRC38,Leucine-rich repeat-containing protein 38,32154,0.00528313496784729,0.0404186004550849,-0.0739373219241191,0.0845035918598137,0.896007750781516
Physical measures,X4270.Volume level set by participant (left),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,33441,-0.00629765957178777,0.0482221407076788,-0.100813055358838,0.0882177362152627,0.89609715979546
Physical measures,X4270.Volume level set by participant (left),BLVRB,Flavin reductase,33441,-0.00314551147286745,0.0242442680527039,-0.0506642768561671,0.0443732539104322,0.896773076007031
Physical measures,X4270.Volume level set by participant (left),SEMA3F,Semaphorin-3F,33434,-0.00876132451915572,0.0675711004956566,-0.141200681490643,0.123678032452331,0.89683768366695
Physical measures,X4270.Volume level set by participant (left),SOD1,Superoxide dismutase [Cu-Zn],33243,0.00473806374877744,0.0366070778636545,-0.0670118088639854,0.0764879363615403,0.897020164025269
Physical measures,X4270.Volume level set by participant (left),LAMP2,Lysosome-associated membrane glycoprotein 2,33140,-0.0124608335881648,0.0966520203588819,-0.201898793491573,0.176977126315244,0.897420210280045
Physical measures,X4270.Volume level set by participant (left),GYS1,"Glycogen [starch] synthase, muscle",33273,0.00252330105480951,0.0195933005141446,-0.0358795679529139,0.0409261700625329,0.897531606599206
Physical measures,X4270.Volume level set by participant (left),ATP6V1G2,V-type proton ATPase subunit G 2,32122,-0.00266099767270267,0.0207698464074297,-0.0433698966312648,0.0380479012858595,0.898058704393081
Physical measures,X4270.Volume level set by participant (left),CLSTN2,Calsyntenin-2,33527,0.0055370892425754,0.0436998699718065,-0.0801146559021652,0.091188834387316,0.89917493551076
Physical measures,X4270.Volume level set by participant (left),PALM2,Paralemmin-2,32353,-0.00700419567700279,0.0555217304685876,-0.115826787395435,0.101818396041429,0.899614555866386
Physical measures,X4270.Volume level set by participant (left),PROK1,Prokineticin-1,33421,-0.00310885084028979,0.0246455592414415,-0.0514141469535151,0.0451964452729356,0.899622006294437
Physical measures,X4270.Volume level set by participant (left),TTF2,Transcription termination factor 2,32154,-0.00523092426766383,0.0415296373600224,-0.0866290134933077,0.07616716495798,0.89976971384207
Physical measures,X4270.Volume level set by participant (left),CCN4,CCN family member 4,33509,-0.00525881678404319,0.0417606356451636,-0.0871096626485638,0.0765920290804774,0.899792027898904
Physical measures,X4270.Volume level set by participant (left),IGSF9,Protein turtle homolog A,32365,-0.00311244344420571,0.0247216536187175,-0.051566884536892,0.0453419976484805,0.899814690509974
Physical measures,X4270.Volume level set by participant (left),PTPRC,Receptor-type tyrosine-protein phosphatase C,32384,-0.0111099841955202,0.0886560808954883,-0.184875902750677,0.162655934359637,0.900276931092658
Physical measures,X4270.Volume level set by participant (left),CCDC50,Coiled-coil domain-containing protein 50,32350,0.00318942848591412,0.0255429766959721,-0.0468748058381912,0.0532536628100194,0.900633460757154
Physical measures,X4270.Volume level set by participant (left),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,33273,-0.0058867650808083,0.0473732440271156,-0.0987383233739549,0.0869647932123383,0.901109478878554
Physical measures,X4270.Volume level set by participant (left),SPRING1,SREBP regulating gene protein,32075,0.00421090602229865,0.0339456412722898,-0.0623225508713893,0.0707443629159866,0.901280142755332
Physical measures,X4270.Volume level set by participant (left),DPEP1,Dipeptidase 1,33356,-0.00425682461509861,0.0343277856078672,-0.0715392844065184,0.0630256351763211,0.901313941839078
Physical measures,X4270.Volume level set by participant (left),GSTA3,Glutathione S-transferase A3,33232,0.00283547366210522,0.0231345687895688,-0.0425082811654496,0.0481792284896601,0.902454882790991
Physical measures,X4270.Volume level set by participant (left),APOB,Apolipoprotein B-100,32381,-0.0105622925053395,0.0862243473121078,-0.179562013237071,0.158437428226392,0.902507897088088
Physical measures,X4270.Volume level set by participant (left),TSC22D1,TSC22 domain family protein 1,32350,-0.00359758292847249,0.0294427700181864,-0.0613054121641179,0.0541102463071729,0.902752439668273
Physical measures,X4270.Volume level set by participant (left),PIGR,Polymeric immunoglobulin receptor,33314,-0.00612470776270309,0.0501286323453237,-0.104376827159538,0.0921274116341314,0.902759371630079
Physical measures,X4270.Volume level set by participant (left),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,32163,0.00389527358337835,0.0322743801057618,-0.0593625114239148,0.0671530585906715,0.903937795491258
Physical measures,X4270.Volume level set by participant (left),CALB2,Calretinin,33219,0.0068285452578815,0.0568156937374807,-0.104530214467581,0.118187304983344,0.904337248148718
Physical measures,X4270.Volume level set by participant (left),CFB,Complement factor B,32252,-0.00718834890996892,0.059907791014774,-0.124607619298926,0.110230921478988,0.904493988322463
Physical measures,X4270.Volume level set by participant (left),SCARF1,Scavenger receptor class F member 1,33533,0.00480996540213887,0.0403015913325374,-0.0741811536096344,0.0838010844139121,0.905001293537927
Physical measures,X4270.Volume level set by participant (left),SMAD5,Mothers against decapentaplegic homolog 5,33386,-0.00959088305175533,0.0814607287658126,-0.169253911432748,0.150072145329237,0.906279268167923
Physical measures,X4270.Volume level set by participant (left),CD8A,T-cell surface glycoprotein CD8 alpha chain,33500,-0.00410820841095923,0.0349624527075074,-0.0726346157176737,0.0644181988957553,0.906463728399782
Physical measures,X4270.Volume level set by participant (left),CES3,Carboxylesterase 3,33386,0.00252847824582435,0.0215324534866307,-0.0396751305879718,0.0447320870796205,0.906524814365917
Physical measures,X4270.Volume level set by participant (left),MERTK,Tyrosine-protein kinase Mer,33527,-0.00761318606653981,0.0649764136598623,-0.13496695683987,0.11974058470679,0.906729156869276
Physical measures,X4270.Volume level set by participant (left),SCLY,Selenocysteine lyase,33489,0.00426776319495092,0.036491484177057,-0.0672555457920808,0.0757910721819826,0.906900448703962
Physical measures,X4270.Volume level set by participant (left),IGHMBP2,DNA-binding protein SMUBP-2,32122,-0.00408153041379157,0.0351250124759708,-0.0729265548666942,0.0647634940391111,0.907496990627246
Physical measures,X4270.Volume level set by participant (left),TBR1,T-box brain protein 1,32154,0.00470856042914843,0.0407151453085636,-0.0750931243756363,0.0845102452339332,0.907935795005993
Physical measures,X4270.Volume level set by participant (left),IRAK4,Interleukin-1 receptor-associated kinase 4,33421,0.00203341415865696,0.0177159542692224,-0.032689856209019,0.0367566845263329,0.908623104419458
Physical measures,X4270.Volume level set by participant (left),AKR1B1,Aldo-keto reductase family 1 member B1,33232,0.00273908280970949,0.0240667934232557,-0.0444318322998717,0.0499099979192906,0.909389662204423
Physical measures,X4270.Volume level set by participant (left),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",32350,0.0032324161821605,0.0286194411442924,-0.0528616884606527,0.0593265208249737,0.91007721407964
Physical measures,X4270.Volume level set by participant (left),CSTB,Cystatin-B,33284,-0.00457529887425382,0.0405188565179968,-0.0839922576495276,0.0748416599010199,0.910098316117635
Physical measures,X4270.Volume level set by participant (left),M6PR,Cation-dependent mannose-6-phosphate receptor,32163,0.00554029650199157,0.0492151224628794,-0.0909213435252521,0.102001936529235,0.910371982670489
Physical measures,X4270.Volume level set by participant (left),TBC1D5,TBC1 domain family member 5,33421,-0.00240799019314729,0.0214406597162465,-0.0444316832369905,0.0396157028506959,0.910580508172571
Physical measures,X4270.Volume level set by participant (left),USO1,General vesicular transport factor p115,33386,-0.00223659034262769,0.0199803057865199,-0.0413979896842067,0.0369248089989513,0.910873697984065
Physical measures,X4270.Volume level set by participant (left),IL20,Interleukin-20,33273,-0.00386728944196802,0.0346623248356704,-0.0718054461198821,0.064070867235946,0.911166582290776
Physical measures,X4270.Volume level set by participant (left),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",32221,-0.00362505178621808,0.0325007930167084,-0.0673266060989665,0.0600765025265303,0.911193144979524
Physical measures,X4270.Volume level set by participant (left),TPSD1,Tryptase delta,32350,0.00585962347018351,0.0529069622803932,-0.0978380225993871,0.109557269539754,0.911814751797507
Physical measures,X4270.Volume level set by participant (left),GP6,Platelet glycoprotein VI,33422,0.00221820284814894,0.0201715258749878,-0.0373179878668272,0.0417543935631251,0.912437981140948
Physical measures,X4270.Volume level set by participant (left),PALM3,Paralemmin-3,32122,-0.0028790722713079,0.0261883590981673,-0.0542082561037158,0.0484501115611,0.912462136055769
Physical measures,X4270.Volume level set by participant (left),AGR2,Anterior gradient protein 2 homolog,33138,0.00186707033652495,0.0169840241110952,-0.0314216169212216,0.0351557575942715,0.912466657092322
Physical measures,X4270.Volume level set by participant (left),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,33144,-0.00302960651379764,0.0275737815778603,-0.0570742184064039,0.0510150053788086,0.912512851415477
Physical measures,X4270.Volume level set by participant (left),VSIG2,V-set and immunoglobulin domain-containing protein 2,32319,0.00388795723163817,0.0354496255229495,-0.0655933087933429,0.0733692232566192,0.912669488925381
Physical measures,X4270.Volume level set by participant (left),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,32384,-0.00837202703474566,0.0766938016806916,-0.158691878328901,0.14194782425941,0.913076986993753
Physical measures,X4270.Volume level set by participant (left),S100A13,Protein S100-A13,32140,-0.00637411577136915,0.0586551341330126,-0.121338178672074,0.108589947129335,0.913466231466167
Physical measures,X4270.Volume level set by participant (left),FGF2,Fibroblast growth factor 2,33421,-0.00281928244232808,0.0260101803399883,-0.0537992359087051,0.0481606710240489,0.913687569486195
Physical measures,X4270.Volume level set by participant (left),TRIM5,Tripartite motif-containing protein 5,33421,-0.00227225321044433,0.0211227705031852,-0.0436728833966874,0.0391283769757987,0.914336318531895
Physical measures,X4270.Volume level set by participant (left),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,33393,-0.00102290015982279,0.0095136176737221,-0.0196695908003181,0.0176237904806725,0.91437920741646
Physical measures,X4270.Volume level set by participant (left),IL17RA,Interleukin-17 receptor A,33441,-0.00418428469017067,0.0390379681851221,-0.08069870233301,0.0723301329526686,0.914644606517671
Physical measures,X4270.Volume level set by participant (left),CCDC134,Coiled-coil domain-containing protein 134,32319,-0.00441761310049712,0.0412854770707114,-0.0853371481590915,0.0765019219580973,0.914790420733818
Physical measures,X4270.Volume level set by participant (left),KIT,Mast/stem cell growth factor receptor Kit,33435,0.00621239678858537,0.0580595974096297,-0.107584414134289,0.12000920771146,0.914791098544267
Physical measures,X4270.Volume level set by participant (left),HEPH,Hephaestin,32365,-0.00830856409454169,0.0781896586006744,-0.161560294951863,0.14494316676278,0.915377432881413
Physical measures,X4270.Volume level set by participant (left),STXBP1,Syntaxin-binding protein 1,32350,-0.00280817041219945,0.0265380177313012,-0.0548226851655497,0.0492063443411508,0.915730326780167
Physical measures,X4270.Volume level set by participant (left),CRELD1,Protein disulfide isomerase CRELD1,32213,-0.0056875442485266,0.0537564999820808,-0.111050284213405,0.0996751957163518,0.915742199535251
Physical measures,X4270.Volume level set by participant (left),CLEC7A,C-type lectin domain family 7 member A,33527,0.00295067119217498,0.0280702809353786,-0.0520670794411671,0.0579684218255171,0.916285082698815
Physical measures,X4270.Volume level set by participant (left),ODAM,Odontogenic ameloblast-associated protein,33204,-0.00341201363367443,0.0326061391050442,-0.067320046279561,0.0604960190122122,0.916661262405318
Physical measures,X4270.Volume level set by participant (left),STX4,Syntaxin-4,33386,-0.00265279261458951,0.0254196018180059,-0.0524752121778811,0.0471696269487021,0.916885915401497
Physical measures,X4270.Volume level set by participant (left),SCGB3A1,Secretoglobin family 3A member 1,32213,0.00833441787812834,0.0798725398110383,-0.148215760151507,0.164884595907763,0.916897095831247
Physical measures,X4270.Volume level set by participant (left),MSLN,Mesothelin,33376,0.0033592154431777,0.0322680874116197,-0.059886235883597,0.0666046667699524,0.917089686226646
Physical measures,X4270.Volume level set by participant (left),CCL19,C-C motif chemokine 19,33500,0.00135378258841077,0.0131502271650619,-0.0244206626551105,0.027128227831932,0.918006946128359
Physical measures,X4270.Volume level set by participant (left),NFKB2,Nuclear factor NF-kappa-B p100 subunit,32235,0.00346680655089319,0.0338030015131081,-0.0627870764147987,0.0697206895165851,0.918315521533795
Physical measures,X4270.Volume level set by participant (left),SERPING1,Plasma protease C1 inhibitor,32381,0.0107695096264405,0.105027522606353,-0.195084434682012,0.216623453934893,0.918330753534425
Physical measures,X4270.Volume level set by participant (left),PSMA1,Proteasome subunit alpha type-1,33232,0.00382405908747409,0.0374769988440919,-0.069630858646946,0.0772789768218942,0.918729244477663
Physical measures,X4270.Volume level set by participant (left),PSMG3,Proteasome assembly chaperone 3,33421,0.00336363806409236,0.0329994684564184,-0.0613153201104878,0.0680425962386725,0.918814462777926
Physical measures,X4270.Volume level set by participant (left),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,33380,0.00321240644044845,0.0320742407250622,-0.0596531053806734,0.0660779182615703,0.92022325184466
Physical measures,X4270.Volume level set by participant (left),RAB44,Ras-related protein Rab-44,32319,0.00482221875150711,0.0483515209150548,-0.0899467622420003,0.0995911997450145,0.920559228708626
Physical measures,X4270.Volume level set by participant (left),CNGB3,Cyclic nucleotide-gated cation channel beta-3,32111,0.0035509864934689,0.0356663401143806,-0.0663550401307172,0.073457013117655,0.920695241410916
Physical measures,X4270.Volume level set by participant (left),SERPINE1,Plasminogen activator inhibitor 1,33533,0.00247685196477257,0.0249965110435308,-0.0465163096805478,0.051470013610093,0.921070661389818
Physical measures,X4270.Volume level set by participant (left),SPRR1B,Cornifin-B,32235,-0.00222092906177367,0.0224187906598109,-0.0461617587550029,0.0417199006314556,0.921088803987485
Physical measures,X4270.Volume level set by participant (left),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,32140,0.00587339542052107,0.0593658225031808,-0.110483616685713,0.122230407526755,0.921191954463834
Physical measures,X4270.Volume level set by participant (left),AKT1S1,Proline-rich AKT1 substrate 1,33219,-0.00276415219957184,0.0280272784000566,-0.0576976178636828,0.0521693134645391,0.921439355465381
Physical measures,X4270.Volume level set by participant (left),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",32111,-0.00343241774172402,0.0348619738849307,-0.0717618865561882,0.0648970510727402,0.921571710619236
Physical measures,X4270.Volume level set by participant (left),TGFBR1,TGF-beta receptor type-1,32140,-0.00915472077088218,0.0929844039165577,-0.191404152447335,0.173094710905571,0.921574072216948
Physical measures,X4270.Volume level set by participant (left),IFNG,Interferon gamma,33273,0.00150024286786246,0.0153058310345137,-0.0284991859597843,0.0314996716955092,0.921920439642459
Physical measures,X4270.Volume level set by participant (left),OCLN,Occludin,32350,0.00449632305430305,0.0459183496626057,-0.085503642284404,0.0944962883930101,0.921998334505563
Physical measures,X4270.Volume level set by participant (left),RILP,Rab-interacting lysosomal protein,33489,-0.00292172141775477,0.0299118681295931,-0.0615489829517573,0.0557055401162478,0.922190418841534
Physical measures,X4270.Volume level set by participant (left),LTA,Lymphotoxin-alpha,33421,0.00420550739134741,0.0431644381343264,-0.0803967913519324,0.0888078061346272,0.922387169461378
Physical measures,X4270.Volume level set by participant (left),FOLR2,Folate receptor beta,33500,0.00563180009375221,0.0579390922776406,-0.107928820770423,0.119192420957928,0.922568072499197
Physical measures,X4270.Volume level set by participant (left),C2,Complement C2,33435,0.00715558756736594,0.0736266307792441,-0.137152608759952,0.151463783894684,0.922579670103162
Physical measures,X4270.Volume level set by participant (left),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,32122,0.00310157071355398,0.0319486918406145,-0.0595178652940504,0.0657210067211584,0.922665607072251
Physical measures,X4270.Volume level set by participant (left),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,33232,0.00282498394166623,0.0297965219604871,-0.0555761991008886,0.061226166984221,0.924468556006145
Physical measures,X4270.Volume level set by participant (left),IFNGR1,Interferon gamma receptor 1,33481,-0.0080252045397946,0.0848106339627332,-0.174254047106752,0.158203638027162,0.924614808159865
Physical measures,X4270.Volume level set by participant (left),BTN2A1,Butyrophilin subfamily 2 member A1,33481,-0.0064258223969431,0.0681195463542394,-0.139940133251252,0.127088488457366,0.924847882202039
Physical measures,X4270.Volume level set by participant (left),EFNA1,Ephrin-A1,33428,0.00618759473455797,0.065620304499802,-0.122428202085054,0.13480339155417,0.924877797135466
Physical measures,X4270.Volume level set by participant (left),CDH17,Cadherin-17,33434,0.00244016817064426,0.0259448927897917,-0.0484118216973475,0.053292158038636,0.925069975410121
Physical measures,X4270.Volume level set by participant (left),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,33423,0.00285351741239147,0.0303711219741855,-0.0566738816570121,0.062380916481795,0.925147037651806
Physical measures,X4270.Volume level set by participant (left),VMO1,Vitelline membrane outer layer protein 1 homolog,33386,-0.00240459580983073,0.0256133890801662,-0.0526068384069565,0.0477976467872951,0.925206251003124
Physical measures,X4270.Volume level set by participant (left),PYDC1,Pyrin domain-containing protein 1,32163,-0.00445333559435107,0.0474708116568188,-0.0974961264417158,0.0885894552530137,0.925260873612596
Physical measures,X4270.Volume level set by participant (left),EIF5,Eukaryotic translation initiation factor 5,32122,-0.00425016634337905,0.0453491185730336,-0.093134438746525,0.0846341060597669,0.925333208980724
Physical measures,X4270.Volume level set by participant (left),EREG,Proepiregulin,33356,0.00203913763516503,0.0221318686199661,-0.0413393248599686,0.0454176001302987,0.926592210867719
Physical measures,X4270.Volume level set by participant (left),TNFSF14,Tumor necrosis factor ligand superfamily member 14,33380,-0.00279463077793156,0.0304946157193291,-0.0625640775878166,0.0569748160319534,0.92698341168927
Physical measures,X4270.Volume level set by participant (left),DNPEP,Aspartyl aminopeptidase,32353,-0.00312998840014111,0.0342408389471374,-0.0702420327365304,0.0639820559362482,0.927168361377968
Physical measures,X4270.Volume level set by participant (left),CDA,Cytidine deaminase,32348,0.00392981759260356,0.0430257476663454,-0.0804006478334334,0.0882602830186405,0.927227600805028
Physical measures,X4270.Volume level set by participant (left),GAS6,Growth arrest-specific protein 6,33455,0.00600863787286044,0.0662844363630077,-0.123908857398635,0.135926133144356,0.927773273313688
Physical measures,X4270.Volume level set by participant (left),SMPD1,Sphingomyelin phosphodiesterase,33458,0.00326407514848445,0.0360152252620151,-0.0673257663650651,0.073853916662034,0.9277882724571
Physical measures,X4270.Volume level set by participant (left),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,32365,-0.00453395481584025,0.0500286185616965,-0.102590047196765,0.0935221375650849,0.927791094087913
Physical measures,X4270.Volume level set by participant (left),FABP9,Fatty acid-binding protein 9,33421,-0.00277976633274336,0.0307435373120987,-0.0630370994644567,0.05747756679897,0.927957146055742
Physical measures,X4270.Volume level set by participant (left),CHRM1,Muscarinic acetylcholine receptor M1,32154,-0.00479748995357608,0.0532017419386482,-0.109072904153327,0.0994779242461744,0.92815015455519
Physical measures,X4270.Volume level set by participant (left),GABARAP,Gamma-aminobutyric acid receptor-associated protein,32319,0.00342488256138347,0.0387009002133845,-0.0724288818568501,0.079278646979617,0.929484558774179
Physical measures,X4270.Volume level set by participant (left),NBN,Nibrin,33273,0.00310259927662518,0.0351415747565138,-0.065774887246142,0.0719800857993923,0.929649330576678
Physical measures,X4270.Volume level set by participant (left),ASGR2,Asialoglycoprotein receptor 2,32381,-0.00672285768372646,0.0767629354264188,-0.157178211119507,0.143732495752054,0.930213127484112
Physical measures,X4270.Volume level set by participant (left),CD207,C-type lectin domain family 4 member K,33230,-0.0040368335951545,0.0461411447770608,-0.0944734773581937,0.0863998101678847,0.930284980330452
Physical measures,X4270.Volume level set by participant (left),MRPL24,"39S ribosomal protein L24, mitochondrial",32122,-0.00454963729204527,0.0521170227337148,-0.106699001850126,0.0975997272660357,0.930438060582186
Physical measures,X4270.Volume level set by participant (left),SCRG1,Scrapie-responsive protein 1,32365,0.00643252369526052,0.0741313803772213,-0.138864981844093,0.151730029234614,0.930854988392731
Physical measures,X4270.Volume level set by participant (left),CCNE1,G1/S-specific cyclin-E1,32140,-0.00184187758459899,0.0212658517776957,-0.0435229470688825,0.0398391918996845,0.930982197382138
Physical measures,X4270.Volume level set by participant (left),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,32213,-0.00277606710451743,0.0321282845206723,-0.0657475047650352,0.0601953705560004,0.931146141061805
Physical measures,X4270.Volume level set by participant (left),CRIP2,Cysteine-rich protein 2,33380,0.00417760141252566,0.0484661054574626,-0.090815965284101,0.0991711681091523,0.931312265357931
Physical measures,X4270.Volume level set by participant (left),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,32122,-0.00538957776136695,0.0633207614754371,-0.129498270253224,0.11871911473049,0.932171796612757
Physical measures,X4270.Volume level set by participant (left),SPRY2,Protein sprouty homolog 2,33273,0.00165296327457238,0.019442314509207,-0.0364539731634733,0.039759899712618,0.932248332727909
Physical measures,X4270.Volume level set by participant (left),RNF168,E3 ubiquitin-protein ligase RNF168,32140,-0.00403914692457464,0.0477024088487616,-0.0975358682681474,0.0894575744189981,0.932522886333933
Physical measures,X4270.Volume level set by participant (left),LDLRAP1,Low density lipoprotein receptor adapter protein 1,32350,-0.0018020593176793,0.0213303442487784,-0.043609534045285,0.0400054154099264,0.932674268221303
Physical measures,X4270.Volume level set by participant (left),SCN3A,Sodium channel protein type 3 subunit alpha,32154,0.00457387326571159,0.0542955670961559,-0.101845438242754,0.110993184774177,0.932867590859134
Physical measures,X4270.Volume level set by participant (left),SCARA5,Scavenger receptor class A member 5,33500,0.00490063934987507,0.0585865624439592,-0.109929023040285,0.119730301740035,0.933338281167093
Physical measures,X4270.Volume level set by participant (left),PPP1R2,Protein phosphatase inhibitor 2,33434,-0.00187739828167619,0.0225087598024479,-0.045994567494474,0.0422397709311216,0.93352942337478
Physical measures,X4270.Volume level set by participant (left),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,32140,-0.00443397926221301,0.0536049972858088,-0.109499773942398,0.100631815417972,0.934079689999999
Physical measures,X4270.Volume level set by participant (left),TRAF3,"TNF receptor-associated factor 3, Isoform 2",32140,0.00459832673520824,0.0559929780407291,-0.105147910224621,0.114344563695037,0.934550823541527
Physical measures,X4270.Volume level set by participant (left),FGA,Fibrinogen alpha chain,32212,-0.0055072031642978,0.0671978993073121,-0.13721508580663,0.126200679478034,0.934684620267535
Physical measures,X4270.Volume level set by participant (left),FNDC1,Fibronectin type III domain-containing protein 1,32353,0.0035901233034614,0.0438598690842245,-0.0823752201016186,0.0895554667085414,0.934764569746947
Physical measures,X4270.Volume level set by participant (left),PPP1R9B,Neurabin-2,33527,-0.00146879036316448,0.0182998121032201,-0.0373364220854759,0.0343988413591469,0.936030179400152
Physical measures,X4270.Volume level set by participant (left),ICAM3,Intercellular adhesion molecule 3,33533,0.00545439089531658,0.0682306395262137,-0.128277662576062,0.139186444366695,0.936286346975551
Physical measures,X4270.Volume level set by participant (left),PLXNA4,Plexin-A4,33421,-0.00169774257290362,0.0214914522264275,-0.0438209889367015,0.0404255037908943,0.937037426448421
Physical measures,X4270.Volume level set by participant (left),IL1RL2,Interleukin-1 receptor-like 2,33273,-0.00340208336952866,0.0436398240521512,-0.0889361385117449,0.0821319717726876,0.937863049548231
Physical measures,X4270.Volume level set by participant (left),NAMPT,Nicotinamide phosphoribosyltransferase,33232,0.00257683587966456,0.0330551816538585,-0.0622113201618981,0.0673649919212272,0.937865163907731
Physical measures,X4270.Volume level set by participant (left),DNLZ,DNL-type zinc finger protein,32111,-0.0016528353995302,0.0216267062883135,-0.0440411797246246,0.0407355089255642,0.939082448944581
Physical measures,X4270.Volume level set by participant (left),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",33219,-0.00269926726286762,0.0354668278056292,-0.0722142497619009,0.0668157152361656,0.939335856353475
Physical measures,X4270.Volume level set by participant (left),ERI1,3'-5' exoribonuclease 1,32235,-0.00467552583041025,0.0619347901137502,-0.126067714453361,0.11671666279254,0.939825914384023
Physical measures,X4270.Volume level set by participant (left),AAMDC,Mth938 domain-containing protein,32163,0.00291888378596632,0.0387339578643425,-0.0729996736281449,0.0788374412000776,0.939932443237243
Physical measures,X4270.Volume level set by participant (left),RUVBL1,RuvB-like 1,33232,-0.00125347767268634,0.0166527008181585,-0.0338927712762769,0.0313858159309043,0.940000225832559
Physical measures,X4270.Volume level set by participant (left),NAA80,N-alpha-acetyltransferase 80,32154,-0.00132984078611586,0.017667316407814,-0.0359577809454312,0.0332980993731995,0.940000860587263
Physical measures,X4270.Volume level set by participant (left),BRD3,Bromodomain-containing protein 3,32122,-0.00317047164564833,0.0424201918441512,-0.0863140476601846,0.079973104368888,0.940423784207184
Physical measures,X4270.Volume level set by participant (left),VEGFC,Vascular endothelial growth factor C,33456,0.00230741374605428,0.0311519547043314,-0.0587504174744353,0.0633652449665439,0.940956626851104
Physical measures,X4270.Volume level set by participant (left),PRAP1,Proline-rich acidic protein 1,32384,-0.00348875511876055,0.0471917010106758,-0.0959844890996851,0.089006978862164,0.941070096494919
Physical measures,X4270.Volume level set by participant (left),REG1B,Lithostathine-1-beta,33533,-0.00225776207974007,0.0311418212510167,-0.0632957317317328,0.0587802075722527,0.942206112726443
Physical measures,X4270.Volume level set by participant (left),SPINT1,Kunitz-type protease inhibitor 1,33408,-0.00501754135401846,0.0692878156010686,-0.140821659932113,0.130786577224076,0.942272528251302
Physical measures,X4270.Volume level set by participant (left),TRIM21,E3 ubiquitin-protein ligase TRIM21,33421,-0.00155699561667798,0.0216340908796003,-0.0439598137406946,0.0408458225073386,0.942627752024019
Physical measures,X4270.Volume level set by participant (left),CRYBB2,Beta-crystallin B2,32353,0.00209863836503311,0.0292083939396479,-0.0551498137566768,0.059347090486743,0.942722684857249
Physical measures,X4270.Volume level set by participant (left),ADA,Adenosine deaminase,33527,0.00354657094198571,0.0493841071901094,-0.0932462791506288,0.1003394210346,0.942749892015134
Physical measures,X4270.Volume level set by participant (left),TEK,Angiopoietin-1 receptor,33456,-0.00563413993759039,0.0787197489836611,-0.159924847945566,0.148656568070385,0.942944012070609
Physical measures,X4270.Volume level set by participant (left),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,32319,0.0022083027141761,0.0308717701639021,-0.0583003668070721,0.0627169722354243,0.942976608239536
Physical measures,X4270.Volume level set by participant (left),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,32025,0.00286720043797684,0.0403505961271907,-0.076219967971317,0.0819543688472707,0.943354107365971
Physical measures,X4270.Volume level set by participant (left),DCLRE1C,Protein artemis,32075,-0.00449425265935361,0.0633508332994179,-0.128661885926213,0.119673380607505,0.943445553932332
Physical measures,X4270.Volume level set by participant (left),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,33509,-0.0040274385024113,0.0569050230004251,-0.115561283583245,0.107506406578422,0.943578594960376
Physical measures,X4270.Volume level set by participant (left),CALCB,Calcitonin gene-related peptide 2,32353,0.00375988125698355,0.0533136922555572,-0.100734955563908,0.108254718077876,0.943778587059509
Physical measures,X4270.Volume level set by participant (left),SMOC1,SPARC-related modular calcium-binding protein 1,33509,-0.00365528891932392,0.0520227957426437,-0.105619968574905,0.0983093907362576,0.943985711499214
Physical measures,X4270.Volume level set by participant (left),CD300C,CMRF35-like molecule 6,33500,0.00357412292451879,0.0513536243161969,-0.0970789807352271,0.104227226584265,0.944514960024467
Physical measures,X4270.Volume level set by participant (left),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",33421,-0.00150838082759511,0.0217606401329663,-0.044159235488209,0.0411424738330188,0.944738893609223
Physical measures,X4270.Volume level set by participant (left),SAG,S-arrestin,32111,-0.00266269581171561,0.0385503796321332,-0.0782214398906967,0.0728960482672655,0.944935268866304
Physical measures,X4270.Volume level set by participant (left),VAMP5,Vesicle-associated membrane protein 5,33273,-0.00216330806730199,0.0314329812061198,-0.0637719512312969,0.0594453350966929,0.945132171877692
Physical measures,X4270.Volume level set by participant (left),SERPINA5,Plasma serine protease inhibitor,32282,0.00390025104996231,0.0581463546035432,-0.110066603972982,0.117867106072907,0.946522555051942
Physical measures,X4270.Volume level set by participant (left),GNAS,Neuroendocrine secretory protein 55,32350,0.0014140717702343,0.0211391964419388,-0.0400187532559658,0.0428468967964344,0.946668297035445
Physical measures,X4270.Volume level set by participant (left),TTR,Transthyretin,32314,0.00534840170452913,0.0800582083870936,-0.151565686734174,0.162262490143233,0.946737517644015
Physical measures,X4270.Volume level set by participant (left),HMBS,Porphobilinogen deaminase,33509,0.00254453596351717,0.0382072533698992,-0.0723416806414852,0.0774307525685196,0.946903014591091
Physical measures,X4270.Volume level set by participant (left),PTK7,Inactive tyrosine-protein kinase 7,33219,-0.00304127821352423,0.0460804244494949,-0.0933589101345343,0.0872763537074858,0.947379845727873
Physical measures,X4270.Volume level set by participant (left),CTF1,Cardiotrophin-1,33273,0.0013749692984134,0.0209405328790457,-0.0396684751445162,0.0424184137413431,0.947649478659262
Physical measures,X4270.Volume level set by participant (left),HSPB6,Heat shock protein beta-6,33509,0.00305279011012244,0.0469685517060553,-0.0890055712337459,0.0951111514539908,0.948178244978267
Physical measures,X4270.Volume level set by participant (left),JAM2,Junctional adhesion molecule B,33500,0.00437733372839473,0.0680587907693143,-0.129017896179461,0.137772563636251,0.948719279888958
Physical measures,X4270.Volume level set by participant (left),PTGR1,Prostaglandin reductase 1,32365,-0.00159881565544749,0.0251220341206687,-0.0508380025319582,0.0476403712210632,0.949256923082634
Physical measures,X4270.Volume level set by participant (left),CXCL16,C-X-C motif chemokine 16,33505,-0.00466872636219489,0.0740519565229451,-0.149810561147167,0.140473108422777,0.949730764497385
Physical measures,X4270.Volume level set by participant (left),TRIAP1,TP53-regulated inhibitor of apoptosis 1,33509,-0.00175406335324251,0.0279602268232694,-0.0565561079268504,0.0530479812203654,0.94997952277022
Physical measures,X4270.Volume level set by participant (left),RNF43,E3 ubiquitin-protein ligase RNF43,32235,0.00206159843042066,0.0331924492970283,-0.0629956021917547,0.067118799052596,0.950476459428034
Physical measures,X4270.Volume level set by participant (left),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",33421,-0.00117363757326647,0.0189864243218289,-0.0383870292440512,0.0360397540975183,0.950711881755917
Physical measures,X4270.Volume level set by participant (left),ZBTB16,Zinc finger and BTB domain-containing protein 16,33232,-0.00148143903495461,0.0246230869649794,-0.0497426894863143,0.046779811416405,0.952025881792062
Physical measures,X4270.Volume level set by participant (left),CRYM,Ketimine reductase mu-crystallin,32111,-0.00160823398640501,0.0267507449778245,-0.0540396941429411,0.050823226170131,0.95206224955706
Physical measures,X4270.Volume level set by participant (left),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",33386,0.00153634790218391,0.0258732859922579,-0.0491752926426417,0.0522479884470095,0.952651011905712
Physical measures,X4270.Volume level set by participant (left),TLR1,Toll-like receptor 1,32140,0.00448375980725177,0.0755552383601387,-0.14360450737862,0.152572026993124,0.952679556227192
Physical measures,X4270.Volume level set by participant (left),HK2,Hexokinase-2,33273,0.00350774636774032,0.0606623939235054,-0.11539054572233,0.122406038457811,0.953890077263958
Physical measures,X4270.Volume level set by participant (left),BMPER,BMP-binding endothelial regulator protein,32213,0.00505275446521593,0.0897080039329141,-0.170774933243296,0.180880442173728,0.955084787639603
Physical measures,X4270.Volume level set by participant (left),TRIM26,Tripartite motif-containing protein 26,32075,0.00211461267853412,0.0375709260563938,-0.0715244023919977,0.0757536277490659,0.955117662179242
Physical measures,X4270.Volume level set by participant (left),ALCAM,CD166 antigen,33533,-0.00500272480999445,0.0893038418855132,-0.1800382549056,0.170032805285611,0.955327788938528
Physical measures,X4270.Volume level set by participant (left),MAPT,Microtubule-associated protein tau,33219,-0.00185545529325806,0.0332696456724232,-0.0670639608112074,0.0633530502246913,0.955526134258061
Physical measures,X4270.Volume level set by participant (left),CD274,Programmed cell death 1 ligand 1,33380,0.00279378922781286,0.0504535885358163,-0.096095244302387,0.101682822758013,0.955842187203978
Physical measures,X4270.Volume level set by participant (left),GBP6,Guanylate-binding protein 6,32122,0.00235416636343699,0.0429536552424971,-0.0818349979118572,0.0865433306387312,0.95629355181864
Physical measures,X4270.Volume level set by participant (left),FGF23,Fibroblast growth factor 23,33505,-0.00143118457107371,0.0270797477967341,-0.0545074902526725,0.0516451211105251,0.957852003867542
Physical measures,X4270.Volume level set by participant (left),HCG22,Protein PBMUCL2,32122,-0.00198619507614942,0.0377563357659315,-0.0759886131773752,0.0720162230250764,0.958047517489469
Physical measures,X4270.Volume level set by participant (left),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,32365,0.00392071540472174,0.074716607574246,-0.1425238354408,0.150365266250244,0.958151951467498
Physical measures,X4270.Volume level set by participant (left),RELB,Transcription factor RelB,32140,0.0021032142979613,0.0401478420144516,-0.0765865560503639,0.0807929846462865,0.958221906365361
Physical measures,X4270.Volume level set by participant (left),HDGF,Hepatoma-derived growth factor,33492,0.000948245545640709,0.0186324601155267,-0.0355713762807917,0.0374678673720731,0.959412603071877
Physical measures,X4270.Volume level set by participant (left),PPM1A,Protein phosphatase 1A,33232,-0.00266080209421679,0.0536808163269239,-0.107875202094988,0.102553597906554,0.960468497047435
Physical measures,X4270.Volume level set by participant (left),PARP1,Poly [ADP-ribose] polymerase 1,33421,0.00157041082004306,0.0317747120481737,-0.0607080247943773,0.0638488464344635,0.960583068676843
Physical measures,X4270.Volume level set by participant (left),DDX58,Antiviral innate immune response receptor RIG-I,33232,0.00157069000970646,0.0318771865887099,-0.060908595704165,0.0640499757235779,0.960702722533313
Physical measures,X4270.Volume level set by participant (left),DEFB118,Beta-defensin 118,32111,-0.00174401021596038,0.0354028602165505,-0.0711336162403993,0.0676455958084786,0.960711910795587
Physical measures,X4270.Volume level set by participant (left),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,32329,0.000570191096797212,0.0116363830354554,-0.0222371196526953,0.0233775018462898,0.960919968384454
Physical measures,X4270.Volume level set by participant (left),BAMBI,BMP and activin membrane-bound inhibitor homolog,33232,-0.00286751863011167,0.0586853983939089,-0.117890899482173,0.11215586222195,0.961029940089292
Physical measures,X4270.Volume level set by participant (left),SSB,Lupus La protein,33219,0.00142158560290188,0.0293230170216503,-0.0560515277595327,0.0588946989653364,0.961334652146509
Physical measures,X4270.Volume level set by participant (left),PLA2G15,Phospholipase A2 group XV,33456,-0.00322987218665151,0.0666434353188318,-0.133851005411562,0.127391261038259,0.961346755671415
Physical measures,X4270.Volume level set by participant (left),KLHL41,Kelch-like protein 41,32350,0.0019158096385889,0.039953019551756,-0.0763921086828528,0.0802237279600306,0.961756060088171
Physical measures,X4270.Volume level set by participant (left),LGALS1,Galectin-1,33434,-0.00240607380328662,0.0510544344831756,-0.102472765390311,0.0976606177837375,0.962412565190489
Physical measures,X4270.Volume level set by participant (left),SH3GLB2,Endophilin-B2,32353,0.00142806288474138,0.0303637059715435,-0.0580848008194839,0.0609409265889667,0.962488989580898
Physical measures,X4270.Volume level set by participant (left),IL33,Interleukin-33,33273,-0.00210718388936431,0.0450329556242113,-0.0903717769128184,0.0861574091340898,0.96268003236196
Physical measures,X4270.Volume level set by participant (left),SH2B3,SH2B adapter protein 3,33232,-0.00088947308820068,0.0192082950706615,-0.0385377314266971,0.0367587852502958,0.963066838988093
Physical measures,X4270.Volume level set by participant (left),GLRX,Glutaredoxin-1,33385,-0.00137848544475929,0.0299101620940077,-0.0600024031490144,0.0572454322594958,0.963241516890044
Physical measures,X4270.Volume level set by participant (left),APOA2,Apolipoprotein A-II,32381,-0.00192854956712251,0.0419070448470165,-0.0840663574672749,0.0802092583330299,0.963295708811912
Physical measures,X4270.Volume level set by participant (left),GSTM4,Glutathione S-transferase Mu 4,32122,-0.00133980319663748,0.0292376267210854,-0.0586455515699649,0.0559659451766899,0.963451227237704
Physical measures,X4270.Volume level set by participant (left),LAT2,Linker for activation of T-cells family member 2,33386,0.000670410886255326,0.0147424692702087,-0.0282248288833538,0.0295656506558644,0.963729875084414
Physical measures,X4270.Volume level set by participant (left),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,32384,-0.00339706417623392,0.0763152676256577,-0.152974988722523,0.146180860370055,0.964496165010872
Physical measures,X4270.Volume level set by participant (left),AGXT,Serine--pyruvate aminotransferase,33434,0.0010041698669617,0.0227449923188206,-0.0435760150779267,0.0455843548118501,0.964786574116673
Physical measures,X4270.Volume level set by participant (left),TEX101,Testis-expressed protein 101,32154,0.00227796393436105,0.0518381233616474,-0.0993247578544677,0.10388068572319,0.964950344194809
Physical measures,X4270.Volume level set by participant (left),ACVRL1,Serine/threonine-protein kinase receptor R3,33363,0.00311940768833891,0.0732880782210176,-0.140525225624856,0.146764041001533,0.966050330854874
Physical measures,X4270.Volume level set by participant (left),LAMP3,Lysosome-associated membrane glycoprotein 3,33509,0.00143030675840412,0.0339127584873294,-0.0650386998767615,0.0678993133935697,0.966359271721155
Physical measures,X4270.Volume level set by participant (left),CLU,Clusterin,32398,-0.00239363499303242,0.0573620937305736,-0.114823338704957,0.110036068718892,0.966716170825351
Physical measures,X4270.Volume level set by participant (left),OMP,Olfactory marker protein,32111,-0.00170540421845563,0.0410049217831143,-0.0820750509133597,0.0786642424764484,0.966826444597436
Physical measures,X4270.Volume level set by participant (left),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,32075,-0.000992066706339662,0.0239364729233585,-0.0479075536361223,0.045923420223443,0.966941572327422
Physical measures,X4270.Volume level set by participant (left),OSMR,Oncostatin-M-specific receptor subunit beta,33475,-0.00337722499931985,0.0819251508811378,-0.16395052072635,0.15719607072771,0.967118791840837
Physical measures,X4270.Volume level set by participant (left),RCOR1,REST corepressor 1,33273,0.00144635049778269,0.0360801584518462,-0.0692707600678358,0.0721634610634012,0.968024558900658
Physical measures,X4270.Volume level set by participant (left),GPC1,Glypican-1,33509,-0.0023378795033674,0.0583384894081421,-0.116681318743326,0.112005559736591,0.968034701067566
Physical measures,X4270.Volume level set by participant (left),GPHA2,Glycoprotein hormone alpha-2,32329,-0.00158434001989321,0.0399982898352126,-0.0799809880969099,0.0768123080571234,0.968404904395499
Physical measures,X4270.Volume level set by participant (left),IL7,Interleukin-7,33421,-0.00105288719378281,0.0266183839297606,-0.0532249196961137,0.051119145308548,0.968448874141438
Physical measures,X4270.Volume level set by participant (left),XRCC4,DNA repair protein XRCC4,33219,-0.00188776627763694,0.0482910899166765,-0.0965383025143228,0.0927627699590489,0.968818408506904
Physical measures,X4270.Volume level set by participant (left),STX6,Syntaxin-6,33232,-0.000943747587625868,0.0242374656511642,-0.0484491802639077,0.0465616850886559,0.968941062387647
Physical measures,X4270.Volume level set by participant (left),ARNT,Aryl hydrocarbon receptor nuclear translocator,33273,0.00181221824488386,0.0466417467909455,-0.0896056054653693,0.093230041955137,0.969007674257948
Physical measures,X4270.Volume level set by participant (left),IL2,Interleukin-2,33273,0.00215499904059397,0.0559594409187141,-0.107525505160086,0.111835503241274,0.969281916484789
Physical measures,X4270.Volume level set by participant (left),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",32154,-0.00175477759205033,0.0458370921282419,-0.0915954781634045,0.0880859229793039,0.969463103656144
Physical measures,X4270.Volume level set by participant (left),IL3,Interleukin-3,32075,0.00129055272125934,0.034057138511171,-0.0654614387606358,0.0680425442031544,0.969773388226834
Physical measures,X4270.Volume level set by participant (left),CD2AP,CD2-associated protein,33434,0.00102061504777588,0.0279011452524976,-0.0536656296471194,0.0557068597426712,0.97082095649031
Physical measures,X4270.Volume level set by participant (left),STK24,Serine/threonine-protein kinase 24,33219,-0.00104796250774692,0.0288583726564955,-0.0576103729144781,0.0555144478989843,0.971032826038085
Physical measures,X4270.Volume level set by participant (left),ARG2,"Arginase-2, mitochondrial",32319,-0.00160917667293404,0.0448534299424184,-0.0895218993600741,0.086303546014206,0.971381876327816
Physical measures,X4270.Volume level set by participant (left),CRTAM,Cytotoxic and regulatory T-cell molecule,33380,-0.0012331698264357,0.0347983920153023,-0.0694380181764282,0.0669716785235568,0.971731633847402
Physical measures,X4270.Volume level set by participant (left),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,33273,-0.00112147278098758,0.0322244436222287,-0.0642813822805559,0.0620384367185807,0.972238470607356
Physical measures,X4270.Volume level set by participant (left),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,33273,0.00172289148202563,0.0505814263596956,-0.0974167041829777,0.100862487147029,0.97282868737344
Physical measures,X4270.Volume level set by participant (left),CLTA,Clathrin light chain A,33273,-0.00116594558354349,0.0361874711131512,-0.0720933889653199,0.0697614977982329,0.974297660703001
Physical measures,X4270.Volume level set by participant (left),HRAS,GTPase Hras,32212,-0.00064904949123498,0.0205103160004007,-0.0408492688520204,0.0395511698695504,0.974755949627934
Physical measures,X4270.Volume level set by participant (left),APOE,Apolipoprotein E,32398,-0.000828359713777074,0.0262939142286901,-0.0523644316020096,0.0507077121744555,0.974868507764232
Physical measures,X4270.Volume level set by participant (left),ZP3,Zona pellucida sperm-binding protein 3,32163,-0.000243824506523282,0.00788504605569821,-0.0156985147756918,0.0152108657626452,0.975332230650416
Physical measures,X4270.Volume level set by participant (left),MUC16,Mucin-16,33386,0.000282998576770628,0.0092894772750165,-0.0179243768822617,0.018490374035803,0.975697346258935
Physical measures,X4270.Volume level set by participant (left),PER3,Period circadian protein homolog 3,32140,-0.000514013867675758,0.0170376463776216,-0.033907800767814,0.0328797730324625,0.975932815715439
Physical measures,X4270.Volume level set by participant (left),DGKZ,Diacylglycerol kinase zeta,33273,-0.00150580296899535,0.0499851587778422,-0.099476714173566,0.0964651082355753,0.975968043443607
Physical measures,X4270.Volume level set by participant (left),SAA4,Serum amyloid A-4 protein,32398,0.00180830293421116,0.0607394953784068,-0.117241108007466,0.120857713875888,0.976250075124068
Physical measures,X4270.Volume level set by participant (left),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,33480,0.000933429081035198,0.0314286782606934,-0.0606667803099239,0.0625336384719943,0.976307036216564
Physical measures,X4270.Volume level set by participant (left),CCL22,C-C motif chemokine 22,33318,-0.000988619148467719,0.0341376896032099,-0.0678984907707592,0.0659212524738238,0.976897339514719
Physical measures,X4270.Volume level set by participant (left),ARG1,Arginase-1,33407,0.000952133068918278,0.0334242688233324,-0.0645594338248132,0.0664636999626497,0.977274945828293
Physical measures,X4270.Volume level set by participant (left),CDH4,Cadherin-4,32111,-0.0012371437985906,0.0435794797795289,-0.0866529241664672,0.084178636569286,0.977353260527314
Physical measures,X4270.Volume level set by participant (left),ITGBL1,Integrin beta-like protein 1,32384,-0.00161933237749565,0.0570729863135603,-0.113482385552074,0.110243720797082,0.977365364966252
Physical measures,X4270.Volume level set by participant (left),IFNW1,Interferon omega-1,32122,-0.00166279501974467,0.0587078836311681,-0.116730246936834,0.113404656897345,0.977405115753251
Physical measures,X4270.Volume level set by participant (left),HLA_DRA,,33400,0.00135382462839009,0.0479162098363915,-0.0925619466509373,0.0952695959077175,0.97746019832573
Physical measures,X4270.Volume level set by participant (left),SLC4A1,Band 3 anion transport protein,32384,-0.00108911175436688,0.0389204521615115,-0.0773731979909293,0.0751949744821956,0.977676398914572
Physical measures,X4270.Volume level set by participant (left),ARAF,Serine/threonine-protein kinase A-Raf,32235,0.000753463255183568,0.0299310131476816,-0.0579113225142723,0.0594182490246394,0.979917355828959
Physical measures,X4270.Volume level set by participant (left),MSR1,Macrophage scavenger receptor types I and II,33500,0.00093904008093426,0.0382955330073514,-0.0741202046134745,0.075998284775343,0.980437671651367
Physical measures,X4270.Volume level set by participant (left),LACRT,Extracellular glycoprotein lacritin,32305,-0.000920284251538398,0.0378618292895896,-0.0751294696591341,0.0732889011560573,0.980608836853453
Physical measures,X4270.Volume level set by participant (left),THRAP3,Thyroid hormone receptor-associated protein 3,32122,-0.000412007692097872,0.0169789397184777,-0.0336907295403142,0.0328667141561185,0.9806412178143
Physical measures,X4270.Volume level set by participant (left),EPHA2,Ephrin type-A receptor 2,33133,-0.00140626142505024,0.0596100050975942,-0.118241871416335,0.115429348566234,0.981179369500476
Physical measures,X4270.Volume level set by participant (left),ITGAX,Integrin alpha-X,32235,0.000872861254108029,0.0372711598472676,-0.0721786120465364,0.0739243345547525,0.98131647956025
Physical measures,X4270.Volume level set by participant (left),FGFBP1,Fibroblast growth factor-binding protein 1,33456,0.00121412805512032,0.054372326972985,-0.10535563281193,0.107783888922171,0.982185301389947
Physical measures,X4270.Volume level set by participant (left),TMED10,Transmembrane emp24 domain-containing protein 10,32122,-0.000877326007701924,0.0403303347139172,-0.0799247820469796,0.0781701300315757,0.982645151691467
Physical measures,X4270.Volume level set by participant (left),EPGN,Epigen,32319,0.000839917387573216,0.0393866882765108,-0.0763579916343879,0.0780378264095343,0.982987018023384
Physical measures,X4270.Volume level set by participant (left),ALDH1A1,Retinal dehydrogenase 1,33441,0.000606594590474323,0.0312882882755953,-0.0607184504296926,0.0619316396106412,0.984532593508616
Physical measures,X4270.Volume level set by participant (left),EFNA4,Ephrin-A4,33363,0.00119757146998929,0.0620162121108617,-0.1203542042673,0.122749347207278,0.98459374492115
Physical measures,X4270.Volume level set by participant (left),CA5A,"Carbonic anhydrase 5A, mitochondrial",33273,0.000372084642718229,0.0194450473521321,-0.0377402081674607,0.0384843774528972,0.984733693282581
Physical measures,X4270.Volume level set by participant (left),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,32163,-0.000805491852440314,0.0436963452776627,-0.0864503285966593,0.0848393448917787,0.985293226144667
Physical measures,X4270.Volume level set by participant (left),CD70,CD70 antigen,33421,0.000751647033516539,0.0410468996929852,-0.0797002763647344,0.0812035704317675,0.985390435643727
Physical measures,X4270.Volume level set by participant (left),ZP4,Zona pellucida sperm-binding protein 4,32075,-0.00107110971781723,0.0586850574073668,-0.116093822236256,0.113951602800622,0.98543843264409
Physical measures,X4270.Volume level set by participant (left),MYL3,Myosin light chain 3,32163,0.000499090656927918,0.0294310813955091,-0.0571858288782699,0.0581840101921257,0.986470604945051
Physical measures,X4270.Volume level set by participant (left),SCGN,Secretagogin,33273,-0.000676998067884264,0.0401280285105106,-0.079327933948485,0.0779739378127165,0.986539947602038
Physical measures,X4270.Volume level set by participant (left),ERC2,ERC protein 2,32154,0.000449996815934006,0.0267166291212425,-0.0519145962617014,0.0528145898935694,0.986562044413747
Physical measures,X4270.Volume level set by participant (left),TPR,Nucleoprotein TPR,32122,0.000722439692929359,0.0437225477713986,-0.0849737539390118,0.0864186333248705,0.986817363565583
Physical measures,X4270.Volume level set by participant (left),MAMDC2,MAM domain-containing protein 2,32365,-0.000951386407224939,0.0578011691759974,-0.11424167799218,0.11233890517773,0.986868115859095
Physical measures,X4270.Volume level set by participant (left),CD40LG,CD40 ligand,33527,-0.000340033139199961,0.0224825140872294,-0.0444057607501696,0.0437256944717697,0.987933316950544
Physical measures,X4270.Volume level set by participant (left),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",32122,0.000676732138715896,0.0451073327755199,-0.0877336401013032,0.089087104378735,0.988030410378463
Physical measures,X4270.Volume level set by participant (left),CNTF,Ciliary neurotrophic factor,32111,0.000839005244876748,0.0596473658851186,-0.116069831889956,0.117747842379709,0.988777620174389
Physical measures,X4270.Volume level set by participant (left),CLPS,Colipase,33422,-0.000355154148697946,0.0252713578974359,-0.0498870156276722,0.0491767073302764,0.988787512549663
Physical measures,X4270.Volume level set by participant (left),ATXN10,Ataxin-10,33219,-0.000333758190985668,0.0253742913236972,-0.0500673691854322,0.0493998528034609,0.989505707623884
Physical measures,X4270.Volume level set by participant (left),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",32075,-0.000480518157033878,0.0369933253294085,-0.0729874358026746,0.0720263994886069,0.989636653242077
Physical measures,X4270.Volume level set by participant (left),KIAA1549,UPF0606 protein KIAA1549,32235,0.000371085487701555,0.0288450437722228,-0.0561652003058551,0.0569073712812582,0.989735994095707
Physical measures,X4270.Volume level set by participant (left),TIMP1,Metalloproteinase inhibitor 1,33290,0.000783640392329777,0.0644065838862399,-0.1254532640247,0.12702054480936,0.990292584820189
Physical measures,X4270.Volume level set by participant (left),TREH,Trehalase,32384,0.000314057017645166,0.026502608957911,-0.0516310565398605,0.0522591705751508,0.990545554201214
Physical measures,X4270.Volume level set by participant (left),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,33386,0.00040721193681285,0.0352632785125271,-0.0687088139477403,0.069523237821366,0.990786681935206
Physical measures,X4270.Volume level set by participant (left),SAP18,Histone deacetylase complex subunit SAP18,32235,0.000321411783665274,0.0283771184398464,-0.0552977403584336,0.0559405639257641,0.990963290504989
Physical measures,X4270.Volume level set by participant (left),IMPG1,Interphotoreceptor matrix proteoglycan 1,32111,0.000671567357243788,0.0708731196919281,-0.138239747238935,0.139582881953423,0.992439902291156
Physical measures,X4270.Volume level set by participant (left),FUT8,"Alpha-(1,6)-fucosyltransferase",33380,-0.000279249989444197,0.0301857592315437,-0.0594433380832698,0.0588848381043814,0.992619041512133
Physical measures,X4270.Volume level set by participant (left),LPCAT2,Lysophosphatidylcholine acyltransferase 2,33386,0.000408792759121424,0.0445959338867806,-0.0869992376589686,0.0878168231772114,0.992686424425332
Physical measures,X4270.Volume level set by participant (left),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,33355,0.00026451957191377,0.0290143588485568,-0.0566036237712576,0.0571326629150852,0.992726110848423
Physical measures,X4270.Volume level set by participant (left),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,32123,0.000443008467020394,0.0524929586645998,-0.102443190515595,0.103329207449636,0.993266641757327
Physical measures,X4270.Volume level set by participant (left),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",32329,0.000150633303545646,0.0203420393241464,-0.0397197637717812,0.0400210303788725,0.994091886712554
Physical measures,X4270.Volume level set by participant (left),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,32111,-0.000467869888227861,0.0636641286689956,-0.125249562079459,0.124313822303004,0.994136562963736
Physical measures,X4270.Volume level set by participant (left),IFNL2,Interferon lambda-2,32111,-0.000219575687854792,0.0307827163828316,-0.0605536997982048,0.0601145484224952,0.994308856876532
Physical measures,X4270.Volume level set by participant (left),CCT5,T-complex protein 1 subunit epsilon,33232,0.00024780329530513,0.0351970345151376,-0.0687383843543646,0.0692339909449749,0.994382732495041
Physical measures,X4270.Volume level set by participant (left),NFKBIE,NF-kappa-B inhibitor epsilon,33232,-0.000259781040421437,0.0370747447996398,-0.0729262808477155,0.0724067187668727,0.994409464384256
Physical measures,X4270.Volume level set by participant (left),RBPMS,RNA-binding protein with multiple splicing,32140,0.000193441838395202,0.0284756356887131,-0.0556188041114825,0.0560056877882729,0.994579996392152
Physical measures,X4270.Volume level set by participant (left),MVK,Mevalonate kinase,33273,-0.000120294456998092,0.0234950297689195,-0.0461705528040803,0.0459299638900841,0.995914967956164
Physical measures,X4270.Volume level set by participant (left),BCL7A,B-cell CLL/lymphoma 7 protein family member A,32075,0.000130404019890829,0.0304269274853284,-0.0595063738513529,0.0597671818911346,0.996580541296533
Physical measures,X4270.Volume level set by participant (left),HDAC8,Histone deacetylase 8,32140,0.000131500611194818,0.0321791352808075,-0.0629396045391879,0.0632026057615776,0.996739545631793
Physical measures,X4270.Volume level set by participant (left),DGCR6,Protein DGCR6,32111,0.000164308482923666,0.0475123200954283,-0.0929598389041158,0.0932884558699631,0.99724082807838
Physical measures,X4270.Volume level set by participant (left),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,32075,-0.000104537522037912,0.0303224708072994,-0.0595365803043447,0.0593275052602689,0.997249367517548
Physical measures,X4270.Volume level set by participant (left),RPGR,X-linked retinitis pigmentosa GTPase regulator,32154,-0.000126973581807057,0.0497762038307268,-0.0976883330900317,0.0974343859264175,0.997964753171053
Physical measures,X4270.Volume level set by participant (left),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,32122,7.38630195435859e-05,0.0414602044341873,-0.0811881376714635,0.0813358637105506,0.998578583707365
Physical measures,X4270.Volume level set by participant (left),TNN,Tenascin-N,32384,7.48894293998336e-05,0.0446168916912303,-0.0873742182854115,0.0875239971442111,0.998660794035971
Physical measures,X4270.Volume level set by participant (left),GDNF,Glial cell line-derived neurotrophic factor,33219,-5.5307785601729e-05,0.046095155781117,-0.090401813116591,0.0902911975453875,0.999042676869542
Physical measures,X4270.Volume level set by participant (left),DLK1,Protein delta homolog 1,33533,-2.93898238233193e-05,0.0325732319929326,-0.0638729245299711,0.0638141448823245,0.999280113262265
Physical measures,X4270.Volume level set by participant (left),ICAM1,Intercellular adhesion molecule 1,33347,-3.45295733354773e-05,0.0616810539077821,-0.120929395232588,0.120860336085917,0.999553350085773
Physical measures,X4270.Volume level set by participant (left),CTLA4,Cytotoxic T-lymphocyte protein 4,32384,-1.39286976321358e-05,0.0682309813413469,-0.133746652126672,0.133718794731408,0.999837124688871
Physical measures,X4270.Volume level set by participant (left),QSOX1,Sulfhydryl oxidase 1,32219,-8.72628133908692e-06,0.0452328079715288,-0.0886650299055355,0.0886475773428573,0.999846077631869
Physical measures,X4270.Volume level set by participant (left),AMIGO1,Amphoterin-induced protein 1,32154,-1.86453485261632e-06,0.0393013708889161,-0.0770325514771281,0.0770288224074229,0.99996214800576
